data_2o3d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2o3d _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.829 0.347 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.06 144.89 31.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.18 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.33 165.14 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 143.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.75 152.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.5 p -143.07 123.08 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.51 41.53 0.23 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.344 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.29 144.17 37.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.89 170.68 19.85 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.555 2.17 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.49 -26.25 70.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.62 2.213 . . . . 0.0 112.191 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -124.49 74.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.77 167.97 24.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -146.39 167.93 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.5 p-90 -65.7 -42.16 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 29.7 tp60 -58.77 -36.23 74.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -73.49 -29.7 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.92 -42.45 66.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.748 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.978 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.78 -26.85 58.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.233 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.43 -41.16 14.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -22.87 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -46.12 -29.9 1.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.246 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -30.4 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.85 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.04 -134.41 3.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.405 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -103.97 103.86 13.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.85 141.93 15.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.3 p -112.29 -29.32 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -154.71 147.36 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.35 127.26 6.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.13 153.64 51.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.1 124.72 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.269 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -82.71 154.99 24.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.33 -33.63 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.52 -30.34 2.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.627 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -95.32 160.63 14.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -138.46 -166.26 10.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.576 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -155.6 145.51 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.9 150.15 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.22 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.85 136.6 47.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.774 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -116.92 160.3 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.08 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.98 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.801 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -25.69 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -47.05 58.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.28 -28.0 62.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 10.9 ttp -67.0 -62.91 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 172' ' ' VAL . 67.0 m -58.96 -32.92 70.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.029 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -64.98 -44.64 88.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -65.59 -48.16 73.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.894 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 11.0 m -65.14 -22.12 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -93.13 -75.45 0.49 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.076 0.465 . . . . 0.0 111.189 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -40.95 95.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 29.0 mt -89.58 23.84 2.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 38.4 t70 -83.65 131.22 34.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.73 61.63 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 p -113.27 146.67 38.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.744 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.21 112.12 8.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -80.85 148.4 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 126.5 46.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.9 p -97.01 146.0 25.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -55.92 -22.94 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -23.12 63.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.96 30.75 4.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -130.19 133.09 46.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.91 161.0 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.23 130.21 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -70.94 114.38 8.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.0 pt -116.74 151.24 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -131.36 135.37 47.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.35 148.22 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.237 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 140.12 16.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.8 t -70.25 118.58 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.203 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.156 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -131.38 133.45 45.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.8 165.16 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.085 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.27 146.27 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.37 144.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -137.97 125.5 22.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.43 40.28 2.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.27 153.58 92.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.27 169.51 20.56 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -27.28 24.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.577 2.185 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -143.03 127.06 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.4 162.72 24.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.81 153.42 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.414 ' CZ2' ' HG3' ' A' ' 135' ' ' GLN . 42.8 p-90 -74.0 -30.07 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 50.8 mt-30 -58.99 -42.99 91.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -77.15 -21.39 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.926 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 180' ' ' PHE . 29.9 tp -70.17 -47.11 63.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.936 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -40.7 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.406 ' HA ' ' HG3' ' A' ' 142' ' ' ARG . 4.5 m-20 -65.96 -26.65 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.81 -31.9 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -93.16 -2.82 54.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 4.0 mmm-85 -62.67 -15.87 54.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.476 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.74 -31.59 11.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.824 0.345 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 175' ' ' LEU . . . -68.38 -31.41 70.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.513 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.94 -98.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.94 156.39 46.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 75.0 t -126.82 149.4 31.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.5 t -117.33 -52.3 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -128.78 149.62 50.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.71 134.57 11.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.026 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.15 134.66 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.33 118.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -103.46 131.66 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.0 mtm105 -62.34 96.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -171.45 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 137.53 37.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.74 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.8 p -166.05 172.36 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.46 173.42 36.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.7 134.26 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.28 127.2 22.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -98.17 108.37 21.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.51 156.76 32.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.13 -67.33 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 144.97 24.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.83 -40.58 97.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.77 -42.62 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -31.83 69.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.5 ttp -67.22 -62.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.418 ' HA ' HG21 ' A' ' 172' ' ' VAL . 98.9 m -53.24 -32.73 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.77 -46.95 85.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.482 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -59.16 -47.55 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.574 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.418 HG21 ' HA ' ' A' ' 169' ' ' THR . 16.2 m -63.29 -22.64 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.026 0.441 . . . . 0.0 110.793 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -85.59 -71.93 0.51 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.268 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -78.68 -36.76 43.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.035 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 76.1 mt -90.51 47.69 1.46 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -108.88 127.33 53.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.831 0.348 . . . . 0.0 110.679 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.9 31.55 18.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -171.92 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -111.15 118.13 35.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.407 ' CD1' HD12 ' A' ' 137' ' ' LEU . 10.8 t80 -97.41 135.06 39.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -122.17 117.36 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.7 p -80.13 149.61 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -54.74 -23.72 19.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -73.72 -23.07 59.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.984 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.17 5.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.86 110.34 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.83 154.41 20.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.001 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.89 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.55 129.74 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.62 143.27 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.291 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -109.95 122.25 47.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.06 151.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.63 169.22 25.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.44 118.97 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.765 0.317 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.58 142.31 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.658 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.2 m -106.96 165.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.63 140.1 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -106.38 140.23 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.56 120.27 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.62 1.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.414 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.51 150.05 84.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 171.02 16.45 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.257 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 -32.59 21.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.589 2.193 . . . . 0.0 112.276 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 t -123.89 115.51 21.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.54 177.05 48.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.22 -175.53 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 32.0 p-90 -67.59 -42.2 82.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.856 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.3 OUTLIER -59.74 -50.57 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.723 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.29 -37.39 85.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.652 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.28 -45.57 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.33 68.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.392 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.21 12.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 30.4 mmm -76.87 -25.57 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -25.27 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.321 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -23.73 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.312 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.15 -26.45 66.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.658 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.79 -65.61 0.34 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.39 125.62 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.074 0.464 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.7 t -101.02 146.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.23 -29.66 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.211 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 56.5 t80 -154.76 160.05 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 111.211 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -157.04 177.33 11.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.85 156.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.97 147.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -123.98 109.23 13.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 mtt85 55.55 -87.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -176.24 36.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 110.93 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.6 -44.59 0.5 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.439 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.4 p -156.67 161.09 39.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.71 -157.48 7.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.573 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.5 m -156.09 142.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.22 119.88 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -104.35 123.25 47.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 23.0 m-85 -99.41 167.57 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.27 -69.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.86 163.92 13.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -26.1 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -57.16 -41.49 79.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -30.06 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.412 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 4.6 ttp -61.01 -63.72 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.425 ' HA ' HG22 ' A' ' 172' ' ' VAL . 97.9 m -57.52 -35.53 70.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.071 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 21.0 t80 -62.56 -47.3 84.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.45 . . . . 0.0 110.653 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.86 84.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.809 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 25.6 m -61.64 -22.75 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.546 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -76.49 0.55 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 8.6 mmtt -58.08 -42.6 85.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.623 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.63 36.16 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.207 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 11.9 t0 -94.51 120.07 34.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.642 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 61.81 66.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.6 p -115.75 170.02 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 131.67 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -109.67 145.27 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.89 116.36 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.99 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -88.7 155.7 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -54.54 -22.69 13.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -19.25 61.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.29 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.732 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.9 150.28 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.21 154.98 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.999 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 172.07 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.262 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -106.45 120.12 41.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.59 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 pt -106.31 145.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -118.99 124.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 172' ' ' VAL . 15.0 t -95.6 141.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.264 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 147.82 26.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.44 116.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 t0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.215 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 170.01 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.152 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.5 p -130.49 160.72 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.447 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 14.3 p -122.26 143.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.03 159.12 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.26 170.91 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.45 44.37 93.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.48 155.23 78.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.735 0.302 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 171.71 11.55 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 112.405 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.12 -26.62 73.03 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.613 2.209 . . . . 0.0 112.346 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -135.9 122.14 20.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.63 -172.72 33.37 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.2 p -172.62 -177.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 44.7 p-90 -59.94 -37.47 79.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 21.6 tt0 -70.38 -32.05 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -68.93 -50.32 50.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.3 tp -67.6 -44.85 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -40.38 63.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -61.14 -26.73 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.236 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -86.72 -43.6 12.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 77.6 mmm -69.51 -26.32 64.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.705 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -45.31 -33.14 2.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.268 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.36 -33.82 63.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.03 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.99 -140.22 6.87 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.511 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 128.99 39.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.72 127.07 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.95 -26.23 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 35.4 t80 -151.73 153.87 35.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.399 . . . . 0.0 111.311 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.429 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.07 149.04 11.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.915 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.51 124.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.01 142.51 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.035 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.96 155.12 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -72.5 -10.95 60.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.397 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.59 -23.18 66.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.25 24.43 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.616 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.4 p -155.54 160.26 40.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.26 -175.79 25.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 162' ' ' PHE . 12.5 t -127.61 133.44 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.3 118.59 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.435 ' CE1' HG11 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -114.62 139.32 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.627 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 6.4 p -71.18 65.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.926 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER 178.81 125.51 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -72.11 -44.84 62.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.546 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.42 -27.79 68.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.668 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.15 -40.59 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.407 ' HE3' ' N ' ' A' ' 169' ' ' THR . 2.0 ttp -59.65 -59.22 5.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.424 ' HA ' HG22 ' A' ' 172' ' ' VAL . 96.9 m -58.35 -36.44 73.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.357 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -62.89 -45.14 93.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -63.64 -44.9 92.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 169' ' ' THR . 24.0 m -71.87 -22.38 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.707 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.31 -26.53 15.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.602 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -110.71 -60.81 1.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.4 mt -63.08 -15.82 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 16.6 p-10 -64.1 159.26 20.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 50.18 58.6 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.196 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.1 p -140.51 164.01 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.978 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -87.96 123.59 32.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -99.25 149.78 22.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 142.46 50.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.5 p -95.56 151.51 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -52.98 -23.97 8.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.79 -22.3 53.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.08 26.68 5.65 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.549 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -107.88 115.62 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.04 152.16 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 135.25 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 135.62 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -131.25 161.43 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.374 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -127.7 128.42 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.637 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 t -111.48 142.95 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.318 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -165.17 141.04 5.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.05 113.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -143.59 142.63 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.4 p -104.25 159.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.439 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 8.6 p -118.98 152.66 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.25 148.67 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.2 127.98 20.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.798 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.55 -0.65 6.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.924 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.78 151.44 32.03 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.817 0.341 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.57 171.86 10.11 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.158 . . . . 0.0 112.161 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.02 -25.63 51.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.424 2.083 . . . . 0.0 112.4 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 125.52 15.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -170.37 -179.63 41.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.4 m -130.8 149.48 52.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.737 0.303 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -63.59 -33.38 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.26 -31.69 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.0 -50.3 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 23.1 tp -60.23 -45.81 91.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -57.43 -39.95 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.041 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.97 -26.96 61.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.489 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -91.19 -22.74 20.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.466 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.423 ' CE ' ' CZ ' ' A' ' 162' ' ' PHE . 4.0 ppp? -99.58 -12.77 19.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.574 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -52.72 -24.92 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.748 0.308 . . . . 0.0 111.446 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -24.4 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -28.18 68.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.562 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 -129.9 2.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.363 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -103.19 108.59 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.067 0.46 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 p -106.12 139.92 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.127 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.24 -40.42 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.405 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 161' ' ' GLU . 7.8 t80 -117.83 145.17 44.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -162.97 133.18 4.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.58 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.63 141.48 48.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.965 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.96 114.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.024 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -85.57 143.78 28.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -73.84 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.42 -49.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.65 -26.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.3 p -106.77 164.26 12.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 111.008 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.68 -175.91 20.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.53 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.6 m -143.42 154.48 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.777 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.32 150.28 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 149' ' ' TYR . 0.9 OUTLIER -132.18 116.22 16.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.788 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.423 ' CZ ' ' CE ' ' A' ' 141' ' ' MET . 5.3 m-85 -92.68 173.78 7.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.59 -70.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 157.92 16.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -32.08 63.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -55.34 -39.99 70.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.12 -30.65 66.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.423 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 7.0 ttp -70.49 -63.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.4 m -53.14 -34.07 55.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.021 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.78 -48.31 79.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.515 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.79 -50.66 69.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.245 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.0 m -62.64 -25.95 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -72.23 0.42 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -56.1 6.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.118 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 46.8 mt -77.19 72.74 3.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.846 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -133.46 120.94 21.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.9 t30 62.04 39.51 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.713 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -92.31 179.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.937 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.472 ' N ' ' OG1' ' A' ' 178' ' ' THR . 6.6 tttp -98.94 125.99 44.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.9 t80 -103.63 143.41 32.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.726 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.39 116.91 26.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.82 152.87 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -68.52 -14.22 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.253 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.83 -23.1 64.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.284 . . . . 0.0 111.112 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.82 31.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.513 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -139.3 144.11 38.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.358 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 154.65 26.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.9 147.61 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.202 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.05 146.05 28.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 29.8 pt -136.4 145.69 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 127.99 54.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.9 t -103.7 143.47 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -161.31 144.49 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.32 113.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 t0 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.98 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' A' ' 165' ' ' LYS . 25.0 t-20 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.751 0.31 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -117.72 150.27 39.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.5 p -133.95 159.98 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.446 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 9.8 p -124.04 147.83 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.13 157.8 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.8 t -161.18 123.36 3.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.09 39.48 0.64 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.95 154.84 45.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.672 0.272 . . . . 0.0 110.758 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.98 166.24 3.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 0.0 112.21 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.74 -27.55 20.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.678 2.252 . . . . 0.0 112.484 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 129.46 15.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.09 -163.68 13.99 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -153.01 162.55 41.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -74.12 -39.18 63.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -36.91 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -36.0 66.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.455 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 22.8 tp -63.17 -45.14 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -28.12 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.186 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -67.07 -26.7 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.29 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 180' ' ' PHE . 6.6 m80 -96.26 -27.95 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.304 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.6 mmm -83.58 -26.28 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.248 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.5 -27.57 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.426 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -53.69 -22.52 9.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.51 66.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 0.0 110.64 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.5 -59.58 0.36 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.369 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -174.38 107.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.7 t -88.67 132.05 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.52 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -133.35 145.26 50.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.75 133.94 6.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.12 152.21 48.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.39 107.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.68 100.69 6.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 64.15 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -179.13 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.04 10.86 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.062 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 p -157.63 174.54 15.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.86 -166.22 19.18 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.414 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.86 159.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 111.016 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.42 145.25 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.09 137.09 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.706 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -113.56 175.67 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.66 -70.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.83 157.97 15.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.405 ' HA ' ' ND2' ' A' ' 121' ' ' ASN . 2.0 tptm -58.14 -29.16 65.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.54 -34.95 76.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.9 -38.48 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.5 ttp -70.79 -62.23 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.403 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 92.5 m -53.38 -36.81 61.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 28.4 t80 -63.79 -46.54 84.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -54.9 -46.14 74.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 169' ' ' THR . 15.9 m -68.91 -23.03 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -87.01 -67.2 0.83 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.975 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 1.5 mptp? -76.81 -48.38 18.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.736 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 52.3 mt -84.49 58.48 4.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -117.84 129.84 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.739 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.16 39.44 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.708 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.2 p -81.37 177.61 8.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.94 99.25 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.0 t80 -88.72 152.67 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.89 140.05 40.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.21 155.05 22.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.637 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -53.03 -22.83 6.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -75.73 -21.07 57.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 20.84 8.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.771 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 116.19 32.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.733 0.301 . . . . 0.0 110.715 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 156.94 18.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.1 166.04 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.25 119.58 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.9 pt -108.32 141.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.98 0.419 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -106.38 128.63 54.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.76 142.89 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.084 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.96 140.84 8.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.3 110.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.4 p30 . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.61 0.243 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 119.96 25.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.6 p -102.62 160.12 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.448 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 11.6 p -120.46 143.71 31.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.99 158.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.4 p -146.75 146.42 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.29 46.14 2.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.559 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.61 145.48 37.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.639 0.257 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.92 170.67 19.15 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.381 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.71 -27.47 52.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 31.08 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.72 118.76 5.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.03 168.91 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 58.6 p-90 -62.59 -41.75 99.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -61.58 -33.73 74.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.03 -38.39 52.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.202 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.84 -44.3 32.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.273 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -53.19 -39.71 63.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -71.63 -26.7 62.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.621 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -26.01 20.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.422 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.429 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 3.3 ppp? -97.01 -10.25 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -18.78 30.89 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.516 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.93 -25.79 3.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.57 -27.42 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.745 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.54 -125.87 1.79 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.457 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.459 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.94 130.94 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.047 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 -29.44 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -163.28 146.95 10.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.97 136.64 19.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -152.07 125.11 8.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.88 131.49 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -98.24 155.01 17.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -10.18 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.411 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -29.0 70.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.45 36.46 0.64 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.592 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.7 p -160.3 160.77 32.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.849 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -149.97 176.78 28.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.576 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.3 m -147.69 146.87 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.324 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.66 147.78 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.08 126.14 33.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.429 ' CZ ' ' HE3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -104.98 166.9 10.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.59 -72.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 151.05 24.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.99 -27.53 5.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.246 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -53.98 -44.16 70.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -30.07 64.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.428 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.1 ttp -65.03 -63.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.1 m -57.69 -34.04 69.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.51 80.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.616 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.415 HG22 ' HD2' ' A' ' 173' ' ' ARG . 4.5 m -65.22 -24.81 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 172' ' ' VAL . 0.0 OUTLIER -76.74 -73.05 0.31 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.233 0.539 . . . . 0.0 110.296 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -58.26 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -77.27 81.52 3.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.45 138.57 19.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.49 46.64 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -109.83 173.25 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.426 ' HD3' ' CD1' ' A' ' 189' ' ' TYR . 0.3 OUTLIER -105.32 103.37 12.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.93 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -68.89 120.17 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.54 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.24 100.8 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.532 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.05 136.87 56.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -59.37 -19.83 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.187 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -68.77 -17.48 64.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.258 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.99 31.04 3.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.56 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -131.74 138.5 48.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.06 156.8 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 138.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.426 ' CD1' ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -79.21 128.77 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.14 140.77 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.371 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -112.7 134.94 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.62 141.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.362 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 123' ' ' VAL . 39.8 mttp -153.34 137.87 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.06 115.38 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.175 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.803 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.901 0.382 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -123.42 121.95 37.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.849 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.97 161.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.38 140.7 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -120.1 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.0 p -111.71 132.99 54.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.58 35.85 0.96 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.88 153.52 52.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 161.74 44.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.477 2.118 . . . . 0.0 112.301 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 -31.43 20.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 90.57 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.63 -163.34 11.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.59 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 170.72 20.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -60.29 -44.25 95.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.797 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -60.47 -31.64 70.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -53.22 60.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.0 -40.16 88.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -39.66 89.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.98 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -87.99 -35.11 17.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.31 -25.21 62.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.4 mtt-85 -46.77 -30.2 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -30.36 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.51 -27.42 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 151.15 -100.43 0.2 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -131.1 111.05 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.961 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.17 151.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 40.7 t -112.7 -31.82 6.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -165.59 150.41 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.95 173.37 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -176.9 135.01 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.56 101.19 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 19.2 p90 -124.12 155.84 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 0.2 OUTLIER 89.38 -4.98 0.4 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.355 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 63.14 31.53 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.94 -45.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.3 p -104.84 160.1 15.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.375 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.06 -179.32 33.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.265 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.6 p -146.07 159.52 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.222 0.534 . . . . 0.0 111.208 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 46.0 t -154.74 141.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.2 125.47 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.37 177.13 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.86 -69.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -88.36 149.84 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -61.33 -34.19 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.58 -33.44 72.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.73 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.18 -37.93 69.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.526 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.47 -63.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.409 ' HA ' HG23 ' A' ' 172' ' ' VAL . 53.9 m -53.73 -31.46 48.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 4.3 t80 -60.43 -50.51 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.244 0.545 . . . . 0.0 110.12 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 175' ' ' LEU . . . -57.55 -53.87 53.27 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' A' ' 169' ' ' THR . 13.9 m -54.82 -22.71 10.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.351 . . . . 0.0 111.752 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -71.75 0.69 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.042 0.449 . . . . 0.0 112.111 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -67.74 -45.55 74.65 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 175' ' ' LEU . 0.1 OUTLIER -123.31 84.16 2.23 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.826 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 176' ' ' ASP . 2.4 p-10 -129.51 -102.03 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.321 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 190' ' ' ILE . 10.3 t-20 -67.62 56.28 0.06 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.467 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -109.39 -167.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -91.36 140.98 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -118.67 133.3 55.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -123.27 119.12 29.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.9 t -79.11 149.83 31.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -55.39 -23.46 24.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.22 -23.0 63.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.13 28.83 4.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.0 136.77 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.69 156.22 18.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.52 168.31 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.43 109.98 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 21.6 pt -102.1 158.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 177' ' ' ASN . 1.2 tmm_? -139.08 117.36 11.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.6 151.45 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.9 144.03 6.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.31 119.71 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.17 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.6 t0 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.926 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.765 0.317 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -79.92 158.07 26.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.7 p -144.18 160.01 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 10.7 p -123.2 141.07 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.09 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 155.61 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.0 t -145.46 138.46 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.89 37.0 3.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.33 152.98 92.25 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.76 171.84 10.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.313 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.99 -28.49 80.7 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.638 2.225 . . . . 0.0 112.249 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m -122.24 -80.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.38 -168.67 0.31 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.806 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 m -164.5 156.23 15.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 44.8 p-90 -59.26 -44.6 92.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -67.5 -32.89 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.603 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.19 -45.32 77.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.421 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 59.7 tp -59.67 -43.84 93.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -37.93 64.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.956 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -64.42 -26.72 68.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.215 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -84.75 -37.51 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.4 mmm -75.85 -20.34 58.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.661 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -43.3 -31.83 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.354 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -34.33 25.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.87 -29.68 66.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.8 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.22 -129.04 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.383 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.29 136.93 37.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 162' ' ' PHE . 92.4 t -115.54 121.37 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.957 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.02 -42.53 16.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.058 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 52.3 t80 -142.98 158.45 43.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -162.99 139.94 7.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.49 161.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.57 133.08 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.85 155.64 37.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.704 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -33.13 -42.78 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.935 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 174.01 65.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.886 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.73 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.814 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.9 p -141.3 -177.13 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.67 176.71 33.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.463 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 126.93 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.66 144.32 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.03 106.92 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.82 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 147' ' ' VAL . 80.4 m-85 -87.53 141.6 28.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.33 -28.62 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -120.0 147.94 44.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -72.1 -32.85 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -60.48 -31.78 70.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -71.66 -35.89 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.639 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.2 ttp -67.97 -62.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.3 m -53.4 -32.24 48.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.465 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 3.1 t80 -61.35 -50.43 72.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.223 0.535 . . . . 0.0 110.076 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 175' ' ' LEU . . . -55.02 -54.1 47.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 169' ' ' THR . 15.3 m -55.87 -22.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.36 -72.47 0.62 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.322 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -35.77 25.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -110.51 75.45 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.83 162.04 36.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.771 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 p30 42.92 58.8 3.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.445 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.5 p -123.63 170.47 10.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -85.57 134.85 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.421 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 24.7 t80 -91.73 146.81 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -119.64 112.8 19.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.1 t -93.95 144.65 25.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -57.72 -25.64 60.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.01 -23.13 64.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.85 18.02 12.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.66 129.28 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.684 0.278 . . . . 0.0 110.712 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 159.61 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.03 133.62 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.239 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.37 122.69 23.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.4 pt -117.63 155.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -119.81 139.53 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.52 135.93 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -152.69 140.49 20.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.52 111.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.649 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.893 0.378 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -102.51 154.07 19.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.62 152.57 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.58 139.54 51.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.15 146.28 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.3 m -142.45 148.71 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.75 49.97 33.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.555 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -130.43 160.21 67.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.621 0.248 . . . . 0.0 111.0 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 128' ' ' LEU . 57.1 Cg_endo -71.1 137.25 31.21 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.371 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.01 -20.08 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.438 2.092 . . . . 0.0 112.544 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -54.58 -60.96 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.204 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.16 116.74 9.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.633 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -168.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.771 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.424 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 38.8 p-90 -64.61 -33.89 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 35.7 mt-30 -65.29 -40.37 93.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -71.84 -38.52 70.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.1 tp -70.45 -46.11 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -57.78 -49.17 77.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.97 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.69 -26.62 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.37 17.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 142' ' ' ARG . 10.8 mtp-105 -45.55 -32.04 2.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -32.72 65.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.46 -29.42 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.769 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.32 -160.99 31.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.388 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.69 122.02 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.418 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.8 t -89.23 130.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.6 t -98.68 -30.54 12.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -153.07 145.13 23.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.024 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -150.12 133.93 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -153.73 111.26 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.9 134.21 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -79.94 152.63 29.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -71.84 -22.28 61.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -42.15 75.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.348 . . . . 0.0 111.116 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 153.53 -27.19 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.543 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -82.56 173.85 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.319 . . . . 0.0 110.719 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.25 177.49 31.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.6 m -149.09 144.32 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.7 t -148.06 137.2 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -117.51 127.53 54.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.54 177.13 5.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -70.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.332 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 163.29 14.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.11 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -71.99 -31.33 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -31.94 67.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -72.36 -36.05 68.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.7 ttp -65.25 -62.18 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.3 m -54.68 -32.96 60.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.41 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 44.4 t80 -63.56 -45.65 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.26 -31.43 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.802 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.452 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 0.7 OUTLIER -84.62 -29.37 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.326 . . . . 0.0 110.888 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 0.7 OUTLIER -105.74 -65.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.863 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 70.2 mt -76.84 66.36 2.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.008 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -120.93 121.01 37.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.53 12.89 8.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -176.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.999 0.428 . . . . 0.0 111.008 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -101.68 144.25 30.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.996 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -124.8 122.81 38.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.293 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -119.62 119.32 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.7 m -87.81 159.39 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -59.95 -17.03 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -92.48 18.59 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.34 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.32 31.09 76.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.544 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 93.3 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 110.8 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.2 144.51 25.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 172.02 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.238 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -106.17 123.51 48.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.7 pt -107.62 152.43 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.706 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -112.63 117.6 32.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.11 133.63 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -153.87 150.46 28.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.49 109.39 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.818 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB3' ' CE ' ' A' ' 165' ' ' LYS . 12.2 m-80 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.845 0.355 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -121.76 169.61 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 1.6 p -117.46 159.62 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.963 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 9.7 t -114.37 156.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -144.35 143.69 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.82 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.26 159.42 41.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.74 45.18 8.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.83 142.94 42.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.97 170.44 20.09 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.29 -20.71 66.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.572 2.181 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.7 m -108.88 -157.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.47 -177.94 48.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -176.8 -175.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 110.747 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 56.3 p-90 -59.27 -43.06 92.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 7.2 tp60 -63.01 -38.72 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -35.48 57.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.29 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.637 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -57.6 -42.48 83.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.5 -26.77 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -89.59 -29.86 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.736 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -19.97 30.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.07 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -46.43 -30.0 1.97 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.32 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.98 -32.43 53.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.88 -28.17 60.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.43 -139.6 6.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.4 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -99.7 101.33 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 162' ' ' PHE . 92.0 t -75.64 120.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.27 -29.07 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 20.4 t80 -146.67 151.59 37.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -159.8 140.92 12.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -135.4 148.92 49.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.16 106.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.17 151.41 31.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -17.7 61.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.207 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.84 -24.41 67.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.72 25.74 2.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.677 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.8 p -151.42 163.35 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.781 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.62 -166.14 18.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.795 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.1 m -147.51 172.68 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.509 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.0 130.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.402 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.48 120.69 39.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 147' ' ' VAL . 85.2 m-85 -104.01 139.71 38.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.61 -30.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.781 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.19 125.91 49.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -53.62 -24.15 13.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -39.23 89.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.49 -31.94 71.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.614 ' HE2' ' OG1' ' A' ' 169' ' ' THR . 9.3 tmm? -61.32 -75.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.798 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.614 ' OG1' ' HE2' ' A' ' 168' ' ' MET . 5.0 m -45.64 -45.04 13.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.751 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.8 -40.21 75.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.954 0.407 . . . . 0.0 110.683 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.563 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.85 -27.65 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.116 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -80.75 -40.12 25.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -103.43 -58.24 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.478 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 96.6 mt -77.53 64.86 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.947 0.403 . . . . 0.0 111.022 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -128.24 138.53 52.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.02 30.2 19.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.7 p -98.41 155.5 17.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -81.24 134.37 35.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -96.04 158.11 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.558 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.14 125.77 30.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.969 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -93.91 149.88 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.831 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -56.16 -23.12 32.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.66 -23.11 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.054 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.19 26.23 6.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.677 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -115.12 136.2 53.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.68 161.1 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.108 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -168.98 170.91 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.006 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.16 126.15 43.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -117.5 137.68 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.335 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -106.15 122.63 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.677 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.62 153.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.468 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.35 140.63 6.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.63 119.59 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.48 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.4 t0 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.715 179.739 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -116.06 170.03 8.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 2.0 t -123.95 165.34 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.202 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.42 136.35 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.402 . . . . 0.0 111.014 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.14 153.99 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 t -141.85 133.57 27.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.44 40.26 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.633 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.05 139.06 28.84 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.531 0.205 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 169.91 21.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.467 2.112 . . . . 0.0 112.284 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.01 -29.79 26.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.455 2.103 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.07 71.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.38 -160.43 8.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.67 174.08 1.89 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.769 0.318 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 52.8 p-90 -72.7 -40.92 65.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 3.6 pt20 -66.85 -34.67 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -29.45 60.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -73.17 -41.34 63.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -64.31 -53.77 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.145 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -56.34 -26.79 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.252 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.495 ' CD2' ' CE1' ' A' ' 180' ' ' PHE . 10.4 m-70 -86.06 -23.09 26.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.388 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -106.66 8.47 31.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 111.544 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -56.9 -15.11 4.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.496 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.83 -23.82 2.09 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.455 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . . . -61.48 -28.23 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.118 0.485 . . . . 0.0 110.396 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 140.46 -55.14 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.427 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.69 117.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 138' ' ' LYS . 61.1 t -100.5 132.26 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.842 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.21 -49.48 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.235 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 14.1 t80 -155.83 160.02 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -147.46 168.01 22.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.75 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -163.14 123.79 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.13 138.96 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.88 155.04 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -70.8 -18.05 62.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.188 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.14 -25.79 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 5.15 8.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.785 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.4 p -131.75 161.14 33.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.2 -169.05 11.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 7.0 m -140.94 167.31 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.72 140.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -131.28 114.3 14.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.455 ' CE2' ' CB ' ' A' ' 144' ' ' ALA . 16.9 m-85 -88.89 176.49 7.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.85 -66.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -96.84 161.11 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.555 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -25.2 62.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.56 -31.26 72.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.06 -31.36 71.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.1 ttp -59.86 -62.11 2.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.67 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.416 ' HA ' HG22 ' A' ' 172' ' ' VAL . 52.1 m -56.81 -32.41 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 170' ' ' TYR . 4.3 t80 -60.54 -50.31 74.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.227 0.537 . . . . 0.0 110.28 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' LEU . . . -57.8 -51.99 67.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.967 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 194' ' ' VAL . 15.8 m -57.11 -22.48 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.974 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -106.52 -73.6 0.68 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.147 0.498 . . . . 0.0 112.25 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -35.18 79.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -125.49 85.5 2.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.645 0.736 . . . . 0.0 111.448 -178.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -142.74 152.69 42.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 71.26 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 p -124.98 169.76 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -89.54 136.35 33.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 140' ' ' HIS . 89.9 t80 -113.74 114.98 27.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.694 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -116.19 103.61 10.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.829 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.6 p -58.45 169.84 0.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.072 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -6.94 34.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.13 -22.93 21.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.712 0.291 . . . . 0.0 111.097 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 30.47 4.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.432 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -112.05 108.28 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.7 156.25 20.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.07 169.7 12.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.59 136.51 43.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.95 142.54 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.282 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.89 150.92 37.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.97 133.58 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -141.22 140.45 33.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.425 ' N ' HG11 ' A' ' 172' ' ' VAL . 37.6 t -68.49 113.94 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.297 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.598 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.64 169.18 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.48 165.12 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.88 136.7 48.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.6 t -105.35 154.11 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.1 p -154.86 121.27 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.78 26.75 4.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 2.9 mt -68.18 155.27 92.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.05 160.57 48.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.627 2.218 . . . . 0.0 112.24 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.43 -28.99 31.92 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m -118.52 72.19 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.79 147.29 16.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.36 175.81 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.672 0.272 . . . . 0.0 111.025 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -73.97 -32.32 63.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.953 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.72 -44.66 90.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.06 -32.08 59.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.459 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 55.3 tp -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -45.06 93.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.195 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.45 -26.77 68.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.727 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 181' ' ' ARG . 22.6 m-70 -99.94 -26.43 14.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.9 4.44 51.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -9.9 45.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.82 -26.74 4.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -28.75 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.92 -164.91 28.16 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.29 106.38 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.117 0.484 . . . . 0.0 110.781 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.85 153.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.0 t -107.64 -59.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.177 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.52 130.94 5.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.817 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.52 140.34 53.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.13 136.71 33.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.999 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.4 118.92 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -93.33 121.22 34.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 63.34 -76.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 1.2 m-20 169.76 -25.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -64.62 -49.93 61.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.633 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -133.63 -179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.9 -159.05 10.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.468 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 m -156.01 158.85 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.4 t -152.05 141.93 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.93 135.01 54.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.85 163.23 13.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.31 -62.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -88.23 152.92 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.58 -30.73 68.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -36.88 85.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.62 -30.62 68.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.763 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.9 ttp -65.14 -64.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -55.04 -32.78 62.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.543 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 64.7 t80 -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -68.02 -39.34 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.634 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.54 -22.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.818 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.543 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 5.7 ptm180 -91.11 -42.08 10.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CD ' ' HG3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -109.42 -30.45 7.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 17.7 mt -94.84 31.51 1.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.61 134.51 45.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 60.71 35.08 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.584 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.36 154.95 17.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 115.63 20.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.459 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.1 t80 -92.8 152.98 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.406 ' O ' ' CD2' ' A' ' 140' ' ' HIS . 0.2 OUTLIER -121.09 113.53 20.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.96 158.77 34.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.73 -13.81 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.182 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.7 20.78 7.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.394 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 25.93 73.26 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.573 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 125.21 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.09 161.07 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.75 159.41 16.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.43 111.87 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.6 pt -112.92 148.7 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.527 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.62 154.59 26.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.411 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.96 144.49 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.148 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 148.01 29.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.38 141.76 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.304 0.573 . . . . 0.0 110.7 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.661 -179.728 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -144.29 128.54 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.775 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.29 165.2 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.06 154.03 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.2 143.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 t -144.62 134.73 24.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.29 39.16 4.06 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.8 mt -89.02 159.46 45.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.58 160.08 47.77 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.574 2.183 . . . . 0.0 112.304 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.4 -45.41 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.534 2.156 . . . . 0.0 112.279 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.9 p -97.46 61.77 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.14 152.75 23.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.28 4.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -73.98 -32.31 63.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -59.23 -42.21 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -73.66 -30.15 62.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.416 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 67.3 tp -66.81 -43.24 84.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -52.97 -30.11 32.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.174 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.69 -26.63 66.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -33.78 16.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 71.7 mmm -72.7 -31.04 64.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.069 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -29.41 23.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.252 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -50.79 -25.62 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.019 0.438 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.53 -27.77 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.53 -69.8 0.28 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -160.48 136.28 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.425 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.4 t -107.59 152.26 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.788 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.4 t -112.07 -33.03 6.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.1 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -162.36 148.95 13.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.72 156.52 45.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.831 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -159.0 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -137.05 95.29 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.781 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 10.8 p90 -123.14 156.09 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 6.9 ttp180 96.27 -3.06 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.487 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 65.36 37.84 6.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -179.23 -52.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.9 p -97.97 163.71 12.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -143.63 -149.47 5.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.469 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.5 p -169.29 160.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.472 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 21.3 t -152.51 149.56 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -127.96 109.11 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -85.1 177.14 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.38 -70.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -95.04 164.13 13.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.145 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -72.25 -31.19 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -59.9 -50.32 74.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -29.07 64.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.699 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.2 ttp -71.11 -64.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.6 m -50.34 -33.92 22.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.15 -45.57 84.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.413 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.45 -47.28 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.446 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 169' ' ' THR . 16.1 m -66.76 -22.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -86.46 -67.64 0.8 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -52.85 9.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 91.2 mt -79.66 60.44 3.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -130.03 141.19 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.65 32.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.265 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.6 p -83.14 -179.15 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 101.95 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.8 t80 -72.94 143.63 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -124.56 107.95 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.007 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 27.5 t -79.54 161.43 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.16 -7.45 51.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -95.41 19.13 11.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.92 28.57 73.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 128.91 55.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 159.73 18.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.02 171.86 6.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.66 119.92 40.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 2.7 pt -107.29 146.53 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -116.34 119.12 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 193' ' ' LYS . 19.4 t -98.23 143.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 192' ' ' VAL . 0.9 OUTLIER -150.41 142.46 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.001 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.62 118.0 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.858 0.361 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 123' ' ' VAL . 25.6 ttm180 -86.61 156.95 19.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 122' ' ' ARG . 3.1 m -132.66 165.17 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.91 147.42 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.0 142.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.6 t -140.01 146.61 39.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.83 64.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.289 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 190' ' ' ILE . 0.0 OUTLIER -98.23 148.4 34.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.675 0.274 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 127.53 19.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 111.976 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -22.53 46.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.298 1.998 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.97 43.39 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.42 -166.76 21.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.417 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.54 145.56 51.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.3 p-90 -73.95 -46.36 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -60.8 -32.38 71.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.812 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -35.79 55.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.38 -37.16 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HD2' ' CZ3' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -66.6 -39.06 88.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 110.404 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -66.94 -26.57 66.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.238 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.62 -22.06 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -111.76 -3.38 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -59.02 -20.67 55.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 111.387 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -50.38 -24.95 3.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.176 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.38 64.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.726 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.64 -116.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.0 111.71 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.3 t -82.79 151.28 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.4 -39.82 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -145.94 148.21 32.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.97 139.53 18.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.89 138.32 30.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.71 118.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -69.15 155.25 40.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.971 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 17.56 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -29.72 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.758 0.314 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 145.95 -16.83 1.76 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.9 p -98.86 -178.48 3.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 111.224 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.7 -176.62 30.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.2 m -153.5 150.38 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -150.65 146.31 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -130.74 131.32 44.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 168' ' ' MET . 3.8 m-85 -104.58 171.1 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.03 -70.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -97.35 155.27 16.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -58.29 -28.56 65.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.36 -32.06 73.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.9 -34.95 66.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.427 ' HA ' ' CD1' ' A' ' 162' ' ' PHE . 8.2 ttp -68.58 -62.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.1 m -53.93 -36.32 62.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.01 -44.22 97.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -60.34 -44.64 95.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.471 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.88 -27.09 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.094 0.473 . . . . 0.0 110.725 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -77.99 -53.39 7.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -65.72 0.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.439 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 41.6 mt -63.69 -118.5 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.47 113.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 64.85 72.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 46.3 p -132.0 -176.94 4.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -103.74 139.93 38.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 181' ' ' ARG . 75.5 t80 -126.85 160.78 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.748 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -141.08 149.07 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.027 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.0 p -109.38 157.37 18.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -20.38 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -79.14 -22.93 44.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.99 29.46 5.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.8 121.89 46.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.1 156.58 17.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.29 171.65 10.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -107.51 121.3 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.241 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 128' ' ' LEU . 28.6 pt -101.84 168.45 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 109.47 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.322 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.0 t -86.76 153.53 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.389 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.98 171.29 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.6 p -87.91 122.36 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.939 0.4 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.223 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.872 0.367 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -105.33 119.96 40.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 7.5 p -108.43 162.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.442 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 10.3 p -128.23 142.31 44.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.63 149.42 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -139.51 123.77 18.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.53 40.56 1.74 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.599 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 142.6 47.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.26 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.77 168.6 23.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.486 2.124 . . . . 0.0 112.31 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.53 -43.26 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.605 2.203 . . . . 0.0 112.329 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.87 79.37 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.9 97.07 0.11 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -175.96 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.78 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.448 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 59.1 p-90 -65.43 -40.87 93.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.448 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 2.5 tt0 -59.6 -32.52 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.01 -36.68 56.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.25 -44.99 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -50.1 75.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -60.81 -26.6 67.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.543 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -95.11 -24.95 16.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.752 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.66 6.48 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.597 0.237 . . . . 0.0 111.565 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -77.89 6.0 8.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.661 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -50.65 -26.07 4.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.72 0.295 . . . . 0.0 111.232 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -65.63 -27.58 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.608 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.14 -94.03 0.13 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.2 142.52 49.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.59 128.9 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.849 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.72 -26.32 13.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.485 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 41.0 t80 -142.92 153.39 43.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.479 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.12 143.13 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.832 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.51 146.51 27.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.748 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.54 133.69 59.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.86 147.97 26.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -70.16 -16.85 63.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.99 -31.38 72.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 134.85 -18.11 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.81 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -108.01 169.85 8.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.6 -167.43 13.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.344 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 m -155.14 154.64 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.714 0.293 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -153.16 142.35 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.237 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -121.68 113.29 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.603 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 13.9 m-85 -81.39 155.8 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.073 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.07 -26.63 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.771 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 149.22 46.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -69.18 -36.22 77.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -32.56 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.71 -30.22 64.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.463 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.8 ttp -69.53 -65.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 94.7 m -56.71 -34.34 67.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 0.0 111.073 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 174' ' ' LYS . 9.3 t80 -59.46 -49.63 77.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.249 0.547 . . . . 0.0 110.621 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.519 ' O ' HD13 ' A' ' 175' ' ' LEU . . . -60.55 -50.17 74.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.225 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 169' ' ' THR . 15.7 m -58.71 -22.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 111.296 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 169' ' ' THR . 9.5 mtp180 -96.41 -37.18 10.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.339 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 170' ' ' TYR . 0.3 OUTLIER -86.59 -69.11 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.817 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -87.2 45.51 1.28 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 15.8 p-10 -83.43 127.1 33.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 47.96 59.98 3.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.24 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -114.85 173.97 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.426 ' HG3' ' CE1' ' A' ' 189' ' ' TYR . 0.2 OUTLIER -95.16 108.53 20.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.953 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -105.06 157.81 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.367 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CD1' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -132.56 138.65 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 p -81.25 171.0 15.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -55.02 -17.86 4.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -82.99 -22.66 33.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.25 -15.07 39.6 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 123.6 19.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 158.95 15.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.64 155.99 13.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 179' ' ' LYS . 2.0 m-85 -86.37 113.63 22.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 pt -119.88 137.61 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.26 152.9 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 t -127.74 137.61 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.263 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -155.55 145.86 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.62 109.29 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -144.02 127.54 16.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.632 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.13 159.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.947 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.46 145.5 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.086 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.21 142.37 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.83 -179.55 5.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.49 32.69 75.53 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mp -81.24 146.01 57.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.679 0.276 . . . . 0.0 110.85 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.15 169.97 20.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.58 2.187 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.42 -27.27 33.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.508 2.139 . . . . 0.0 112.197 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.36 117.03 22.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.47 175.78 46.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.432 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.66 179.62 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.891 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.431 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 51.3 p-90 -73.14 -39.1 65.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 46.2 tt0 -63.0 -31.08 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 -44.72 84.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.06 -47.05 54.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.407 ' CG ' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -56.32 -47.18 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.2 -26.73 65.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.518 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 180' ' ' PHE . 45.7 t-80 -87.93 -29.27 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.37 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.445 ' HE1' ' CE1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.1 -11.16 24.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.605 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -54.58 -21.64 10.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.801 0.334 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -49.91 -24.42 2.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.211 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.01 -26.7 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.941 0.401 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.43 -110.25 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.51 125.31 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.407 ' CG1' ' CG ' ' A' ' 138' ' ' LYS . 84.3 t -97.78 146.07 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.39 -67.48 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -127.82 133.18 49.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.036 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.55 135.94 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -139.93 126.08 19.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.29 142.99 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.922 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -117.13 153.93 31.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.023 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -73.67 -16.43 61.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.1 -26.08 68.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.56 12.14 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.752 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.5 p -143.97 165.93 26.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 110.661 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.21 -161.51 10.88 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.546 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.3 m -156.38 155.77 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.66 0.267 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.3 t -150.78 142.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -123.35 126.28 46.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.56 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.01 177.06 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.3 t -76.29 -68.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 154.44 22.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -71.96 -34.41 68.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.84 -35.17 66.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -32.05 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.61 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.473 ' HA ' ' CE2' ' A' ' 162' ' ' PHE . 3.0 ttp -58.94 -63.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.815 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 173' ' ' ARG . 95.6 m -56.65 -35.04 67.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 15.7 t80 -61.3 -44.85 96.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -67.14 -45.32 77.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.271 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 2.1 m -71.97 -21.97 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 111.273 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 169' ' ' THR . 18.1 mmm180 -90.85 -50.67 5.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.53 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 0.5 OUTLIER -88.62 -52.57 5.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.3 mt -69.33 -4.76 19.5 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 67.6 t0 -53.9 123.83 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.086 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 60.81 76.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.23 161.75 18.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -85.65 93.95 8.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.43 ' HA ' ' CE1' ' A' ' 140' ' ' HIS . 40.7 t80 -74.64 154.69 38.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.81 129.21 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.3 p -97.45 162.93 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -6.1 45.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.239 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.7 18.26 9.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.694 0.283 . . . . 0.0 111.334 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.01 73.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.546 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.05 155.52 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.97 161.05 22.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.96 157.42 11.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.149 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -103.42 114.15 28.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.99 158.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.64 127.67 42.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.09 145.36 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.863 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.58 150.25 24.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.11 118.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.326 -179.794 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.095 0.474 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.407 ' NH1' ' CG1' ' A' ' 159' ' ' VAL . 52.7 ttp85 -144.25 147.68 33.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.6 m -132.77 165.06 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.95 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.77 150.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.145 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.89 121.41 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 t -114.75 158.75 21.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.41 46.72 3.98 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.93 167.31 34.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.83 170.11 19.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.717 2.278 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.72 -25.98 45.99 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -134.6 82.68 1.98 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.71 -165.32 10.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -171.82 176.67 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.426 ' CH2' ' HG2' ' A' ' 135' ' ' GLN . 41.5 p-90 -73.35 -33.94 65.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.735 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HG2' ' CH2' ' A' ' 134' ' ' TRP . 19.4 mt-30 -58.78 -43.23 90.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.789 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.06 -32.3 56.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.441 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 37.3 tp -59.89 -38.17 81.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -43.03 63.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.38 -26.8 68.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.393 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -88.28 -39.91 14.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.425 ' HE1' ' CZ ' ' A' ' 162' ' ' PHE . 2.1 ppp? -80.16 -5.71 56.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.392 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -53.1 -22.62 6.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -31.15 11.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.071 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 170' ' ' TYR . . . -68.43 -28.7 67.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.41 -159.1 25.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -58.91 117.17 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.5 126.11 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 9.0 t -66.93 -63.81 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.727 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 161' ' ' GLU . 7.1 p90 -171.61 150.34 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.88 4.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.22 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -163.38 153.69 15.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.97 122.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.04 139.64 52.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 76.1 0.62 3.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.726 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.93 11.84 8.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.11 -53.05 0.14 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.56 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.7 p -98.96 159.94 14.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -144.73 179.54 21.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.608 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.407 ' CG1' ' NH1' ' A' ' 122' ' ' ARG . 22.9 m -137.43 154.44 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.991 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.7 t -142.6 126.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.179 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 149' ' ' TYR . 2.5 mt-10 -111.99 130.04 55.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.727 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CZ ' ' HE1' ' A' ' 141' ' ' MET . 0.7 OUTLIER -109.51 137.62 47.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.971 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.62 -28.85 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -129.3 142.39 50.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -59.04 -27.49 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.205 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -54.98 -46.33 75.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.099 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -32.56 68.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.2 ttp -61.49 -66.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.4 m -54.84 -35.76 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 15.7 t80 -61.57 -47.93 83.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.06 74.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.8 m -65.61 -22.84 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.5 -72.64 0.4 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.122 0.487 . . . . 0.0 110.453 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -54.67 12.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.92 76.64 6.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.802 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -141.38 134.51 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.71 25.84 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.16 -174.33 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 145.19 38.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 29.8 t80 -93.16 158.61 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 1.3 tmt_? -125.85 107.17 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.71 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 p -75.74 151.14 37.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -54.67 -23.06 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.44 -19.5 61.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.12 -6.2 36.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.81 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.95 159.62 23.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.747 0.308 . . . . 0.0 110.838 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.7 161.0 29.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.118 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.09 16.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.03 115.66 15.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.54 161.7 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.184 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.11 113.09 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 t -91.0 159.08 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.03 144.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.85 134.69 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.272 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.901 0.381 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -109.18 168.33 9.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.098 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.22 159.88 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.8 t -106.06 146.33 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 157' ' ' THR . 12.3 p -121.9 150.77 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -137.15 170.91 15.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.918 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.94 44.31 96.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.46 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.422 ' N ' HD21 ' A' ' 128' ' ' LEU . 3.5 mm? -83.92 140.48 40.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.647 0.261 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.95 170.46 20.37 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.538 2.159 . . . . 0.0 112.204 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.04 -26.83 65.83 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.17 . . . . 0.0 112.265 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.0 34.84 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.49 111.6 3.88 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.469 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.57 179.61 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.802 0.334 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.447 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 47.5 p-90 -68.63 -41.72 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.447 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.5 OUTLIER -70.55 -36.06 73.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.78 -57.96 10.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.71 -47.02 88.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.416 ' CG ' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.04 -43.76 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.186 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.56 -26.33 65.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.604 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -88.16 -21.14 24.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.695 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 11.0 ptm -112.38 1.62 16.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.84 -17.59 56.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.89 -21.89 4.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.85 68.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.162 0.506 . . . . 0.0 110.481 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.3 -104.47 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.73 107.34 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 110.771 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.416 ' CG1' ' CG ' ' A' ' 138' ' ' LYS . 96.4 t -79.25 125.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.27 -52.4 6.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -140.57 160.01 40.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.165 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -159.4 134.98 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -146.52 114.4 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.17 112.11 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.227 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -69.22 155.23 40.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -92.68 37.53 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -114.96 -28.85 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 147.87 -21.49 1.45 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 12.0 p -129.09 167.01 18.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.584 0.23 . . . . 0.0 111.059 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.02 -161.43 8.75 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.242 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 m -158.02 144.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -141.06 149.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.925 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.41 134.57 48.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.306 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -121.39 132.71 54.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.157 179.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 5.2 p -70.08 65.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 111.183 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 7.3 ttm-85 172.82 127.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.144 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.18 -40.4 96.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -58.93 -37.27 76.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.56 -34.77 72.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.407 ' HE1' ' N ' ' A' ' 169' ' ' THR . 7.8 ttp -60.83 -63.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.414 ' HA ' HG23 ' A' ' 172' ' ' VAL . 70.5 m -61.69 -33.45 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 11.6 t80 -63.55 -48.58 76.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.88 82.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 26.6 m -64.04 -22.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.409 ' CZ ' ' CG2' ' A' ' 169' ' ' THR . 0.0 OUTLIER -93.34 -75.11 0.51 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 3.9 mmtt -57.17 -49.19 76.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.64 58.53 3.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.602 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 6.0 t0 -122.86 135.61 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 44.1 t30 54.02 29.76 10.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.87 177.38 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 103.56 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -68.93 117.47 10.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.79 105.28 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 144.09 29.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -21.65 64.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.623 0.249 . . . . 0.0 111.073 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 31.0 3.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.725 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.36 134.66 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 156.57 22.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.9 143.85 2.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -83.62 120.25 25.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.0 pt -112.67 155.6 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.21 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.7 t -103.04 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -147.16 145.31 29.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.07 124.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.073 0.463 . . . . 0.0 110.724 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.3 t0 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.722 -179.551 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.815 0.341 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 161.79 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.86 149.35 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.2 t -117.24 144.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.83 146.44 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -149.22 117.14 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.11 39.67 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.493 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mp -99.22 155.12 36.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.5 166.52 29.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.543 2.162 . . . . 0.0 112.397 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.17 -27.53 35.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.3 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.94 36.59 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.805 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -93.02 123.37 7.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 p -94.3 150.99 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 0.0 110.798 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.44 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 30.7 p-90 -74.02 -40.02 63.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -55.55 -40.58 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.27 -32.55 55.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.43 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 68.7 tp -61.63 -42.24 98.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -47.45 68.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.97 -26.74 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.032 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 181' ' ' ARG . 39.5 t-80 -86.1 -31.48 21.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.18 3.61 55.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.451 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -55.56 -20.87 14.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.462 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -49.69 -32.56 13.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 111.003 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 170' ' ' TYR . . . -70.9 -29.42 65.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.756 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.75 -172.79 26.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.414 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.22 106.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.1 t -74.07 125.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.043 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -56.17 4.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -154.03 148.34 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -143.6 141.23 30.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.181 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -143.41 141.67 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.29 115.95 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.249 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.85 155.36 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 35.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.294 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -114.76 -22.62 9.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.196 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 31.36 1.1 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 p -161.26 169.97 21.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.744 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.84 175.38 32.16 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.632 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -142.83 142.05 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.312 . . . . 0.0 111.061 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.55 157.91 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.68 128.31 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 68.3 m-85 -108.53 154.52 21.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -71.04 -68.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.22 162.26 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -50.08 30.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.015 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -32.4 46.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -35.88 72.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.408 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 5.2 ttp -67.62 -59.76 3.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.321 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.8 m -50.58 -35.06 28.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.855 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 49.6 t80 -64.23 -46.95 81.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.733 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.44 -43.05 79.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.0 m -79.92 -34.69 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.411 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 11.9 ptt85 -79.68 -30.33 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.715 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 170' ' ' TYR . 0.1 OUTLIER -106.98 -57.3 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.207 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.4 mt -81.24 66.75 6.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -116.89 131.23 57.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.2 m120 57.63 30.37 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.1 p -73.33 -177.67 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.979 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 95.09 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.026 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 5.9 t80 -68.95 135.35 50.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.612 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 140' ' ' HIS . 4.0 ttm-85 -116.52 100.91 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.4 t -60.85 161.3 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -9.68 58.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.084 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 21.69 6.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.341 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 27.34 73.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.617 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.57 134.6 54.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.27 156.42 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.96 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.31 160.31 26.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -98.27 110.97 23.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.53 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.7 pt -107.13 136.26 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.463 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.37 109.83 22.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.16 142.01 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.246 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -150.37 157.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.78 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 25.3 t -78.01 114.85 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.28 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.703 0.287 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.61 117.5 52.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.95 -168.27 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.406 2.071 . . . . 0.0 112.415 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -169.83 172.47 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.872 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.14 32.57 2.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.341 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.13 99.58 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -172.72 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -156.75 123.28 1.28 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.281 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.21 109.1 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.576 2.184 . . . . 0.0 112.168 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.5 157.51 22.41 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.433 2.088 . . . . 0.0 112.198 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -161.6 39.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.709 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.45 -44.88 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.018 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.43 -57.34 0.51 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.129 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 73.16 163.92 0.28 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.938 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -79.45 -12.81 59.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.366 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.41 116.83 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.829 0.347 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.06 144.89 31.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.18 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.33 165.14 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 143.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.75 152.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.5 p -143.07 123.08 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.51 41.53 0.23 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.344 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.29 144.17 37.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.89 170.68 19.85 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.555 2.17 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.49 -26.25 70.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.62 2.213 . . . . 0.0 112.191 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -124.49 74.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.77 167.97 24.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -146.39 167.93 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.5 p-90 -65.7 -42.16 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 29.7 tp60 -58.77 -36.23 74.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -73.49 -29.7 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.92 -42.45 66.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.748 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.978 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.78 -26.85 58.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.233 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.43 -41.16 14.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -22.87 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -46.12 -29.9 1.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.246 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -30.4 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.85 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.04 -134.41 3.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.405 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -103.97 103.86 13.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.85 141.93 15.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.3 p -112.29 -29.32 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -154.71 147.36 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.35 127.26 6.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.13 153.64 51.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.1 124.72 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.269 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -82.71 154.99 24.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.33 -33.63 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.52 -30.34 2.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.627 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -95.32 160.63 14.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -138.46 -166.26 10.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.576 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -155.6 145.51 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.9 150.15 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.22 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.85 136.6 47.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.774 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -116.92 160.3 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.08 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.98 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.801 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -25.69 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -47.05 58.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.28 -28.0 62.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 10.9 ttp -67.0 -62.91 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 172' ' ' VAL . 67.0 m -58.96 -32.92 70.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.029 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -64.98 -44.64 88.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -65.59 -48.16 73.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.894 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 11.0 m -65.14 -22.12 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -93.13 -75.45 0.49 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.076 0.465 . . . . 0.0 111.189 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -40.95 95.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 29.0 mt -89.58 23.84 2.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 38.4 t70 -83.65 131.22 34.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.73 61.63 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 p -113.27 146.67 38.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.744 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.21 112.12 8.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -80.85 148.4 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 126.5 46.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.9 p -97.01 146.0 25.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -55.92 -22.94 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -23.12 63.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.96 30.75 4.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -130.19 133.09 46.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.91 161.0 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.23 130.21 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -70.94 114.38 8.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 22.0 pt -116.74 151.24 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -131.36 135.37 47.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.35 148.22 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.237 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 140.12 16.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.8 t -70.25 118.58 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.203 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -49.99 117.24 2.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.156 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.25 -143.59 5.15 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.75 88.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.02 117.47 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.46 91.08 1.9 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.7 -24.71 18.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.575 2.184 . . . . 0.0 112.395 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 p -57.65 -167.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -49.3 156.53 0.57 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -59.05 -79.66 0.1 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.26 120.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 111.03 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.1 t -59.09 99.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -53.83 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.0 t -115.03 44.35 1.81 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 -71.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.0 p 175.67 -51.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.33 10.63 7.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.2 m 68.07 -65.8 0.24 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.774 0.321 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.99 177.41 0.23 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.14 32.98 12.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -149.86 36.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.5 t -117.6 166.23 12.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 53.88 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 0.0 111.03 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.72 -81.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.838 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 18.8 ttp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.8 0.333 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.2 134.01 35.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.03 -73.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.465 2.11 . . . . 0.0 112.328 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -143.48 31.23 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.22 66.59 0.45 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -176.23 114.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -75.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.98 67.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.628 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.19 176.45 4.66 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.13 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.12 -67.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.453 2.102 . . . . 0.0 112.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.6 t 169.38 72.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 -153.66 89.37 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -176.99 -42.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.72 64.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.82 30.58 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -112.03 131.6 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -131.38 133.45 45.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.8 165.16 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.085 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.27 146.27 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.37 144.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -137.97 125.5 22.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.43 40.28 2.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.27 153.58 92.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.27 169.51 20.56 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -27.28 24.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.577 2.185 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -143.03 127.06 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.4 162.72 24.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.81 153.42 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.414 ' CZ2' ' HG3' ' A' ' 135' ' ' GLN . 42.8 p-90 -74.0 -30.07 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 50.8 mt-30 -58.99 -42.99 91.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -77.15 -21.39 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.926 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 180' ' ' PHE . 29.9 tp -70.17 -47.11 63.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.936 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -40.7 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.406 ' HA ' ' HG3' ' A' ' 142' ' ' ARG . 4.5 m-20 -65.96 -26.65 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.81 -31.9 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -93.16 -2.82 54.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HG3' ' HA ' ' A' ' 139' ' ' ASP . 4.0 mmm-85 -62.67 -15.87 54.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.476 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.74 -31.59 11.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.824 0.345 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 175' ' ' LEU . . . -68.38 -31.41 70.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.513 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.94 -98.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.94 156.39 46.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 75.0 t -126.82 149.4 31.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.5 t -117.33 -52.3 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -128.78 149.62 50.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.71 134.57 11.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.026 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.15 134.66 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.33 118.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -103.46 131.66 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.0 mtm105 -62.34 96.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -171.45 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 137.53 37.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.74 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.8 p -166.05 172.36 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.46 173.42 36.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.7 134.26 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.28 127.2 22.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -98.17 108.37 21.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.51 156.76 32.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.13 -67.33 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 144.97 24.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.83 -40.58 97.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.77 -42.62 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -31.83 69.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.5 ttp -67.22 -62.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.418 ' HA ' HG21 ' A' ' 172' ' ' VAL . 98.9 m -53.24 -32.73 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.77 -46.95 85.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.482 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -59.16 -47.55 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.574 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.418 HG21 ' HA ' ' A' ' 169' ' ' THR . 16.2 m -63.29 -22.64 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.026 0.441 . . . . 0.0 110.793 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -85.59 -71.93 0.51 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.268 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -78.68 -36.76 43.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.035 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 76.1 mt -90.51 47.69 1.46 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -108.88 127.33 53.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.831 0.348 . . . . 0.0 110.679 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.9 31.55 18.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -171.92 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -111.15 118.13 35.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.407 ' CD1' HD12 ' A' ' 137' ' ' LEU . 10.8 t80 -97.41 135.06 39.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -122.17 117.36 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.7 p -80.13 149.61 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -54.74 -23.72 19.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -73.72 -23.07 59.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.984 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.17 5.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.86 110.34 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.83 154.41 20.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.001 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.89 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.55 129.74 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.62 143.27 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.291 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -109.95 122.25 47.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.06 151.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.63 169.22 25.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.44 118.97 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.39 121.1 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 115.33 -67.38 0.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.65 -11.23 29.65 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.819 2.346 . . . . 0.0 112.561 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 38.35 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.52 80.75 0.15 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.84 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.45 -156.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.632 2.221 . . . . 0.0 112.192 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.8 t 72.32 -66.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -109.08 163.73 13.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.76 -134.74 3.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.547 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.61 52.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.945 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 p -101.33 31.91 3.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -119.35 119.07 32.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.2 -78.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.833 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 54.7 p -124.88 173.73 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 -79.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.95 56.32 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.98 151.02 26.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.6 p -173.81 -170.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.82 -50.14 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -144.55 164.51 30.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.35 -179.74 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.956 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.29 -47.25 51.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.014 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.5 55.79 0.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.55 -45.31 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.535 2.157 . . . . 0.0 112.371 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.73 126.3 47.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.66 145.9 4.7 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -154.47 168.05 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 0.0 110.862 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -134.99 -60.18 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.2 98.64 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.86 156.8 64.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.456 2.104 . . . . 0.0 112.301 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.31 173.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.9 t -78.68 129.49 34.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -148.39 175.4 11.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.638 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.66 160.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.45 19.21 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 54.03 34.31 19.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.991 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 61.3 74.82 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.041 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.58 142.31 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.658 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.2 m -106.96 165.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.63 140.1 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -106.38 140.23 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.56 120.27 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.62 1.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.414 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.51 150.05 84.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 171.02 16.45 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.257 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 -32.59 21.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.589 2.193 . . . . 0.0 112.276 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 t -123.89 115.51 21.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.54 177.05 48.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.22 -175.53 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 32.0 p-90 -67.59 -42.2 82.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.856 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.3 OUTLIER -59.74 -50.57 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.723 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.29 -37.39 85.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.652 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.28 -45.57 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.33 68.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.392 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.21 12.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 30.4 mmm -76.87 -25.57 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -25.27 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.321 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -23.73 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.312 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.15 -26.45 66.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.658 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.79 -65.61 0.34 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.39 125.62 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.074 0.464 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.7 t -101.02 146.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.23 -29.66 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.211 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 56.5 t80 -154.76 160.05 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 111.211 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -157.04 177.33 11.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.85 156.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.97 147.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -123.98 109.23 13.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 mtt85 55.55 -87.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -176.24 36.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 110.93 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.6 -44.59 0.5 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.439 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.4 p -156.67 161.09 39.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.71 -157.48 7.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.573 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.5 m -156.09 142.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.22 119.88 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -104.35 123.25 47.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 23.0 m-85 -99.41 167.57 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.27 -69.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.86 163.92 13.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -26.1 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -57.16 -41.49 79.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -30.06 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.412 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 4.6 ttp -61.01 -63.72 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.425 ' HA ' HG22 ' A' ' 172' ' ' VAL . 97.9 m -57.52 -35.53 70.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.071 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 21.0 t80 -62.56 -47.3 84.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.45 . . . . 0.0 110.653 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.86 84.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.809 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 25.6 m -61.64 -22.75 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.546 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -76.49 0.55 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 8.6 mmtt -58.08 -42.6 85.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.623 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.63 36.16 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.207 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 11.9 t0 -94.51 120.07 34.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.642 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 61.81 66.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.6 p -115.75 170.02 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 131.67 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -109.67 145.27 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.89 116.36 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.99 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -88.7 155.7 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -54.54 -22.69 13.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -19.25 61.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.29 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.732 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.9 150.28 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.21 154.98 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.999 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 172.07 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.262 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -106.45 120.12 41.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.59 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 pt -106.31 145.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -118.99 124.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 172' ' ' VAL . 15.0 t -95.6 141.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.264 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 147.82 26.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.44 116.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -76.3 -21.4 56.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.12 85.87 0.4 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.549 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.22 -26.74 35.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.265 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -109.77 135.56 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.435 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 17.4 m -141.88 64.47 17.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 199' ' ' SER . 3.6 Cg_exo -76.45 168.16 24.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.885 2.39 . . . . 0.0 112.218 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.16 -168.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.32 -168.99 2.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -96.56 84.49 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.607 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 -168.29 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 111.018 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.5 m -137.78 103.62 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.05 123.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.88 72.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.93 131.93 3.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.2 p -118.58 -7.54 10.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 63.69 -166.81 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.883 0.373 . . . . 0.0 110.518 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.1 p -103.27 117.23 34.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 59.04 165.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 78.3 p -177.54 83.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.991 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -138.0 -81.0 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 10.0 t 178.76 -78.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.907 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.98 31.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.976 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.831 0.348 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 108' ' ' PRO . . . 59.49 53.13 4.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 107' ' ' ALA . 60.9 Cg_endo -73.25 -45.55 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.407 2.071 . . . . 0.0 112.388 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.53 177.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.35 70.69 2.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.575 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -89.45 -166.09 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -71.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.037 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . 142.95 -61.97 0.52 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.816 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 113' ' ' GLY . 11.1 Cg_endo -54.69 148.22 46.03 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.646 2.231 . . . . 0.0 112.319 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.8 -159.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.617 2.211 . . . . 0.0 112.279 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.96 79.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.36 107.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -171.99 178.13 3.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.65 -86.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 48.64 27.17 1.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.272 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 m120 52.97 92.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 170.01 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.152 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.5 p -130.49 160.72 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.447 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 14.3 p -122.26 143.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.03 159.12 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.26 170.91 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.45 44.37 93.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.48 155.23 78.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.735 0.302 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 171.71 11.55 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 112.405 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.12 -26.62 73.03 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.613 2.209 . . . . 0.0 112.346 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -135.9 122.14 20.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.63 -172.72 33.37 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.2 p -172.62 -177.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 44.7 p-90 -59.94 -37.47 79.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 21.6 tt0 -70.38 -32.05 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -68.93 -50.32 50.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.3 tp -67.6 -44.85 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -40.38 63.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -61.14 -26.73 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.236 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -86.72 -43.6 12.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 77.6 mmm -69.51 -26.32 64.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.705 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -45.31 -33.14 2.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.268 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.36 -33.82 63.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.03 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.99 -140.22 6.87 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.511 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 128.99 39.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.72 127.07 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.95 -26.23 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 35.4 t80 -151.73 153.87 35.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.399 . . . . 0.0 111.311 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.429 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.07 149.04 11.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.915 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.51 124.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.01 142.51 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.035 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.96 155.12 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -72.5 -10.95 60.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.397 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.59 -23.18 66.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.25 24.43 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.616 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.4 p -155.54 160.26 40.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.26 -175.79 25.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 162' ' ' PHE . 12.5 t -127.61 133.44 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.3 118.59 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.435 ' CE1' HG11 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -114.62 139.32 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.627 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 6.4 p -71.18 65.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.926 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER 178.81 125.51 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -72.11 -44.84 62.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.546 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.42 -27.79 68.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.668 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.15 -40.59 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.407 ' HE3' ' N ' ' A' ' 169' ' ' THR . 2.0 ttp -59.65 -59.22 5.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.424 ' HA ' HG22 ' A' ' 172' ' ' VAL . 96.9 m -58.35 -36.44 73.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.357 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -62.89 -45.14 93.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -63.64 -44.9 92.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 169' ' ' THR . 24.0 m -71.87 -22.38 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.707 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.31 -26.53 15.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.602 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -110.71 -60.81 1.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.4 mt -63.08 -15.82 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 16.6 p-10 -64.1 159.26 20.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 50.18 58.6 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.196 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.1 p -140.51 164.01 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.978 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -87.96 123.59 32.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -99.25 149.78 22.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 142.46 50.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.5 p -95.56 151.51 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -52.98 -23.97 8.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.79 -22.3 53.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.08 26.68 5.65 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.549 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -107.88 115.62 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.04 152.16 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 135.25 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 135.62 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -131.25 161.43 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.374 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -127.7 128.42 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.637 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 t -111.48 142.95 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.318 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -165.17 141.04 5.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.05 113.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.51 27.36 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.65 -112.64 0.86 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.403 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.51 123.53 13.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.414 2.076 . . . . 0.0 112.206 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -122.28 28.5 7.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.149 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 17.7 p -85.25 160.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 201' ' ' SER . 39.1 Cg_exo -59.38 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.411 2.074 . . . . 0.0 112.079 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 200' ' ' PRO . 2.1 p 161.81 -82.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.879 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.93 76.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.762 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -137.21 9.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.575 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -74.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.811 0.339 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.2 m 62.93 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -165.71 160.04 16.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.852 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -23.88 67.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.073 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 61.57 156.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.941 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.8 m -135.74 -158.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt-85 68.69 97.01 0.06 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.9 p -177.37 71.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.11 -80.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 49.4 -170.05 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -136.37 137.66 40.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.1 m 179.91 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 pp -46.67 107.23 0.1 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.988 0.423 . . . . 0.0 111.345 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -177.69 -72.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.992 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 36.7 mtp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.93 141.21 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.01 -168.69 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.154 . . . . 0.0 112.383 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -151.33 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.74 150.53 15.97 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.414 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 33.25 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.29 34.11 2.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.698 ' N ' ' CD ' ' A' ' 114' ' ' PRO . . . -110.23 4.55 30.0 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.603 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 113' ' ' GLY . 90.6 Cg_endo -79.39 164.86 23.72 Favored 'Trans proline' 0 C--N 1.353 0.811 0 CA-C-N 120.137 1.968 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.96 124.65 16.42 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.5 2.134 . . . . 0.0 112.111 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.14 -175.84 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 53.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 117.07 6.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.1 m -150.92 102.41 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -114.36 31.04 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.59 152.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -143.59 142.63 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.4 p -104.25 159.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.439 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 8.6 p -118.98 152.66 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.25 148.67 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.2 127.98 20.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.798 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.55 -0.65 6.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.924 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.78 151.44 32.03 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.817 0.341 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.57 171.86 10.11 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.158 . . . . 0.0 112.161 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.02 -25.63 51.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.424 2.083 . . . . 0.0 112.4 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 125.52 15.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -170.37 -179.63 41.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.4 m -130.8 149.48 52.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.737 0.303 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -63.59 -33.38 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.26 -31.69 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.0 -50.3 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 23.1 tp -60.23 -45.81 91.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -57.43 -39.95 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.041 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.97 -26.96 61.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.489 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -91.19 -22.74 20.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.466 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.423 ' CE ' ' CZ ' ' A' ' 162' ' ' PHE . 4.0 ppp? -99.58 -12.77 19.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.574 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -52.72 -24.92 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.748 0.308 . . . . 0.0 111.446 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -24.4 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -28.18 68.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.562 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 -129.9 2.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.363 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -103.19 108.59 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.067 0.46 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 p -106.12 139.92 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.127 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.24 -40.42 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.405 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 161' ' ' GLU . 7.8 t80 -117.83 145.17 44.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -162.97 133.18 4.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.58 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.63 141.48 48.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.965 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.96 114.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.024 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -85.57 143.78 28.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -73.84 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.42 -49.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.65 -26.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.3 p -106.77 164.26 12.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 111.008 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.68 -175.91 20.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.53 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.6 m -143.42 154.48 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.777 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.32 150.28 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 149' ' ' TYR . 0.9 OUTLIER -132.18 116.22 16.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.788 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.423 ' CZ ' ' CE ' ' A' ' 141' ' ' MET . 5.3 m-85 -92.68 173.78 7.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.59 -70.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 157.92 16.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -32.08 63.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -55.34 -39.99 70.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.12 -30.65 66.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.423 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 7.0 ttp -70.49 -63.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.4 m -53.14 -34.07 55.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.021 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.78 -48.31 79.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.515 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.79 -50.66 69.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.245 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.0 m -62.64 -25.95 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -72.23 0.42 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -56.1 6.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.118 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 46.8 mt -77.19 72.74 3.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.846 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -133.46 120.94 21.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.9 t30 62.04 39.51 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.713 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -92.31 179.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.937 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.472 ' N ' ' OG1' ' A' ' 178' ' ' THR . 6.6 tttp -98.94 125.99 44.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.9 t80 -103.63 143.41 32.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.726 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.39 116.91 26.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.82 152.87 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -68.52 -14.22 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.253 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.83 -23.1 64.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.284 . . . . 0.0 111.112 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.82 31.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.513 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -139.3 144.11 38.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.358 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 154.65 26.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.9 147.61 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.202 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.05 146.05 28.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 29.8 pt -136.4 145.69 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 127.99 54.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.9 t -103.7 143.47 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -161.31 144.49 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.32 113.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -87.15 54.94 3.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.98 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.472 ' N ' ' HD3' ' A' ' 197' ' ' PRO . . . -161.59 61.1 0.29 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 196' ' ' GLY . 5.2 Cg_exo -79.28 178.05 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.996 2.464 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 63.21 -119.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.68 -52.73 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.412 0.148 . . . . 0.0 111.24 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -42.34 166.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.665 2.243 . . . . 0.0 112.798 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.3 t -42.05 155.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.001 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -117.55 -175.88 2.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.726 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.03 -96.25 2.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.419 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -108.51 -88.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.494 0.188 . . . . 0.0 110.67 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.1 m 43.59 -162.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.62 68.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.412 . . . . 0.0 110.437 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.0 p -85.62 -165.91 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.293 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -111.93 -165.09 0.96 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.957 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 210' ' ' ARG . 1.4 m 72.15 -165.12 0.13 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.993 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER 55.85 27.62 11.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.231 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.7 t -120.42 -43.16 2.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.989 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -157.4 148.42 21.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.4 t -160.24 -83.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 48.31 80.16 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.897 0.38 . . . . 0.0 111.198 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.1 p -57.72 -27.01 62.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.55 101.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.14 -73.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.853 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 61.5 mmm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.66 54.38 1.67 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.01 61.45 3.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.547 2.165 . . . . 0.0 112.332 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.04 59.61 0.6 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.79 41.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 60.25 62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -113.12 -26.45 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -55.47 148.06 26.77 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.66 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.22 159.42 40.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.613 2.209 . . . . 0.0 112.402 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.36 -69.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.638 2.225 . . . . 0.0 112.324 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.11 -173.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 79.07 107.42 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.132 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' SER . 6.6 ttt85 -112.54 -80.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.571 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 1.4 p 159.77 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 119' ' ' SER . 2.0 mm-40 91.53 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 111.412 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' A' ' 165' ' ' LYS . 25.0 t-20 53.66 24.8 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 111.057 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -117.72 150.27 39.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.5 p -133.95 159.98 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.446 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 9.8 p -124.04 147.83 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.13 157.8 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.8 t -161.18 123.36 3.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.09 39.48 0.64 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.95 154.84 45.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.672 0.272 . . . . 0.0 110.758 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.98 166.24 3.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 0.0 112.21 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.74 -27.55 20.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.678 2.252 . . . . 0.0 112.484 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 129.46 15.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.09 -163.68 13.99 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -153.01 162.55 41.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -74.12 -39.18 63.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -36.91 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -36.0 66.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.455 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 22.8 tp -63.17 -45.14 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -28.12 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.186 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -67.07 -26.7 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.29 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 180' ' ' PHE . 6.6 m80 -96.26 -27.95 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.304 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.6 mmm -83.58 -26.28 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.248 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.5 -27.57 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.426 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -53.69 -22.52 9.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.51 66.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 0.0 110.64 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.5 -59.58 0.36 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.369 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -174.38 107.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.7 t -88.67 132.05 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.52 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -133.35 145.26 50.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.75 133.94 6.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.12 152.21 48.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.39 107.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.68 100.69 6.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 64.15 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -179.13 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.04 10.86 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.062 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 p -157.63 174.54 15.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.86 -166.22 19.18 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.414 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.86 159.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 111.016 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.42 145.25 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.09 137.09 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.706 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -113.56 175.67 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.66 -70.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.83 157.97 15.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.405 ' HA ' ' ND2' ' A' ' 121' ' ' ASN . 2.0 tptm -58.14 -29.16 65.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.54 -34.95 76.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.9 -38.48 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.5 ttp -70.79 -62.23 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.403 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 92.5 m -53.38 -36.81 61.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 28.4 t80 -63.79 -46.54 84.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -54.9 -46.14 74.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 169' ' ' THR . 15.9 m -68.91 -23.03 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -87.01 -67.2 0.83 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.975 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 1.5 mptp? -76.81 -48.38 18.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.736 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 52.3 mt -84.49 58.48 4.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -117.84 129.84 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.739 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.16 39.44 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.708 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.2 p -81.37 177.61 8.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.94 99.25 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.0 t80 -88.72 152.67 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.89 140.05 40.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.21 155.05 22.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.637 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -53.03 -22.83 6.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -75.73 -21.07 57.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 20.84 8.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.771 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 116.19 32.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.733 0.301 . . . . 0.0 110.715 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 156.94 18.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.1 166.04 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.25 119.58 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.9 pt -108.32 141.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.98 0.419 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -106.38 128.63 54.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.76 142.89 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.084 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.96 140.84 8.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.3 110.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.42 -170.67 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -177.05 91.75 0.08 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.542 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.41 -162.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.657 2.238 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.55 165.84 12.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 76.69 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.512 2.141 . . . . 0.0 112.187 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.72 132.76 42.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -95.77 -176.43 3.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -55.45 -28.46 50.92 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.575 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -89.37 53.35 2.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.6 p 52.4 -89.91 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 48.12 94.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.739 0.304 . . . . 0.0 111.293 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.0 t 62.69 38.11 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.83 118.37 18.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 p -130.94 132.32 45.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.26 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.759 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.1 t -158.09 140.97 14.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -146.18 171.23 15.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.63 34.95 20.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -176.14 123.94 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 13.3 t -106.37 167.68 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.8 mt -119.24 -74.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -133.68 66.54 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.815 0.34 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.38 146.56 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.977 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.95 -94.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.335 2.024 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 46.87 -171.42 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.838 0.351 . . . . 0.0 111.357 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 111' ' ' ARG . . . 86.49 71.27 1.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.856 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 58.27 157.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.61 -54.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -150.59 106.28 0.31 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.55 108.02 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.487 2.125 . . . . 0.0 112.284 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.56 138.01 37.44 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.702 2.268 . . . . 0.0 112.259 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.3 m -179.72 48.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.959 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -115.06 -20.92 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.57 18.35 2.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.751 0.31 . . . . 0.0 111.327 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.59 92.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.49 16.74 11.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.342 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -111.8 -0.15 16.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 119.96 25.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.6 p -102.62 160.12 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.448 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 11.6 p -120.46 143.71 31.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.99 158.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.4 p -146.75 146.42 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.29 46.14 2.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.559 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.61 145.48 37.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.639 0.257 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.92 170.67 19.15 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.381 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.71 -27.47 52.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 31.08 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.72 118.76 5.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.03 168.91 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 58.6 p-90 -62.59 -41.75 99.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -61.58 -33.73 74.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.03 -38.39 52.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.202 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.84 -44.3 32.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.273 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -53.19 -39.71 63.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -71.63 -26.7 62.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.621 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -26.01 20.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.422 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.429 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 3.3 ppp? -97.01 -10.25 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -18.78 30.89 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.516 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.93 -25.79 3.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.57 -27.42 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.745 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.54 -125.87 1.79 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.457 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.459 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.94 130.94 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.047 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 -29.44 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -163.28 146.95 10.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.97 136.64 19.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -152.07 125.11 8.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.88 131.49 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -98.24 155.01 17.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -10.18 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.411 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -29.0 70.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.45 36.46 0.64 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.592 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.7 p -160.3 160.77 32.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.849 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -149.97 176.78 28.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.576 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.3 m -147.69 146.87 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.324 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.66 147.78 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.08 126.14 33.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.429 ' CZ ' ' HE3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -104.98 166.9 10.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.59 -72.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 151.05 24.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.99 -27.53 5.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.246 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -53.98 -44.16 70.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -30.07 64.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.428 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.1 ttp -65.03 -63.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.1 m -57.69 -34.04 69.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.51 80.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.616 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.415 HG22 ' HD2' ' A' ' 173' ' ' ARG . 4.5 m -65.22 -24.81 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 172' ' ' VAL . 0.0 OUTLIER -76.74 -73.05 0.31 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.233 0.539 . . . . 0.0 110.296 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -58.26 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -77.27 81.52 3.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.45 138.57 19.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.49 46.64 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -109.83 173.25 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.426 ' HD3' ' CD1' ' A' ' 189' ' ' TYR . 0.3 OUTLIER -105.32 103.37 12.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.93 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -68.89 120.17 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.54 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.24 100.8 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.532 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.05 136.87 56.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -59.37 -19.83 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.187 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -68.77 -17.48 64.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.258 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.99 31.04 3.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.56 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -131.74 138.5 48.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.06 156.8 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 138.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.426 ' CD1' ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -79.21 128.77 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -125.14 140.77 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.371 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -112.7 134.94 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.62 141.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.362 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 123' ' ' VAL . 39.8 mttp -153.34 137.87 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.06 115.38 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.175 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -97.58 91.33 5.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.803 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -168.74 160.07 33.41 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.24 -148.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.897 2.398 . . . . 0.0 112.308 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.25 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.95 0.405 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.632 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 12.6 p -82.61 -32.4 0.57 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.221 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 199' ' ' SER . 55.2 Cg_exo -52.88 -161.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.319 2.013 . . . . 0.0 112.865 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 200' ' ' PRO . 2.3 m 91.16 -35.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.04 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 120.25 2.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.748 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.46 127.44 4.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.325 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? 62.29 36.05 14.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 110.683 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 -70.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -144.66 123.66 12.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.988 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.5 p -162.99 29.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.78 29.74 4.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.9 p -75.5 169.86 17.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 61.64 43.04 10.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -61.53 1.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -57.64 148.72 23.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.082 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -150.21 176.35 10.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -71.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.8 p -177.92 -114.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.592 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.53 135.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.959 0.409 . . . . 0.0 111.015 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -177.13 169.89 2.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.944 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.9 mmm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.709 0.29 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.82 56.49 2.93 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.006 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.53 -40.14 6.06 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.647 2.231 . . . . 0.0 112.357 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 59.76 37.38 22.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.67 -50.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.287 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' TYR . 3.5 ptp180 -100.37 -29.87 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 0.0 110.802 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 24.9 p90 43.99 84.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.413 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . -55.98 -62.77 5.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.808 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 113' ' ' GLY . 12.4 Cg_endo -56.34 108.28 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.706 2.271 . . . . 0.0 112.269 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.47 135.7 47.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.434 2.089 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.7 p -151.9 48.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -100.03 75.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -166.22 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.8 m 57.99 106.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -55.89 5.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.631 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 41.93 60.93 2.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.428 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -123.42 121.95 37.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.849 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.97 161.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.38 140.7 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -120.1 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.0 p -111.71 132.99 54.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.58 35.85 0.96 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.88 153.52 52.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 161.74 44.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.477 2.118 . . . . 0.0 112.301 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 -31.43 20.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 90.57 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.63 -163.34 11.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.59 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 170.72 20.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -60.29 -44.25 95.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.797 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -60.47 -31.64 70.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -53.22 60.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.0 -40.16 88.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -39.66 89.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.98 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -87.99 -35.11 17.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.31 -25.21 62.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.4 mtt-85 -46.77 -30.2 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -30.36 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.51 -27.42 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 151.15 -100.43 0.2 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -131.1 111.05 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.961 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.17 151.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 40.7 t -112.7 -31.82 6.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -165.59 150.41 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.95 173.37 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -176.9 135.01 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.56 101.19 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 19.2 p90 -124.12 155.84 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 0.2 OUTLIER 89.38 -4.98 0.4 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.355 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 63.14 31.53 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.94 -45.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.3 p -104.84 160.1 15.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.375 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.06 -179.32 33.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.265 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.6 p -146.07 159.52 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.222 0.534 . . . . 0.0 111.208 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 46.0 t -154.74 141.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.2 125.47 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.37 177.13 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.86 -69.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -88.36 149.84 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -61.33 -34.19 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.58 -33.44 72.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.73 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.18 -37.93 69.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.526 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.47 -63.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.409 ' HA ' HG23 ' A' ' 172' ' ' VAL . 53.9 m -53.73 -31.46 48.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 4.3 t80 -60.43 -50.51 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.244 0.545 . . . . 0.0 110.12 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 175' ' ' LEU . . . -57.55 -53.87 53.27 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' A' ' 169' ' ' THR . 13.9 m -54.82 -22.71 10.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.351 . . . . 0.0 111.752 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -71.75 0.69 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.042 0.449 . . . . 0.0 112.111 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -67.74 -45.55 74.65 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 175' ' ' LEU . 0.1 OUTLIER -123.31 84.16 2.23 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.826 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 176' ' ' ASP . 2.4 p-10 -129.51 -102.03 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.321 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 190' ' ' ILE . 10.3 t-20 -67.62 56.28 0.06 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.467 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -109.39 -167.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -91.36 140.98 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -118.67 133.3 55.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -123.27 119.12 29.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.9 t -79.11 149.83 31.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -55.39 -23.46 24.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.22 -23.0 63.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.13 28.83 4.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.0 136.77 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.69 156.22 18.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.52 168.31 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.43 109.98 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 21.6 pt -102.1 158.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 177' ' ' ASN . 1.2 tmm_? -139.08 117.36 11.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.6 151.45 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.9 144.03 6.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.31 119.71 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.17 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -85.36 56.29 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.926 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -154.9 128.51 2.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.55 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.93 -150.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.526 2.15 . . . . 0.0 112.075 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.66 24.86 1.62 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.947 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.41 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 18.4 p -179.97 63.5 0.13 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 199' ' ' SER . 31.4 Cg_exo -58.94 -64.03 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.716 2.277 . . . . 0.0 112.386 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 m 62.65 -164.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -55.01 91.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.989 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -85.67 -177.2 50.34 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.58 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -177.73 -38.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.298 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.0 m -54.24 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.115 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -65.89 83.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -141.18 -75.79 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 57.97 26.32 13.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.008 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 27.8 p 55.66 102.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -74.02 -168.79 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.747 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.2 t -105.73 -102.75 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.873 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 60.91 138.78 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 38.5 p 50.51 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -173.62 1.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.9 p -97.31 -73.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.658 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.72 67.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.14 90.88 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 45.7 t60 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.834 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.82 0.343 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 64.35 89.39 0.1 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.123 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.41 105.12 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.528 2.152 . . . . 0.0 112.189 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -125.64 163.67 22.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.58 27.41 15.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.507 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -33.2 59.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -100.43 29.32 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.07 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -60.15 120.4 22.63 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.27 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.43 107.18 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.501 2.134 . . . . 0.0 112.3 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.11 -158.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.732 2.288 . . . . 0.0 112.21 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 p -67.24 -164.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.85 60.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -170.43 126.46 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.78 158.65 32.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -169.91 56.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.25 -20.37 13.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.097 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -79.92 158.07 26.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 2.7 p -144.18 160.01 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 10.7 p -123.2 141.07 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.09 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 155.61 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.0 t -145.46 138.46 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.89 37.0 3.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.33 152.98 92.25 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.76 171.84 10.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.313 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.99 -28.49 80.7 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.638 2.225 . . . . 0.0 112.249 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m -122.24 -80.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.38 -168.67 0.31 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.806 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 m -164.5 156.23 15.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 44.8 p-90 -59.26 -44.6 92.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -67.5 -32.89 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.603 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.19 -45.32 77.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.421 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 59.7 tp -59.67 -43.84 93.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -37.93 64.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.956 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -64.42 -26.72 68.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.215 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -84.75 -37.51 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.4 mmm -75.85 -20.34 58.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.661 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -43.3 -31.83 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.354 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -34.33 25.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.87 -29.68 66.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.8 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.22 -129.04 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.383 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.29 136.93 37.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 162' ' ' PHE . 92.4 t -115.54 121.37 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.957 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.02 -42.53 16.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.058 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 52.3 t80 -142.98 158.45 43.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -162.99 139.94 7.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.49 161.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.57 133.08 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.85 155.64 37.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.704 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -33.13 -42.78 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.935 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 174.01 65.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.886 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.73 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.814 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.9 p -141.3 -177.13 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.67 176.71 33.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.463 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 126.93 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 t -119.66 144.32 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.03 106.92 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.82 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 147' ' ' VAL . 80.4 m-85 -87.53 141.6 28.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.33 -28.62 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -120.0 147.94 44.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -72.1 -32.85 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -60.48 -31.78 70.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -71.66 -35.89 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.639 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.2 ttp -67.97 -62.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.3 m -53.4 -32.24 48.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.465 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 3.1 t80 -61.35 -50.43 72.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.223 0.535 . . . . 0.0 110.076 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 175' ' ' LEU . . . -55.02 -54.1 47.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 169' ' ' THR . 15.3 m -55.87 -22.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.36 -72.47 0.62 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.322 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -35.77 25.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -110.51 75.45 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.83 162.04 36.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.771 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 p30 42.92 58.8 3.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.445 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.5 p -123.63 170.47 10.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -85.57 134.85 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.421 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 24.7 t80 -91.73 146.81 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -119.64 112.8 19.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.1 t -93.95 144.65 25.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -57.72 -25.64 60.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.01 -23.13 64.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.85 18.02 12.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.66 129.28 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.684 0.278 . . . . 0.0 110.712 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 159.61 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.03 133.62 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.239 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.37 122.69 23.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 7.4 pt -117.63 155.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -119.81 139.53 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.52 135.93 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -152.69 140.49 20.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.52 111.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.3 116.65 4.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.649 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -104.22 99.17 1.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.928 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.63 -177.61 3.71 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.6 2.2 . . . . 0.0 112.177 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -97.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.953 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 164.26 18.9 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.08 116.42 2.79 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.574 2.183 . . . . 0.0 112.29 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.44 -174.2 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.55 173.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 204' ' ' ARG . . . -125.01 158.73 19.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.389 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 34.25 77.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.623 0.369 . . . . 0.0 111.776 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.54 158.52 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -112.33 114.91 27.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.4 m -136.63 -81.68 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.92 -169.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.359 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 t -93.35 -138.28 0.2 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.574 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 74.02 47.63 0.15 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.924 0.393 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.05 145.01 32.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.42 161.44 5.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -63.08 -166.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -169.81 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 74.4 m 64.35 -78.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.416 ' O ' ' HG3' ' A' ' 217' ' ' GLU . 6.5 mp -126.37 -79.64 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 216' ' ' LEU . 0.1 OUTLIER 53.94 173.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.253 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.929 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 29.9 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.791 0.329 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.14 151.7 40.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.64 -70.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.7 2.267 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -48.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 67.78 -154.65 53.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 173.34 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 62.28 -168.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -58.3 140.93 46.3 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.31 112.09 3.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.605 2.203 . . . . 0.0 112.38 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.79 118.97 5.51 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.4 2.067 . . . . 0.0 112.291 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.5 t -167.01 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.08 28.79 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -176.24 138.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.0 p -170.96 176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 58.19 27.83 15.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.15 28.44 7.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.983 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -102.51 154.07 19.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.62 152.57 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.58 139.54 51.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.15 146.28 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.3 m -142.45 148.71 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.75 49.97 33.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.555 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -130.43 160.21 67.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.621 0.248 . . . . 0.0 111.0 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 128' ' ' LEU . 57.1 Cg_endo -71.1 137.25 31.21 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.371 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.01 -20.08 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.438 2.092 . . . . 0.0 112.544 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -54.58 -60.96 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.204 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.16 116.74 9.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.633 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -168.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.771 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.424 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 38.8 p-90 -64.61 -33.89 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 35.7 mt-30 -65.29 -40.37 93.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -71.84 -38.52 70.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.1 tp -70.45 -46.11 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -57.78 -49.17 77.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.97 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.69 -26.62 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.37 17.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 142' ' ' ARG . 10.8 mtp-105 -45.55 -32.04 2.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -32.72 65.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.46 -29.42 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.769 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.32 -160.99 31.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.388 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.69 122.02 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.418 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.8 t -89.23 130.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.6 t -98.68 -30.54 12.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -153.07 145.13 23.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.024 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -150.12 133.93 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -153.73 111.26 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.9 134.21 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -79.94 152.63 29.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -71.84 -22.28 61.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -42.15 75.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.348 . . . . 0.0 111.116 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 153.53 -27.19 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.543 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -82.56 173.85 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.319 . . . . 0.0 110.719 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.25 177.49 31.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.6 m -149.09 144.32 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.7 t -148.06 137.2 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -117.51 127.53 54.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.54 177.13 5.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -70.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.332 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 163.29 14.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.11 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -71.99 -31.33 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -31.94 67.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -72.36 -36.05 68.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.7 ttp -65.25 -62.18 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.3 m -54.68 -32.96 60.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.41 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 44.4 t80 -63.56 -45.65 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.26 -31.43 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.802 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.452 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 0.7 OUTLIER -84.62 -29.37 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.326 . . . . 0.0 110.888 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 0.7 OUTLIER -105.74 -65.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.863 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 70.2 mt -76.84 66.36 2.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.008 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -120.93 121.01 37.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.53 12.89 8.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -176.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.999 0.428 . . . . 0.0 111.008 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -101.68 144.25 30.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.996 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -124.8 122.81 38.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.293 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -119.62 119.32 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.7 m -87.81 159.39 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -59.95 -17.03 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -92.48 18.59 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.34 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.32 31.09 76.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.544 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 93.3 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 110.8 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.2 144.51 25.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 172.02 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.238 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -106.17 123.51 48.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.7 pt -107.62 152.43 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.706 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -112.63 117.6 32.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.11 133.63 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -153.87 150.46 28.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.49 109.39 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.14 -79.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.89 140.84 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.26 89.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.28 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -104.9 49.95 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.798 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.444 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 47.2 p -142.87 50.09 1.38 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 199' ' ' SER . 84.3 Cg_endo -80.09 96.95 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.548 2.165 . . . . 0.0 112.475 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 30.9 t -63.27 82.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -77.25 80.44 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -92.03 13.08 67.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.771 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 55.48 74.2 0.38 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.903 0.382 . . . . 0.0 111.037 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 p -172.14 136.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.14 -33.21 8.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.21 87.85 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.71 30.49 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.29 30.98 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.881 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.53 104.36 7.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 78.0 p -174.73 -171.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 4.6 ptt85 -58.8 88.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.53 166.52 24.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.104 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -83.81 98.57 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -76.16 63.38 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.4 mt -155.68 179.74 8.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.39 142.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 28.3 mtm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.771 0.319 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.18 82.47 0.22 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.79 -68.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.565 2.177 . . . . 0.0 112.317 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 126.46 53.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.52 -157.76 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 67.08 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.4 t80 59.93 81.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.7 146.28 43.3 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.8 150.09 38.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.617 2.211 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.56 73.92 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.552 2.168 . . . . 0.0 112.257 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.79 118.8 35.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -162.75 30.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -71.41 -15.17 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.1 p -53.7 92.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.77 36.32 3.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB3' ' CE ' ' A' ' 165' ' ' LYS . 12.2 m-80 -78.29 76.34 4.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -121.76 169.61 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 1.6 p -117.46 159.62 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.963 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 9.7 t -114.37 156.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -144.35 143.69 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.82 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.26 159.42 41.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.74 45.18 8.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.83 142.94 42.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.97 170.44 20.09 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.29 -20.71 66.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.572 2.181 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.7 m -108.88 -157.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.47 -177.94 48.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -176.8 -175.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 110.747 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 56.3 p-90 -59.27 -43.06 92.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 7.2 tp60 -63.01 -38.72 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -35.48 57.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.29 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.637 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -57.6 -42.48 83.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.5 -26.77 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -89.59 -29.86 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.736 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -19.97 30.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.07 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -46.43 -30.0 1.97 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.32 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.98 -32.43 53.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.88 -28.17 60.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.43 -139.6 6.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.4 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -99.7 101.33 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 162' ' ' PHE . 92.0 t -75.64 120.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.27 -29.07 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 20.4 t80 -146.67 151.59 37.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -159.8 140.92 12.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -135.4 148.92 49.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.16 106.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.17 151.41 31.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -17.7 61.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.207 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.84 -24.41 67.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.72 25.74 2.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.677 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.8 p -151.42 163.35 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.781 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.62 -166.14 18.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.795 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.1 m -147.51 172.68 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.509 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.0 130.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.402 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.48 120.69 39.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 147' ' ' VAL . 85.2 m-85 -104.01 139.71 38.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.61 -30.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.781 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.19 125.91 49.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -53.62 -24.15 13.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -39.23 89.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.49 -31.94 71.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.614 ' HE2' ' OG1' ' A' ' 169' ' ' THR . 9.3 tmm? -61.32 -75.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.798 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.614 ' OG1' ' HE2' ' A' ' 168' ' ' MET . 5.0 m -45.64 -45.04 13.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.751 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.8 -40.21 75.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.954 0.407 . . . . 0.0 110.683 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.563 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.85 -27.65 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.116 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -80.75 -40.12 25.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -103.43 -58.24 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.478 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 96.6 mt -77.53 64.86 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.947 0.403 . . . . 0.0 111.022 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -128.24 138.53 52.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.02 30.2 19.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.7 p -98.41 155.5 17.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -81.24 134.37 35.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -96.04 158.11 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.558 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.14 125.77 30.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.969 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -93.91 149.88 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.831 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -56.16 -23.12 32.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.66 -23.11 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.054 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.19 26.23 6.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.677 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -115.12 136.2 53.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.68 161.1 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.108 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -168.98 170.91 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.006 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.16 126.15 43.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -117.5 137.68 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.335 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -106.15 122.63 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.677 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.62 153.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.468 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.35 140.63 6.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.63 119.59 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.48 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.96 136.58 36.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -160.94 -98.58 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.87 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.34 -67.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.483 2.122 . . . . 0.0 112.688 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -138.46 7.65 2.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.768 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.3 p 49.4 57.29 18.2 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-O 120.725 0.297 . . . . 0.0 111.318 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.22 124.27 4.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.667 2.244 . . . . 0.0 112.356 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -60.18 -47.17 87.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 68.43 -69.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.91 174.84 30.88 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -125.29 -70.91 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.3 t -172.5 -76.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 27.6 mtm105 -157.32 42.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -120.48 -48.89 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 -148.09 106.47 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.8 p -159.92 39.53 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -76.2 -30.13 57.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m 62.2 116.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.05 75.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.73 -170.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.73 90.84 3.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 81.8 p -133.67 83.5 2.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.96 157.63 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.18 42.11 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.843 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.963 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.797 0.332 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.65 92.92 7.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.43 125.49 13.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.524 2.149 . . . . 0.0 112.275 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.69 -67.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.52 -48.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.603 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -174.65 65.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.06 -26.8 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.429 ' C ' ' HD2' ' A' ' 115' ' ' PRO . . . -56.53 161.61 7.14 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.934 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' N ' ' CD ' ' A' ' 115' ' ' PRO . 7.5 Cg_endo -54.84 -33.55 81.94 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.844 2.363 . . . . 0.0 113.844 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 48.9 Cg_exo -57.23 -153.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.021 1.814 . . . . 0.0 112.686 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.9 m -40.79 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.66 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 117' ' ' ARG . 5.5 ttm105 -136.94 -37.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.07 172.68 8.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.989 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.2 p -132.98 11.02 4.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.29 17.45 8.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.457 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 m120 55.58 105.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -116.06 170.03 8.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 2.0 t -123.95 165.34 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.202 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.42 136.35 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.402 . . . . 0.0 111.014 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.14 153.99 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 t -141.85 133.57 27.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.44 40.26 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.633 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.05 139.06 28.84 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.531 0.205 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 169.91 21.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.467 2.112 . . . . 0.0 112.284 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.01 -29.79 26.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.455 2.103 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.07 71.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.38 -160.43 8.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.67 174.08 1.89 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.769 0.318 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 52.8 p-90 -72.7 -40.92 65.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 3.6 pt20 -66.85 -34.67 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -29.45 60.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -73.17 -41.34 63.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -64.31 -53.77 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.145 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -56.34 -26.79 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.252 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.495 ' CD2' ' CE1' ' A' ' 180' ' ' PHE . 10.4 m-70 -86.06 -23.09 26.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.388 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -106.66 8.47 31.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 111.544 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -56.9 -15.11 4.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.496 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.83 -23.82 2.09 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.455 ' CB ' ' CE2' ' A' ' 162' ' ' PHE . . . -61.48 -28.23 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.118 0.485 . . . . 0.0 110.396 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 140.46 -55.14 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.427 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.69 117.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 138' ' ' LYS . 61.1 t -100.5 132.26 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.842 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.21 -49.48 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.235 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 14.1 t80 -155.83 160.02 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -147.46 168.01 22.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.75 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -163.14 123.79 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.13 138.96 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.88 155.04 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -70.8 -18.05 62.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.188 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.14 -25.79 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 5.15 8.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.785 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.4 p -131.75 161.14 33.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 110.773 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.2 -169.05 11.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 7.0 m -140.94 167.31 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.72 140.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -131.28 114.3 14.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.455 ' CE2' ' CB ' ' A' ' 144' ' ' ALA . 16.9 m-85 -88.89 176.49 7.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.85 -66.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -96.84 161.11 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.555 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -25.2 62.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.56 -31.26 72.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.06 -31.36 71.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.1 ttp -59.86 -62.11 2.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.67 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.416 ' HA ' HG22 ' A' ' 172' ' ' VAL . 52.1 m -56.81 -32.41 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 170' ' ' TYR . 4.3 t80 -60.54 -50.31 74.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.227 0.537 . . . . 0.0 110.28 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' LEU . . . -57.8 -51.99 67.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.967 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 194' ' ' VAL . 15.8 m -57.11 -22.48 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.974 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -106.52 -73.6 0.68 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.147 0.498 . . . . 0.0 112.25 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -35.18 79.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -125.49 85.5 2.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.645 0.736 . . . . 0.0 111.448 -178.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -142.74 152.69 42.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 71.26 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 p -124.98 169.76 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -89.54 136.35 33.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 140' ' ' HIS . 89.9 t80 -113.74 114.98 27.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.694 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -116.19 103.61 10.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.829 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.6 p -58.45 169.84 0.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.072 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -6.94 34.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.13 -22.93 21.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.712 0.291 . . . . 0.0 111.097 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 30.47 4.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.432 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -112.05 108.28 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.7 156.25 20.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.07 169.7 12.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.59 136.51 43.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.95 142.54 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.282 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.89 150.92 37.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.97 133.58 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.331 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -141.22 140.45 33.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.425 ' N ' HG11 ' A' ' 172' ' ' VAL . 37.6 t -68.49 113.94 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.297 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.1 124.72 40.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.598 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -108.69 -68.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.705 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.5 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.651 2.234 . . . . 0.0 112.626 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 152.28 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 202' ' ' TYR . 4.2 p -119.84 175.83 2.07 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 199' ' ' SER . 31.6 Cg_exo -59.19 -145.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.827 2.352 . . . . 0.0 112.19 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 202' ' ' TYR . 1.5 m -73.78 1.05 11.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 201' ' ' SER . 19.6 m-85 67.26 -69.96 0.12 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.809 0.338 . . . . 0.0 111.072 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.92 174.05 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.218 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.91 -163.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.671 0.272 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 t 69.9 -137.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.709 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -46.8 108.92 0.16 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.856 0.36 . . . . 0.0 111.26 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 m -133.42 91.06 2.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.801 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -59.13 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.4 p -117.11 -169.27 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.82 28.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.46 -47.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -98.57 31.87 2.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.5 100.47 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 120.78 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.2 m -129.9 78.25 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.0 122.53 32.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.78 -77.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.15 90.28 3.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.27 152.39 75.86 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.517 2.144 . . . . 0.0 112.25 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.74 -30.5 67.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.08 116.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.454 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 101.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -173.43 4.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.96 57.49 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.768 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HG2' ' HD3' ' A' ' 115' ' ' PRO . 4.1 Cg_exo -40.63 -51.45 3.53 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.087 2.525 . . . . 0.0 112.897 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.437 ' HD3' ' HG2' ' A' ' 114' ' ' PRO . 78.6 Cg_exo -47.08 173.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.543 2.162 . . . . 0.0 112.61 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -136.49 44.47 2.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.752 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 71.77 -63.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.92 152.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.46 -32.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 74.38 51.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.823 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 63.33 88.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.02 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.64 169.18 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.48 165.12 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.88 136.7 48.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.6 t -105.35 154.11 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.1 p -154.86 121.27 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.78 26.75 4.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 2.9 mt -68.18 155.27 92.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.05 160.57 48.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.627 2.218 . . . . 0.0 112.24 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.43 -28.99 31.92 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m -118.52 72.19 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.79 147.29 16.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.36 175.81 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.672 0.272 . . . . 0.0 111.025 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -73.97 -32.32 63.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.953 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.72 -44.66 90.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.06 -32.08 59.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.459 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 55.3 tp -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -45.06 93.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.195 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.45 -26.77 68.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.727 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 181' ' ' ARG . 22.6 m-70 -99.94 -26.43 14.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.9 4.44 51.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -9.9 45.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.82 -26.74 4.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.37 -28.75 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.92 -164.91 28.16 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.29 106.38 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.117 0.484 . . . . 0.0 110.781 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.85 153.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.0 t -107.64 -59.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.177 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.52 130.94 5.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.817 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.52 140.34 53.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.13 136.71 33.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.999 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.4 118.92 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -93.33 121.22 34.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 63.34 -76.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 1.2 m-20 169.76 -25.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -64.62 -49.93 61.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.633 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.2 p -133.63 -179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.9 -159.05 10.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.468 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 m -156.01 158.85 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.4 t -152.05 141.93 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.93 135.01 54.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.85 163.23 13.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.31 -62.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -88.23 152.92 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.58 -30.73 68.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -36.88 85.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.62 -30.62 68.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.763 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.9 ttp -65.14 -64.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -55.04 -32.78 62.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.543 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 64.7 t80 -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -68.02 -39.34 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.634 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.54 -22.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.818 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.543 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 5.7 ptm180 -91.11 -42.08 10.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CD ' ' HG3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -109.42 -30.45 7.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 17.7 mt -94.84 31.51 1.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.61 134.51 45.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 60.71 35.08 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.584 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.36 154.95 17.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 115.63 20.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.459 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.1 t80 -92.8 152.98 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.406 ' O ' ' CD2' ' A' ' 140' ' ' HIS . 0.2 OUTLIER -121.09 113.53 20.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.96 158.77 34.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.73 -13.81 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.182 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.7 20.78 7.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.394 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 25.93 73.26 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.573 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 125.21 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.09 161.07 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.75 159.41 16.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.43 111.87 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.6 pt -112.92 148.7 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.527 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.62 154.59 26.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.411 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.96 144.49 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.148 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 148.01 29.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.38 141.76 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.304 0.573 . . . . 0.0 110.7 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -83.0 11.64 5.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.661 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.96 90.69 0.57 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.348 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.47 113.11 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.727 2.285 . . . . 0.0 112.443 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.09 -170.1 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.3 t -156.35 102.63 2.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -51.27 90.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.426 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -126.61 -84.06 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 57.68 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' SER . . . -132.77 -102.02 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.446 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -174.3 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.34 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 t -96.34 119.93 35.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.28 164.27 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.3 t -109.48 146.13 35.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.64 70.34 10.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.68 62.84 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.98 50.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.852 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p 50.52 -177.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.37 35.66 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 30.75 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -19.28 65.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.86 68.67 0.51 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.843 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.5 -29.64 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -179.34 3.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.932 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.854 0.359 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -108.65 141.34 23.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 -43.66 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.476 2.117 . . . . 0.0 112.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 178.92 4.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.11 -30.67 9.01 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.436 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.73 -174.22 4.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.734 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.408 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 39.5 p90 -101.55 112.5 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -131.41 107.21 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.583 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.68 111.79 2.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.496 2.13 . . . . 0.0 112.232 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.65 145.3 39.15 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.384 2.056 . . . . 0.0 112.419 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.23 -174.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.33 94.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -70.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER 178.81 -162.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 119' ' ' SER . 0.9 OUTLIER 82.0 -8.57 1.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.675 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.98 160.59 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.936 0.398 . . . . 0.0 111.128 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -144.29 128.54 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.775 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.29 165.2 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.06 154.03 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.2 143.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 t -144.62 134.73 24.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.29 39.16 4.06 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.8 mt -89.02 159.46 45.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.58 160.08 47.77 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.574 2.183 . . . . 0.0 112.304 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.4 -45.41 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.534 2.156 . . . . 0.0 112.279 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.9 p -97.46 61.77 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.14 152.75 23.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.28 4.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -73.98 -32.31 63.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -59.23 -42.21 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -73.66 -30.15 62.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.416 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 67.3 tp -66.81 -43.24 84.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -52.97 -30.11 32.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.174 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.69 -26.63 66.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -33.78 16.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 71.7 mmm -72.7 -31.04 64.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.069 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -29.41 23.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.252 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -50.79 -25.62 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.019 0.438 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.53 -27.77 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.53 -69.8 0.28 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -160.48 136.28 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.425 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.4 t -107.59 152.26 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.788 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.4 t -112.07 -33.03 6.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.1 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -162.36 148.95 13.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.72 156.52 45.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.831 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -159.0 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -137.05 95.29 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.781 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 10.8 p90 -123.14 156.09 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 6.9 ttp180 96.27 -3.06 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.487 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 65.36 37.84 6.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -179.23 -52.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.9 p -97.97 163.71 12.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -143.63 -149.47 5.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.469 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.5 p -169.29 160.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 21.3 t -152.51 149.56 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -127.96 109.11 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -85.1 177.14 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.38 -70.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -95.04 164.13 13.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.145 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -72.25 -31.19 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -59.9 -50.32 74.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -29.07 64.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.699 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.2 ttp -71.11 -64.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.6 m -50.34 -33.92 22.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.15 -45.57 84.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.413 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.45 -47.28 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.446 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 169' ' ' THR . 16.1 m -66.76 -22.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -86.46 -67.64 0.8 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -52.85 9.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 91.2 mt -79.66 60.44 3.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -130.03 141.19 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.65 32.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.265 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.6 p -83.14 -179.15 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 101.95 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.8 t80 -72.94 143.63 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -124.56 107.95 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.007 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 27.5 t -79.54 161.43 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.16 -7.45 51.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -95.41 19.13 11.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.92 28.57 73.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 128.91 55.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 159.73 18.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.02 171.86 6.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.66 119.92 40.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 2.7 pt -107.29 146.53 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -116.34 119.12 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 193' ' ' LYS . 19.4 t -98.23 143.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 192' ' ' VAL . 0.9 OUTLIER -150.41 142.46 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.001 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.62 118.0 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.8 77.45 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.841 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -126.59 97.89 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.571 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.57 -24.13 21.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.558 2.172 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.05 -174.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 1.9 t 59.41 64.54 2.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 199' ' ' SER . 6.1 Cg_exo -78.22 57.73 6.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.971 2.447 . . . . 0.0 112.31 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 m -178.46 136.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.256 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 202' ' ' TYR . 0.6 OUTLIER -147.35 -63.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.624 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 39.8 -96.53 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.296 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.19 13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 0.0 111.433 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 -171.31 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.444 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -60.3 91.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.85 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.66 -54.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.708 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 210' ' ' ARG . 0.7 OUTLIER 63.47 13.74 7.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.81 -89.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.558 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -154.12 161.41 41.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.695 0.283 . . . . 0.0 110.871 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.1 m -125.34 159.6 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -68.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -165.06 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 66.82 46.78 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 110.972 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.39 108.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.806 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.51 51.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.47 91.74 3.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 8.0 t60 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.9 179.907 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 ptp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.819 0.342 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.96 20.81 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.26 98.22 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.501 2.134 . . . . 0.0 112.22 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.05 96.44 6.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.12 12.49 3.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.803 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.41 23.18 5.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 58.73 161.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.048 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.08 -167.57 2.47 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.605 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.09 110.26 2.9 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.609 2.206 . . . . 0.0 112.15 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 116' ' ' SER . 9.7 Cg_exo -70.67 -72.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.573 2.182 . . . . 0.0 112.207 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.6 p 165.57 152.43 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.58 134.82 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.31 122.93 0.93 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m -163.81 -148.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.769 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 76.76 57.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.001 0.429 . . . . 0.0 110.804 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.68 41.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.714 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 123' ' ' VAL . 25.6 ttm180 -86.61 156.95 19.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 122' ' ' ARG . 3.1 m -132.66 165.17 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.91 147.42 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.0 142.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.6 t -140.01 146.61 39.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.83 64.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.289 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 190' ' ' ILE . 0.0 OUTLIER -98.23 148.4 34.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.675 0.274 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 127.53 19.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 111.976 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -22.53 46.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.298 1.998 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.97 43.39 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.42 -166.76 21.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.417 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.54 145.56 51.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.3 p-90 -73.95 -46.36 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -60.8 -32.38 71.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.812 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -35.79 55.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.38 -37.16 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HD2' ' CZ3' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -66.6 -39.06 88.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 110.404 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -66.94 -26.57 66.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.238 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.62 -22.06 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -111.76 -3.38 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -59.02 -20.67 55.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 111.387 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -50.38 -24.95 3.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.176 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.38 64.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.726 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.64 -116.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.0 111.71 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.3 t -82.79 151.28 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.4 -39.82 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -145.94 148.21 32.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.97 139.53 18.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.89 138.32 30.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.71 118.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -69.15 155.25 40.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.971 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 17.56 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -29.72 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.758 0.314 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 145.95 -16.83 1.76 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.9 p -98.86 -178.48 3.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 111.224 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.7 -176.62 30.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.2 m -153.5 150.38 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -150.65 146.31 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -130.74 131.32 44.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 168' ' ' MET . 3.8 m-85 -104.58 171.1 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.03 -70.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -97.35 155.27 16.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -58.29 -28.56 65.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.36 -32.06 73.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.9 -34.95 66.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.427 ' HA ' ' CD1' ' A' ' 162' ' ' PHE . 8.2 ttp -68.58 -62.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.1 m -53.93 -36.32 62.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.01 -44.22 97.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -60.34 -44.64 95.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.471 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.88 -27.09 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.094 0.473 . . . . 0.0 110.725 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -77.99 -53.39 7.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -65.72 0.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.439 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 41.6 mt -63.69 -118.5 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.47 113.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 64.85 72.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 46.3 p -132.0 -176.94 4.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -103.74 139.93 38.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 181' ' ' ARG . 75.5 t80 -126.85 160.78 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.748 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -141.08 149.07 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.027 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.0 p -109.38 157.37 18.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -20.38 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -79.14 -22.93 44.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.99 29.46 5.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.8 121.89 46.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.1 156.58 17.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.29 171.65 10.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -107.51 121.3 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.241 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 128' ' ' LEU . 28.6 pt -101.84 168.45 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 109.47 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.322 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.0 t -86.76 153.53 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.389 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.98 171.29 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.6 p -87.91 122.36 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.939 0.4 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -48.86 -34.92 13.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.28 80.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.627 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.3 -53.22 7.49 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.525 2.15 . . . . 0.0 112.23 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 30.0 ttp85 -92.36 105.89 18.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.423 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER -177.77 -56.7 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 71.2 Cg_exo -50.32 152.15 8.76 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.313 2.009 . . . . 0.0 112.312 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 -63.58 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -54.13 179.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.093 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.65 -72.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.597 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -176.47 -40.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.1 m -147.31 100.66 3.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -118.91 30.76 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.69 88.06 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 100.36 11.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.984 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m 64.52 -75.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -52.09 -80.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.033 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 34.2 t 63.53 -78.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -173.72 146.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.9 t -50.95 98.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -54.72 141.34 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -89.96 107.98 19.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.0 -173.2 2.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.817 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.94 46.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.024 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.8 p80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.881 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.826 0.346 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.408 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . . . -178.06 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 107' ' ' ALA . 41.1 Cg_endo -67.3 -29.81 38.06 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.492 2.128 . . . . 0.0 112.345 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -98.26 162.68 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.64 -24.73 13.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.652 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 61.27 90.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -179.86 -74.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.7 -77.83 0.39 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.549 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.427 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 6.2 Cg_exo -37.82 -49.32 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.41 2.74 . . . . 0.0 113.009 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 52.2 Cg_exo -55.1 88.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.308 2.005 . . . . 0.0 112.268 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 p -128.13 110.62 12.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -143.99 29.09 1.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.09 162.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.24 100.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.4 -41.65 76.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.011 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -175.2 94.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -105.33 119.96 40.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 124' ' ' VAL . 7.5 p -108.43 162.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.442 ' N ' ' CG2' ' A' ' 123' ' ' VAL . 10.3 p -128.23 142.31 44.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.63 149.42 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -139.51 123.77 18.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.53 40.56 1.74 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.599 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.13 142.6 47.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.26 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.77 168.6 23.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.486 2.124 . . . . 0.0 112.31 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.53 -43.26 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.605 2.203 . . . . 0.0 112.329 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.87 79.37 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.9 97.07 0.11 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -175.96 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.78 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.448 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 59.1 p-90 -65.43 -40.87 93.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.448 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 2.5 tt0 -59.6 -32.52 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.01 -36.68 56.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.25 -44.99 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -50.1 75.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -60.81 -26.6 67.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.543 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -95.11 -24.95 16.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.752 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.66 6.48 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.597 0.237 . . . . 0.0 111.565 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -77.89 6.0 8.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.661 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -50.65 -26.07 4.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.72 0.295 . . . . 0.0 111.232 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -65.63 -27.58 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.608 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.14 -94.03 0.13 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.2 142.52 49.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.59 128.9 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.849 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.72 -26.32 13.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.485 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 41.0 t80 -142.92 153.39 43.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.479 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.12 143.13 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.832 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.51 146.51 27.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.748 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.54 133.69 59.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.86 147.97 26.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -70.16 -16.85 63.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.99 -31.38 72.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 134.85 -18.11 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.81 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -108.01 169.85 8.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.6 -167.43 13.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.344 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 m -155.14 154.64 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.714 0.293 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -153.16 142.35 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.237 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -121.68 113.29 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.603 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 13.9 m-85 -81.39 155.8 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.073 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.07 -26.63 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.771 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 149.22 46.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -69.18 -36.22 77.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -32.56 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.71 -30.22 64.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.463 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.8 ttp -69.53 -65.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 94.7 m -56.71 -34.34 67.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 0.0 111.073 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 174' ' ' LYS . 9.3 t80 -59.46 -49.63 77.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.249 0.547 . . . . 0.0 110.621 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.519 ' O ' HD13 ' A' ' 175' ' ' LEU . . . -60.55 -50.17 74.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.225 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 169' ' ' THR . 15.7 m -58.71 -22.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 111.296 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 169' ' ' THR . 9.5 mtp180 -96.41 -37.18 10.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.339 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 170' ' ' TYR . 0.3 OUTLIER -86.59 -69.11 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.817 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -87.2 45.51 1.28 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 15.8 p-10 -83.43 127.1 33.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 47.96 59.98 3.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.24 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -114.85 173.97 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.426 ' HG3' ' CE1' ' A' ' 189' ' ' TYR . 0.2 OUTLIER -95.16 108.53 20.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.953 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -105.06 157.81 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.367 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CD1' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -132.56 138.65 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 p -81.25 171.0 15.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -55.02 -17.86 4.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -82.99 -22.66 33.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.25 -15.07 39.6 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 123.6 19.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 158.95 15.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.64 155.99 13.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 179' ' ' LYS . 2.0 m-85 -86.37 113.63 22.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.4 pt -119.88 137.61 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.26 152.9 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 t -127.74 137.61 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.263 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -155.55 145.86 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.62 109.29 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.66 93.24 9.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -55.97 158.27 8.62 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.666 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.41 -167.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.649 2.232 . . . . 0.0 112.287 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 131.86 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 0.6 OUTLIER -59.44 -50.89 84.95 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.1 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 199' ' ' SER . 83.8 Cg_exo -47.62 119.26 3.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.619 2.213 . . . . 0.0 112.441 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.5 m -65.78 -68.35 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.979 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 202' ' ' TYR . 0.0 OUTLIER -140.06 -76.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 119.19 119.1 2.8 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.486 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -65.68 -175.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 t 61.01 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -70.4 93.04 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -80.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.963 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 177.22 -178.45 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.8 t -129.39 107.66 9.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -97.39 -53.2 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.973 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.59 168.29 13.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 59.97 31.46 20.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.2 m -114.18 94.45 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 62.77 146.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 69.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.63 31.71 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 63.14 -79.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 5.3 m170 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.93 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.761 0.315 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.413 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . . . -178.47 -61.64 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 107' ' ' ALA . 69.5 Cg_endo -74.56 61.84 5.35 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.502 2.135 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.0 ttm-85 51.36 39.72 24.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.037 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.11 -75.47 1.13 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.455 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.0 88.73 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -93.59 -31.21 14.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.84 -165.51 33.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.83 157.84 58.9 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.529 2.153 . . . . 0.0 112.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.4 -68.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.441 2.094 . . . . 0.0 112.065 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 m 43.95 57.69 4.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.335 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -126.68 -38.89 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -135.73 144.37 45.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.8 m -160.47 56.43 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.021 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.43 30.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 60.32 105.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.49 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -144.02 127.54 16.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.632 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.13 159.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.947 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.46 145.5 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.086 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.21 142.37 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.83 -179.55 5.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.49 32.69 75.53 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 mp -81.24 146.01 57.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.679 0.276 . . . . 0.0 110.85 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.15 169.97 20.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.58 2.187 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.42 -27.27 33.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.508 2.139 . . . . 0.0 112.197 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.36 117.03 22.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.47 175.78 46.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.432 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.66 179.62 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.891 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.431 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 51.3 p-90 -73.14 -39.1 65.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 46.2 tt0 -63.0 -31.08 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 -44.72 84.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.06 -47.05 54.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' CG ' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -56.32 -47.18 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.2 -26.73 65.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.518 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 180' ' ' PHE . 45.7 t-80 -87.93 -29.27 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.37 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.445 ' HE1' ' CE1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.1 -11.16 24.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.605 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -54.58 -21.64 10.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.801 0.334 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -49.91 -24.42 2.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.211 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.01 -26.7 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.941 0.401 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.43 -110.25 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.51 125.31 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.407 ' CG1' ' CG ' ' A' ' 138' ' ' LYS . 84.3 t -97.78 146.07 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.39 -67.48 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -127.82 133.18 49.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.036 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.55 135.94 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -139.93 126.08 19.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.6 m -116.29 142.99 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.922 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -117.13 153.93 31.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.023 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -73.67 -16.43 61.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.1 -26.08 68.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.56 12.14 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.752 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.5 p -143.97 165.93 26.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 110.661 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.21 -161.51 10.88 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.546 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.3 m -156.38 155.77 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.66 0.267 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.3 t -150.78 142.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -123.35 126.28 46.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.56 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.01 177.06 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.3 t -76.29 -68.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 154.44 22.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -71.96 -34.41 68.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.84 -35.17 66.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -32.05 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.61 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.473 ' HA ' ' CE2' ' A' ' 162' ' ' PHE . 3.0 ttp -58.94 -63.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.815 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 173' ' ' ARG . 95.6 m -56.65 -35.04 67.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 15.7 t80 -61.3 -44.85 96.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -67.14 -45.32 77.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.271 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 2.1 m -71.97 -21.97 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 111.273 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 169' ' ' THR . 18.1 mmm180 -90.85 -50.67 5.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.53 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 0.5 OUTLIER -88.62 -52.57 5.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.3 mt -69.33 -4.76 19.5 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 67.6 t0 -53.9 123.83 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.086 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 60.81 76.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.23 161.75 18.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -85.65 93.95 8.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.43 ' HA ' ' CE1' ' A' ' 140' ' ' HIS . 40.7 t80 -74.64 154.69 38.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.81 129.21 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.3 p -97.45 162.93 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -6.1 45.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.239 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.7 18.26 9.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.694 0.283 . . . . 0.0 111.334 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.01 73.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.546 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.05 155.52 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.97 161.05 22.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.96 157.42 11.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.149 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -103.42 114.15 28.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.99 158.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.64 127.67 42.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.09 145.36 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.863 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.58 150.25 24.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.11 118.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -55.1 92.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.326 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 57.56 83.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.679 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.0 -157.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.506 2.137 . . . . 0.0 111.997 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -78.4 113.64 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.725 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.411 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 1.4 t -62.13 -52.1 69.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 199' ' ' SER . 79.8 Cg_exo -44.63 -29.01 3.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.633 2.222 . . . . 0.0 112.658 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.5 m -100.34 115.31 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.17 168.24 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.28 102.29 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.566 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 31.44 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -161.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 72.35 74.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.8 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.3 40.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -98.19 149.5 22.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 79.8 p -177.65 38.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -159.86 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.687 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m 76.97 149.26 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -110.65 114.92 28.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 112.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -169.23 150.72 4.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.805 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.1 t 60.72 31.59 20.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tp -102.09 -161.12 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.826 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 74.64 -67.88 0.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.0 m80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.919 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.57 142.58 94.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.654 0.264 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.1 -168.31 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.561 2.174 . . . . 0.0 112.474 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -98.95 136.23 39.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.804 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.41 -141.57 12.95 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.57 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 29.85 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.985 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -85.8 79.06 9.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.71 -178.67 33.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.73 174.94 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.587 2.191 . . . . 0.0 112.303 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.44 148.74 10.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.678 2.252 . . . . 0.0 112.374 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.9 p -70.53 -169.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -141.89 -44.05 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 70.55 -64.51 0.37 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.83 -167.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 72.95 -1.97 2.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.966 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.86 146.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.095 0.474 . . . . 0.0 111.27 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.407 ' NH1' ' CG1' ' A' ' 159' ' ' VAL . 52.7 ttp85 -144.25 147.68 33.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.6 m -132.77 165.06 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.95 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.77 150.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.145 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.89 121.41 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 t -114.75 158.75 21.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.41 46.72 3.98 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.93 167.31 34.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.83 170.11 19.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.717 2.278 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.72 -25.98 45.99 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -134.6 82.68 1.98 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.71 -165.32 10.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -171.82 176.67 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.426 ' CH2' ' HG2' ' A' ' 135' ' ' GLN . 41.5 p-90 -73.35 -33.94 65.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.735 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HG2' ' CH2' ' A' ' 134' ' ' TRP . 19.4 mt-30 -58.78 -43.23 90.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.789 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.06 -32.3 56.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.441 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 37.3 tp -59.89 -38.17 81.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -43.03 63.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.38 -26.8 68.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.393 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -88.28 -39.91 14.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.425 ' HE1' ' CZ ' ' A' ' 162' ' ' PHE . 2.1 ppp? -80.16 -5.71 56.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.392 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -53.1 -22.62 6.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -31.15 11.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.071 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 170' ' ' TYR . . . -68.43 -28.7 67.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.41 -159.1 25.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -58.91 117.17 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.5 126.11 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 9.0 t -66.93 -63.81 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.727 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 161' ' ' GLU . 7.1 p90 -171.61 150.34 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.88 4.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.22 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -163.38 153.69 15.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.97 122.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.04 139.64 52.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 76.1 0.62 3.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.726 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.93 11.84 8.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.11 -53.05 0.14 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.56 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.7 p -98.96 159.94 14.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.817 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -144.73 179.54 21.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.608 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.407 ' CG1' ' NH1' ' A' ' 122' ' ' ARG . 22.9 m -137.43 154.44 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.991 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.7 t -142.6 126.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.179 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 149' ' ' TYR . 2.5 mt-10 -111.99 130.04 55.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.727 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CZ ' ' HE1' ' A' ' 141' ' ' MET . 0.7 OUTLIER -109.51 137.62 47.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.971 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.62 -28.85 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -129.3 142.39 50.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -59.04 -27.49 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.205 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -54.98 -46.33 75.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.099 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -32.56 68.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.2 ttp -61.49 -66.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.4 m -54.84 -35.76 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 15.7 t80 -61.57 -47.93 83.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.06 74.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.8 m -65.61 -22.84 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.5 -72.64 0.4 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.122 0.487 . . . . 0.0 110.453 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -54.67 12.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.92 76.64 6.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.802 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -141.38 134.51 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.71 25.84 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.16 -174.33 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 145.19 38.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 29.8 t80 -93.16 158.61 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 1.3 tmt_? -125.85 107.17 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.71 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 p -75.74 151.14 37.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -54.67 -23.06 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.44 -19.5 61.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.12 -6.2 36.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.81 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.95 159.62 23.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.747 0.308 . . . . 0.0 110.838 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.7 161.0 29.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.118 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.09 16.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.03 115.66 15.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.54 161.7 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.184 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.11 113.09 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.3 t -91.0 159.08 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.03 144.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.85 134.69 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -46.77 159.57 0.1 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.272 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.67 -102.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.91 169.69 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.544 2.163 . . . . 0.0 112.469 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 171.59 7.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.411 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER -92.44 -53.0 0.27 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 30.2 Cg_exo -61.68 92.95 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.443 2.095 . . . . 0.0 112.024 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -116.41 166.54 11.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.5 -65.6 0.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.201 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.81 -92.64 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.814 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 117.5 29.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -78.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -176.06 -42.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -115.05 -169.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 -47.0 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.9 p -151.3 174.9 12.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -2.5 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.368 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.3 p 59.59 109.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -79.76 76.46 6.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -170.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.17 122.43 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.3 m 60.45 173.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.1 tp -111.99 54.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 218' ' ' HIS . 15.6 mt-10 -85.94 111.6 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' A' ' 217' ' ' GLU . 27.9 p-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.421 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.4 mtm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.899 0.38 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 108' ' ' PRO . . . -131.63 52.57 9.51 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 107' ' ' ALA . 72.6 Cg_endo -76.39 171.95 17.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 112.354 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.94 155.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.74 69.79 1.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.549 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.65 173.36 10.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 110.838 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.82 172.36 6.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -132.4 149.98 19.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.517 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.09 111.07 3.09 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.06 -173.89 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.493 2.129 . . . . 0.0 112.058 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -167.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 3.7 ttm-85 -158.89 -38.1 0.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.989 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER 178.07 146.82 0.14 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.045 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.425 ' N ' ' HG3' ' A' ' 118' ' ' ARG . 62.5 p -106.33 150.64 25.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.542 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -143.59 41.09 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.246 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -130.2 44.79 2.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.901 0.381 . . . . 0.0 110.669 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -109.18 168.33 9.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.098 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.22 159.88 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.8 t -106.06 146.33 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 157' ' ' THR . 12.3 p -121.9 150.77 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -137.15 170.91 15.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.918 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.94 44.31 96.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.46 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.422 ' N ' HD21 ' A' ' 128' ' ' LEU . 3.5 mm? -83.92 140.48 40.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.647 0.261 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.95 170.46 20.37 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.538 2.159 . . . . 0.0 112.204 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.04 -26.83 65.83 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.17 . . . . 0.0 112.265 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.0 34.84 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.49 111.6 3.88 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.469 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.57 179.61 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.802 0.334 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.447 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 47.5 p-90 -68.63 -41.72 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.447 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.5 OUTLIER -70.55 -36.06 73.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.78 -57.96 10.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.71 -47.02 88.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.416 ' CG ' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.04 -43.76 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.186 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.56 -26.33 65.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.604 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -88.16 -21.14 24.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.695 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 11.0 ptm -112.38 1.62 16.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.84 -17.59 56.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.89 -21.89 4.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.85 68.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.162 0.506 . . . . 0.0 110.481 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.3 -104.47 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.73 107.34 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 110.771 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.416 ' CG1' ' CG ' ' A' ' 138' ' ' LYS . 96.4 t -79.25 125.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.27 -52.4 6.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -140.57 160.01 40.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.165 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -159.4 134.98 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -146.52 114.4 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.17 112.11 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.227 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -69.22 155.23 40.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -92.68 37.53 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -114.96 -28.85 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 147.87 -21.49 1.45 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 12.0 p -129.09 167.01 18.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.584 0.23 . . . . 0.0 111.059 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.02 -161.43 8.75 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.242 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 m -158.02 144.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -141.06 149.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.925 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.41 134.57 48.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.306 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -121.39 132.71 54.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.157 179.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 164' ' ' ARG . 5.2 p -70.08 65.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 111.183 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 7.3 ttm-85 172.82 127.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.144 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.18 -40.4 96.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -58.93 -37.27 76.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.56 -34.77 72.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.407 ' HE1' ' N ' ' A' ' 169' ' ' THR . 7.8 ttp -60.83 -63.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.414 ' HA ' HG23 ' A' ' 172' ' ' VAL . 70.5 m -61.69 -33.45 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 11.6 t80 -63.55 -48.58 76.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.88 82.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 176' ' ' ASP . 26.6 m -64.04 -22.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.409 ' CZ ' ' CG2' ' A' ' 169' ' ' THR . 0.0 OUTLIER -93.34 -75.11 0.51 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 3.9 mmtt -57.17 -49.19 76.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.64 58.53 3.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.602 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 6.0 t0 -122.86 135.61 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 44.1 t30 54.02 29.76 10.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.87 177.38 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 103.56 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -68.93 117.47 10.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.79 105.28 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 144.09 29.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -21.65 64.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.623 0.249 . . . . 0.0 111.073 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 31.0 3.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.725 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.36 134.66 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 156.57 22.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.9 143.85 2.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -83.62 120.25 25.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 40.0 pt -112.67 155.6 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.21 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.7 t -103.04 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -147.16 145.31 29.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.07 124.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.073 0.463 . . . . 0.0 110.724 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -42.27 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.722 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 63.77 123.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.289 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.05 -48.27 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.443 2.095 . . . . 0.0 112.534 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 138.28 51.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.968 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.55 146.96 4.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 -175.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.302 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 12.8 p 58.56 -179.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 60.46 80.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 155.14 -77.17 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.59 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.17 148.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 110.953 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.2 p -132.68 -85.56 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 61.74 2.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 111.239 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -106.54 -168.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.95 159.06 21.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.45 -162.79 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.71 96.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 t -171.01 91.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? 60.73 71.71 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 28.0 m -59.63 -58.46 8.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.01 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 69.72 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.969 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.2 p -141.39 110.64 6.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.73 -179.25 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -100.36 -36.65 9.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.895 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.794 0.33 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.87 120.88 45.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.64 -55.04 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.373 2.049 . . . . 0.0 112.331 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.59 170.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.5 -157.18 20.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.66 -113.36 0.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.01 -0.112 . . . . 0.0 110.755 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 112' ' ' TYR . 11.8 t80 179.86 56.73 0.01 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.846 0.355 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 114' ' ' PRO . . . -178.1 49.89 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.892 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HG2' ' HD3' ' A' ' 115' ' ' PRO . 3.9 Cg_exo -41.0 -51.26 3.85 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.996 2.464 . . . . 0.0 112.728 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.435 ' HD3' ' HG2' ' A' ' 114' ' ' PRO . 79.8 Cg_exo -47.36 -59.02 1.4 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.462 2.108 . . . . 0.0 112.471 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.69 124.51 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -159.98 33.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -128.24 -53.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.02 31.07 19.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.32 30.08 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -152.58 98.62 2.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 161.79 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.86 149.35 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.027 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.2 t -117.24 144.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.83 146.44 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -149.22 117.14 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.11 39.67 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.493 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mp -99.22 155.12 36.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.5 166.52 29.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.543 2.162 . . . . 0.0 112.397 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.17 -27.53 35.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.3 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.94 36.59 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.805 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -93.02 123.37 7.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 p -94.3 150.99 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 0.0 110.798 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.44 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 30.7 p-90 -74.02 -40.02 63.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -55.55 -40.58 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.27 -32.55 55.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.43 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 68.7 tp -61.63 -42.24 98.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -47.45 68.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.97 -26.74 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.032 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 181' ' ' ARG . 39.5 t-80 -86.1 -31.48 21.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.18 3.61 55.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.451 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -55.56 -20.87 14.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.462 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -49.69 -32.56 13.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 111.003 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 170' ' ' TYR . . . -70.9 -29.42 65.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.756 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.75 -172.79 26.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.414 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.22 106.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.1 t -74.07 125.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.043 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -56.17 4.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -154.03 148.34 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -143.6 141.23 30.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.181 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -143.41 141.67 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.29 115.95 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.249 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.85 155.36 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 35.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.294 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -114.76 -22.62 9.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.196 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 31.36 1.1 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 p -161.26 169.97 21.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.744 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.84 175.38 32.16 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.632 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -142.83 142.05 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.312 . . . . 0.0 111.061 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.55 157.91 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.68 128.31 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 68.3 m-85 -108.53 154.52 21.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -71.04 -68.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.22 162.26 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -50.08 30.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.015 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -32.4 46.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -35.88 72.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.408 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 5.2 ttp -67.62 -59.76 3.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.321 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.8 m -50.58 -35.06 28.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.855 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 49.6 t80 -64.23 -46.95 81.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.733 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.44 -43.05 79.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.0 m -79.92 -34.69 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.411 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 11.9 ptt85 -79.68 -30.33 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.715 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 170' ' ' TYR . 0.1 OUTLIER -106.98 -57.3 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.207 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.4 mt -81.24 66.75 6.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -116.89 131.23 57.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.2 m120 57.63 30.37 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.1 p -73.33 -177.67 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.979 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 95.09 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.026 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 5.9 t80 -68.95 135.35 50.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.612 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 140' ' ' HIS . 4.0 ttm-85 -116.52 100.91 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.4 t -60.85 161.3 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -9.68 58.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.084 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 21.69 6.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.341 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 27.34 73.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.617 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.57 134.6 54.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.27 156.42 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.96 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.31 160.31 26.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -98.27 110.97 23.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.53 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 13.7 pt -107.13 136.26 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.463 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.37 109.83 22.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.16 142.01 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.246 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -150.37 157.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.78 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 25.3 t -78.01 114.85 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -47.68 -65.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.28 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 82.27 -107.32 2.79 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.423 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 32.3 Cg_exo -58.42 -151.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.642 2.228 . . . . 0.0 112.057 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 197' ' ' PRO . 15.2 mtp85 81.0 -127.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.411 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.4 OUTLIER -33.14 -54.86 0.64 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 53.6 Cg_exo -52.14 -58.82 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.365 2.043 . . . . 0.0 112.084 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.5 m 61.77 118.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.73 27.84 5.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.44 -171.48 18.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.69 -43.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -53.96 52.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -140.11 66.43 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.4 t -137.55 70.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 43.27 65.49 0.96 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.507 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.74 146.81 35.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -150.37 56.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.5 p 58.28 -169.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 -166.25 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.6 m 61.8 -124.25 0.79 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.599 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -154.86 26.36 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.73 0.3 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.73 -173.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 126.06 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.794 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -123.61 -167.38 1.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.977 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 217' ' ' GLU . 46.0 p-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.326 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.829 0.347 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.404 ' HB3' ' CG ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -144.06 144.89 31.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.18 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 194' ' ' VAL . 34.0 m -113.33 165.14 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 158' ' ' GLY . 12.3 p -117.04 143.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.75 152.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.5 p -143.07 123.08 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 130.51 41.53 0.23 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -86.29 144.17 37.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.89 170.68 19.85 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.555 2.17 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.49 -26.25 70.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.62 2.213 . . . . 0.0 112.191 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -124.49 74.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.77 167.97 24.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -146.39 167.93 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.427 ' HB3' HG22 ' A' ' 152' ' ' VAL . 61.5 p-90 -65.7 -42.16 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 29.7 tp60 -58.77 -36.23 74.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -73.49 -29.7 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.92 -42.45 66.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.748 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.808 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.978 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.78 -26.85 58.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.233 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.43 -41.16 14.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.861 ' SD ' HG21 ' A' ' 160' ' ' VAL . 0.0 OUTLIER -73.68 -22.87 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -46.12 -29.9 1.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.246 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -30.4 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.733 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.11 -28.85 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.04 -134.41 3.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.405 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -103.97 103.86 13.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.808 HG11 ' CG ' ' A' ' 138' ' ' LYS . 99.5 t -73.85 141.93 15.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.969 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.3 p -112.29 -29.32 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -154.71 147.36 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.35 127.26 6.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.13 153.64 51.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 152' ' ' VAL . 34.4 m -143.1 124.72 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -82.71 154.99 24.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.33 -33.63 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.52 -30.34 2.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.627 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -95.32 160.63 14.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -138.46 -166.26 10.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.576 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -155.6 145.51 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.861 HG21 ' SD ' ' A' ' 141' ' ' MET . 24.5 t -133.9 150.15 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.22 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.2 mt-10 -131.85 136.6 47.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.774 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -116.92 160.3 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.08 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.98 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.801 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -25.69 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -47.05 58.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.28 -28.0 62.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.456 ' O ' HG22 ' A' ' 172' ' ' VAL . 10.9 ttp -67.0 -62.91 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' CG2' ' A' ' 172' ' ' VAL . 67.0 m -58.96 -32.92 70.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.029 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -64.98 -44.64 88.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -65.59 -48.16 73.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.894 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.894 HG23 ' HD3' ' A' ' 173' ' ' ARG . 11.0 m -65.14 -22.12 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.894 ' HD3' HG23 ' A' ' 172' ' ' VAL . 6.1 mpt_? -93.13 -75.45 0.49 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.076 0.465 . . . . 0.0 111.189 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -40.95 95.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 144' ' ' ALA . 29.0 mt -89.58 23.84 2.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 38.4 t70 -83.65 131.22 34.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.73 61.63 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 p -113.27 146.67 38.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.744 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.21 112.12 8.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -80.85 148.4 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 126.5 46.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.9 p -97.01 146.0 25.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -55.92 -22.94 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -23.12 63.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.96 30.75 4.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -130.19 133.09 46.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.91 161.0 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.23 130.21 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -70.94 114.38 8.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 127' ' ' GLY . 22.0 pt -116.74 151.24 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -131.36 135.37 47.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.35 148.22 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.237 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -156.05 140.12 16.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 123' ' ' VAL . 23.8 t -70.25 118.58 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.203 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.156 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -131.38 133.45 45.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 160' ' ' VAL . 3.5 m -103.8 165.16 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.085 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.27 146.27 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.37 144.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -137.97 125.5 22.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.43 40.28 2.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.27 153.58 92.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.27 169.51 20.56 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -27.28 24.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.577 2.185 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -143.03 127.06 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.4 162.72 24.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.81 153.42 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 135' ' ' GLN . 42.8 p-90 -74.0 -30.07 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 50.8 mt-30 -58.99 -42.99 91.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -77.15 -21.39 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.926 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 152' ' ' VAL . 29.9 tp -70.17 -47.11 63.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.936 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -40.7 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 142' ' ' ARG . 4.5 m-20 -65.96 -26.65 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.81 -31.9 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -93.16 -2.82 54.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.435 ' HG2' HG23 ' A' ' 147' ' ' VAL . 4.0 mmm-85 -62.67 -15.87 54.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.476 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.74 -31.59 11.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.824 0.345 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 1.113 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.38 -31.41 70.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.513 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.94 -98.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.94 156.39 46.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 142' ' ' ARG . 75.0 t -126.82 149.4 31.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.5 t -117.33 -52.3 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -128.78 149.62 50.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.71 134.57 11.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.026 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 159' ' ' VAL . 4.3 m-20 -149.15 134.66 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 137' ' ' LEU . 29.6 m -128.33 118.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -103.46 131.66 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.0 mtm105 -62.34 96.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -171.45 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 157' ' ' THR . . . 137.53 37.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.74 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 156' ' ' GLY . 1.8 p -166.05 172.36 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.46 173.42 36.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 151' ' ' ASP . 5.8 m -141.7 134.26 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 123' ' ' VAL . 12.9 t -140.28 127.2 22.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -98.17 108.37 21.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.51 156.76 32.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.13 -67.33 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 144.97 24.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.83 -40.58 97.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.77 -42.62 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -31.83 69.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.5 ttp -67.22 -62.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 98.9 m -53.24 -32.73 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.416 ' CE2' ' HG2' ' A' ' 174' ' ' LYS . 88.5 t80 -62.77 -46.95 85.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.482 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -59.16 -47.55 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.574 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 169' ' ' THR . 16.2 m -63.29 -22.64 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.026 0.441 . . . . 0.0 110.793 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -85.59 -71.93 0.51 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.268 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -78.68 -36.76 43.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.035 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 1.113 HD12 ' HB2' ' A' ' 144' ' ' ALA . 76.1 mt -90.51 47.69 1.46 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -108.88 127.33 53.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.831 0.348 . . . . 0.0 110.679 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.9 31.55 18.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -171.92 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -111.15 118.13 35.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 10.8 t80 -97.41 135.06 39.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -122.17 117.36 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.7 p -80.13 149.61 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -54.74 -23.72 19.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -73.72 -23.07 59.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.984 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.17 5.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.86 110.34 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.83 154.41 20.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.001 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.89 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.55 129.74 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.62 143.27 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.291 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -109.95 122.25 47.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.06 151.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -156.63 169.22 25.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.44 118.97 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.765 0.317 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -131.58 142.31 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.658 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 160' ' ' VAL . 28.2 m -106.96 165.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.63 140.1 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.545 ' CG2' HG23 ' A' ' 160' ' ' VAL . 15.3 t -106.38 140.23 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.56 120.27 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.62 1.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.414 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -75.51 150.05 84.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 171.02 16.45 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.257 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 -32.59 21.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.589 2.193 . . . . 0.0 112.276 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 t -123.89 115.51 21.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.54 177.05 48.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.22 -175.53 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 32.0 p-90 -67.59 -42.2 82.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.856 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.3 OUTLIER -59.74 -50.57 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.723 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.29 -37.39 85.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.652 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.28 -45.57 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.45 -28.33 68.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.107 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.392 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.21 12.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.64 ' HG3' HG21 ' A' ' 160' ' ' VAL . 30.4 mmm -76.87 -25.57 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.216 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -51.54 -25.27 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.321 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -23.73 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.312 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.15 -26.45 66.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.658 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.79 -65.61 0.34 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.39 125.62 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.074 0.464 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 142' ' ' ARG . 89.7 t -101.02 146.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.23 -29.66 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.211 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 56.5 t80 -154.76 160.05 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 111.211 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -157.04 177.33 11.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.85 156.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.97 147.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -123.98 109.23 13.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 mtt85 55.55 -87.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -176.24 36.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 110.93 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 157' ' ' THR . . . -118.6 -44.59 0.5 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.422 ' CA ' HD23 ' A' ' 128' ' ' LEU . 10.4 p -156.67 161.09 39.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.71 -157.48 7.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.573 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.508 HG21 ' NH2' ' A' ' 122' ' ' ARG . 30.5 m -156.09 142.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 141' ' ' MET . 21.9 t -134.22 119.88 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -104.35 123.25 47.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 23.0 m-85 -99.41 167.57 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.27 -69.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.86 163.92 13.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -26.1 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -57.16 -41.49 79.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -30.06 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.417 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 4.6 ttp -61.01 -63.72 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 172' ' ' VAL . 97.9 m -57.52 -35.53 70.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.071 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 21.0 t80 -62.56 -47.3 84.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.45 . . . . 0.0 110.653 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.86 84.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.809 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 192' ' ' VAL . 25.6 m -61.64 -22.75 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.546 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -76.49 0.55 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 8.6 mmtt -58.08 -42.6 85.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.623 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.63 36.16 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.207 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 11.9 t0 -94.51 120.07 34.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.642 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 61.81 66.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.6 p -115.75 170.02 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 131.67 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -109.67 145.27 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.89 116.36 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.99 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -88.7 155.7 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -54.54 -22.69 13.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -19.25 61.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.29 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.732 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.9 150.28 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.21 154.98 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.999 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 172.07 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.262 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -106.45 120.12 41.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.59 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 pt -106.31 145.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -118.99 124.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 172' ' ' VAL . 15.0 t -95.6 141.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.264 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 147.82 26.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -71.44 116.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 t0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.215 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 170.01 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.152 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.5 p -130.49 160.72 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.504 ' N ' HG22 ' A' ' 123' ' ' VAL . 14.3 p -122.26 143.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 126' ' ' SER . 21.5 t -125.03 159.12 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -141.26 170.91 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 65.45 44.37 93.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 157' ' ' THR . 3.9 mm? -78.48 155.23 78.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.735 0.302 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 171.71 11.55 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 112.405 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.12 -26.62 73.03 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.613 2.209 . . . . 0.0 112.346 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -135.9 122.14 20.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.63 -172.72 33.37 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.2 p -172.62 -177.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 44.7 p-90 -59.94 -37.47 79.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 21.6 tt0 -70.38 -32.05 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -68.93 -50.32 50.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.79 HD22 ' CG1' ' A' ' 152' ' ' VAL . 11.3 tp -67.6 -44.85 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.89 -40.38 63.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -61.14 -26.73 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.236 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -86.72 -43.6 12.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.705 ' HG3' HG21 ' A' ' 160' ' ' VAL . 77.6 mmm -69.51 -26.32 64.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -45.31 -33.14 2.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.268 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.36 -33.82 63.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.03 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.99 -140.22 6.87 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.511 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 128.99 39.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.735 HG22 ' HD2' ' A' ' 162' ' ' PHE . 89.5 t -102.72 127.07 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.95 -26.23 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 35.4 t80 -151.73 153.87 35.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.399 . . . . 0.0 111.311 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.429 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.07 149.04 11.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.915 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.51 124.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.79 ' CG1' HD22 ' A' ' 137' ' ' LEU . 30.6 m -122.01 142.51 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.035 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.96 155.12 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -72.5 -10.95 60.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.397 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.59 -23.18 66.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.25 24.43 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.616 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.478 ' HA ' HD23 ' A' ' 128' ' ' LEU . 33.4 p -155.54 160.26 40.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.26 -175.79 25.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 141' ' ' MET . 12.5 t -127.61 133.44 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.3 118.59 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.735 ' HD2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -114.62 139.32 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.627 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 163' ' ' VAL . 6.4 p -71.18 65.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.926 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER 178.81 125.51 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -72.11 -44.84 62.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.546 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.42 -27.79 68.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.668 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.15 -40.59 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.548 ' SD ' HG13 ' A' ' 194' ' ' VAL . 2.0 ttp -59.65 -59.22 5.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.9 m -58.35 -36.44 73.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.357 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -62.89 -45.14 93.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -63.64 -44.9 92.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 192' ' ' VAL . 24.0 m -71.87 -22.38 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.707 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 17.8 ptt180 -96.31 -26.53 15.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.602 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 73.9 mmtt -110.71 -60.81 1.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.959 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.4 mt -63.08 -15.82 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 178' ' ' THR . 16.6 p-10 -64.1 159.26 20.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 50.18 58.6 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.196 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 176' ' ' ASP . 76.1 p -140.51 164.01 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.978 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -87.96 123.59 32.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -99.25 149.78 22.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 142.46 50.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.5 p -95.56 151.51 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -52.98 -23.97 8.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.79 -22.3 53.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.08 26.68 5.65 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.549 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -107.88 115.62 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.04 152.16 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 135.25 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 135.62 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 127' ' ' GLY . 37.0 pt -131.25 161.43 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.374 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -127.7 128.42 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.637 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 172' ' ' VAL . 4.3 t -111.48 142.95 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.318 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -165.17 141.04 5.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 172' ' ' VAL . 23.2 t -59.05 113.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 3.2 m120 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.583 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 2.1 tmm_? -143.59 142.63 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.044 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.4 p -104.25 159.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 193' ' ' LYS . 8.6 p -118.98 152.66 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.25 148.67 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.573 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -141.2 127.98 20.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.798 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.514 ' C ' HG22 ' A' ' 190' ' ' ILE . . . 127.55 -0.65 6.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.924 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.806 HD12 HG21 ' A' ' 190' ' ' ILE . 1.6 mp -56.78 151.44 32.03 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.817 0.341 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.57 171.86 10.11 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.158 . . . . 0.0 112.161 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.02 -25.63 51.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.424 2.083 . . . . 0.0 112.4 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 125.52 15.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -170.37 -179.63 41.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.4 m -130.8 149.48 52.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.737 0.303 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -63.59 -33.38 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.26 -31.69 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.0 -50.3 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 23.1 tp -60.23 -45.81 91.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' HG22 ' A' ' 147' ' ' VAL . 9.6 tttm -57.43 -39.95 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.97 -26.96 61.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.489 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -91.19 -22.74 20.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.466 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 4.0 ppp? -99.58 -12.77 19.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.574 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -52.72 -24.92 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.748 0.308 . . . . 0.0 111.446 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -24.4 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.853 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -66.89 -28.18 68.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.562 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 -129.9 2.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.363 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -103.19 108.59 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.067 0.46 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' HE2' ' A' ' 138' ' ' LYS . 12.0 p -106.12 139.92 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.24 -40.42 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.405 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 161' ' ' GLU . 7.8 t80 -117.83 145.17 44.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 160' ' ' VAL . . . -162.97 133.18 4.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.63 141.48 48.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.965 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.603 HG12 HD21 ' A' ' 128' ' ' LEU . 28.6 m -128.96 114.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.024 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -85.57 143.78 28.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -73.84 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.42 -49.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.65 -26.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 126' ' ' SER . 30.3 p -106.77 164.26 12.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.68 -175.91 20.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.53 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.583 HG11 ' CZ ' ' A' ' 122' ' ' ARG . 26.6 m -143.42 154.48 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 123' ' ' VAL . 2.0 t -149.32 150.28 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 149' ' ' TYR . 0.9 OUTLIER -132.18 116.22 16.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.788 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 141' ' ' MET . 5.3 m-85 -92.68 173.78 7.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.59 -70.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 157.92 16.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -56.16 -32.08 63.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -55.34 -39.99 70.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.12 -30.65 66.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.433 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 7.0 ttp -70.49 -63.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.4 m -53.14 -34.07 55.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.021 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.78 -48.31 79.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.515 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -55.79 -50.66 69.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.245 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 192' ' ' VAL . 16.0 m -62.64 -25.95 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -72.23 0.42 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -56.1 6.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.118 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.853 HD12 ' HB2' ' A' ' 144' ' ' ALA . 46.8 mt -77.19 72.74 3.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.846 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -133.46 120.94 21.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.9 t30 62.04 39.51 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.713 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -92.31 179.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.937 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.472 ' N ' ' OG1' ' A' ' 178' ' ' THR . 6.6 tttp -98.94 125.99 44.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.9 t80 -103.63 143.41 32.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.726 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.39 116.91 26.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.82 152.87 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -68.52 -14.22 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.253 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.83 -23.1 64.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.284 . . . . 0.0 111.112 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.82 31.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.513 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -139.3 144.11 38.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.358 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 154.65 26.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.9 147.61 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.202 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.05 146.05 28.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.806 HG21 HD12 ' A' ' 128' ' ' LEU . 29.8 pt -136.4 145.69 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 127.99 54.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 172' ' ' VAL . 8.9 t -103.7 143.47 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 124' ' ' VAL . 12.8 mttt -161.31 144.49 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.9 p -64.32 113.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 t0 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.98 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 121' ' ' ASN . 9.2 t30 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.751 0.31 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -117.72 150.27 39.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.5 p -133.95 159.98 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.492 ' N ' HG22 ' A' ' 123' ' ' VAL . 9.8 p -124.04 147.83 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 126' ' ' SER . 26.7 t -118.13 157.8 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 125' ' ' VAL . 35.8 t -161.18 123.36 3.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.09 39.48 0.64 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.95 154.84 45.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.672 0.272 . . . . 0.0 110.758 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 12.6 Cg_endo -55.98 166.24 3.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 0.0 112.21 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.74 -27.55 20.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.678 2.252 . . . . 0.0 112.484 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 129.46 15.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.09 -163.68 13.99 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -153.01 162.55 41.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HB3' HG22 ' A' ' 152' ' ' VAL . 60.4 p-90 -74.12 -39.18 63.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -36.91 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -36.0 66.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 22.8 tp -63.17 -45.14 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -28.12 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.186 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -67.07 -26.7 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.29 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -96.26 -27.95 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.304 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 147' ' ' VAL . 38.6 mmm -83.58 -26.28 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.248 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.519 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -51.5 -27.57 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.426 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -53.69 -22.52 9.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.51 66.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 0.0 110.64 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.5 -59.58 0.36 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.369 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -174.38 107.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 141' ' ' MET . 84.7 t -88.67 132.05 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.52 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -133.35 145.26 50.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.75 133.94 6.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -138.12 152.21 48.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 134' ' ' TRP . 2.9 m -144.39 107.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.68 100.69 6.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 64.15 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -179.13 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.04 10.86 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.062 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.436 HG22 ' CB ' ' A' ' 126' ' ' SER . 54.5 p -157.63 174.54 15.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -160.86 -166.22 19.18 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.414 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 151' ' ' ASP . 24.7 m -149.86 159.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 111.016 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.42 145.25 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.09 137.09 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.706 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 147' ' ' VAL . 34.3 m-85 -113.56 175.67 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.66 -70.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.83 157.97 15.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -58.14 -29.16 65.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.54 -34.95 76.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.9 -38.48 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.5 ttp -70.79 -62.23 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 173' ' ' ARG . 92.5 m -53.38 -36.81 61.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 28.4 t80 -63.79 -46.54 84.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -54.9 -46.14 74.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 192' ' ' VAL . 15.9 m -68.91 -23.03 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.549 ' HD2' HG22 ' A' ' 169' ' ' THR . 10.2 mtp180 -87.01 -67.2 0.83 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.975 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 1.5 mptp? -76.81 -48.38 18.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.736 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 52.3 mt -84.49 58.48 4.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -117.84 129.84 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.739 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.16 39.44 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.708 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.2 p -81.37 177.61 8.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.94 99.25 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.0 t80 -88.72 152.67 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.89 140.05 40.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.21 155.05 22.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.637 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -53.03 -22.83 6.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -75.73 -21.07 57.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 20.84 8.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.771 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 116.19 32.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.733 0.301 . . . . 0.0 110.715 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 156.94 18.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -165.1 166.04 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.25 119.58 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.9 pt -108.32 141.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.98 0.419 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -106.38 128.63 54.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 172' ' ' VAL . 3.9 t -111.76 142.89 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.084 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.96 140.84 8.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.3 110.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.4 p30 . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.61 0.243 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 119.96 25.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.6 p -102.62 160.12 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 193' ' ' LYS . 11.6 p -120.46 143.71 31.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -129.99 158.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 125' ' ' VAL . 21.4 p -146.75 146.42 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 95.29 46.14 2.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.559 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.61 145.48 37.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.639 0.257 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.92 170.67 19.15 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.381 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.71 -27.47 52.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 31.08 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.72 118.76 5.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.03 168.91 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 58.6 p-90 -62.59 -41.75 99.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -61.58 -33.73 74.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.429 ' OD2' ' CE1' ' A' ' 183' ' ' HIS . 8.7 t0 -77.03 -38.39 52.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.202 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.84 -44.3 32.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.273 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.791 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.1 ttmm -53.19 -39.71 63.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -71.63 -26.7 62.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.621 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -26.01 20.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.422 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.694 ' CE ' HG11 ' A' ' 160' ' ' VAL . 3.3 ppp? -97.01 -10.25 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -18.78 30.89 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.516 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.93 -25.79 3.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -69.57 -27.42 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.745 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.54 -125.87 1.79 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.457 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.459 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.791 HG11 ' HG3' ' A' ' 138' ' ' LYS . 84.0 t -79.94 130.94 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.047 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 -29.44 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -163.28 146.95 10.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.97 136.64 19.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -152.07 125.11 8.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 158' ' ' GLY . 31.3 m -127.88 131.49 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -98.24 155.01 17.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -10.18 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.411 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -29.0 70.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 157' ' ' THR . . . 123.45 36.46 0.64 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.592 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' GLY . 16.7 p -160.3 160.77 32.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.849 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 152' ' ' VAL . . . -149.97 176.78 28.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.576 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.3 m -147.69 146.87 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.324 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.694 HG11 ' CE ' ' A' ' 141' ' ' MET . 3.5 t -141.66 147.78 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.08 126.14 33.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 1.0 OUTLIER -104.98 166.9 10.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.59 -72.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 151.05 24.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.99 -27.53 5.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.246 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -53.98 -44.16 70.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -30.07 64.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.439 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.1 ttp -65.03 -63.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.1 m -57.69 -34.04 69.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.51 80.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.616 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 192' ' ' VAL . 4.5 m -65.22 -24.81 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.446 ' HD2' HG23 ' A' ' 172' ' ' VAL . 0.0 OUTLIER -76.74 -73.05 0.31 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.233 0.539 . . . . 0.0 110.296 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -58.26 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.7 mt -77.27 81.52 3.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.45 138.57 19.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.49 46.64 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -109.83 173.25 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.445 ' HD3' ' CD1' ' A' ' 189' ' ' TYR . 0.3 OUTLIER -105.32 103.37 12.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.93 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -68.89 120.17 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.54 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.24 100.8 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.532 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.05 136.87 56.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.429 ' CE1' ' OD2' ' A' ' 136' ' ' ASP . 1.7 p80 -59.37 -19.83 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.187 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -68.77 -17.48 64.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.258 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.99 31.04 3.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.56 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -131.74 138.5 48.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.06 156.8 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 138.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.445 ' CD1' ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -79.21 128.77 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 127' ' ' GLY . 5.4 pt -125.14 140.77 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.371 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -112.7 134.94 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 172' ' ' VAL . 12.2 t -109.62 141.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.362 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 124' ' ' VAL . 39.8 mttp -153.34 137.87 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 194' ' ' VAL . 11.1 p -67.06 115.38 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.175 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.803 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.901 0.382 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -123.42 121.95 37.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.849 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 194' ' ' VAL . 26.1 m -106.97 161.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 158' ' ' GLY . 24.4 t -113.38 140.7 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -120.1 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.0 p -111.71 132.99 54.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.58 35.85 0.96 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 137' ' ' LEU . 4.0 mm? -87.88 153.52 52.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 161.74 44.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.477 2.118 . . . . 0.0 112.301 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 -31.43 20.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 90.57 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.63 -163.34 11.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.59 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 170.72 20.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -60.29 -44.25 95.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.797 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -60.47 -31.64 70.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -53.22 60.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.606 HD13 HD11 ' A' ' 128' ' ' LEU . 63.2 tp -60.0 -40.16 88.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.68 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -60.75 -39.66 89.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.908 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.98 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -87.99 -35.11 17.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.503 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -71.31 -25.21 62.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.4 mtt-85 -46.77 -30.2 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -30.36 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.51 -27.42 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 151.15 -100.43 0.2 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -131.1 111.05 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.961 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 138' ' ' LYS . 95.1 t -78.17 151.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 40.7 t -112.7 -31.82 6.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -165.59 150.41 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.95 173.37 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -176.9 135.01 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.429 HG12 ' HG ' ' A' ' 128' ' ' LEU . 4.2 m -125.56 101.19 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 19.2 p90 -124.12 155.84 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 0.2 OUTLIER 89.38 -4.98 0.4 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.355 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 63.14 31.53 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.94 -45.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.3 p -104.84 160.1 15.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.375 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -159.06 -179.32 33.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.265 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.6 p -146.07 159.52 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.222 0.534 . . . . 0.0 111.208 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 46.0 t -154.74 141.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.2 125.47 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.37 177.13 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.86 -69.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -88.36 149.84 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -61.33 -34.19 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.58 -33.44 72.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.73 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.446 ' OD1' ' HB1' ' A' ' 144' ' ' ALA . 36.9 t0 -72.18 -37.93 69.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.526 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.47 -63.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.428 ' HA ' HG22 ' A' ' 172' ' ' VAL . 53.9 m -53.73 -31.46 48.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 4.3 t80 -60.43 -50.51 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.244 0.545 . . . . 0.0 110.12 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 175' ' ' LEU . . . -57.55 -53.87 53.27 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 169' ' ' THR . 13.9 m -54.82 -22.71 10.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.351 . . . . 0.0 111.752 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -71.75 0.69 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.042 0.449 . . . . 0.0 112.111 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -67.74 -45.55 74.65 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -123.31 84.16 2.23 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.826 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 2.4 p-10 -129.51 -102.03 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.321 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 190' ' ' ILE . 59.3 t30 -67.62 56.28 0.06 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.467 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -109.39 -167.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -91.36 140.98 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -118.67 133.3 55.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -123.27 119.12 29.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.9 t -79.11 149.83 31.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -55.39 -23.46 24.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.22 -23.0 63.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.13 28.83 4.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.0 136.77 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.69 156.22 18.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.52 168.31 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.43 109.98 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 21.6 pt -102.1 158.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 177' ' ' ASN . 1.2 tmm_? -139.08 117.36 11.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.6 151.45 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.9 144.03 6.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.5 t -61.31 119.71 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 14.6 t0 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.926 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.765 0.317 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -79.92 158.07 26.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.7 p -144.18 160.01 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.496 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.7 p -123.2 141.07 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.09 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -118.82 155.61 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 125' ' ' VAL . 11.0 t -145.46 138.46 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 100.89 37.0 3.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.33 152.98 92.25 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.76 171.84 10.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.313 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.99 -28.49 80.7 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.638 2.225 . . . . 0.0 112.249 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m -122.24 -80.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.38 -168.67 0.31 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.806 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 m -164.5 156.23 15.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 44.8 p-90 -59.26 -44.6 92.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -67.5 -32.89 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.603 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.19 -45.32 77.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.427 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 59.7 tp -59.67 -43.84 93.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.88 -37.93 64.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.956 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -64.42 -26.72 68.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.215 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -84.75 -37.51 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.529 ' HA ' HD21 ' A' ' 175' ' ' LEU . 32.4 mmm -75.85 -20.34 58.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.661 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -43.3 -31.83 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.354 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -50.62 -34.33 25.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.87 -29.68 66.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.8 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.22 -129.04 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.383 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.29 136.93 37.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.532 HG22 ' CE1' ' A' ' 162' ' ' PHE . 92.4 t -115.54 121.37 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.957 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.02 -42.53 16.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.058 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 52.3 t80 -142.98 158.45 43.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -162.99 139.94 7.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.49 161.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.57 133.08 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.85 155.64 37.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.704 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -33.13 -42.78 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.935 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 174.01 65.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.886 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.73 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.814 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 126' ' ' SER . 13.9 p -141.3 -177.13 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.141 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.67 176.71 33.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.463 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 126.93 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 123' ' ' VAL . 16.9 t -119.66 144.32 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.03 106.92 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.82 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.532 ' CE1' HG22 ' A' ' 147' ' ' VAL . 80.4 m-85 -87.53 141.6 28.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.33 -28.62 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -120.0 147.94 44.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -72.1 -32.85 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -60.48 -31.78 70.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.416 ' O ' ' HB1' ' A' ' 144' ' ' ALA . 62.0 m-20 -71.66 -35.89 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.484 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.2 ttp -67.97 -62.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.3 m -53.4 -32.24 48.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 3.1 t80 -61.35 -50.43 72.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.223 0.535 . . . . 0.0 110.076 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 175' ' ' LEU . . . -55.02 -54.1 47.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 194' ' ' VAL . 15.3 m -55.87 -22.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.36 -72.47 0.62 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.322 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -35.77 25.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -110.51 75.45 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.83 162.04 36.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.771 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 p30 42.92 58.8 3.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.445 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.5 p -123.63 170.47 10.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -85.57 134.85 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 187' ' ' THR . 24.7 t80 -91.73 146.81 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -119.64 112.8 19.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.1 t -93.95 144.65 25.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -57.72 -25.64 60.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.01 -23.13 64.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.85 18.02 12.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.66 129.28 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.684 0.278 . . . . 0.0 110.712 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 180' ' ' PHE . 0.2 OUTLIER -101.52 159.61 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.008 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.03 133.62 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.239 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.37 122.69 23.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 127' ' ' GLY . 7.4 pt -117.63 155.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -119.81 139.53 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.52 135.93 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 124' ' ' VAL . 29.2 mmmt -152.69 140.49 20.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.533 HG23 HG11 ' A' ' 172' ' ' VAL . 21.6 t -63.52 111.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.649 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.893 0.378 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -102.51 154.07 19.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.62 152.57 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.58 139.54 51.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.15 146.28 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.3 m -142.45 148.71 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.75 49.97 33.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.555 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.769 ' CB ' HG22 ' A' ' 190' ' ' ILE . 0.3 OUTLIER -130.43 160.21 67.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.621 0.248 . . . . 0.0 111.0 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 57.1 Cg_endo -71.1 137.25 31.21 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.371 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.01 -20.08 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.438 2.092 . . . . 0.0 112.544 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -54.58 -60.96 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.204 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.16 116.74 9.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.633 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -168.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.771 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 38.8 p-90 -64.61 -33.89 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 35.7 mt-30 -65.29 -40.37 93.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -71.84 -38.52 70.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.496 HD22 HG12 ' A' ' 152' ' ' VAL . 46.1 tp -70.45 -46.11 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.4 tttt -57.78 -49.17 77.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.69 -26.62 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.37 17.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 142' ' ' ARG . 10.8 mtp-105 -45.55 -32.04 2.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -32.72 65.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.801 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -76.46 -29.42 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.32 -160.99 31.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.388 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.69 122.02 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.418 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 138' ' ' LYS . 93.8 t -89.23 130.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.006 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.6 t -98.68 -30.54 12.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.406 ' O ' HG13 ' A' ' 160' ' ' VAL . 22.0 t80 -153.07 145.13 23.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.024 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -150.12 133.93 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 159' ' ' VAL . 36.8 t0 -153.73 111.26 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 137' ' ' LEU . 27.5 m -92.9 134.21 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -79.94 152.63 29.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -71.84 -22.28 61.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -42.15 75.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.348 . . . . 0.0 111.116 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 153.53 -27.19 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.543 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -82.56 173.85 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.319 . . . . 0.0 110.719 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.25 177.49 31.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 151' ' ' ASP . 29.6 m -149.09 144.32 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 149' ' ' TYR . 3.7 t -148.06 137.2 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -117.51 127.53 54.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.54 177.13 5.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -70.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.332 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 163.29 14.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.11 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -71.99 -31.33 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -31.94 67.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -72.36 -36.05 68.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.672 ' SD ' HG13 ' A' ' 194' ' ' VAL . 7.7 ttp -65.25 -62.18 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.606 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.3 m -54.68 -32.96 60.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.422 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 44.4 t80 -63.56 -45.65 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.26 -31.43 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.802 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.468 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 0.7 OUTLIER -84.62 -29.37 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.326 . . . . 0.0 110.888 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.468 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 0.7 OUTLIER -105.74 -65.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.863 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 144' ' ' ALA . 70.2 mt -76.84 66.36 2.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 177' ' ' ASN . 22.9 t0 -120.93 121.01 37.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER 68.53 12.89 8.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -176.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.999 0.428 . . . . 0.0 111.008 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -101.68 144.25 30.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.996 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -124.8 122.81 38.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.293 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HG3' HG23 ' A' ' 187' ' ' THR . 6.1 ttt-85 -119.62 119.32 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.7 m -87.81 159.39 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -59.95 -17.03 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -92.48 18.59 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.34 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.32 31.09 76.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.544 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 93.3 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 110.8 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -92.2 144.51 25.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -170.06 172.02 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.238 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -106.17 123.51 48.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.769 HG22 ' CB ' ' A' ' 128' ' ' LEU . 13.7 pt -107.62 152.43 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.706 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -112.63 117.6 32.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.11 133.63 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -153.87 150.46 28.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.672 HG13 ' SD ' ' A' ' 168' ' ' MET . 21.8 t -62.49 109.39 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.818 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE ' ' A' ' 165' ' ' LYS . 12.2 m-80 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.845 0.355 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -121.76 169.61 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 160' ' ' VAL . 1.6 p -117.46 159.62 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.963 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 195' ' ' ASP . 9.7 t -114.37 156.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.43 ' N ' HG12 ' A' ' 124' ' ' VAL . 19.3 t -144.35 143.69 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.82 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.448 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -137.26 159.42 41.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.74 45.18 8.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.1 mm? -83.83 142.94 42.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.97 170.44 20.09 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.29 -20.71 66.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.572 2.181 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.7 m -108.88 -157.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.47 -177.94 48.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -176.8 -175.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 110.747 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 56.3 p-90 -59.27 -43.06 92.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 7.2 tp60 -63.01 -38.72 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -35.48 57.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.802 HD22 HG22 ' A' ' 152' ' ' VAL . 30.6 tp -62.29 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.637 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -57.6 -42.48 83.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.5 -26.77 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -89.59 -29.86 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.736 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.525 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -85.44 -19.97 30.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.07 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -46.43 -30.0 1.97 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.32 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.98 -32.43 53.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.88 -28.17 60.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.43 -139.6 6.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.4 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -99.7 101.33 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 162' ' ' PHE . 92.0 t -75.64 120.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.27 -29.07 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 20.4 t80 -146.67 151.59 37.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -159.8 140.92 12.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 159' ' ' VAL . 6.1 t70 -135.4 148.92 49.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.802 HG22 HD22 ' A' ' 137' ' ' LEU . 1.8 t -146.16 106.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.17 151.41 31.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -17.7 61.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.207 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.84 -24.41 67.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.72 25.74 2.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.677 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 126' ' ' SER . 31.8 p -151.42 163.35 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.781 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.62 -166.14 18.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.795 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 151' ' ' ASP . 34.1 m -147.51 172.68 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.509 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.892 HG23 HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -155.0 130.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.402 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.48 120.69 39.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.858 ' CE2' HG22 ' A' ' 147' ' ' VAL . 85.2 m-85 -104.01 139.71 38.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.61 -30.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.781 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.19 125.91 49.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CE ' ' HA ' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -53.62 -24.15 13.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -39.23 89.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.49 -31.94 71.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.583 ' HE3' ' H ' ' A' ' 169' ' ' THR . 9.3 tmm? -61.32 -75.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.798 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.585 HG23 ' NH1' ' A' ' 173' ' ' ARG . 5.0 m -45.64 -45.04 13.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.751 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.8 -40.21 75.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.954 0.407 . . . . 0.0 110.683 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.563 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 192' ' ' VAL . 15.4 m -78.85 -27.65 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.116 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.585 ' NH1' HG23 ' A' ' 169' ' ' THR . 4.5 mmt85 -80.75 -40.12 25.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -103.43 -58.24 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.478 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 96.6 mt -77.53 64.86 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.947 0.403 . . . . 0.0 111.022 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -128.24 138.53 52.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.02 30.2 19.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.7 p -98.41 155.5 17.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -81.24 134.37 35.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -96.04 158.11 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.558 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.683 ' HG2' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -133.14 125.77 30.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.969 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -93.91 149.88 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.831 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -56.16 -23.12 32.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.66 -23.11 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.054 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.19 26.23 6.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.677 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -115.12 136.2 53.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -110.68 161.1 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -168.98 170.91 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.006 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.16 126.15 43.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -117.5 137.68 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.335 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -106.15 122.63 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.677 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 172' ' ' VAL . 3.0 t -104.62 153.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.468 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -164.35 140.63 6.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.675 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.481 HG23 ' SD ' ' A' ' 168' ' ' MET . 11.7 p -66.63 119.59 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.48 . . . . 0.0 111.289 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 124' ' ' VAL . 9.4 t0 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -116.06 170.03 8.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 168' ' ' MET . 2.0 t -123.95 165.34 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.202 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 193' ' ' LYS . 7.4 p -122.42 136.35 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.402 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.14 153.99 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 157' ' ' THR . 3.1 t -141.85 133.57 27.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.44 40.26 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.633 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 128' ' ' LEU . 2.4 mm? -89.05 139.06 28.84 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.531 0.205 . . . . 0.0 110.99 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 169.91 21.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.467 2.112 . . . . 0.0 112.284 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.01 -29.79 26.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.455 2.103 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.07 71.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.38 -160.43 8.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.67 174.08 1.89 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.769 0.318 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 52.8 p-90 -72.7 -40.92 65.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 3.6 pt20 -66.85 -34.67 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -29.45 60.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -73.17 -41.34 63.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -64.31 -53.77 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.145 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -56.34 -26.79 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.252 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.495 ' CD2' ' CE1' ' A' ' 180' ' ' PHE . 10.4 m-70 -86.06 -23.09 26.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.388 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.907 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.5 ppp? -106.66 8.47 31.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 111.544 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -56.9 -15.11 4.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.496 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.827 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -49.83 -23.82 2.09 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.506 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . . . -61.48 -28.23 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.118 0.485 . . . . 0.0 110.396 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 140.46 -55.14 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.427 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.69 117.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.469 ' CG1' ' HG3' ' A' ' 138' ' ' LYS . 61.1 t -100.5 132.26 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.842 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.21 -49.48 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.235 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 14.1 t80 -155.83 160.02 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -147.46 168.01 22.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.75 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.4 t70 -163.14 123.79 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.019 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.13 138.96 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.88 155.04 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -70.8 -18.05 62.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.188 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.14 -25.79 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 5.15 8.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.785 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 126' ' ' SER . 8.4 p -131.75 161.14 33.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.2 -169.05 11.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 151' ' ' ASP . 7.0 m -140.94 167.31 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.907 HG11 ' SD ' ' A' ' 141' ' ' MET . 21.9 t -152.72 140.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -131.28 114.3 14.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 144' ' ' ALA . 16.9 m-85 -88.89 176.49 7.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.85 -66.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -96.84 161.11 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.555 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -25.2 62.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.56 -31.26 72.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.06 -31.36 71.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.724 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.1 ttp -59.86 -62.11 2.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.67 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 172' ' ' VAL . 52.1 m -56.81 -32.41 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 170' ' ' TYR . 4.3 t80 -60.54 -50.31 74.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.227 0.537 . . . . 0.0 110.28 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' LEU . . . -57.8 -51.99 67.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.967 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.82 HG11 HG23 ' A' ' 194' ' ' VAL . 15.8 m -57.11 -22.48 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.974 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -106.52 -73.6 0.68 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.147 0.498 . . . . 0.0 112.25 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -35.18 79.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -125.49 85.5 2.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.645 0.736 . . . . 0.0 111.448 -178.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -142.74 152.69 42.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 71.26 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 p -124.98 169.76 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -89.54 136.35 33.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 140' ' ' HIS . 89.9 t80 -113.74 114.98 27.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.694 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -116.19 103.61 10.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.829 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.6 p -58.45 169.84 0.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.072 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -6.94 34.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.13 -22.93 21.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.712 0.291 . . . . 0.0 111.097 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 30.47 4.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.432 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -112.05 108.28 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.7 156.25 20.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.07 169.7 12.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.59 136.51 43.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.95 142.54 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.282 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.89 150.92 37.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 123' ' ' VAL . 4.0 t -114.97 133.58 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.331 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.665 ' O ' HG12 ' A' ' 124' ' ' VAL . 2.6 mtpm? -141.22 140.45 33.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.82 HG23 HG11 ' A' ' 172' ' ' VAL . 37.6 t -68.49 113.94 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.297 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.598 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.64 169.18 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 194' ' ' VAL . 4.3 m -125.48 165.12 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.88 136.7 48.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.6 t -105.35 154.11 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 157' ' ' THR . 28.1 p -154.86 121.27 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.78 26.75 4.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' HG22 ' A' ' 190' ' ' ILE . 2.9 mt -68.18 155.27 92.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 188' ' ' ALA . 42.8 Cg_endo -68.05 160.57 48.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.627 2.218 . . . . 0.0 112.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.43 -28.99 31.92 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m -118.52 72.19 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.79 147.29 16.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.36 175.81 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.672 0.272 . . . . 0.0 111.025 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -73.97 -32.32 63.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.953 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.72 -44.66 90.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.06 -32.08 59.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 55.3 tp -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.15 -45.06 93.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.195 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.45 -26.77 68.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.727 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -99.94 -26.43 14.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.824 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -96.9 4.44 51.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -9.9 45.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.82 -26.74 4.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.804 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.37 -28.75 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.92 -164.91 28.16 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.6 m-20 -60.29 106.38 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.117 0.484 . . . . 0.0 110.781 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.1 t -73.85 153.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.0 t -107.64 -59.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.177 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.52 130.94 5.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.817 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.52 140.34 53.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.13 136.71 33.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.999 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 152' ' ' VAL . 26.7 m -119.4 118.92 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.927 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -93.33 121.22 34.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 63.34 -76.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 1.2 m-20 169.76 -25.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -64.62 -49.93 61.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.633 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 126' ' ' SER . 33.2 p -133.63 -179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.9 -159.05 10.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.468 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 m -156.01 158.85 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.824 HG11 ' SD ' ' A' ' 141' ' ' MET . 16.4 t -152.05 141.93 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.93 135.01 54.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.85 163.23 13.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 146' ' ' ASP . 46.9 t -80.31 -62.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -88.23 152.92 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.58 -30.73 68.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -36.88 85.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.62 -30.62 68.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.763 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.9 ttp -65.14 -64.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -55.04 -32.78 62.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.558 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 64.7 t80 -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . . . -68.02 -39.34 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.634 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 194' ' ' VAL . 11.7 m -79.54 -22.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.818 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.558 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 5.7 ptm180 -91.11 -42.08 10.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HD2' ' HG3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -109.42 -30.45 7.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 144' ' ' ALA . 17.7 mt -94.84 31.51 1.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.61 134.51 45.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 60.71 35.08 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.584 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.36 154.95 17.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.468 ' HD3' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER -81.06 115.63 20.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.1 t80 -92.8 152.98 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.09 113.53 20.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.96 158.77 34.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.73 -13.81 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.182 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.7 20.78 7.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.394 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 25.93 73.26 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.573 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 125.21 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.468 HG22 ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -94.09 161.07 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 129' ' ' PRO . . . -165.75 159.41 16.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.43 111.87 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 128' ' ' LEU . 5.6 pt -112.92 148.7 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.527 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.62 154.59 26.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.411 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 172' ' ' VAL . 12.3 t -125.96 144.49 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.148 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 148.01 29.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 123' ' ' VAL . 14.6 t -78.38 141.76 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.304 0.573 . . . . 0.0 110.7 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.661 -179.728 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -144.29 128.54 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.775 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.951 HG12 ' HA ' ' A' ' 194' ' ' VAL . 23.7 m -104.29 165.2 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 195' ' ' ASP . 23.3 t -119.06 154.03 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.093 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.2 143.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 157' ' ' THR . 4.5 t -144.62 134.73 24.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.29 39.16 4.06 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.47 HD21 HD13 ' A' ' 137' ' ' LEU . 15.8 mt -89.02 159.46 45.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.58 160.08 47.77 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.574 2.183 . . . . 0.0 112.304 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.4 -45.41 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.534 2.156 . . . . 0.0 112.279 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.9 p -97.46 61.77 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.14 152.75 23.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.28 4.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.417 ' HB3' HG23 ' A' ' 152' ' ' VAL . 45.1 p-90 -73.98 -32.31 63.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -59.23 -42.21 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -73.66 -30.15 62.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.47 HD13 HD21 ' A' ' 128' ' ' LEU . 67.3 tp -66.81 -43.24 84.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.639 ' HG3' HG11 ' A' ' 147' ' ' VAL . 5.5 ttpt -52.97 -30.11 32.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.69 -26.63 66.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -33.78 16.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.543 ' HB2' HG21 ' A' ' 147' ' ' VAL . 71.7 mmm -72.7 -31.04 64.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.069 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -29.41 23.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.252 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -50.79 -25.62 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.019 0.438 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.861 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -74.53 -27.77 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.53 -69.8 0.28 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -160.48 136.28 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.425 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.4 t -107.59 152.26 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.788 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.4 t -112.07 -33.03 6.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.1 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -162.36 148.95 13.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.72 156.52 45.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.831 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -159.0 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 134' ' ' TRP . 17.6 t -137.05 95.29 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 10.8 p90 -123.14 156.09 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 6.9 ttp180 96.27 -3.06 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.487 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 65.36 37.84 6.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -179.23 -52.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 126' ' ' SER . 3.9 p -97.97 163.71 12.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -143.63 -149.47 5.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.469 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.5 p -169.29 160.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.472 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 21.3 t -152.51 149.56 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -127.96 109.11 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HE2' HG21 ' A' ' 123' ' ' VAL . 95.7 m-85 -85.1 177.14 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.038 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.38 -70.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -95.04 164.13 13.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.145 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -72.25 -31.19 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -59.9 -50.32 74.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.25 -29.07 64.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.699 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.2 ttp -71.11 -64.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.6 m -50.34 -33.92 22.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.15 -45.57 84.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.413 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.45 -47.28 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.446 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 192' ' ' VAL . 16.1 m -66.76 -22.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -86.46 -67.64 0.8 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -52.85 9.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 144' ' ' ALA . 91.2 mt -79.66 60.44 3.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -130.03 141.19 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 44.65 32.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.265 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.6 p -83.14 -179.15 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 101.95 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.8 t80 -72.94 143.63 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -124.56 107.95 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.007 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 27.5 t -79.54 161.43 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -7.45 51.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -95.41 19.13 11.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.92 28.57 73.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 128.91 55.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 159.73 18.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.02 171.86 6.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.66 119.92 40.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 2.7 pt -107.29 146.53 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -116.34 119.12 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 172' ' ' VAL . 19.4 t -98.23 143.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.41 142.46 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.951 ' HA ' HG12 ' A' ' 123' ' ' VAL . 12.6 p -74.62 118.0 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.474 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.841 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.858 0.361 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 123' ' ' VAL . 25.6 ttm180 -86.61 156.95 19.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.414 ' N ' ' HG2' ' A' ' 122' ' ' ARG . 3.1 m -132.66 165.17 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.91 147.42 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.0 142.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.6 t -140.01 146.61 39.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.83 64.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.289 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 190' ' ' ILE . 0.0 OUTLIER -98.23 148.4 34.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.675 0.274 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 30.9 Cg_endo -63.69 127.53 19.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 111.976 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -22.53 46.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.298 1.998 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.97 43.39 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.42 -166.76 21.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.417 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.54 145.56 51.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.3 p-90 -73.95 -46.36 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -60.8 -32.38 71.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.812 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -35.79 55.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.651 HD22 HG12 ' A' ' 152' ' ' VAL . 51.6 tp -61.38 -37.16 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.482 ' HB3' HG11 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -66.6 -39.06 88.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 110.404 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -66.94 -26.57 66.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.238 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.464 ' HE1' HD11 ' A' ' 190' ' ' ILE . 0.8 OUTLIER -86.62 -22.06 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.834 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.8 ppp? -111.76 -3.38 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -59.02 -20.67 55.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 111.387 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -50.38 -24.95 3.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.176 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 171' ' ' ALA . . . -69.17 -26.38 64.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.726 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.64 -116.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.0 111.71 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 138' ' ' LYS . 89.3 t -82.79 151.28 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 163' ' ' VAL . 1.3 m -119.4 -39.82 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -145.94 148.21 32.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.97 139.53 18.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -142.89 138.32 30.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 137' ' ' LEU . 34.2 m -117.71 118.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -69.15 155.25 40.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.971 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 17.56 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -29.72 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.758 0.314 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 145.95 -16.83 1.76 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.9 p -98.86 -178.48 3.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 111.224 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.7 -176.62 30.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 151' ' ' ASP . 17.2 m -153.5 150.38 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 111.044 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.834 HG11 ' SD ' ' A' ' 141' ' ' MET . 10.5 t -150.65 146.31 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -130.74 131.32 44.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 168' ' ' MET . 3.8 m-85 -104.58 171.1 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.748 HG22 ' SG ' ' A' ' 148' ' ' CYS . 55.5 t -70.03 -70.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -97.35 155.27 16.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -58.29 -28.56 65.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.36 -32.06 73.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.9 -34.95 66.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.43 ' HA ' ' CD1' ' A' ' 162' ' ' PHE . 8.2 ttp -68.58 -62.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.1 m -53.93 -36.32 62.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.01 -44.22 97.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -60.34 -44.64 95.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.471 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.88 -27.09 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.094 0.473 . . . . 0.0 110.725 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -77.99 -53.39 7.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -65.72 0.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.439 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 41.6 mt -63.69 -118.5 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.47 113.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 64.85 72.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 46.3 p -132.0 -176.94 4.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -103.74 139.93 38.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 181' ' ' ARG . 75.5 t80 -126.85 160.78 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.748 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -141.08 149.07 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.027 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.0 p -109.38 157.37 18.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -20.38 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -79.14 -22.93 44.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.99 29.46 5.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.8 121.89 46.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.1 156.58 17.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -167.29 171.65 10.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.29 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -107.51 121.3 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.241 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 128' ' ' LEU . 28.6 pt -101.84 168.45 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 109.47 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.322 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.0 t -86.76 153.53 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.389 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.98 171.29 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 194' ' ' VAL . 12.6 p -87.91 122.36 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.939 0.4 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.223 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.872 0.367 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.478 ' NH2' HG12 ' A' ' 159' ' ' VAL . 2.4 tpt180 -105.33 119.96 40.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 160' ' ' VAL . 7.5 p -108.43 162.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.558 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.3 p -128.23 142.31 44.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.63 149.42 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.1 t -139.51 123.77 18.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 107.53 40.56 1.74 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.599 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -82.13 142.6 47.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.26 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.77 168.6 23.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.486 2.124 . . . . 0.0 112.31 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.53 -43.26 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.605 2.203 . . . . 0.0 112.329 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.87 79.37 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.9 97.07 0.11 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -175.96 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.78 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.448 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 59.1 p-90 -65.43 -40.87 93.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.448 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 2.5 tt0 -59.6 -32.52 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.01 -36.68 56.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.25 -44.99 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -59.51 -50.1 75.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -60.81 -26.6 67.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.543 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -95.11 -24.95 16.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.752 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.433 ' HE3' HD21 ' A' ' 175' ' ' LEU . 0.0 OUTLIER -100.66 6.48 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.597 0.237 . . . . 0.0 111.565 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -77.89 6.0 8.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.661 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -50.65 -26.07 4.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.72 0.295 . . . . 0.0 111.232 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -65.63 -27.58 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.608 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.14 -94.03 0.13 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.2 142.52 49.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.59 128.9 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.849 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.72 -26.32 13.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.485 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 160' ' ' VAL . 41.0 t80 -142.92 153.39 43.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.479 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . . . -163.12 143.13 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.832 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -149.51 146.51 27.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.748 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.54 133.69 59.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.86 147.97 26.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -70.16 -16.85 63.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.99 -31.38 72.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 134.85 -18.11 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.81 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 126' ' ' SER . 17.7 p -108.01 169.85 8.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.6 -167.43 13.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.344 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' NH2' ' A' ' 122' ' ' ARG . 35.5 m -155.14 154.64 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.714 0.293 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -153.16 142.35 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.237 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -121.68 113.29 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.603 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 13.9 m-85 -81.39 155.8 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.073 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.07 -26.63 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.771 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 149.22 46.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -69.18 -36.22 77.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -32.56 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.71 -30.22 64.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.47 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.8 ttp -69.53 -65.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 94.7 m -56.71 -34.34 67.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 0.0 111.073 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 174' ' ' LYS . 9.3 t80 -59.46 -49.63 77.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.249 0.547 . . . . 0.0 110.621 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 175' ' ' LEU . . . -60.55 -50.17 74.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.225 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 192' ' ' VAL . 15.7 m -58.71 -22.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 111.296 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 169' ' ' THR . 9.5 mtp180 -96.41 -37.18 10.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.339 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 170' ' ' TYR . 0.3 OUTLIER -86.59 -69.11 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.817 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -87.2 45.51 1.28 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 15.8 p-10 -83.43 127.1 33.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 47.96 59.98 3.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.24 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -114.85 173.97 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HG3' ' CE1' ' A' ' 189' ' ' TYR . 0.2 OUTLIER -95.16 108.53 20.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.953 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -105.06 157.81 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.367 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HB3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -132.56 138.65 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 p -81.25 171.0 15.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -55.02 -17.86 4.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -82.99 -22.66 33.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.25 -15.07 39.6 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 123.6 19.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -94.41 158.95 15.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.64 155.99 13.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 179' ' ' LYS . 2.0 m-85 -86.37 113.63 22.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 pt -119.88 137.61 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.26 152.9 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 172' ' ' VAL . 13.6 t -127.74 137.61 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.263 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 124' ' ' VAL . 9.8 mtpp -155.55 145.86 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.8 p -68.62 109.29 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -144.02 127.54 16.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.632 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.13 159.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.947 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.46 145.5 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.086 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.21 142.37 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.9 OUTLIER -134.83 -179.55 5.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.49 32.69 75.53 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.606 HD21 HG12 ' A' ' 152' ' ' VAL . 2.3 mp -81.24 146.01 57.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.679 0.276 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.15 169.97 20.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.58 2.187 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.42 -27.27 33.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.508 2.139 . . . . 0.0 112.197 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.36 117.03 22.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.47 175.78 46.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.432 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.577 ' C ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -138.66 179.62 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.891 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.431 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 51.3 p-90 -73.14 -39.1 65.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 46.2 tt0 -63.0 -31.08 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 -44.72 84.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.06 -47.05 54.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.852 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -56.32 -47.18 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.2 -26.73 65.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.518 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 180' ' ' PHE . 45.7 t-80 -87.93 -29.27 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.37 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -97.1 -11.16 24.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.605 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -54.58 -21.64 10.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.801 0.334 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -49.91 -24.42 2.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.211 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.01 -26.7 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.941 0.401 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.43 -110.25 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.51 125.31 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.852 HG11 ' CG ' ' A' ' 138' ' ' LYS . 84.3 t -97.78 146.07 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.39 -67.48 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -127.82 133.18 49.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.036 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 138' ' ' LYS . . . -128.55 135.94 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -139.93 126.08 19.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.606 HG12 HD21 ' A' ' 128' ' ' LEU . 5.6 m -116.29 142.99 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -117.13 153.93 31.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.023 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -73.67 -16.43 61.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.1 -26.08 68.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.56 12.14 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.752 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 126' ' ' SER . 11.5 p -143.97 165.93 26.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 110.661 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.21 -161.51 10.88 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.546 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.3 m -156.38 155.77 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.66 0.267 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.3 t -150.78 142.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -123.35 126.28 46.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.56 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.01 177.06 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.3 t -76.29 -68.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 154.44 22.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -71.96 -34.41 68.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.84 -35.17 66.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -32.05 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.61 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 172' ' ' VAL . 3.0 ttp -58.94 -63.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.815 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 173' ' ' ARG . 95.6 m -56.65 -35.04 67.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 15.7 t80 -61.3 -44.85 96.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -67.14 -45.32 77.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.271 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 168' ' ' MET . 2.1 m -71.97 -21.97 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 111.273 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.534 ' HG3' HG22 ' A' ' 169' ' ' THR . 18.1 mmm180 -90.85 -50.67 5.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.53 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 0.5 OUTLIER -88.62 -52.57 5.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.3 mt -69.33 -4.76 19.5 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 67.6 t0 -53.9 123.83 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.086 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 60.81 76.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.23 161.75 18.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' HG21 ' A' ' 187' ' ' THR . 4.3 tptp -85.65 93.95 8.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.435 ' HA ' ' CE1' ' A' ' 140' ' ' HIS . 40.7 t80 -74.64 154.69 38.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.81 129.21 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.3 p -97.45 162.93 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -6.1 45.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.239 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.7 18.26 9.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.694 0.283 . . . . 0.0 111.334 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.01 73.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.546 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.05 155.52 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.511 HG21 ' NZ ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -120.97 161.05 22.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.96 157.42 11.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.149 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -103.42 114.15 28.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.99 158.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.64 127.67 42.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 172' ' ' VAL . 21.3 t -103.09 145.36 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.863 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.58 150.25 24.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 172' ' ' VAL . 22.0 t -71.11 118.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.326 -179.794 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.095 0.474 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.407 ' NH1' ' CG1' ' A' ' 159' ' ' VAL . 52.7 ttp85 -144.25 147.68 33.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 194' ' ' VAL . 18.6 m -132.77 165.06 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.95 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 158' ' ' GLY . 5.9 t -119.77 150.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.145 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.55 HG22 HG13 ' A' ' 192' ' ' VAL . 6.6 t -132.89 121.41 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.002 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.638 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.7 t -114.75 158.75 21.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 90.41 46.72 3.98 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.93 167.31 34.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.83 170.11 19.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.717 2.278 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.72 -25.98 45.99 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -134.6 82.68 1.98 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.71 -165.32 10.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -171.82 176.67 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.647 ' HB3' HG23 ' A' ' 152' ' ' VAL . 41.5 p-90 -73.35 -33.94 65.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.735 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.453 ' HG2' ' CH2' ' A' ' 134' ' ' TRP . 19.4 mt-30 -58.78 -43.23 90.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.789 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.06 -32.3 56.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.448 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 37.3 tp -59.89 -38.17 81.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -43.03 63.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.38 -26.8 68.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.393 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -88.28 -39.91 14.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.747 ' CE ' HG11 ' A' ' 160' ' ' VAL . 2.1 ppp? -80.16 -5.71 56.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.392 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -53.1 -22.62 6.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -31.15 11.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.071 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.512 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -68.43 -28.7 67.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.41 -159.1 25.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -58.91 117.17 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.5 126.11 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 9.0 t -66.93 -63.81 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.727 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 161' ' ' GLU . 7.1 p90 -171.61 150.34 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.88 4.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.22 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 159' ' ' VAL . 8.3 t0 -163.38 153.69 15.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 134' ' ' TRP . 45.9 t -130.97 122.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.04 139.64 52.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 76.1 0.62 3.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.726 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.93 11.84 8.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.11 -53.05 0.14 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.56 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 126' ' ' SER . 22.7 p -98.96 159.94 14.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -144.73 179.54 21.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.608 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 151' ' ' ASP . 22.9 m -137.43 154.44 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.991 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' CE ' ' A' ' 141' ' ' MET . 4.7 t -142.6 126.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.179 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 149' ' ' TYR . 2.5 mt-10 -111.99 130.04 55.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.727 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.7 OUTLIER -109.51 137.62 47.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.971 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.62 -28.85 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -129.3 142.39 50.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -59.04 -27.49 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.205 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -54.98 -46.33 75.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.099 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.27 -32.56 68.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.442 ' HE2' ' OG1' ' A' ' 169' ' ' THR . 5.2 ttp -61.49 -66.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.576 HG22 ' HD2' ' A' ' 173' ' ' ARG . 96.4 m -54.84 -35.76 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 15.7 t80 -61.57 -47.93 83.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.06 74.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 176' ' ' ASP . 11.8 m -65.61 -22.84 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -80.5 -72.64 0.4 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.122 0.487 . . . . 0.0 110.453 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -54.67 12.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 144' ' ' ALA . 7.3 mt -79.92 76.64 6.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.802 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 20.6 p-10 -141.38 134.51 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.71 25.84 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.16 -174.33 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 145.19 38.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 29.8 t80 -93.16 158.61 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 1.3 tmt_? -125.85 107.17 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.71 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 p -75.74 151.14 37.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -54.67 -23.06 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.44 -19.5 61.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.12 -6.2 36.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.81 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.95 159.62 23.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.747 0.308 . . . . 0.0 110.838 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.7 161.0 29.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.118 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.09 16.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.03 115.66 15.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.7 pt -114.54 161.7 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.11 113.09 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 125' ' ' VAL . 4.3 t -91.0 159.08 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.415 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.7 OUTLIER -176.03 144.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 111.143 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.4 t -59.85 134.69 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.272 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.901 0.381 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -109.18 168.33 9.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.098 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.22 159.88 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.8 t -106.06 146.33 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 HD21 ' A' ' 128' ' ' LEU . 12.3 p -121.9 150.77 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.1 OUTLIER -137.15 170.91 15.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.918 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 63.94 44.31 96.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.46 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 HG13 ' A' ' 125' ' ' VAL . 3.5 mm? -83.92 140.48 40.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.647 0.261 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.95 170.46 20.37 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.538 2.159 . . . . 0.0 112.204 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.04 -26.83 65.83 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.17 . . . . 0.0 112.265 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.0 34.84 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.49 111.6 3.88 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.469 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.57 179.61 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.802 0.334 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.447 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 47.5 p-90 -68.63 -41.72 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.447 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.5 OUTLIER -70.55 -36.06 73.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.78 -57.96 10.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.71 -47.02 88.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.04 -43.76 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.186 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.56 -26.33 65.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.604 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -88.16 -21.14 24.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.695 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.79 ' SD ' HG21 ' A' ' 160' ' ' VAL . 11.0 ptm -112.38 1.62 16.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.84 -17.59 56.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.89 -21.89 4.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.85 68.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.162 0.506 . . . . 0.0 110.481 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.3 -104.47 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.73 107.34 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 110.771 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.704 HG22 ' CD2' ' A' ' 162' ' ' PHE . 96.4 t -79.25 125.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.27 -52.4 6.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 151' ' ' ASP . 80.3 t80 -140.57 160.01 40.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -159.4 134.98 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' A' ' 149' ' ' TYR . 35.0 t0 -146.52 114.4 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.17 112.11 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.227 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -69.22 155.23 40.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -92.68 37.53 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -114.96 -28.85 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 147.87 -21.49 1.45 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 126' ' ' SER . 12.0 p -129.09 167.01 18.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.584 0.23 . . . . 0.0 111.059 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.475 ' CA ' HG12 ' A' ' 125' ' ' VAL . . . -142.02 -161.43 8.75 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.242 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 158' ' ' GLY . 22.3 m -158.02 144.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.79 HG21 ' SD ' ' A' ' 141' ' ' MET . 59.3 t -141.06 149.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.925 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.41 134.57 48.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.306 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.704 ' CD2' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -121.39 132.71 54.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.157 179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 163' ' ' VAL . 5.2 p -70.08 65.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 111.183 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 7.3 ttm-85 172.82 127.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.144 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.18 -40.4 96.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -58.93 -37.27 76.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.56 -34.77 72.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.8 ttp -60.83 -63.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.523 HG23 ' CZ ' ' A' ' 173' ' ' ARG . 70.5 m -61.69 -33.45 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 11.6 t80 -63.55 -48.58 76.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.88 82.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 192' ' ' VAL . 26.6 m -64.04 -22.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.523 ' CZ ' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER -93.34 -75.11 0.51 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 3.9 mmtt -57.17 -49.19 76.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 141' ' ' MET . 29.5 mt -92.64 58.53 3.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.602 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 6.0 t0 -122.86 135.61 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 44.1 t30 54.02 29.76 10.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.87 177.38 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 103.56 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -68.93 117.47 10.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.79 105.28 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 144.09 29.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -21.65 64.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.623 0.249 . . . . 0.0 111.073 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 31.0 3.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.725 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.36 134.66 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 156.57 22.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.9 143.85 2.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -83.62 120.25 25.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 127' ' ' GLY . 40.0 pt -112.67 155.6 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.21 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 172' ' ' VAL . 7.7 t -103.04 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -147.16 145.31 29.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 194' ' ' VAL . 13.6 p -73.07 124.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.073 0.463 . . . . 0.0 110.724 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.3 t0 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.722 -179.551 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.815 0.341 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 161.79 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' A' ' 162' ' ' PHE . 2.9 t -123.86 149.35 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.027 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 195' ' ' ASP . 23.2 t -117.24 144.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.03 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.83 146.44 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -149.22 117.14 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.11 39.67 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.493 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.635 ' HG ' HG22 ' A' ' 190' ' ' ILE . 1.5 mp -99.22 155.12 36.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 60.3 Cg_endo -72.5 166.52 29.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.543 2.162 . . . . 0.0 112.397 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.17 -27.53 35.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.3 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.94 36.59 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.805 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 152' ' ' VAL . . . -93.02 123.37 7.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 p -94.3 150.99 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 0.0 110.798 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.44 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 30.7 p-90 -74.02 -40.02 63.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -55.55 -40.58 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.27 -32.55 55.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 68.7 tp -61.63 -42.24 98.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -67.89 -47.45 68.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.97 -26.74 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.032 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -86.1 -31.48 21.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.775 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.474 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -93.18 3.61 55.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.451 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -55.56 -20.87 14.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.462 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -49.69 -32.56 13.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 111.003 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -70.9 -29.42 65.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.756 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.75 -172.79 26.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.414 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.22 106.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.435 HG11 ' CG ' ' A' ' 138' ' ' LYS . 86.1 t -74.07 125.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.043 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -56.17 4.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -154.03 148.34 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -143.6 141.23 30.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.181 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -143.41 141.67 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 132' ' ' GLY . 22.5 m -128.29 115.95 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.249 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.85 155.36 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 35.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.294 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -114.76 -22.62 9.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.196 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 157' ' ' THR . . . 122.06 31.36 1.1 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.608 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 156' ' ' GLY . 9.7 p -161.26 169.97 21.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.84 175.38 32.16 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.632 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -142.83 142.05 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.312 . . . . 0.0 111.061 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 141' ' ' MET . 11.4 t -134.55 157.91 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.206 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.423 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -131.68 128.31 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 68.3 m-85 -108.53 154.52 21.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -71.04 -68.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.22 162.26 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -50.08 30.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.015 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -32.4 46.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -35.88 72.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.418 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 5.2 ttp -67.62 -59.76 3.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.321 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.8 m -50.58 -35.06 28.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.855 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 49.6 t80 -64.23 -46.95 81.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.733 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -56.44 -43.05 79.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 192' ' ' VAL . 13.0 m -79.92 -34.69 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 11.9 ptt85 -79.68 -30.33 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.715 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 170' ' ' TYR . 0.1 OUTLIER -106.98 -57.3 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.207 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.4 mt -81.24 66.75 6.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -116.89 131.23 57.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.2 m120 57.63 30.37 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.1 p -73.33 -177.67 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.979 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 95.09 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.026 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 5.9 t80 -68.95 135.35 50.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.612 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -116.52 100.91 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.4 t -60.85 161.3 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -9.68 58.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.084 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 21.69 6.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.341 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 27.34 73.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.617 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.57 134.6 54.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.27 156.42 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.96 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -162.31 160.31 26.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -98.27 110.97 23.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.53 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.635 HG22 ' HG ' ' A' ' 128' ' ' LEU . 13.7 pt -107.13 136.26 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.463 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.37 109.83 22.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 172' ' ' VAL . 5.1 t -87.16 142.01 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.246 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -150.37 157.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.78 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 172' ' ' VAL . 25.3 t -78.01 114.85 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.568 ' HA ' HG23 ' A' ' 124' ' ' VAL . 19.0 t0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.28 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.703 0.287 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.61 117.5 52.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.95 -168.27 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.406 2.071 . . . . 0.0 112.415 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -169.83 172.47 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.872 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.14 32.57 2.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.341 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.13 99.58 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -172.72 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -156.75 123.28 1.28 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.281 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.21 109.1 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.576 2.184 . . . . 0.0 112.168 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.5 157.51 22.41 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.433 2.088 . . . . 0.0 112.198 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -161.6 39.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.709 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.45 -44.88 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.018 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.43 -57.34 0.51 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.129 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 73.16 163.92 0.28 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.938 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -79.45 -12.81 59.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.366 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.41 116.83 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.829 0.347 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.404 ' HB3' ' CG ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -144.06 144.89 31.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.18 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 194' ' ' VAL . 34.0 m -113.33 165.14 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 158' ' ' GLY . 12.3 p -117.04 143.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.75 152.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.5 p -143.07 123.08 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 130.51 41.53 0.23 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -86.29 144.17 37.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.89 170.68 19.85 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.555 2.17 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.49 -26.25 70.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.62 2.213 . . . . 0.0 112.191 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -124.49 74.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.77 167.97 24.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -146.39 167.93 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.427 ' HB3' HG22 ' A' ' 152' ' ' VAL . 61.5 p-90 -65.7 -42.16 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 29.7 tp60 -58.77 -36.23 74.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -73.49 -29.7 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.92 -42.45 66.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.748 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.808 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.978 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.78 -26.85 58.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.233 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.43 -41.16 14.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.861 ' SD ' HG21 ' A' ' 160' ' ' VAL . 0.0 OUTLIER -73.68 -22.87 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -46.12 -29.9 1.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.246 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -30.4 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.733 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.11 -28.85 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.04 -134.41 3.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.405 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -103.97 103.86 13.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.808 HG11 ' CG ' ' A' ' 138' ' ' LYS . 99.5 t -73.85 141.93 15.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.969 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.3 p -112.29 -29.32 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -154.71 147.36 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.35 127.26 6.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.13 153.64 51.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 152' ' ' VAL . 34.4 m -143.1 124.72 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -82.71 154.99 24.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.33 -33.63 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.52 -30.34 2.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.627 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -95.32 160.63 14.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -138.46 -166.26 10.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.576 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -155.6 145.51 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.861 HG21 ' SD ' ' A' ' 141' ' ' MET . 24.5 t -133.9 150.15 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.22 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.2 mt-10 -131.85 136.6 47.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.774 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -116.92 160.3 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.08 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.98 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.801 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -25.69 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -47.05 58.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.28 -28.0 62.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.456 ' O ' HG22 ' A' ' 172' ' ' VAL . 10.9 ttp -67.0 -62.91 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' CG2' ' A' ' 172' ' ' VAL . 67.0 m -58.96 -32.92 70.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.029 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -64.98 -44.64 88.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -65.59 -48.16 73.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.894 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.894 HG23 ' HD3' ' A' ' 173' ' ' ARG . 11.0 m -65.14 -22.12 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.894 ' HD3' HG23 ' A' ' 172' ' ' VAL . 6.1 mpt_? -93.13 -75.45 0.49 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.076 0.465 . . . . 0.0 111.189 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -40.95 95.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 144' ' ' ALA . 29.0 mt -89.58 23.84 2.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 38.4 t70 -83.65 131.22 34.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.73 61.63 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 p -113.27 146.67 38.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.744 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.21 112.12 8.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -80.85 148.4 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 126.5 46.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.9 p -97.01 146.0 25.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -55.92 -22.94 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -23.12 63.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.96 30.75 4.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -130.19 133.09 46.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.91 161.0 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.23 130.21 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -70.94 114.38 8.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 127' ' ' GLY . 22.0 pt -116.74 151.24 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -131.36 135.37 47.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.35 148.22 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.237 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -156.05 140.12 16.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 123' ' ' VAL . 23.8 t -70.25 118.58 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.203 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -49.99 117.24 2.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.156 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.25 -143.59 5.15 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.75 88.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.02 117.47 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.46 91.08 1.9 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.7 -24.71 18.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.575 2.184 . . . . 0.0 112.395 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 p -57.65 -167.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -49.3 156.53 0.57 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -59.05 -79.66 0.1 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.26 120.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 111.03 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.1 t -59.09 99.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -53.83 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.0 t -115.03 44.35 1.81 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 -71.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.0 p 175.67 -51.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.33 10.63 7.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.2 m 68.07 -65.8 0.24 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.774 0.321 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.99 177.41 0.23 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.14 32.98 12.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -149.86 36.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.5 t -117.6 166.23 12.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 53.88 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 0.0 111.03 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.72 -81.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.838 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 18.8 ttp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.8 0.333 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.2 134.01 35.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.03 -73.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.465 2.11 . . . . 0.0 112.328 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -143.48 31.23 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.22 66.59 0.45 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -176.23 114.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -75.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.98 67.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.628 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.19 176.45 4.66 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.13 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.12 -67.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.453 2.102 . . . . 0.0 112.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.6 t 169.38 72.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 -153.66 89.37 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -176.99 -42.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.72 64.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.82 30.58 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -112.03 131.6 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -131.38 133.45 45.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 160' ' ' VAL . 3.5 m -103.8 165.16 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.085 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.27 146.27 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.37 144.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -137.97 125.5 22.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.43 40.28 2.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.27 153.58 92.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.27 169.51 20.56 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -27.28 24.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.577 2.185 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -143.03 127.06 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.4 162.72 24.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.81 153.42 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 135' ' ' GLN . 42.8 p-90 -74.0 -30.07 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 50.8 mt-30 -58.99 -42.99 91.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -77.15 -21.39 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.926 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 152' ' ' VAL . 29.9 tp -70.17 -47.11 63.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.936 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -40.7 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 142' ' ' ARG . 4.5 m-20 -65.96 -26.65 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.81 -31.9 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -93.16 -2.82 54.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.435 ' HG2' HG23 ' A' ' 147' ' ' VAL . 4.0 mmm-85 -62.67 -15.87 54.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.476 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.74 -31.59 11.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.824 0.345 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 1.113 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.38 -31.41 70.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.513 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.94 -98.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.94 156.39 46.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 142' ' ' ARG . 75.0 t -126.82 149.4 31.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.5 t -117.33 -52.3 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -128.78 149.62 50.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.71 134.57 11.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.026 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 159' ' ' VAL . 4.3 m-20 -149.15 134.66 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 137' ' ' LEU . 29.6 m -128.33 118.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -103.46 131.66 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.0 mtm105 -62.34 96.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -171.45 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 157' ' ' THR . . . 137.53 37.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.74 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 156' ' ' GLY . 1.8 p -166.05 172.36 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.46 173.42 36.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 151' ' ' ASP . 5.8 m -141.7 134.26 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 123' ' ' VAL . 12.9 t -140.28 127.2 22.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -98.17 108.37 21.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.51 156.76 32.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.13 -67.33 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 144.97 24.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.83 -40.58 97.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.77 -42.62 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -31.83 69.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.5 ttp -67.22 -62.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 98.9 m -53.24 -32.73 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.416 ' CE2' ' HG2' ' A' ' 174' ' ' LYS . 88.5 t80 -62.77 -46.95 85.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.482 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -59.16 -47.55 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.574 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 169' ' ' THR . 16.2 m -63.29 -22.64 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.026 0.441 . . . . 0.0 110.793 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -85.59 -71.93 0.51 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.268 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -78.68 -36.76 43.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.035 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 1.113 HD12 ' HB2' ' A' ' 144' ' ' ALA . 76.1 mt -90.51 47.69 1.46 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -108.88 127.33 53.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.831 0.348 . . . . 0.0 110.679 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.9 31.55 18.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -171.92 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -111.15 118.13 35.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 10.8 t80 -97.41 135.06 39.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -122.17 117.36 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.7 p -80.13 149.61 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -54.74 -23.72 19.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -73.72 -23.07 59.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.984 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.17 5.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.86 110.34 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.83 154.41 20.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.001 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.89 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.55 129.74 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.62 143.27 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.291 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -109.95 122.25 47.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.06 151.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -156.63 169.22 25.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.759 HG12 ' HD2' ' A' ' 197' ' ' PRO . 17.5 t -91.44 118.97 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.39 121.1 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 115.33 -67.38 0.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.759 ' HD2' HG12 ' A' ' 194' ' ' VAL . 20.3 Cg_exo -65.65 -11.23 29.65 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.819 2.346 . . . . 0.0 112.561 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 38.35 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.52 80.75 0.15 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.84 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.45 -156.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.632 2.221 . . . . 0.0 112.192 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.8 t 72.32 -66.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -109.08 163.73 13.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.76 -134.74 3.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.547 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.61 52.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.945 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 p -101.33 31.91 3.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -119.35 119.07 32.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.2 -78.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.833 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 54.7 p -124.88 173.73 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 -79.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.95 56.32 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.98 151.02 26.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.6 p -173.81 -170.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.82 -50.14 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.651 ' C ' HD13 ' A' ' 216' ' ' LEU . 1.4 m -144.55 164.51 30.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.35 -179.74 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.956 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.29 -47.25 51.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.485 ' C ' HD23 ' A' ' 216' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.014 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.5 55.79 0.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.55 -45.31 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.535 2.157 . . . . 0.0 112.371 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.73 126.3 47.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.66 145.9 4.7 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -154.47 168.05 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 0.0 110.862 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -134.99 -60.18 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.2 98.64 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.86 156.8 64.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.456 2.104 . . . . 0.0 112.301 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.31 173.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.9 t -78.68 129.49 34.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -148.39 175.4 11.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.638 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.66 160.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.45 19.21 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 54.03 34.31 19.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.991 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 61.3 74.82 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.041 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -131.58 142.31 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.658 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 160' ' ' VAL . 28.2 m -106.96 165.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.63 140.1 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.545 ' CG2' HG23 ' A' ' 160' ' ' VAL . 15.3 t -106.38 140.23 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.56 120.27 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.62 1.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.414 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -75.51 150.05 84.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 171.02 16.45 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.257 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 -32.59 21.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.589 2.193 . . . . 0.0 112.276 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 t -123.89 115.51 21.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.54 177.05 48.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.22 -175.53 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 32.0 p-90 -67.59 -42.2 82.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.856 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.3 OUTLIER -59.74 -50.57 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.723 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.29 -37.39 85.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.652 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.28 -45.57 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.45 -28.33 68.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.107 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.392 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.21 12.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.64 ' HG3' HG21 ' A' ' 160' ' ' VAL . 30.4 mmm -76.87 -25.57 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.216 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -51.54 -25.27 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.321 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -23.73 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.312 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.15 -26.45 66.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.658 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.79 -65.61 0.34 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.39 125.62 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.074 0.464 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 142' ' ' ARG . 89.7 t -101.02 146.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.23 -29.66 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.211 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 56.5 t80 -154.76 160.05 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 111.211 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -157.04 177.33 11.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.85 156.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.97 147.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -123.98 109.23 13.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 mtt85 55.55 -87.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -176.24 36.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 110.93 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 157' ' ' THR . . . -118.6 -44.59 0.5 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.422 ' CA ' HD23 ' A' ' 128' ' ' LEU . 10.4 p -156.67 161.09 39.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.71 -157.48 7.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.573 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.508 HG21 ' NH2' ' A' ' 122' ' ' ARG . 30.5 m -156.09 142.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 141' ' ' MET . 21.9 t -134.22 119.88 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -104.35 123.25 47.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 23.0 m-85 -99.41 167.57 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.27 -69.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.86 163.92 13.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -26.1 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -57.16 -41.49 79.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -30.06 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.417 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 4.6 ttp -61.01 -63.72 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 172' ' ' VAL . 97.9 m -57.52 -35.53 70.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.071 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 21.0 t80 -62.56 -47.3 84.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.45 . . . . 0.0 110.653 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.86 84.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.809 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 192' ' ' VAL . 25.6 m -61.64 -22.75 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.546 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -76.49 0.55 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 8.6 mmtt -58.08 -42.6 85.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.623 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.63 36.16 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.207 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 11.9 t0 -94.51 120.07 34.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.642 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 61.81 66.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.6 p -115.75 170.02 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 131.67 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -109.67 145.27 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.89 116.36 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.99 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -88.7 155.7 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -54.54 -22.69 13.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -19.25 61.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.29 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.732 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.9 150.28 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.21 154.98 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.999 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 172.07 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.262 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -106.45 120.12 41.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.59 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 pt -106.31 145.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -118.99 124.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 172' ' ' VAL . 15.0 t -95.6 141.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.264 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 147.82 26.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -71.44 116.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -76.3 -21.4 56.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.12 85.87 0.4 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.549 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.22 -26.74 35.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.265 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -109.77 135.56 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.436 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 17.4 m -141.88 64.47 17.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 199' ' ' SER . 3.6 Cg_exo -76.45 168.16 24.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.885 2.39 . . . . 0.0 112.218 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.16 -168.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.32 -168.99 2.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -96.56 84.49 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.607 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 -168.29 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 111.018 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.5 m -137.78 103.62 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.05 123.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.88 72.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.93 131.93 3.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.2 p -118.58 -7.54 10.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 63.69 -166.81 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.883 0.373 . . . . 0.0 110.518 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.1 p -103.27 117.23 34.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 59.04 165.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 78.3 p -177.54 83.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.991 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -138.0 -81.0 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.552 ' O ' HD22 ' A' ' 216' ' ' LEU . 10.0 t 178.76 -78.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.907 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 215' ' ' SER . 0.1 OUTLIER -163.98 31.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.976 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.831 0.348 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 108' ' ' PRO . . . 59.49 53.13 4.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 107' ' ' ALA . 60.9 Cg_endo -73.25 -45.55 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.407 2.071 . . . . 0.0 112.388 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.53 177.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.35 70.69 2.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.575 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -89.45 -166.09 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -71.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.037 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . 142.95 -61.97 0.52 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.816 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 113' ' ' GLY . 11.1 Cg_endo -54.69 148.22 46.03 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.646 2.231 . . . . 0.0 112.319 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 34.0 Cg_exo -57.8 -159.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.617 2.211 . . . . 0.0 112.279 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.96 79.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.36 107.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -171.99 178.13 3.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.65 -86.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 48.64 27.17 1.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.272 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 m120 52.97 92.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 170.01 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.152 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.5 p -130.49 160.72 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.504 ' N ' HG22 ' A' ' 123' ' ' VAL . 14.3 p -122.26 143.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 126' ' ' SER . 21.5 t -125.03 159.12 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -141.26 170.91 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 65.45 44.37 93.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 157' ' ' THR . 3.9 mm? -78.48 155.23 78.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.735 0.302 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 171.71 11.55 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 112.405 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.12 -26.62 73.03 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.613 2.209 . . . . 0.0 112.346 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -135.9 122.14 20.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.63 -172.72 33.37 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.2 p -172.62 -177.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 44.7 p-90 -59.94 -37.47 79.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 21.6 tt0 -70.38 -32.05 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -68.93 -50.32 50.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.79 HD22 ' CG1' ' A' ' 152' ' ' VAL . 11.3 tp -67.6 -44.85 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.89 -40.38 63.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -61.14 -26.73 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.236 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -86.72 -43.6 12.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.705 ' HG3' HG21 ' A' ' 160' ' ' VAL . 77.6 mmm -69.51 -26.32 64.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -45.31 -33.14 2.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.268 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.36 -33.82 63.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.03 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.99 -140.22 6.87 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.511 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 128.99 39.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.735 HG22 ' HD2' ' A' ' 162' ' ' PHE . 89.5 t -102.72 127.07 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.95 -26.23 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 35.4 t80 -151.73 153.87 35.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.399 . . . . 0.0 111.311 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.429 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.07 149.04 11.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.915 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.51 124.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.79 ' CG1' HD22 ' A' ' 137' ' ' LEU . 30.6 m -122.01 142.51 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.035 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.96 155.12 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -72.5 -10.95 60.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.397 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.59 -23.18 66.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.25 24.43 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.616 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.478 ' HA ' HD23 ' A' ' 128' ' ' LEU . 33.4 p -155.54 160.26 40.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.26 -175.79 25.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 141' ' ' MET . 12.5 t -127.61 133.44 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.3 118.59 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.735 ' HD2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -114.62 139.32 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.627 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 163' ' ' VAL . 6.4 p -71.18 65.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.926 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER 178.81 125.51 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -72.11 -44.84 62.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.546 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.42 -27.79 68.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.668 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.15 -40.59 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.548 ' SD ' HG13 ' A' ' 194' ' ' VAL . 2.0 ttp -59.65 -59.22 5.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.9 m -58.35 -36.44 73.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.357 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -62.89 -45.14 93.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -63.64 -44.9 92.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 192' ' ' VAL . 24.0 m -71.87 -22.38 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.707 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 17.8 ptt180 -96.31 -26.53 15.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.602 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 73.9 mmtt -110.71 -60.81 1.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.959 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.4 mt -63.08 -15.82 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 178' ' ' THR . 16.6 p-10 -64.1 159.26 20.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 50.18 58.6 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.196 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 176' ' ' ASP . 76.1 p -140.51 164.01 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.978 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -87.96 123.59 32.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -99.25 149.78 22.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 142.46 50.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.5 p -95.56 151.51 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -52.98 -23.97 8.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.79 -22.3 53.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.08 26.68 5.65 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.549 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -107.88 115.62 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.04 152.16 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 135.25 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 135.62 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 127' ' ' GLY . 37.0 pt -131.25 161.43 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.374 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -127.7 128.42 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.637 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 172' ' ' VAL . 4.3 t -111.48 142.95 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.318 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -165.17 141.04 5.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 172' ' ' VAL . 23.2 t -59.05 113.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.51 27.36 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 194' ' ' VAL . . . -143.65 -112.64 0.86 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.403 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.51 123.53 13.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.414 2.076 . . . . 0.0 112.206 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -122.28 28.5 7.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.149 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 17.7 p -85.25 160.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 201' ' ' SER . 39.1 Cg_exo -59.38 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.411 2.074 . . . . 0.0 112.079 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 200' ' ' PRO . 2.1 p 161.81 -82.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.879 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.93 76.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.762 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -137.21 9.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.575 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -74.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.811 0.339 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.2 m 62.93 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -165.71 160.04 16.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.852 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -23.88 67.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.073 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 61.57 156.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.941 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.8 m -135.74 -158.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt-85 68.69 97.01 0.06 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.9 p -177.37 71.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.11 -80.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 49.4 -170.05 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -136.37 137.66 40.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.1 m 179.91 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 216' ' ' LEU . 2.6 pp -46.67 107.23 0.1 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.988 0.423 . . . . 0.0 111.345 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -177.69 -72.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.992 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 36.7 mtp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.93 141.21 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.01 -168.69 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.154 . . . . 0.0 112.383 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -151.33 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.74 150.53 15.97 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.414 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 33.25 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.29 34.11 2.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.698 ' N ' ' CD ' ' A' ' 114' ' ' PRO . . . -110.23 4.55 30.0 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.603 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 113' ' ' GLY . 90.6 Cg_endo -79.39 164.86 23.72 Favored 'Trans proline' 0 C--N 1.353 0.811 0 CA-C-N 120.137 1.968 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.96 124.65 16.42 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.5 2.134 . . . . 0.0 112.111 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.14 -175.84 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 53.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 117.07 6.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.1 m -150.92 102.41 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -114.36 31.04 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 3.2 m120 61.59 152.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.583 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 2.1 tmm_? -143.59 142.63 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.044 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.4 p -104.25 159.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 193' ' ' LYS . 8.6 p -118.98 152.66 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.25 148.67 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.573 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -141.2 127.98 20.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.798 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.514 ' C ' HG22 ' A' ' 190' ' ' ILE . . . 127.55 -0.65 6.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.924 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.806 HD12 HG21 ' A' ' 190' ' ' ILE . 1.6 mp -56.78 151.44 32.03 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.817 0.341 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.57 171.86 10.11 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.158 . . . . 0.0 112.161 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.02 -25.63 51.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.424 2.083 . . . . 0.0 112.4 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 125.52 15.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -170.37 -179.63 41.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.4 m -130.8 149.48 52.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.737 0.303 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -63.59 -33.38 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.26 -31.69 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.0 -50.3 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 23.1 tp -60.23 -45.81 91.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' HG22 ' A' ' 147' ' ' VAL . 9.6 tttm -57.43 -39.95 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.97 -26.96 61.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.489 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -91.19 -22.74 20.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.466 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 4.0 ppp? -99.58 -12.77 19.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.574 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -52.72 -24.92 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.748 0.308 . . . . 0.0 111.446 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -24.4 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.853 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -66.89 -28.18 68.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.562 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 -129.9 2.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.363 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -103.19 108.59 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.067 0.46 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' HE2' ' A' ' 138' ' ' LYS . 12.0 p -106.12 139.92 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.24 -40.42 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.405 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 161' ' ' GLU . 7.8 t80 -117.83 145.17 44.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 160' ' ' VAL . . . -162.97 133.18 4.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.63 141.48 48.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.965 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.603 HG12 HD21 ' A' ' 128' ' ' LEU . 28.6 m -128.96 114.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.024 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -85.57 143.78 28.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -73.84 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.42 -49.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.65 -26.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 126' ' ' SER . 30.3 p -106.77 164.26 12.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.68 -175.91 20.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.53 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.583 HG11 ' CZ ' ' A' ' 122' ' ' ARG . 26.6 m -143.42 154.48 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 123' ' ' VAL . 2.0 t -149.32 150.28 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 149' ' ' TYR . 0.9 OUTLIER -132.18 116.22 16.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.788 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 141' ' ' MET . 5.3 m-85 -92.68 173.78 7.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.59 -70.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 157.92 16.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -56.16 -32.08 63.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -55.34 -39.99 70.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.12 -30.65 66.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.433 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 7.0 ttp -70.49 -63.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.4 m -53.14 -34.07 55.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.021 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.78 -48.31 79.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.515 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -55.79 -50.66 69.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.245 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 192' ' ' VAL . 16.0 m -62.64 -25.95 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -72.23 0.42 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -56.1 6.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.118 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.853 HD12 ' HB2' ' A' ' 144' ' ' ALA . 46.8 mt -77.19 72.74 3.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.846 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -133.46 120.94 21.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.9 t30 62.04 39.51 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.713 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -92.31 179.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.937 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.472 ' N ' ' OG1' ' A' ' 178' ' ' THR . 6.6 tttp -98.94 125.99 44.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.9 t80 -103.63 143.41 32.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.726 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.39 116.91 26.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.82 152.87 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -68.52 -14.22 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.253 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.83 -23.1 64.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.284 . . . . 0.0 111.112 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.82 31.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.513 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -139.3 144.11 38.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.358 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 154.65 26.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.9 147.61 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.202 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.05 146.05 28.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.806 HG21 HD12 ' A' ' 128' ' ' LEU . 29.8 pt -136.4 145.69 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 127.99 54.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 172' ' ' VAL . 8.9 t -103.7 143.47 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 124' ' ' VAL . 12.8 mttt -161.31 144.49 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.9 p -64.32 113.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -87.15 54.94 3.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.98 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.473 ' N ' ' HD3' ' A' ' 197' ' ' PRO . . . -161.59 61.1 0.29 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 196' ' ' GLY . 5.2 Cg_exo -79.28 178.05 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.996 2.464 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 63.21 -119.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.425 ' H ' ' HD2' ' A' ' 200' ' ' PRO . 0.2 OUTLIER -178.68 -52.73 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.412 0.148 . . . . 0.0 111.24 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 199' ' ' SER . 75.3 Cg_exo -42.34 166.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.665 2.243 . . . . 0.0 112.798 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.3 t -42.05 155.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.001 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -117.55 -175.88 2.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.726 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.03 -96.25 2.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.419 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -108.51 -88.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.494 0.188 . . . . 0.0 110.67 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.1 m 43.59 -162.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.62 68.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.412 . . . . 0.0 110.437 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.0 p -85.62 -165.91 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.293 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -111.93 -165.09 0.96 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.957 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 210' ' ' ARG . 1.4 m 72.15 -165.12 0.13 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.993 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER 55.85 27.62 11.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.231 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.7 t -120.42 -43.16 2.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.989 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -157.4 148.42 21.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.4 t -160.24 -83.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 48.31 80.16 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.897 0.38 . . . . 0.0 111.198 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.1 p -57.72 -27.01 62.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.55 101.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.14 -73.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.853 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 61.5 mmm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.66 54.38 1.67 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.01 61.45 3.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.547 2.165 . . . . 0.0 112.332 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.04 59.61 0.6 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.79 41.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 60.25 62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -113.12 -26.45 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -55.47 148.06 26.77 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.66 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 74.4 Cg_endo -75.22 159.42 40.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.613 2.209 . . . . 0.0 112.402 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 14.4 Cg_exo -68.36 -69.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.638 2.225 . . . . 0.0 112.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.11 -173.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 79.07 107.42 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.132 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' SER . 6.6 ttt85 -112.54 -80.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.571 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 1.4 p 159.77 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 119' ' ' SER . 2.0 mm-40 91.53 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 111.412 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 9.2 t30 53.66 24.8 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 111.057 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -117.72 150.27 39.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.5 p -133.95 159.98 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.492 ' N ' HG22 ' A' ' 123' ' ' VAL . 9.8 p -124.04 147.83 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 126' ' ' SER . 26.7 t -118.13 157.8 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 125' ' ' VAL . 35.8 t -161.18 123.36 3.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.09 39.48 0.64 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.95 154.84 45.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.672 0.272 . . . . 0.0 110.758 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 12.6 Cg_endo -55.98 166.24 3.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 0.0 112.21 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.74 -27.55 20.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.678 2.252 . . . . 0.0 112.484 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 129.46 15.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.09 -163.68 13.99 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -153.01 162.55 41.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HB3' HG22 ' A' ' 152' ' ' VAL . 60.4 p-90 -74.12 -39.18 63.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -36.91 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -36.0 66.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 22.8 tp -63.17 -45.14 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -28.12 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.186 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -67.07 -26.7 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.29 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -96.26 -27.95 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.304 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 147' ' ' VAL . 38.6 mmm -83.58 -26.28 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.248 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.519 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -51.5 -27.57 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.426 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -53.69 -22.52 9.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.51 66.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 0.0 110.64 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.5 -59.58 0.36 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.369 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -174.38 107.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 141' ' ' MET . 84.7 t -88.67 132.05 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.52 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -133.35 145.26 50.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.75 133.94 6.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -138.12 152.21 48.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 134' ' ' TRP . 2.9 m -144.39 107.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.68 100.69 6.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 64.15 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -179.13 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.04 10.86 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.062 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.436 HG22 ' CB ' ' A' ' 126' ' ' SER . 54.5 p -157.63 174.54 15.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -160.86 -166.22 19.18 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.414 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 151' ' ' ASP . 24.7 m -149.86 159.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 111.016 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.42 145.25 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.09 137.09 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.706 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 147' ' ' VAL . 34.3 m-85 -113.56 175.67 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.66 -70.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.83 157.97 15.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -58.14 -29.16 65.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.54 -34.95 76.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.9 -38.48 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.5 ttp -70.79 -62.23 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 173' ' ' ARG . 92.5 m -53.38 -36.81 61.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 28.4 t80 -63.79 -46.54 84.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -54.9 -46.14 74.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 192' ' ' VAL . 15.9 m -68.91 -23.03 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.549 ' HD2' HG22 ' A' ' 169' ' ' THR . 10.2 mtp180 -87.01 -67.2 0.83 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.975 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 1.5 mptp? -76.81 -48.38 18.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.736 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 52.3 mt -84.49 58.48 4.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -117.84 129.84 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.739 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.16 39.44 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.708 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.2 p -81.37 177.61 8.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.94 99.25 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.0 t80 -88.72 152.67 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.89 140.05 40.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.21 155.05 22.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.637 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -53.03 -22.83 6.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -75.73 -21.07 57.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 20.84 8.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.771 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 116.19 32.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.733 0.301 . . . . 0.0 110.715 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 156.94 18.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -165.1 166.04 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.25 119.58 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.9 pt -108.32 141.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.98 0.419 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -106.38 128.63 54.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 172' ' ' VAL . 3.9 t -111.76 142.89 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.084 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.96 140.84 8.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.3 110.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.42 -170.67 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -177.05 91.75 0.08 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.542 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.41 -162.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.657 2.238 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.55 165.84 12.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 76.69 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.512 2.141 . . . . 0.0 112.187 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.72 132.76 42.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -95.77 -176.43 3.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -55.45 -28.46 50.92 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.575 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -89.37 53.35 2.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.6 p 52.4 -89.91 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 48.12 94.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.739 0.304 . . . . 0.0 111.293 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.0 t 62.69 38.11 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.83 118.37 18.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 p -130.94 132.32 45.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.26 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.759 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.1 t -158.09 140.97 14.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -146.18 171.23 15.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.63 34.95 20.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -176.14 123.94 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 13.3 t -106.37 167.68 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.8 mt -119.24 -74.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -133.68 66.54 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.815 0.34 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.38 146.56 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.977 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.95 -94.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.335 2.024 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 46.87 -171.42 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.838 0.351 . . . . 0.0 111.357 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 111' ' ' ARG . . . 86.49 71.27 1.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.856 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 58.27 157.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.61 -54.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -150.59 106.28 0.31 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.55 108.02 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.487 2.125 . . . . 0.0 112.284 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.56 138.01 37.44 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.702 2.268 . . . . 0.0 112.259 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.3 m -179.72 48.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.959 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -115.06 -20.92 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.57 18.35 2.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.751 0.31 . . . . 0.0 111.327 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.59 92.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.49 16.74 11.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.342 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -111.8 -0.15 16.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 119.96 25.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.6 p -102.62 160.12 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 193' ' ' LYS . 11.6 p -120.46 143.71 31.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -129.99 158.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 125' ' ' VAL . 21.4 p -146.75 146.42 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 95.29 46.14 2.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.559 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.61 145.48 37.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.639 0.257 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.92 170.67 19.15 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.381 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.71 -27.47 52.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 31.08 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.72 118.76 5.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.03 168.91 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 58.6 p-90 -62.59 -41.75 99.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -61.58 -33.73 74.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.429 ' OD2' ' CE1' ' A' ' 183' ' ' HIS . 8.7 t0 -77.03 -38.39 52.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.202 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.84 -44.3 32.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.273 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.791 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.1 ttmm -53.19 -39.71 63.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -71.63 -26.7 62.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.621 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -26.01 20.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.422 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.694 ' CE ' HG11 ' A' ' 160' ' ' VAL . 3.3 ppp? -97.01 -10.25 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -18.78 30.89 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.516 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.93 -25.79 3.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -69.57 -27.42 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.745 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.54 -125.87 1.79 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.457 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.459 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.791 HG11 ' HG3' ' A' ' 138' ' ' LYS . 84.0 t -79.94 130.94 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.047 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 -29.44 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -163.28 146.95 10.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.97 136.64 19.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -152.07 125.11 8.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 158' ' ' GLY . 31.3 m -127.88 131.49 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -98.24 155.01 17.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -10.18 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.411 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -29.0 70.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 157' ' ' THR . . . 123.45 36.46 0.64 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.592 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' GLY . 16.7 p -160.3 160.77 32.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.849 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 152' ' ' VAL . . . -149.97 176.78 28.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.576 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.3 m -147.69 146.87 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.324 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.694 HG11 ' CE ' ' A' ' 141' ' ' MET . 3.5 t -141.66 147.78 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.08 126.14 33.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 1.0 OUTLIER -104.98 166.9 10.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.59 -72.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 151.05 24.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.99 -27.53 5.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.246 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -53.98 -44.16 70.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -30.07 64.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.439 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.1 ttp -65.03 -63.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.1 m -57.69 -34.04 69.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.51 80.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.616 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 192' ' ' VAL . 4.5 m -65.22 -24.81 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.446 ' HD2' HG23 ' A' ' 172' ' ' VAL . 0.0 OUTLIER -76.74 -73.05 0.31 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.233 0.539 . . . . 0.0 110.296 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -58.26 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.7 mt -77.27 81.52 3.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.45 138.57 19.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.49 46.64 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -109.83 173.25 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.445 ' HD3' ' CD1' ' A' ' 189' ' ' TYR . 0.3 OUTLIER -105.32 103.37 12.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.93 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -68.89 120.17 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.54 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.24 100.8 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.532 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.05 136.87 56.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.429 ' CE1' ' OD2' ' A' ' 136' ' ' ASP . 1.7 p80 -59.37 -19.83 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.187 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -68.77 -17.48 64.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.258 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.99 31.04 3.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.56 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -131.74 138.5 48.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.06 156.8 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 138.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.445 ' CD1' ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -79.21 128.77 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 127' ' ' GLY . 5.4 pt -125.14 140.77 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.371 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -112.7 134.94 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 172' ' ' VAL . 12.2 t -109.62 141.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.362 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 124' ' ' VAL . 39.8 mttp -153.34 137.87 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 194' ' ' VAL . 11.1 p -67.06 115.38 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.175 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -97.58 91.33 5.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.803 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -168.74 160.07 33.41 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.24 -148.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.897 2.398 . . . . 0.0 112.308 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.25 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.95 0.405 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.632 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 12.6 p -82.61 -32.4 0.57 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.221 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 199' ' ' SER . 55.2 Cg_exo -52.88 -161.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.319 2.013 . . . . 0.0 112.865 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 200' ' ' PRO . 2.3 m 91.16 -35.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.04 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 120.25 2.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.748 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.46 127.44 4.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.325 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? 62.29 36.05 14.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 110.683 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 -70.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -144.66 123.66 12.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.988 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.5 p -162.99 29.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.78 29.74 4.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.9 p -75.5 169.86 17.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 61.64 43.04 10.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -61.53 1.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -57.64 148.72 23.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.082 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -150.21 176.35 10.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -71.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.8 p -177.92 -114.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.592 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.53 135.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.959 0.409 . . . . 0.0 111.015 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -177.13 169.89 2.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.944 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.9 mmm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.709 0.29 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.82 56.49 2.93 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.006 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.53 -40.14 6.06 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.647 2.231 . . . . 0.0 112.357 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 59.76 37.38 22.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.67 -50.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.287 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' TYR . 3.5 ptp180 -100.37 -29.87 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 0.0 110.802 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 112' ' ' TYR . 24.9 p90 43.99 84.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . -55.98 -62.77 5.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.808 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 113' ' ' GLY . 12.4 Cg_endo -56.34 108.28 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.706 2.271 . . . . 0.0 112.269 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.47 135.7 47.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.434 2.089 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.7 p -151.9 48.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -100.03 75.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -166.22 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.8 m 57.99 106.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -55.89 5.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.631 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 41.93 60.93 2.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.428 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -123.42 121.95 37.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.849 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 194' ' ' VAL . 26.1 m -106.97 161.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 158' ' ' GLY . 24.4 t -113.38 140.7 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -120.1 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.0 p -111.71 132.99 54.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.58 35.85 0.96 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 137' ' ' LEU . 4.0 mm? -87.88 153.52 52.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 161.74 44.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.477 2.118 . . . . 0.0 112.301 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 -31.43 20.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 90.57 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.63 -163.34 11.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.59 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 170.72 20.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -60.29 -44.25 95.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.797 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -60.47 -31.64 70.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -53.22 60.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.606 HD13 HD11 ' A' ' 128' ' ' LEU . 63.2 tp -60.0 -40.16 88.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.68 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -60.75 -39.66 89.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.908 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.98 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -87.99 -35.11 17.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.503 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -71.31 -25.21 62.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.4 mtt-85 -46.77 -30.2 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -30.36 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.51 -27.42 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 151.15 -100.43 0.2 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -131.1 111.05 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.961 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 138' ' ' LYS . 95.1 t -78.17 151.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 40.7 t -112.7 -31.82 6.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -165.59 150.41 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.95 173.37 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -176.9 135.01 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.429 HG12 ' HG ' ' A' ' 128' ' ' LEU . 4.2 m -125.56 101.19 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 19.2 p90 -124.12 155.84 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 0.2 OUTLIER 89.38 -4.98 0.4 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.355 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 63.14 31.53 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.94 -45.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.3 p -104.84 160.1 15.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.375 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -159.06 -179.32 33.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.265 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.6 p -146.07 159.52 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.222 0.534 . . . . 0.0 111.208 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 46.0 t -154.74 141.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.2 125.47 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.37 177.13 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.86 -69.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -88.36 149.84 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -61.33 -34.19 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.58 -33.44 72.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.73 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' OD1' ' HB1' ' A' ' 144' ' ' ALA . 36.9 t0 -72.18 -37.93 69.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.526 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.47 -63.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.428 ' HA ' HG22 ' A' ' 172' ' ' VAL . 53.9 m -53.73 -31.46 48.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 4.3 t80 -60.43 -50.51 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.244 0.545 . . . . 0.0 110.12 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 175' ' ' LEU . . . -57.55 -53.87 53.27 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 169' ' ' THR . 13.9 m -54.82 -22.71 10.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.351 . . . . 0.0 111.752 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -71.75 0.69 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.042 0.449 . . . . 0.0 112.111 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -67.74 -45.55 74.65 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -123.31 84.16 2.23 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.826 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 2.4 p-10 -129.51 -102.03 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.321 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 190' ' ' ILE . 59.3 t30 -67.62 56.28 0.06 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.467 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -109.39 -167.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -91.36 140.98 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -118.67 133.3 55.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -123.27 119.12 29.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.9 t -79.11 149.83 31.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -55.39 -23.46 24.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.22 -23.0 63.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.13 28.83 4.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.0 136.77 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.69 156.22 18.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.52 168.31 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.43 109.98 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 21.6 pt -102.1 158.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 177' ' ' ASN . 1.2 tmm_? -139.08 117.36 11.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.6 151.45 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.9 144.03 6.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.5 t -61.31 119.71 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 14.6 t0 -85.36 56.29 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 197' ' ' PRO . . . -154.9 128.51 2.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.55 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 196' ' ' GLY . 31.6 Cg_exo -58.93 -150.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.526 2.15 . . . . 0.0 112.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.66 24.86 1.62 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.947 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.419 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 18.4 p -179.97 63.5 0.13 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 199' ' ' SER . 31.4 Cg_exo -58.94 -64.03 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.716 2.277 . . . . 0.0 112.386 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 m 62.65 -164.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -55.01 91.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.989 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -85.67 -177.2 50.34 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.58 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -177.73 -38.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.298 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.0 m -54.24 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.115 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -65.89 83.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -141.18 -75.79 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 57.97 26.32 13.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.008 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 27.8 p 55.66 102.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -74.02 -168.79 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.747 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.2 t -105.73 -102.75 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.873 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 60.91 138.78 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 38.5 p 50.51 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -173.62 1.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.9 p -97.31 -73.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.658 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.72 67.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.14 90.88 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 45.7 t60 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.834 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.82 0.343 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 64.35 89.39 0.1 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.123 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.41 105.12 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.528 2.152 . . . . 0.0 112.189 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -125.64 163.67 22.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.58 27.41 15.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.507 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -33.2 59.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -100.43 29.32 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.07 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -60.15 120.4 22.63 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.27 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.43 107.18 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.501 2.134 . . . . 0.0 112.3 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.11 -158.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.732 2.288 . . . . 0.0 112.21 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 p -67.24 -164.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.85 60.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -170.43 126.46 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.78 158.65 32.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -169.91 56.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -104.25 -20.37 13.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.097 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -79.92 158.07 26.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.7 p -144.18 160.01 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.496 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.7 p -123.2 141.07 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.09 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -118.82 155.61 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 125' ' ' VAL . 11.0 t -145.46 138.46 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 100.89 37.0 3.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.33 152.98 92.25 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.76 171.84 10.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.313 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.99 -28.49 80.7 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.638 2.225 . . . . 0.0 112.249 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m -122.24 -80.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.38 -168.67 0.31 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.806 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 m -164.5 156.23 15.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 44.8 p-90 -59.26 -44.6 92.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -67.5 -32.89 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.603 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.19 -45.32 77.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.427 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 59.7 tp -59.67 -43.84 93.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.88 -37.93 64.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.956 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -64.42 -26.72 68.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.215 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -84.75 -37.51 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.529 ' HA ' HD21 ' A' ' 175' ' ' LEU . 32.4 mmm -75.85 -20.34 58.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.661 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -43.3 -31.83 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.354 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -50.62 -34.33 25.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.87 -29.68 66.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.8 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.22 -129.04 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.383 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.29 136.93 37.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.532 HG22 ' CE1' ' A' ' 162' ' ' PHE . 92.4 t -115.54 121.37 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.957 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.02 -42.53 16.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.058 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 52.3 t80 -142.98 158.45 43.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -162.99 139.94 7.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.49 161.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.57 133.08 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.85 155.64 37.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.704 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -33.13 -42.78 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.935 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 174.01 65.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.886 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.73 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.814 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 126' ' ' SER . 13.9 p -141.3 -177.13 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.141 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.67 176.71 33.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.463 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 126.93 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 123' ' ' VAL . 16.9 t -119.66 144.32 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.03 106.92 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.82 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.532 ' CE1' HG22 ' A' ' 147' ' ' VAL . 80.4 m-85 -87.53 141.6 28.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.33 -28.62 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -120.0 147.94 44.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -72.1 -32.85 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -60.48 -31.78 70.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.416 ' O ' ' HB1' ' A' ' 144' ' ' ALA . 62.0 m-20 -71.66 -35.89 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.484 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.2 ttp -67.97 -62.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.3 m -53.4 -32.24 48.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 3.1 t80 -61.35 -50.43 72.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.223 0.535 . . . . 0.0 110.076 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 175' ' ' LEU . . . -55.02 -54.1 47.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 194' ' ' VAL . 15.3 m -55.87 -22.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.36 -72.47 0.62 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.322 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -35.77 25.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -110.51 75.45 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.83 162.04 36.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.771 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 p30 42.92 58.8 3.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.445 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.5 p -123.63 170.47 10.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -85.57 134.85 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 187' ' ' THR . 24.7 t80 -91.73 146.81 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -119.64 112.8 19.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.1 t -93.95 144.65 25.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -57.72 -25.64 60.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.01 -23.13 64.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.85 18.02 12.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.66 129.28 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.684 0.278 . . . . 0.0 110.712 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 180' ' ' PHE . 0.2 OUTLIER -101.52 159.61 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.008 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.03 133.62 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.239 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.37 122.69 23.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 127' ' ' GLY . 7.4 pt -117.63 155.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -119.81 139.53 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.52 135.93 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 124' ' ' VAL . 29.2 mmmt -152.69 140.49 20.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.533 HG23 HG11 ' A' ' 172' ' ' VAL . 21.6 t -63.52 111.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.3 116.65 4.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.649 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -104.22 99.17 1.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.928 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.63 -177.61 3.71 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.6 2.2 . . . . 0.0 112.177 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -97.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.953 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 164.26 18.9 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.08 116.42 2.79 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.574 2.183 . . . . 0.0 112.29 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.44 -174.2 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.55 173.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 204' ' ' ARG . . . -125.01 158.73 19.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.389 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 34.25 77.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.623 0.369 . . . . 0.0 111.776 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.54 158.52 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -112.33 114.91 27.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.4 m -136.63 -81.68 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.92 -169.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.359 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 t -93.35 -138.28 0.2 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.574 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 74.02 47.63 0.15 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.924 0.393 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.05 145.01 32.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.42 161.44 5.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -63.08 -166.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -169.81 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 74.4 m 64.35 -78.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 217' ' ' GLU . 6.5 mp -126.37 -79.64 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 216' ' ' LEU . 0.1 OUTLIER 53.94 173.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.253 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.929 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 29.9 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.791 0.329 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.14 151.7 40.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.64 -70.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.7 2.267 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -48.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 67.78 -154.65 53.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 173.34 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 62.28 -168.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -58.3 140.93 46.3 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.31 112.09 3.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.605 2.203 . . . . 0.0 112.38 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.79 118.97 5.51 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.4 2.067 . . . . 0.0 112.291 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.5 t -167.01 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.08 28.79 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -176.24 138.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.0 p -170.96 176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 58.19 27.83 15.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.15 28.44 7.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.983 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -102.51 154.07 19.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.62 152.57 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.58 139.54 51.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.15 146.28 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.3 m -142.45 148.71 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.75 49.97 33.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.555 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.769 ' CB ' HG22 ' A' ' 190' ' ' ILE . 0.3 OUTLIER -130.43 160.21 67.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.621 0.248 . . . . 0.0 111.0 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 57.1 Cg_endo -71.1 137.25 31.21 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.371 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.01 -20.08 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.438 2.092 . . . . 0.0 112.544 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -54.58 -60.96 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.204 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.16 116.74 9.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.633 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -168.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.771 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 38.8 p-90 -64.61 -33.89 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 35.7 mt-30 -65.29 -40.37 93.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -71.84 -38.52 70.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.496 HD22 HG12 ' A' ' 152' ' ' VAL . 46.1 tp -70.45 -46.11 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.4 tttt -57.78 -49.17 77.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.69 -26.62 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.37 17.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 142' ' ' ARG . 10.8 mtp-105 -45.55 -32.04 2.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -32.72 65.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.801 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -76.46 -29.42 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.32 -160.99 31.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.388 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.69 122.02 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.418 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 138' ' ' LYS . 93.8 t -89.23 130.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.006 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.6 t -98.68 -30.54 12.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.406 ' O ' HG13 ' A' ' 160' ' ' VAL . 22.0 t80 -153.07 145.13 23.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.024 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -150.12 133.93 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 159' ' ' VAL . 36.8 t0 -153.73 111.26 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 137' ' ' LEU . 27.5 m -92.9 134.21 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -79.94 152.63 29.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -71.84 -22.28 61.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -42.15 75.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.348 . . . . 0.0 111.116 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 153.53 -27.19 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.543 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -82.56 173.85 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.319 . . . . 0.0 110.719 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.25 177.49 31.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 151' ' ' ASP . 29.6 m -149.09 144.32 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 149' ' ' TYR . 3.7 t -148.06 137.2 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -117.51 127.53 54.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.54 177.13 5.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -70.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.332 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 163.29 14.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.11 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -71.99 -31.33 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -31.94 67.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -72.36 -36.05 68.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.672 ' SD ' HG13 ' A' ' 194' ' ' VAL . 7.7 ttp -65.25 -62.18 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.606 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.3 m -54.68 -32.96 60.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.422 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 44.4 t80 -63.56 -45.65 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.26 -31.43 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.802 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.468 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 0.7 OUTLIER -84.62 -29.37 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.326 . . . . 0.0 110.888 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.468 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 0.7 OUTLIER -105.74 -65.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.863 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 144' ' ' ALA . 70.2 mt -76.84 66.36 2.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 177' ' ' ASN . 22.9 t0 -120.93 121.01 37.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER 68.53 12.89 8.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -176.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.999 0.428 . . . . 0.0 111.008 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -101.68 144.25 30.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.996 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -124.8 122.81 38.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.293 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HG3' HG23 ' A' ' 187' ' ' THR . 6.1 ttt-85 -119.62 119.32 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.7 m -87.81 159.39 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -59.95 -17.03 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -92.48 18.59 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.34 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.32 31.09 76.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.544 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 93.3 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 110.8 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -92.2 144.51 25.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -170.06 172.02 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.238 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -106.17 123.51 48.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.769 HG22 ' CB ' ' A' ' 128' ' ' LEU . 13.7 pt -107.62 152.43 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.706 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -112.63 117.6 32.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.11 133.63 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -153.87 150.46 28.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.672 HG13 ' SD ' ' A' ' 168' ' ' MET . 21.8 t -62.49 109.39 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.14 -79.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.89 140.84 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.26 89.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.28 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -104.9 49.95 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.798 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 47.2 p -142.87 50.09 1.38 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 199' ' ' SER . 84.3 Cg_endo -80.09 96.95 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.548 2.165 . . . . 0.0 112.475 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 30.9 t -63.27 82.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -77.25 80.44 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -92.03 13.08 67.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.771 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 55.48 74.2 0.38 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.903 0.382 . . . . 0.0 111.037 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 p -172.14 136.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.14 -33.21 8.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.21 87.85 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.71 30.49 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.29 30.98 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.881 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.53 104.36 7.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 78.0 p -174.73 -171.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 4.6 ptt85 -58.8 88.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.53 166.52 24.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.104 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -83.81 98.57 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -76.16 63.38 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 216' ' ' LEU . 23.4 mt -155.68 179.74 8.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.39 142.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 28.3 mtm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.771 0.319 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.18 82.47 0.22 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.79 -68.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.565 2.177 . . . . 0.0 112.317 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 126.46 53.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.52 -157.76 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 67.08 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.4 t80 59.93 81.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.7 146.28 43.3 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.8 150.09 38.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.617 2.211 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.56 73.92 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.552 2.168 . . . . 0.0 112.257 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.79 118.8 35.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -162.75 30.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -71.41 -15.17 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.1 p -53.7 92.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.77 36.32 3.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE ' ' A' ' 165' ' ' LYS . 12.2 m-80 -78.29 76.34 4.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -121.76 169.61 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 160' ' ' VAL . 1.6 p -117.46 159.62 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.963 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 199' ' ' SER . 9.7 t -114.37 156.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' N ' HG12 ' A' ' 124' ' ' VAL . 19.3 t -144.35 143.69 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.82 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.448 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -137.26 159.42 41.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.74 45.18 8.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.1 mm? -83.83 142.94 42.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.97 170.44 20.09 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.29 -20.71 66.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.572 2.181 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.7 m -108.88 -157.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.47 -177.94 48.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -176.8 -175.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 110.747 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 56.3 p-90 -59.27 -43.06 92.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 7.2 tp60 -63.01 -38.72 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -35.48 57.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.802 HD22 HG22 ' A' ' 152' ' ' VAL . 30.6 tp -62.29 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.637 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -57.6 -42.48 83.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.5 -26.77 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -89.59 -29.86 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.736 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.525 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -85.44 -19.97 30.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.07 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -46.43 -30.0 1.97 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.32 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.98 -32.43 53.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.88 -28.17 60.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.43 -139.6 6.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.4 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -99.7 101.33 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 162' ' ' PHE . 92.0 t -75.64 120.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.27 -29.07 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 20.4 t80 -146.67 151.59 37.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -159.8 140.92 12.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 159' ' ' VAL . 6.1 t70 -135.4 148.92 49.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.802 HG22 HD22 ' A' ' 137' ' ' LEU . 1.8 t -146.16 106.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.17 151.41 31.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -17.7 61.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.207 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.84 -24.41 67.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.72 25.74 2.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.677 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 126' ' ' SER . 31.8 p -151.42 163.35 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.781 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.62 -166.14 18.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.795 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 151' ' ' ASP . 34.1 m -147.51 172.68 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.509 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.892 HG23 HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -155.0 130.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.402 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.48 120.69 39.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.858 ' CE2' HG22 ' A' ' 147' ' ' VAL . 85.2 m-85 -104.01 139.71 38.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.61 -30.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.781 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.19 125.91 49.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CE ' ' HA ' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -53.62 -24.15 13.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -39.23 89.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.49 -31.94 71.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.583 ' HE3' ' H ' ' A' ' 169' ' ' THR . 9.3 tmm? -61.32 -75.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.798 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.585 HG23 ' NH1' ' A' ' 173' ' ' ARG . 5.0 m -45.64 -45.04 13.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.751 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.8 -40.21 75.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.954 0.407 . . . . 0.0 110.683 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.563 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 192' ' ' VAL . 15.4 m -78.85 -27.65 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.116 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.585 ' NH1' HG23 ' A' ' 169' ' ' THR . 4.5 mmt85 -80.75 -40.12 25.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -103.43 -58.24 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.478 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 96.6 mt -77.53 64.86 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.947 0.403 . . . . 0.0 111.022 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -128.24 138.53 52.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.02 30.2 19.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.7 p -98.41 155.5 17.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -81.24 134.37 35.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -96.04 158.11 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.558 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.683 ' HG2' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -133.14 125.77 30.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.969 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -93.91 149.88 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.831 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -56.16 -23.12 32.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.66 -23.11 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.054 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.19 26.23 6.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.677 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -115.12 136.2 53.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -110.68 161.1 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -168.98 170.91 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.006 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.16 126.15 43.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -117.5 137.68 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.335 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -106.15 122.63 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.677 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 172' ' ' VAL . 3.0 t -104.62 153.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.468 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -164.35 140.63 6.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.675 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.481 HG23 ' SD ' ' A' ' 168' ' ' MET . 11.7 p -66.63 119.59 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.48 . . . . 0.0 111.289 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 124' ' ' VAL . 9.4 t0 -80.96 136.58 36.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -160.94 -98.58 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.87 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.34 -67.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.483 2.122 . . . . 0.0 112.688 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -138.46 7.65 2.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.768 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.662 ' HB2' HG21 ' A' ' 124' ' ' VAL . 53.3 p 49.4 57.29 18.2 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-O 120.725 0.297 . . . . 0.0 111.318 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.22 124.27 4.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.667 2.244 . . . . 0.0 112.356 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -60.18 -47.17 87.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 68.43 -69.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.91 174.84 30.88 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -125.29 -70.91 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.3 t -172.5 -76.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 27.6 mtm105 -157.32 42.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -120.48 -48.89 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 -148.09 106.47 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.8 p -159.92 39.53 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -76.2 -30.13 57.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m 62.2 116.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.05 75.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.73 -170.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.73 90.84 3.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 81.8 p -133.67 83.5 2.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 218' ' ' HIS . 0.6 OUTLIER -71.96 157.63 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.18 42.11 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.843 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.472 ' N ' HD12 ' A' ' 216' ' ' LEU . 5.2 m-70 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.797 0.332 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.65 92.92 7.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.43 125.49 13.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.524 2.149 . . . . 0.0 112.275 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.69 -67.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.52 -48.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.603 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -174.65 65.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.06 -26.8 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.458 ' C ' ' HD2' ' A' ' 115' ' ' PRO . . . -56.53 161.61 7.14 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.934 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' N ' ' CD ' ' A' ' 115' ' ' PRO . 7.5 Cg_endo -54.84 -33.55 81.94 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.844 2.363 . . . . 0.0 113.844 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 48.9 Cg_exo -57.23 -153.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.021 1.814 . . . . 0.0 112.686 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.9 m -40.79 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.66 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HB3' ' NH1' ' A' ' 117' ' ' ARG . 5.5 ttm105 -136.94 -37.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.07 172.68 8.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.989 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.2 p -132.98 11.02 4.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.29 17.45 8.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.457 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 m120 55.58 105.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -116.06 170.03 8.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 168' ' ' MET . 2.0 t -123.95 165.34 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.202 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 193' ' ' LYS . 7.4 p -122.42 136.35 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.402 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.14 153.99 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 157' ' ' THR . 3.1 t -141.85 133.57 27.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.44 40.26 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.633 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 128' ' ' LEU . 2.4 mm? -89.05 139.06 28.84 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.531 0.205 . . . . 0.0 110.99 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 169.91 21.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.467 2.112 . . . . 0.0 112.284 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.01 -29.79 26.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.455 2.103 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.07 71.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.38 -160.43 8.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.67 174.08 1.89 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.769 0.318 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 52.8 p-90 -72.7 -40.92 65.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 3.6 pt20 -66.85 -34.67 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -29.45 60.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -73.17 -41.34 63.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -64.31 -53.77 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.145 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -56.34 -26.79 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.252 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.495 ' CD2' ' CE1' ' A' ' 180' ' ' PHE . 10.4 m-70 -86.06 -23.09 26.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.388 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.907 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.5 ppp? -106.66 8.47 31.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 111.544 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -56.9 -15.11 4.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.496 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.827 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -49.83 -23.82 2.09 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.506 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . . . -61.48 -28.23 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.118 0.485 . . . . 0.0 110.396 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 140.46 -55.14 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.427 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.69 117.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.469 ' CG1' ' HG3' ' A' ' 138' ' ' LYS . 61.1 t -100.5 132.26 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.842 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.21 -49.48 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.235 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 14.1 t80 -155.83 160.02 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -147.46 168.01 22.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.75 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.4 t70 -163.14 123.79 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.019 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.13 138.96 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.88 155.04 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -70.8 -18.05 62.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.188 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.14 -25.79 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 5.15 8.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.785 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 126' ' ' SER . 8.4 p -131.75 161.14 33.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.2 -169.05 11.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 151' ' ' ASP . 7.0 m -140.94 167.31 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.907 HG11 ' SD ' ' A' ' 141' ' ' MET . 21.9 t -152.72 140.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -131.28 114.3 14.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 144' ' ' ALA . 16.9 m-85 -88.89 176.49 7.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.85 -66.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -96.84 161.11 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.555 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -25.2 62.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.56 -31.26 72.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.06 -31.36 71.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.724 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.1 ttp -59.86 -62.11 2.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.67 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 172' ' ' VAL . 52.1 m -56.81 -32.41 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 170' ' ' TYR . 4.3 t80 -60.54 -50.31 74.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.227 0.537 . . . . 0.0 110.28 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' LEU . . . -57.8 -51.99 67.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.967 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.82 HG11 HG23 ' A' ' 194' ' ' VAL . 15.8 m -57.11 -22.48 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.974 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -106.52 -73.6 0.68 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.147 0.498 . . . . 0.0 112.25 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -35.18 79.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -125.49 85.5 2.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.645 0.736 . . . . 0.0 111.448 -178.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -142.74 152.69 42.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 71.26 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 p -124.98 169.76 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -89.54 136.35 33.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 140' ' ' HIS . 89.9 t80 -113.74 114.98 27.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.694 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -116.19 103.61 10.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.829 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.6 p -58.45 169.84 0.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.072 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -6.94 34.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.13 -22.93 21.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.712 0.291 . . . . 0.0 111.097 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 30.47 4.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.432 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -112.05 108.28 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.7 156.25 20.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.07 169.7 12.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.59 136.51 43.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.95 142.54 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.282 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.89 150.92 37.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 123' ' ' VAL . 4.0 t -114.97 133.58 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.331 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.665 ' O ' HG12 ' A' ' 124' ' ' VAL . 2.6 mtpm? -141.22 140.45 33.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.82 HG23 HG11 ' A' ' 172' ' ' VAL . 37.6 t -68.49 113.94 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.297 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.4 OUTLIER -96.1 124.72 40.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.598 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -108.69 -68.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.705 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.5 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.651 2.234 . . . . 0.0 112.626 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 152.28 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.401 ' CB ' ' CD ' ' A' ' 200' ' ' PRO . 4.2 p -119.84 175.83 2.07 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 199' ' ' SER . 31.6 Cg_exo -59.19 -145.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.827 2.352 . . . . 0.0 112.19 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 202' ' ' TYR . 1.5 m -73.78 1.05 11.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 201' ' ' SER . 19.6 m-85 67.26 -69.96 0.12 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.809 0.338 . . . . 0.0 111.072 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.92 174.05 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.218 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.91 -163.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.671 0.272 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 t 69.9 -137.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.709 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -46.8 108.92 0.16 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.856 0.36 . . . . 0.0 111.26 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 m -133.42 91.06 2.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.801 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -59.13 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.4 p -117.11 -169.27 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.82 28.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.46 -47.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -98.57 31.87 2.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.5 100.47 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 120.78 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.535 ' C ' HD22 ' A' ' 216' ' ' LEU . 1.2 m -129.9 78.25 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 215' ' ' SER . 4.0 mm? -128.0 122.53 32.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.78 -77.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.15 90.28 3.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.27 152.39 75.86 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.517 2.144 . . . . 0.0 112.25 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.74 -30.5 67.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.08 116.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.454 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 101.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -173.43 4.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.96 57.49 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.768 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.452 ' HG2' ' HD3' ' A' ' 115' ' ' PRO . 4.1 Cg_exo -40.63 -51.45 3.53 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.087 2.525 . . . . 0.0 112.897 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' HD3' ' HG2' ' A' ' 114' ' ' PRO . 78.6 Cg_exo -47.08 173.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.543 2.162 . . . . 0.0 112.61 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -136.49 44.47 2.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.752 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 71.77 -63.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.92 152.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.46 -32.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 74.38 51.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.823 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.33 88.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.02 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.64 169.18 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 194' ' ' VAL . 4.3 m -125.48 165.12 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.88 136.7 48.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.6 t -105.35 154.11 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 157' ' ' THR . 28.1 p -154.86 121.27 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.78 26.75 4.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' HG22 ' A' ' 190' ' ' ILE . 2.9 mt -68.18 155.27 92.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 188' ' ' ALA . 42.8 Cg_endo -68.05 160.57 48.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.627 2.218 . . . . 0.0 112.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.43 -28.99 31.92 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m -118.52 72.19 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.79 147.29 16.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.36 175.81 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.672 0.272 . . . . 0.0 111.025 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -73.97 -32.32 63.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.953 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.72 -44.66 90.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.06 -32.08 59.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 55.3 tp -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.15 -45.06 93.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.195 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.45 -26.77 68.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.727 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -99.94 -26.43 14.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.824 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -96.9 4.44 51.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -9.9 45.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.82 -26.74 4.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.804 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.37 -28.75 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.92 -164.91 28.16 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.6 m-20 -60.29 106.38 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.117 0.484 . . . . 0.0 110.781 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.1 t -73.85 153.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.0 t -107.64 -59.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.177 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.52 130.94 5.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.817 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.52 140.34 53.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.13 136.71 33.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.999 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 152' ' ' VAL . 26.7 m -119.4 118.92 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.927 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -93.33 121.22 34.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 63.34 -76.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 1.2 m-20 169.76 -25.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -64.62 -49.93 61.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.633 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 126' ' ' SER . 33.2 p -133.63 -179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.9 -159.05 10.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.468 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 m -156.01 158.85 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.824 HG11 ' SD ' ' A' ' 141' ' ' MET . 16.4 t -152.05 141.93 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.93 135.01 54.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.85 163.23 13.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 146' ' ' ASP . 46.9 t -80.31 -62.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -88.23 152.92 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.58 -30.73 68.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -36.88 85.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.62 -30.62 68.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.763 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.9 ttp -65.14 -64.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -55.04 -32.78 62.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.558 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 64.7 t80 -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . . . -68.02 -39.34 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.634 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 194' ' ' VAL . 11.7 m -79.54 -22.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.818 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.558 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 5.7 ptm180 -91.11 -42.08 10.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HD2' ' HG3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -109.42 -30.45 7.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 144' ' ' ALA . 17.7 mt -94.84 31.51 1.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.61 134.51 45.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 60.71 35.08 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.584 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.36 154.95 17.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.468 ' HD3' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER -81.06 115.63 20.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.1 t80 -92.8 152.98 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.09 113.53 20.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.96 158.77 34.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.73 -13.81 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.182 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.7 20.78 7.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.394 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 25.93 73.26 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.573 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 125.21 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.468 HG22 ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -94.09 161.07 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 129' ' ' PRO . . . -165.75 159.41 16.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.43 111.87 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 128' ' ' LEU . 5.6 pt -112.92 148.7 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.527 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.62 154.59 26.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.411 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 172' ' ' VAL . 12.3 t -125.96 144.49 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.148 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 148.01 29.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 123' ' ' VAL . 14.6 t -78.38 141.76 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.304 0.573 . . . . 0.0 110.7 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -83.0 11.64 5.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.661 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.538 ' H ' HG12 ' A' ' 194' ' ' VAL . . . -111.96 90.69 0.57 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.348 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.47 113.11 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.727 2.285 . . . . 0.0 112.443 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.09 -170.1 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.3 t -156.35 102.63 2.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -51.27 90.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.426 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -126.61 -84.06 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 57.68 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' SER . . . -132.77 -102.02 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.446 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -174.3 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.34 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 t -96.34 119.93 35.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.28 164.27 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.3 t -109.48 146.13 35.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.64 70.34 10.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.68 62.84 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.98 50.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.852 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p 50.52 -177.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.37 35.66 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 30.75 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -19.28 65.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.86 68.67 0.51 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.843 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.5 -29.64 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -179.34 3.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.932 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.854 0.359 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -108.65 141.34 23.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 -43.66 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.476 2.117 . . . . 0.0 112.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 178.92 4.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.11 -30.67 9.01 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.436 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.73 -174.22 4.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.734 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 112' ' ' TYR . 39.5 p90 -101.55 112.5 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -131.41 107.21 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.583 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.68 111.79 2.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.496 2.13 . . . . 0.0 112.232 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.65 145.3 39.15 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.384 2.056 . . . . 0.0 112.419 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.23 -174.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.33 94.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -70.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER 178.81 -162.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 119' ' ' SER . 0.9 OUTLIER 82.0 -8.57 1.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.675 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.98 160.59 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.936 0.398 . . . . 0.0 111.128 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -144.29 128.54 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.775 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.951 HG12 ' HA ' ' A' ' 194' ' ' VAL . 23.7 m -104.29 165.2 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 195' ' ' ASP . 23.3 t -119.06 154.03 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.093 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.2 143.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 157' ' ' THR . 4.5 t -144.62 134.73 24.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.29 39.16 4.06 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.47 HD21 HD13 ' A' ' 137' ' ' LEU . 15.8 mt -89.02 159.46 45.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.58 160.08 47.77 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.574 2.183 . . . . 0.0 112.304 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.4 -45.41 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.534 2.156 . . . . 0.0 112.279 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.9 p -97.46 61.77 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.14 152.75 23.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.28 4.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.417 ' HB3' HG23 ' A' ' 152' ' ' VAL . 45.1 p-90 -73.98 -32.31 63.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -59.23 -42.21 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -73.66 -30.15 62.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.47 HD13 HD21 ' A' ' 128' ' ' LEU . 67.3 tp -66.81 -43.24 84.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.639 ' HG3' HG11 ' A' ' 147' ' ' VAL . 5.5 ttpt -52.97 -30.11 32.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.69 -26.63 66.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -33.78 16.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.543 ' HB2' HG21 ' A' ' 147' ' ' VAL . 71.7 mmm -72.7 -31.04 64.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.069 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -29.41 23.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.252 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -50.79 -25.62 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.019 0.438 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.861 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -74.53 -27.77 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.53 -69.8 0.28 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -160.48 136.28 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.425 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.4 t -107.59 152.26 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.788 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.4 t -112.07 -33.03 6.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.1 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -162.36 148.95 13.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.72 156.52 45.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.831 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -159.0 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 134' ' ' TRP . 17.6 t -137.05 95.29 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 10.8 p90 -123.14 156.09 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 6.9 ttp180 96.27 -3.06 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.487 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 65.36 37.84 6.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -179.23 -52.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 126' ' ' SER . 3.9 p -97.97 163.71 12.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -143.63 -149.47 5.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.469 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.5 p -169.29 160.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 21.3 t -152.51 149.56 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -127.96 109.11 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HE2' HG21 ' A' ' 123' ' ' VAL . 95.7 m-85 -85.1 177.14 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.038 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.38 -70.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -95.04 164.13 13.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.145 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -72.25 -31.19 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -59.9 -50.32 74.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.25 -29.07 64.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.699 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.2 ttp -71.11 -64.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.6 m -50.34 -33.92 22.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.15 -45.57 84.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.413 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.45 -47.28 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.446 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 192' ' ' VAL . 16.1 m -66.76 -22.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -86.46 -67.64 0.8 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -52.85 9.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 144' ' ' ALA . 91.2 mt -79.66 60.44 3.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -130.03 141.19 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 44.65 32.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.265 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.6 p -83.14 -179.15 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 101.95 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.8 t80 -72.94 143.63 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -124.56 107.95 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.007 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 27.5 t -79.54 161.43 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -7.45 51.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -95.41 19.13 11.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.92 28.57 73.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 128.91 55.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 159.73 18.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.02 171.86 6.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.66 119.92 40.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 2.7 pt -107.29 146.53 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -116.34 119.12 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 172' ' ' VAL . 19.4 t -98.23 143.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.41 142.46 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.951 ' HA ' HG12 ' A' ' 123' ' ' VAL . 12.6 p -74.62 118.0 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.474 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -116.8 77.45 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.841 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -126.59 97.89 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.571 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.57 -24.13 21.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.558 2.172 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.05 -174.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 1.9 t 59.41 64.54 2.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 199' ' ' SER . 6.1 Cg_exo -78.22 57.73 6.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.971 2.447 . . . . 0.0 112.31 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 m -178.46 136.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.256 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 202' ' ' TYR . 0.6 OUTLIER -147.35 -63.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.624 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 39.8 -96.53 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.296 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.19 13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 0.0 111.433 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 -171.31 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.444 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -60.3 91.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.85 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.66 -54.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.708 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 210' ' ' ARG . 0.7 OUTLIER 63.47 13.74 7.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.81 -89.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.558 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -154.12 161.41 41.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.695 0.283 . . . . 0.0 110.871 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.1 m -125.34 159.6 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -68.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -165.06 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 66.82 46.78 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 110.972 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.39 108.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.806 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 216' ' ' LEU . 1.9 pp -154.51 51.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.47 91.74 3.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 8.0 t60 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.9 179.907 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 ptp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.819 0.342 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.96 20.81 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.26 98.22 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.501 2.134 . . . . 0.0 112.22 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.05 96.44 6.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.12 12.49 3.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.803 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.41 23.18 5.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 58.73 161.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.048 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.08 -167.57 2.47 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.605 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.09 110.26 2.9 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.609 2.206 . . . . 0.0 112.15 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 116' ' ' SER . 9.7 Cg_exo -70.67 -72.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.573 2.182 . . . . 0.0 112.207 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.6 p 165.57 152.43 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.58 134.82 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.31 122.93 0.93 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m -163.81 -148.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.769 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 76.76 57.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.001 0.429 . . . . 0.0 110.804 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.68 41.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.714 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 123' ' ' VAL . 25.6 ttm180 -86.61 156.95 19.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.414 ' N ' ' HG2' ' A' ' 122' ' ' ARG . 3.1 m -132.66 165.17 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.91 147.42 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.0 142.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.6 t -140.01 146.61 39.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.83 64.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.289 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 190' ' ' ILE . 0.0 OUTLIER -98.23 148.4 34.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.675 0.274 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 30.9 Cg_endo -63.69 127.53 19.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 111.976 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -22.53 46.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.298 1.998 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.97 43.39 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.42 -166.76 21.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.417 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.54 145.56 51.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.3 p-90 -73.95 -46.36 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -60.8 -32.38 71.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.812 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -35.79 55.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.651 HD22 HG12 ' A' ' 152' ' ' VAL . 51.6 tp -61.38 -37.16 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.482 ' HB3' HG11 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -66.6 -39.06 88.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 110.404 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -66.94 -26.57 66.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.238 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.464 ' HE1' HD11 ' A' ' 190' ' ' ILE . 0.8 OUTLIER -86.62 -22.06 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.834 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.8 ppp? -111.76 -3.38 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -59.02 -20.67 55.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 111.387 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -50.38 -24.95 3.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.176 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 171' ' ' ALA . . . -69.17 -26.38 64.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.726 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.64 -116.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.0 111.71 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 138' ' ' LYS . 89.3 t -82.79 151.28 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 163' ' ' VAL . 1.3 m -119.4 -39.82 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -145.94 148.21 32.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.97 139.53 18.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -142.89 138.32 30.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 137' ' ' LEU . 34.2 m -117.71 118.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -69.15 155.25 40.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.971 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 17.56 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -29.72 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.758 0.314 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 145.95 -16.83 1.76 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.9 p -98.86 -178.48 3.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 111.224 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.7 -176.62 30.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 151' ' ' ASP . 17.2 m -153.5 150.38 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 111.044 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.834 HG11 ' SD ' ' A' ' 141' ' ' MET . 10.5 t -150.65 146.31 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -130.74 131.32 44.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 168' ' ' MET . 3.8 m-85 -104.58 171.1 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.748 HG22 ' SG ' ' A' ' 148' ' ' CYS . 55.5 t -70.03 -70.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -97.35 155.27 16.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -58.29 -28.56 65.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.36 -32.06 73.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.9 -34.95 66.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.43 ' HA ' ' CD1' ' A' ' 162' ' ' PHE . 8.2 ttp -68.58 -62.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.1 m -53.93 -36.32 62.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.01 -44.22 97.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -60.34 -44.64 95.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.471 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.88 -27.09 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.094 0.473 . . . . 0.0 110.725 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -77.99 -53.39 7.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -65.72 0.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.439 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 41.6 mt -63.69 -118.5 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.47 113.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 64.85 72.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 46.3 p -132.0 -176.94 4.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -103.74 139.93 38.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 181' ' ' ARG . 75.5 t80 -126.85 160.78 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.748 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -141.08 149.07 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.027 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.0 p -109.38 157.37 18.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -20.38 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -79.14 -22.93 44.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.99 29.46 5.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.8 121.89 46.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.1 156.58 17.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -167.29 171.65 10.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.29 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -107.51 121.3 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.241 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 128' ' ' LEU . 28.6 pt -101.84 168.45 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 109.47 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.322 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.0 t -86.76 153.53 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.389 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.98 171.29 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 196' ' ' GLY . 12.6 p -87.91 122.36 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.939 0.4 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -48.86 -34.92 13.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.508 ' H ' HG22 ' A' ' 194' ' ' VAL . . . -114.28 80.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.627 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.3 -53.22 7.49 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.525 2.15 . . . . 0.0 112.23 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 30.0 ttp85 -92.36 105.89 18.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER -177.77 -56.7 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 71.2 Cg_exo -50.32 152.15 8.76 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.313 2.009 . . . . 0.0 112.312 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 -63.58 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -54.13 179.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.093 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.65 -72.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.597 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -176.47 -40.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.1 m -147.31 100.66 3.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -118.91 30.76 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.69 88.06 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 100.36 11.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.984 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m 64.52 -75.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -52.09 -80.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.033 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 34.2 t 63.53 -78.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -173.72 146.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.9 t -50.95 98.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.65 ' HD2' HD21 ' A' ' 216' ' ' LEU . 11.7 ptt-85 -54.72 141.34 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -89.96 107.98 19.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.65 HD21 ' HD2' ' A' ' 214' ' ' ARG . 2.0 mm? -116.0 -173.2 2.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.817 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.94 46.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.024 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.8 p80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.881 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.826 0.346 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.677 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -178.06 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 41.1 Cg_endo -67.3 -29.81 38.06 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.492 2.128 . . . . 0.0 112.345 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -98.26 162.68 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.64 -24.73 13.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.652 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 61.27 90.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -179.86 -74.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.7 -77.83 0.39 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.549 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.436 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 6.2 Cg_exo -37.82 -49.32 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.41 2.74 . . . . 0.0 113.009 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 52.2 Cg_exo -55.1 88.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.308 2.005 . . . . 0.0 112.268 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 p -128.13 110.62 12.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -143.99 29.09 1.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.09 162.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.24 100.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.4 -41.65 76.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.011 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.6 OUTLIER -175.2 94.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.478 ' NH2' HG12 ' A' ' 159' ' ' VAL . 2.4 tpt180 -105.33 119.96 40.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 160' ' ' VAL . 7.5 p -108.43 162.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.558 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.3 p -128.23 142.31 44.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.63 149.42 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.1 t -139.51 123.77 18.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 107.53 40.56 1.74 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.599 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -82.13 142.6 47.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.26 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.77 168.6 23.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.486 2.124 . . . . 0.0 112.31 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.53 -43.26 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.605 2.203 . . . . 0.0 112.329 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.87 79.37 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.9 97.07 0.11 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -175.96 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.78 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.448 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 59.1 p-90 -65.43 -40.87 93.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.448 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 2.5 tt0 -59.6 -32.52 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.01 -36.68 56.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.25 -44.99 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -59.51 -50.1 75.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -60.81 -26.6 67.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.543 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -95.11 -24.95 16.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.752 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.433 ' HE3' HD21 ' A' ' 175' ' ' LEU . 0.0 OUTLIER -100.66 6.48 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.597 0.237 . . . . 0.0 111.565 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -77.89 6.0 8.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.661 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -50.65 -26.07 4.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.72 0.295 . . . . 0.0 111.232 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -65.63 -27.58 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.608 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.14 -94.03 0.13 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.2 142.52 49.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.59 128.9 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.849 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.72 -26.32 13.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.485 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 160' ' ' VAL . 41.0 t80 -142.92 153.39 43.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.479 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . . . -163.12 143.13 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.832 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -149.51 146.51 27.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.748 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.54 133.69 59.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.86 147.97 26.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -70.16 -16.85 63.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.99 -31.38 72.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 134.85 -18.11 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.81 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 126' ' ' SER . 17.7 p -108.01 169.85 8.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.6 -167.43 13.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.344 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' NH2' ' A' ' 122' ' ' ARG . 35.5 m -155.14 154.64 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.714 0.293 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -153.16 142.35 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.237 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -121.68 113.29 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.603 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 13.9 m-85 -81.39 155.8 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.073 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.07 -26.63 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.771 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 149.22 46.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -69.18 -36.22 77.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -32.56 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.71 -30.22 64.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.47 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.8 ttp -69.53 -65.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 94.7 m -56.71 -34.34 67.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 0.0 111.073 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 174' ' ' LYS . 9.3 t80 -59.46 -49.63 77.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.249 0.547 . . . . 0.0 110.621 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 175' ' ' LEU . . . -60.55 -50.17 74.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.225 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 192' ' ' VAL . 15.7 m -58.71 -22.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 111.296 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 169' ' ' THR . 9.5 mtp180 -96.41 -37.18 10.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.339 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 170' ' ' TYR . 0.3 OUTLIER -86.59 -69.11 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.817 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -87.2 45.51 1.28 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 15.8 p-10 -83.43 127.1 33.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 47.96 59.98 3.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.24 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -114.85 173.97 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HG3' ' CE1' ' A' ' 189' ' ' TYR . 0.2 OUTLIER -95.16 108.53 20.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.953 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -105.06 157.81 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.367 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HB3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -132.56 138.65 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 p -81.25 171.0 15.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -55.02 -17.86 4.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -82.99 -22.66 33.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.25 -15.07 39.6 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 123.6 19.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -94.41 158.95 15.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.64 155.99 13.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 179' ' ' LYS . 2.0 m-85 -86.37 113.63 22.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 pt -119.88 137.61 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.26 152.9 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 172' ' ' VAL . 13.6 t -127.74 137.61 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.263 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 124' ' ' VAL . 9.8 mtpp -155.55 145.86 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.8 p -68.62 109.29 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.66 93.24 9.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -55.97 158.27 8.62 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.666 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.41 -167.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.649 2.232 . . . . 0.0 112.287 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 131.86 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 0.6 OUTLIER -59.44 -50.89 84.95 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.1 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 199' ' ' SER . 83.8 Cg_exo -47.62 119.26 3.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.619 2.213 . . . . 0.0 112.441 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.5 m -65.78 -68.35 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.979 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 202' ' ' TYR . 0.0 OUTLIER -140.06 -76.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 119.19 119.1 2.8 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.486 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -65.68 -175.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 t 61.01 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -70.4 93.04 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -80.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.963 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 177.22 -178.45 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.8 t -129.39 107.66 9.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -97.39 -53.2 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.973 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.59 168.29 13.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 59.97 31.46 20.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.2 m -114.18 94.45 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 62.77 146.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 69.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.63 31.71 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 63.14 -79.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 5.3 m170 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.93 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.761 0.315 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -178.47 -61.64 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 69.5 Cg_endo -74.56 61.84 5.35 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.502 2.135 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.0 ttm-85 51.36 39.72 24.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.037 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.11 -75.47 1.13 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.455 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.0 88.73 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -93.59 -31.21 14.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.84 -165.51 33.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 55.3 Cg_endo -69.83 157.84 58.9 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.529 2.153 . . . . 0.0 112.227 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 34.4 Cg_exo -60.4 -68.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.441 2.094 . . . . 0.0 112.065 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 m 43.95 57.69 4.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.335 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -126.68 -38.89 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -135.73 144.37 45.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.8 m -160.47 56.43 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.021 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.43 30.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 60.32 105.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.49 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -144.02 127.54 16.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.632 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.13 159.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.947 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.46 145.5 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.086 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.21 142.37 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.9 OUTLIER -134.83 -179.55 5.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.49 32.69 75.53 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.606 HD21 HG12 ' A' ' 152' ' ' VAL . 2.3 mp -81.24 146.01 57.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.679 0.276 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.15 169.97 20.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.58 2.187 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.42 -27.27 33.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.508 2.139 . . . . 0.0 112.197 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.36 117.03 22.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.47 175.78 46.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.432 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.577 ' C ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -138.66 179.62 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.891 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.431 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 51.3 p-90 -73.14 -39.1 65.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 46.2 tt0 -63.0 -31.08 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 -44.72 84.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.06 -47.05 54.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.852 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -56.32 -47.18 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.2 -26.73 65.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.518 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 180' ' ' PHE . 45.7 t-80 -87.93 -29.27 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.37 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -97.1 -11.16 24.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.605 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -54.58 -21.64 10.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.801 0.334 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -49.91 -24.42 2.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.211 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.01 -26.7 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.941 0.401 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.43 -110.25 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.51 125.31 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.852 HG11 ' CG ' ' A' ' 138' ' ' LYS . 84.3 t -97.78 146.07 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.39 -67.48 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -127.82 133.18 49.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.036 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 138' ' ' LYS . . . -128.55 135.94 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -139.93 126.08 19.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.606 HG12 HD21 ' A' ' 128' ' ' LEU . 5.6 m -116.29 142.99 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -117.13 153.93 31.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.023 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -73.67 -16.43 61.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.1 -26.08 68.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.56 12.14 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.752 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 126' ' ' SER . 11.5 p -143.97 165.93 26.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 110.661 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.21 -161.51 10.88 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.546 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.3 m -156.38 155.77 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.66 0.267 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.3 t -150.78 142.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -123.35 126.28 46.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.56 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.01 177.06 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.3 t -76.29 -68.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 154.44 22.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -71.96 -34.41 68.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.84 -35.17 66.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -32.05 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.61 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 172' ' ' VAL . 3.0 ttp -58.94 -63.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.815 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 173' ' ' ARG . 95.6 m -56.65 -35.04 67.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 15.7 t80 -61.3 -44.85 96.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -67.14 -45.32 77.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.271 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 168' ' ' MET . 2.1 m -71.97 -21.97 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 111.273 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.534 ' HG3' HG22 ' A' ' 169' ' ' THR . 18.1 mmm180 -90.85 -50.67 5.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.53 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 0.5 OUTLIER -88.62 -52.57 5.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.3 mt -69.33 -4.76 19.5 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 67.6 t0 -53.9 123.83 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.086 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 60.81 76.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.23 161.75 18.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' HG21 ' A' ' 187' ' ' THR . 4.3 tptp -85.65 93.95 8.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.435 ' HA ' ' CE1' ' A' ' 140' ' ' HIS . 40.7 t80 -74.64 154.69 38.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.81 129.21 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.3 p -97.45 162.93 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -6.1 45.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.239 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.7 18.26 9.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.694 0.283 . . . . 0.0 111.334 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.01 73.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.546 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.05 155.52 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.511 HG21 ' NZ ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -120.97 161.05 22.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.96 157.42 11.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.149 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -103.42 114.15 28.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.99 158.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.64 127.67 42.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 172' ' ' VAL . 21.3 t -103.09 145.36 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.863 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.58 150.25 24.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 172' ' ' VAL . 22.0 t -71.11 118.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -55.1 92.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.326 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 57.56 83.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.679 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.0 -157.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.506 2.137 . . . . 0.0 111.997 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -78.4 113.64 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.725 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.411 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 1.4 t -62.13 -52.1 69.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 199' ' ' SER . 79.8 Cg_exo -44.63 -29.01 3.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.633 2.222 . . . . 0.0 112.658 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.5 m -100.34 115.31 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.17 168.24 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.28 102.29 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.566 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 31.44 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -161.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 72.35 74.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.8 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.3 40.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -98.19 149.5 22.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 79.8 p -177.65 38.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -159.86 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.687 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m 76.97 149.26 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -110.65 114.92 28.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 112.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -169.23 150.72 4.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.805 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.1 t 60.72 31.59 20.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tp -102.09 -161.12 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.826 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 74.64 -67.88 0.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.0 m80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.919 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.57 142.58 94.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.654 0.264 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.1 -168.31 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.561 2.174 . . . . 0.0 112.474 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -98.95 136.23 39.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.804 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.41 -141.57 12.95 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.57 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 29.85 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.985 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -85.8 79.06 9.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.71 -178.67 33.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.73 174.94 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.587 2.191 . . . . 0.0 112.303 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.44 148.74 10.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.678 2.252 . . . . 0.0 112.374 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.9 p -70.53 -169.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -141.89 -44.05 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 70.55 -64.51 0.37 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER 65.83 -167.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' SER . 2.9 mt-10 72.95 -1.97 2.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.966 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.477 ' ND2' ' HD2' ' A' ' 165' ' ' LYS . 3.1 m120 59.86 146.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.095 0.474 . . . . 0.0 111.27 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.407 ' NH1' ' CG1' ' A' ' 159' ' ' VAL . 52.7 ttp85 -144.25 147.68 33.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 194' ' ' VAL . 18.6 m -132.77 165.06 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.95 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 158' ' ' GLY . 5.9 t -119.77 150.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.145 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.55 HG22 HG13 ' A' ' 192' ' ' VAL . 6.6 t -132.89 121.41 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.002 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.638 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.7 t -114.75 158.75 21.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 90.41 46.72 3.98 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.93 167.31 34.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.83 170.11 19.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.717 2.278 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.72 -25.98 45.99 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -134.6 82.68 1.98 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.71 -165.32 10.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -171.82 176.67 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.647 ' HB3' HG23 ' A' ' 152' ' ' VAL . 41.5 p-90 -73.35 -33.94 65.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.735 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.453 ' HG2' ' CH2' ' A' ' 134' ' ' TRP . 19.4 mt-30 -58.78 -43.23 90.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.789 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.06 -32.3 56.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.448 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 37.3 tp -59.89 -38.17 81.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -43.03 63.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.38 -26.8 68.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.393 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -88.28 -39.91 14.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.747 ' CE ' HG11 ' A' ' 160' ' ' VAL . 2.1 ppp? -80.16 -5.71 56.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.392 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -53.1 -22.62 6.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -31.15 11.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.071 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.512 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -68.43 -28.7 67.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.41 -159.1 25.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -58.91 117.17 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.5 126.11 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 9.0 t -66.93 -63.81 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.727 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 161' ' ' GLU . 7.1 p90 -171.61 150.34 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.88 4.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.22 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 159' ' ' VAL . 8.3 t0 -163.38 153.69 15.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 134' ' ' TRP . 45.9 t -130.97 122.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.04 139.64 52.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 76.1 0.62 3.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.726 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.93 11.84 8.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.11 -53.05 0.14 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.56 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 126' ' ' SER . 22.7 p -98.96 159.94 14.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -144.73 179.54 21.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.608 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 151' ' ' ASP . 22.9 m -137.43 154.44 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.991 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' CE ' ' A' ' 141' ' ' MET . 4.7 t -142.6 126.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.179 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 149' ' ' TYR . 2.5 mt-10 -111.99 130.04 55.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.727 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.7 OUTLIER -109.51 137.62 47.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.971 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.62 -28.85 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -129.3 142.39 50.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.477 ' HD2' ' ND2' ' A' ' 121' ' ' ASN . 1.7 tptm -59.04 -27.49 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.205 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -54.98 -46.33 75.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.099 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.27 -32.56 68.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.442 ' HE2' ' OG1' ' A' ' 169' ' ' THR . 5.2 ttp -61.49 -66.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.576 HG22 ' HD2' ' A' ' 173' ' ' ARG . 96.4 m -54.84 -35.76 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 15.7 t80 -61.57 -47.93 83.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.06 74.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 176' ' ' ASP . 11.8 m -65.61 -22.84 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -80.5 -72.64 0.4 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.122 0.487 . . . . 0.0 110.453 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -54.67 12.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 144' ' ' ALA . 7.3 mt -79.92 76.64 6.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.802 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 20.6 p-10 -141.38 134.51 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.71 25.84 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.16 -174.33 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 145.19 38.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 29.8 t80 -93.16 158.61 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 1.3 tmt_? -125.85 107.17 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.71 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 p -75.74 151.14 37.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -54.67 -23.06 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.44 -19.5 61.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.12 -6.2 36.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.81 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.95 159.62 23.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.747 0.308 . . . . 0.0 110.838 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.7 161.0 29.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.118 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.09 16.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.03 115.66 15.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.7 pt -114.54 161.7 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.11 113.09 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 125' ' ' VAL . 4.3 t -91.0 159.08 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.415 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.7 OUTLIER -176.03 144.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 111.143 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.4 t -59.85 134.69 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -46.77 159.57 0.1 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.272 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.67 -102.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.91 169.69 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.544 2.163 . . . . 0.0 112.469 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 171.59 7.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.414 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER -92.44 -53.0 0.27 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 30.2 Cg_exo -61.68 92.95 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.443 2.095 . . . . 0.0 112.024 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -116.41 166.54 11.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.5 -65.6 0.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.201 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.81 -92.64 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.814 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 117.5 29.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -78.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -176.06 -42.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -115.05 -169.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 -47.0 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.9 p -151.3 174.9 12.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -2.5 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.368 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.3 p 59.59 109.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -79.76 76.46 6.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -170.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.17 122.43 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.3 m 60.45 173.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.1 tp -111.99 54.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 218' ' ' HIS . 15.6 mt-10 -85.94 111.6 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' A' ' 217' ' ' GLU . 27.9 p-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.421 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.4 mtm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.899 0.38 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 108' ' ' PRO . . . -131.63 52.57 9.51 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 107' ' ' ALA . 72.6 Cg_endo -76.39 171.95 17.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 112.354 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.94 155.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.74 69.79 1.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.549 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.65 173.36 10.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 110.838 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.82 172.36 6.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -132.4 149.98 19.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.517 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.09 111.07 3.09 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.06 -173.89 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.493 2.129 . . . . 0.0 112.058 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -167.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 3.7 ttm-85 -158.89 -38.1 0.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.989 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER 178.07 146.82 0.14 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.045 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 118' ' ' ARG . 62.5 p -106.33 150.64 25.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.542 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -143.59 41.09 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.246 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -130.2 44.79 2.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.901 0.381 . . . . 0.0 110.669 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -109.18 168.33 9.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.098 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.22 159.88 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.8 t -106.06 146.33 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 HD21 ' A' ' 128' ' ' LEU . 12.3 p -121.9 150.77 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.1 OUTLIER -137.15 170.91 15.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.918 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 63.94 44.31 96.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.46 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 HG13 ' A' ' 125' ' ' VAL . 3.5 mm? -83.92 140.48 40.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.647 0.261 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.95 170.46 20.37 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.538 2.159 . . . . 0.0 112.204 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.04 -26.83 65.83 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.17 . . . . 0.0 112.265 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.0 34.84 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.49 111.6 3.88 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.469 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.57 179.61 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.802 0.334 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.447 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 47.5 p-90 -68.63 -41.72 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.447 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.5 OUTLIER -70.55 -36.06 73.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.78 -57.96 10.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.71 -47.02 88.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.04 -43.76 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.186 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.56 -26.33 65.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.604 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -88.16 -21.14 24.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.695 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.79 ' SD ' HG21 ' A' ' 160' ' ' VAL . 11.0 ptm -112.38 1.62 16.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.84 -17.59 56.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.89 -21.89 4.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.85 68.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.162 0.506 . . . . 0.0 110.481 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.3 -104.47 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.73 107.34 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 110.771 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.704 HG22 ' CD2' ' A' ' 162' ' ' PHE . 96.4 t -79.25 125.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.27 -52.4 6.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 151' ' ' ASP . 80.3 t80 -140.57 160.01 40.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -159.4 134.98 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' A' ' 149' ' ' TYR . 35.0 t0 -146.52 114.4 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.17 112.11 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.227 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -69.22 155.23 40.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -92.68 37.53 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -114.96 -28.85 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 147.87 -21.49 1.45 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 126' ' ' SER . 12.0 p -129.09 167.01 18.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.584 0.23 . . . . 0.0 111.059 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.475 ' CA ' HG12 ' A' ' 125' ' ' VAL . . . -142.02 -161.43 8.75 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.242 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 158' ' ' GLY . 22.3 m -158.02 144.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.79 HG21 ' SD ' ' A' ' 141' ' ' MET . 59.3 t -141.06 149.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.925 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.41 134.57 48.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.306 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.704 ' CD2' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -121.39 132.71 54.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.157 179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 163' ' ' VAL . 5.2 p -70.08 65.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 111.183 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 7.3 ttm-85 172.82 127.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.144 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.18 -40.4 96.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -58.93 -37.27 76.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.56 -34.77 72.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.8 ttp -60.83 -63.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.523 HG23 ' CZ ' ' A' ' 173' ' ' ARG . 70.5 m -61.69 -33.45 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 11.6 t80 -63.55 -48.58 76.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.88 82.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 192' ' ' VAL . 26.6 m -64.04 -22.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.523 ' CZ ' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER -93.34 -75.11 0.51 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 3.9 mmtt -57.17 -49.19 76.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 141' ' ' MET . 29.5 mt -92.64 58.53 3.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.602 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 6.0 t0 -122.86 135.61 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 44.1 t30 54.02 29.76 10.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.87 177.38 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 103.56 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -68.93 117.47 10.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.79 105.28 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 144.09 29.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -21.65 64.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.623 0.249 . . . . 0.0 111.073 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 31.0 3.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.725 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.36 134.66 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 156.57 22.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.9 143.85 2.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -83.62 120.25 25.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 127' ' ' GLY . 40.0 pt -112.67 155.6 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.21 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 172' ' ' VAL . 7.7 t -103.04 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -147.16 145.31 29.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 194' ' ' VAL . 13.6 p -73.07 124.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.073 0.463 . . . . 0.0 110.724 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -42.27 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.722 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 63.77 123.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.289 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.05 -48.27 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.443 2.095 . . . . 0.0 112.534 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 138.28 51.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.968 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.55 146.96 4.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 -175.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.302 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 12.8 p 58.56 -179.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 60.46 80.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 155.14 -77.17 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.59 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.17 148.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 110.953 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.2 p -132.68 -85.56 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 61.74 2.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 111.239 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -106.54 -168.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.95 159.06 21.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.45 -162.79 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.71 96.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 t -171.01 91.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? 60.73 71.71 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 28.0 m -59.63 -58.46 8.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.01 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 69.72 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.969 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.2 p -141.39 110.64 6.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.73 -179.25 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -100.36 -36.65 9.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.895 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.794 0.33 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.87 120.88 45.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.64 -55.04 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.373 2.049 . . . . 0.0 112.331 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.59 170.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.5 -157.18 20.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.66 -113.36 0.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.01 -0.112 . . . . 0.0 110.755 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 112' ' ' TYR . 11.8 t80 179.86 56.73 0.01 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.846 0.355 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 114' ' ' PRO . . . -178.1 49.89 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.892 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.442 ' HG2' ' HD3' ' A' ' 115' ' ' PRO . 3.9 Cg_exo -41.0 -51.26 3.85 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.996 2.464 . . . . 0.0 112.728 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HD3' ' HG2' ' A' ' 114' ' ' PRO . 79.8 Cg_exo -47.36 -59.02 1.4 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.462 2.108 . . . . 0.0 112.471 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.69 124.51 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -159.98 33.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -128.24 -53.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.02 31.07 19.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.32 30.08 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -152.58 98.62 2.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 161.79 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' A' ' 162' ' ' PHE . 2.9 t -123.86 149.35 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.027 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 195' ' ' ASP . 23.2 t -117.24 144.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.03 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.83 146.44 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -149.22 117.14 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.11 39.67 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.493 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.635 ' HG ' HG22 ' A' ' 190' ' ' ILE . 1.5 mp -99.22 155.12 36.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 60.3 Cg_endo -72.5 166.52 29.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.543 2.162 . . . . 0.0 112.397 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.17 -27.53 35.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.3 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.94 36.59 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.805 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 152' ' ' VAL . . . -93.02 123.37 7.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 p -94.3 150.99 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 0.0 110.798 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.44 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 30.7 p-90 -74.02 -40.02 63.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -55.55 -40.58 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.27 -32.55 55.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 68.7 tp -61.63 -42.24 98.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -67.89 -47.45 68.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.97 -26.74 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.032 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -86.1 -31.48 21.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.775 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.474 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -93.18 3.61 55.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.451 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -55.56 -20.87 14.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.462 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -49.69 -32.56 13.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 111.003 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -70.9 -29.42 65.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.756 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.75 -172.79 26.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.414 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.22 106.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.435 HG11 ' CG ' ' A' ' 138' ' ' LYS . 86.1 t -74.07 125.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.043 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -56.17 4.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -154.03 148.34 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -143.6 141.23 30.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.181 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -143.41 141.67 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 132' ' ' GLY . 22.5 m -128.29 115.95 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.249 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.85 155.36 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 35.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.294 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -114.76 -22.62 9.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.196 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 157' ' ' THR . . . 122.06 31.36 1.1 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.608 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 156' ' ' GLY . 9.7 p -161.26 169.97 21.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.84 175.38 32.16 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.632 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -142.83 142.05 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.312 . . . . 0.0 111.061 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 141' ' ' MET . 11.4 t -134.55 157.91 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.206 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.423 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -131.68 128.31 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 68.3 m-85 -108.53 154.52 21.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -71.04 -68.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.22 162.26 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -50.08 30.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.015 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -32.4 46.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -35.88 72.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.418 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 5.2 ttp -67.62 -59.76 3.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.321 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.8 m -50.58 -35.06 28.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.855 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 49.6 t80 -64.23 -46.95 81.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.733 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -56.44 -43.05 79.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 192' ' ' VAL . 13.0 m -79.92 -34.69 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 11.9 ptt85 -79.68 -30.33 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.715 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 170' ' ' TYR . 0.1 OUTLIER -106.98 -57.3 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.207 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.4 mt -81.24 66.75 6.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -116.89 131.23 57.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.2 m120 57.63 30.37 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.1 p -73.33 -177.67 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.979 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 95.09 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.026 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 5.9 t80 -68.95 135.35 50.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.612 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -116.52 100.91 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.4 t -60.85 161.3 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -9.68 58.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.084 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 21.69 6.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.341 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 27.34 73.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.617 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.57 134.6 54.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.27 156.42 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.96 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -162.31 160.31 26.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -98.27 110.97 23.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.53 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.635 HG22 ' HG ' ' A' ' 128' ' ' LEU . 13.7 pt -107.13 136.26 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.463 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.37 109.83 22.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 172' ' ' VAL . 5.1 t -87.16 142.01 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.246 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -150.37 157.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.78 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 172' ' ' VAL . 25.3 t -78.01 114.85 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.568 ' HA ' HG23 ' A' ' 124' ' ' VAL . 19.0 t0 -47.68 -65.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.28 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 82.27 -107.32 2.79 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.423 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 32.3 Cg_exo -58.42 -151.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.642 2.228 . . . . 0.0 112.057 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 197' ' ' PRO . 15.2 mtp85 81.0 -127.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.4 OUTLIER -33.14 -54.86 0.64 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 202' ' ' TYR . 53.6 Cg_exo -52.14 -58.82 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.365 2.043 . . . . 0.0 112.084 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.5 m 61.77 118.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 200' ' ' PRO . 5.9 m-85 -128.73 27.84 5.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.44 -171.48 18.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.69 -43.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -53.96 52.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -140.11 66.43 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.4 t -137.55 70.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 43.27 65.49 0.96 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.507 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.74 146.81 35.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -150.37 56.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.5 p 58.28 -169.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 -166.25 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.6 m 61.8 -124.25 0.79 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.599 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -154.86 26.36 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.73 0.3 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.73 -173.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -76.17 126.06 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.794 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -123.61 -167.38 1.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.977 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 217' ' ' GLU . 46.0 p-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.326 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.829 0.347 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.404 ' HB3' ' CG ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -144.06 144.89 31.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.18 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 194' ' ' VAL . 34.0 m -113.33 165.14 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 158' ' ' GLY . 12.3 p -117.04 143.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.75 152.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.5 p -143.07 123.08 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 130.51 41.53 0.23 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -86.29 144.17 37.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.89 170.68 19.85 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.555 2.17 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.49 -26.25 70.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.62 2.213 . . . . 0.0 112.191 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -124.49 74.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.77 167.97 24.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -146.39 167.93 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.427 ' HB3' HG22 ' A' ' 152' ' ' VAL . 61.5 p-90 -65.7 -42.16 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 29.7 tp60 -58.77 -36.23 74.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -73.49 -29.7 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.92 -42.45 66.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.748 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.808 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.978 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.78 -26.85 58.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.233 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.43 -41.16 14.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.861 ' SD ' HG21 ' A' ' 160' ' ' VAL . 0.0 OUTLIER -73.68 -22.87 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -46.12 -29.9 1.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.246 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -30.4 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.733 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.11 -28.85 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.04 -134.41 3.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.405 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -103.97 103.86 13.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.808 HG11 ' CG ' ' A' ' 138' ' ' LYS . 99.5 t -73.85 141.93 15.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.969 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.3 p -112.29 -29.32 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -154.71 147.36 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.35 127.26 6.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.13 153.64 51.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 152' ' ' VAL . 34.4 m -143.1 124.72 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -82.71 154.99 24.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.33 -33.63 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.52 -30.34 2.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.627 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -95.32 160.63 14.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -138.46 -166.26 10.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.576 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -155.6 145.51 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.861 HG21 ' SD ' ' A' ' 141' ' ' MET . 24.5 t -133.9 150.15 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.22 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.2 mt-10 -131.85 136.6 47.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.774 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -116.92 160.3 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.08 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.98 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.801 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -25.69 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -47.05 58.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.28 -28.0 62.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.456 ' O ' HG22 ' A' ' 172' ' ' VAL . 10.9 ttp -67.0 -62.91 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' CG2' ' A' ' 172' ' ' VAL . 67.0 m -58.96 -32.92 70.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.029 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -64.98 -44.64 88.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -65.59 -48.16 73.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.894 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.894 HG23 ' HD3' ' A' ' 173' ' ' ARG . 11.0 m -65.14 -22.12 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.894 ' HD3' HG23 ' A' ' 172' ' ' VAL . 6.1 mpt_? -93.13 -75.45 0.49 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.076 0.465 . . . . 0.0 111.189 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -40.95 95.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 144' ' ' ALA . 29.0 mt -89.58 23.84 2.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 38.4 t70 -83.65 131.22 34.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.73 61.63 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 p -113.27 146.67 38.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.744 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.21 112.12 8.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -80.85 148.4 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 126.5 46.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.9 p -97.01 146.0 25.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -55.92 -22.94 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -23.12 63.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.96 30.75 4.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -130.19 133.09 46.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.91 161.0 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.23 130.21 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -70.94 114.38 8.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 127' ' ' GLY . 22.0 pt -116.74 151.24 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -131.36 135.37 47.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.35 148.22 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.237 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -156.05 140.12 16.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 123' ' ' VAL . 23.8 t -70.25 118.58 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.203 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.156 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -131.38 133.45 45.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 160' ' ' VAL . 3.5 m -103.8 165.16 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.085 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.27 146.27 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.37 144.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -137.97 125.5 22.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.43 40.28 2.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.27 153.58 92.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.27 169.51 20.56 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -27.28 24.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.577 2.185 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -143.03 127.06 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.4 162.72 24.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.81 153.42 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 135' ' ' GLN . 42.8 p-90 -74.0 -30.07 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 50.8 mt-30 -58.99 -42.99 91.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -77.15 -21.39 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.926 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 152' ' ' VAL . 29.9 tp -70.17 -47.11 63.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.936 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -40.7 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 142' ' ' ARG . 4.5 m-20 -65.96 -26.65 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.81 -31.9 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -93.16 -2.82 54.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.435 ' HG2' HG23 ' A' ' 147' ' ' VAL . 4.0 mmm-85 -62.67 -15.87 54.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.476 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.74 -31.59 11.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.824 0.345 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 1.113 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.38 -31.41 70.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.513 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.94 -98.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.94 156.39 46.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 142' ' ' ARG . 75.0 t -126.82 149.4 31.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.5 t -117.33 -52.3 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -128.78 149.62 50.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.71 134.57 11.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.026 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 159' ' ' VAL . 4.3 m-20 -149.15 134.66 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 137' ' ' LEU . 29.6 m -128.33 118.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -103.46 131.66 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.0 mtm105 -62.34 96.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -171.45 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 157' ' ' THR . . . 137.53 37.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.74 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 156' ' ' GLY . 1.8 p -166.05 172.36 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.46 173.42 36.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 151' ' ' ASP . 5.8 m -141.7 134.26 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 123' ' ' VAL . 12.9 t -140.28 127.2 22.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -98.17 108.37 21.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.51 156.76 32.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.13 -67.33 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 144.97 24.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.83 -40.58 97.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.77 -42.62 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -31.83 69.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.5 ttp -67.22 -62.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 98.9 m -53.24 -32.73 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.416 ' CE2' ' HG2' ' A' ' 174' ' ' LYS . 88.5 t80 -62.77 -46.95 85.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.482 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -59.16 -47.55 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.574 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 169' ' ' THR . 16.2 m -63.29 -22.64 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.026 0.441 . . . . 0.0 110.793 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -85.59 -71.93 0.51 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.268 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -78.68 -36.76 43.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.035 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 1.113 HD12 ' HB2' ' A' ' 144' ' ' ALA . 76.1 mt -90.51 47.69 1.46 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -108.88 127.33 53.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.831 0.348 . . . . 0.0 110.679 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.9 31.55 18.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -171.92 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -111.15 118.13 35.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 10.8 t80 -97.41 135.06 39.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -122.17 117.36 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.7 p -80.13 149.61 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -54.74 -23.72 19.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -73.72 -23.07 59.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.984 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.17 5.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.86 110.34 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.83 154.41 20.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.001 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.89 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.55 129.74 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.62 143.27 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.291 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -109.95 122.25 47.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.06 151.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -156.63 169.22 25.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.5 t -91.44 118.97 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.765 0.317 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -131.58 142.31 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.658 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 160' ' ' VAL . 28.2 m -106.96 165.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.63 140.1 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.545 ' CG2' HG23 ' A' ' 160' ' ' VAL . 15.3 t -106.38 140.23 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.56 120.27 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.62 1.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.414 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -75.51 150.05 84.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 171.02 16.45 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.257 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 -32.59 21.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.589 2.193 . . . . 0.0 112.276 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 t -123.89 115.51 21.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.54 177.05 48.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.22 -175.53 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 32.0 p-90 -67.59 -42.2 82.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.856 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.3 OUTLIER -59.74 -50.57 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.723 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.29 -37.39 85.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.652 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.28 -45.57 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.45 -28.33 68.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.107 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.392 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.21 12.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.64 ' HG3' HG21 ' A' ' 160' ' ' VAL . 30.4 mmm -76.87 -25.57 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.216 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -51.54 -25.27 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.321 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -23.73 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.312 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.15 -26.45 66.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.658 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.79 -65.61 0.34 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.39 125.62 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.074 0.464 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 142' ' ' ARG . 89.7 t -101.02 146.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.23 -29.66 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.211 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 56.5 t80 -154.76 160.05 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 111.211 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -157.04 177.33 11.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.85 156.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.97 147.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -123.98 109.23 13.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 mtt85 55.55 -87.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -176.24 36.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 110.93 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 157' ' ' THR . . . -118.6 -44.59 0.5 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.422 ' CA ' HD23 ' A' ' 128' ' ' LEU . 10.4 p -156.67 161.09 39.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.71 -157.48 7.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.573 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.508 HG21 ' NH2' ' A' ' 122' ' ' ARG . 30.5 m -156.09 142.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 141' ' ' MET . 21.9 t -134.22 119.88 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -104.35 123.25 47.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 23.0 m-85 -99.41 167.57 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.27 -69.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.86 163.92 13.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -26.1 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -57.16 -41.49 79.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -30.06 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.417 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 4.6 ttp -61.01 -63.72 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 172' ' ' VAL . 97.9 m -57.52 -35.53 70.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.071 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 21.0 t80 -62.56 -47.3 84.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.45 . . . . 0.0 110.653 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.86 84.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.809 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 192' ' ' VAL . 25.6 m -61.64 -22.75 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.546 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -76.49 0.55 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 8.6 mmtt -58.08 -42.6 85.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.623 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.63 36.16 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.207 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 11.9 t0 -94.51 120.07 34.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.642 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 61.81 66.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.6 p -115.75 170.02 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 131.67 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -109.67 145.27 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.89 116.36 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.99 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -88.7 155.7 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -54.54 -22.69 13.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -19.25 61.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.29 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.732 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.9 150.28 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.21 154.98 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.999 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 172.07 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.262 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -106.45 120.12 41.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.59 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 pt -106.31 145.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -118.99 124.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 172' ' ' VAL . 15.0 t -95.6 141.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.264 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 147.82 26.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -71.44 116.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 t0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.215 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 170.01 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.152 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.5 p -130.49 160.72 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.504 ' N ' HG22 ' A' ' 123' ' ' VAL . 14.3 p -122.26 143.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 126' ' ' SER . 21.5 t -125.03 159.12 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -141.26 170.91 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 65.45 44.37 93.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 157' ' ' THR . 3.9 mm? -78.48 155.23 78.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.735 0.302 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 171.71 11.55 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 112.405 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.12 -26.62 73.03 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.613 2.209 . . . . 0.0 112.346 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -135.9 122.14 20.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.63 -172.72 33.37 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.2 p -172.62 -177.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 44.7 p-90 -59.94 -37.47 79.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 21.6 tt0 -70.38 -32.05 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -68.93 -50.32 50.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.79 HD22 ' CG1' ' A' ' 152' ' ' VAL . 11.3 tp -67.6 -44.85 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.89 -40.38 63.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -61.14 -26.73 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.236 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -86.72 -43.6 12.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.705 ' HG3' HG21 ' A' ' 160' ' ' VAL . 77.6 mmm -69.51 -26.32 64.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -45.31 -33.14 2.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.268 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.36 -33.82 63.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.03 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.99 -140.22 6.87 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.511 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 128.99 39.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.735 HG22 ' HD2' ' A' ' 162' ' ' PHE . 89.5 t -102.72 127.07 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.95 -26.23 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 35.4 t80 -151.73 153.87 35.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.399 . . . . 0.0 111.311 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.429 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.07 149.04 11.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.915 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.51 124.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.79 ' CG1' HD22 ' A' ' 137' ' ' LEU . 30.6 m -122.01 142.51 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.035 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.96 155.12 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -72.5 -10.95 60.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.397 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.59 -23.18 66.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.25 24.43 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.616 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.478 ' HA ' HD23 ' A' ' 128' ' ' LEU . 33.4 p -155.54 160.26 40.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.26 -175.79 25.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 141' ' ' MET . 12.5 t -127.61 133.44 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.3 118.59 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.735 ' HD2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -114.62 139.32 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.627 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 163' ' ' VAL . 6.4 p -71.18 65.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.926 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER 178.81 125.51 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -72.11 -44.84 62.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.546 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.42 -27.79 68.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.668 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.15 -40.59 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.548 ' SD ' HG13 ' A' ' 194' ' ' VAL . 2.0 ttp -59.65 -59.22 5.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.9 m -58.35 -36.44 73.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.357 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -62.89 -45.14 93.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -63.64 -44.9 92.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 192' ' ' VAL . 24.0 m -71.87 -22.38 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.707 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 17.8 ptt180 -96.31 -26.53 15.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.602 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 73.9 mmtt -110.71 -60.81 1.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.959 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.4 mt -63.08 -15.82 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 178' ' ' THR . 16.6 p-10 -64.1 159.26 20.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 50.18 58.6 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.196 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 176' ' ' ASP . 76.1 p -140.51 164.01 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.978 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -87.96 123.59 32.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -99.25 149.78 22.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 142.46 50.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.5 p -95.56 151.51 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -52.98 -23.97 8.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.79 -22.3 53.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.08 26.68 5.65 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.549 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -107.88 115.62 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.04 152.16 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 135.25 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 135.62 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 127' ' ' GLY . 37.0 pt -131.25 161.43 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.374 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -127.7 128.42 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.637 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 172' ' ' VAL . 4.3 t -111.48 142.95 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.318 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -165.17 141.04 5.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 172' ' ' VAL . 23.2 t -59.05 113.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 3.2 m120 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.583 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 2.1 tmm_? -143.59 142.63 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.044 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.4 p -104.25 159.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 193' ' ' LYS . 8.6 p -118.98 152.66 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.25 148.67 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.573 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -141.2 127.98 20.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.798 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.514 ' C ' HG22 ' A' ' 190' ' ' ILE . . . 127.55 -0.65 6.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.924 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.806 HD12 HG21 ' A' ' 190' ' ' ILE . 1.6 mp -56.78 151.44 32.03 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.817 0.341 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.57 171.86 10.11 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.158 . . . . 0.0 112.161 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.02 -25.63 51.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.424 2.083 . . . . 0.0 112.4 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 125.52 15.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -170.37 -179.63 41.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.4 m -130.8 149.48 52.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.737 0.303 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -63.59 -33.38 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.26 -31.69 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.0 -50.3 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 23.1 tp -60.23 -45.81 91.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' HG22 ' A' ' 147' ' ' VAL . 9.6 tttm -57.43 -39.95 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.97 -26.96 61.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.489 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -91.19 -22.74 20.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.466 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 4.0 ppp? -99.58 -12.77 19.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.574 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -52.72 -24.92 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.748 0.308 . . . . 0.0 111.446 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -24.4 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.853 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -66.89 -28.18 68.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.562 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 -129.9 2.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.363 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -103.19 108.59 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.067 0.46 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' HE2' ' A' ' 138' ' ' LYS . 12.0 p -106.12 139.92 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.24 -40.42 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.405 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 161' ' ' GLU . 7.8 t80 -117.83 145.17 44.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 160' ' ' VAL . . . -162.97 133.18 4.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.63 141.48 48.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.965 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.603 HG12 HD21 ' A' ' 128' ' ' LEU . 28.6 m -128.96 114.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.024 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -85.57 143.78 28.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -73.84 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.42 -49.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.65 -26.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 126' ' ' SER . 30.3 p -106.77 164.26 12.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.68 -175.91 20.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.53 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.583 HG11 ' CZ ' ' A' ' 122' ' ' ARG . 26.6 m -143.42 154.48 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 123' ' ' VAL . 2.0 t -149.32 150.28 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 149' ' ' TYR . 0.9 OUTLIER -132.18 116.22 16.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.788 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 141' ' ' MET . 5.3 m-85 -92.68 173.78 7.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.59 -70.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 157.92 16.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -56.16 -32.08 63.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -55.34 -39.99 70.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.12 -30.65 66.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.433 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 7.0 ttp -70.49 -63.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.4 m -53.14 -34.07 55.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.021 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.78 -48.31 79.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.515 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -55.79 -50.66 69.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.245 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 192' ' ' VAL . 16.0 m -62.64 -25.95 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -72.23 0.42 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -56.1 6.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.118 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.853 HD12 ' HB2' ' A' ' 144' ' ' ALA . 46.8 mt -77.19 72.74 3.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.846 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -133.46 120.94 21.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.9 t30 62.04 39.51 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.713 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -92.31 179.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.937 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.472 ' N ' ' OG1' ' A' ' 178' ' ' THR . 6.6 tttp -98.94 125.99 44.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.9 t80 -103.63 143.41 32.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.726 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.39 116.91 26.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.82 152.87 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -68.52 -14.22 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.253 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.83 -23.1 64.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.284 . . . . 0.0 111.112 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.82 31.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.513 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -139.3 144.11 38.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.358 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 154.65 26.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.9 147.61 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.202 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.05 146.05 28.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.806 HG21 HD12 ' A' ' 128' ' ' LEU . 29.8 pt -136.4 145.69 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 127.99 54.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 172' ' ' VAL . 8.9 t -103.7 143.47 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 124' ' ' VAL . 12.8 mttt -161.31 144.49 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.9 p -64.32 113.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 t0 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.98 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 165' ' ' LYS . 25.0 t-20 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.751 0.31 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -117.72 150.27 39.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.5 p -133.95 159.98 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.492 ' N ' HG22 ' A' ' 123' ' ' VAL . 9.8 p -124.04 147.83 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 126' ' ' SER . 26.7 t -118.13 157.8 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 125' ' ' VAL . 35.8 t -161.18 123.36 3.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.09 39.48 0.64 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.95 154.84 45.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.672 0.272 . . . . 0.0 110.758 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 12.6 Cg_endo -55.98 166.24 3.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 0.0 112.21 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.74 -27.55 20.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.678 2.252 . . . . 0.0 112.484 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 129.46 15.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.09 -163.68 13.99 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -153.01 162.55 41.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HB3' HG22 ' A' ' 152' ' ' VAL . 60.4 p-90 -74.12 -39.18 63.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -36.91 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -36.0 66.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 22.8 tp -63.17 -45.14 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -28.12 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.186 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -67.07 -26.7 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.29 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 180' ' ' PHE . 6.6 m80 -96.26 -27.95 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.304 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 147' ' ' VAL . 38.6 mmm -83.58 -26.28 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.248 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.519 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -51.5 -27.57 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.426 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -53.69 -22.52 9.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.51 66.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 0.0 110.64 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.5 -59.58 0.36 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.369 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -174.38 107.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 141' ' ' MET . 84.7 t -88.67 132.05 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.52 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -133.35 145.26 50.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.75 133.94 6.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -138.12 152.21 48.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 134' ' ' TRP . 2.9 m -144.39 107.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.68 100.69 6.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 64.15 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -179.13 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.04 10.86 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.062 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.436 HG22 ' CB ' ' A' ' 126' ' ' SER . 54.5 p -157.63 174.54 15.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -160.86 -166.22 19.18 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.414 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 151' ' ' ASP . 24.7 m -149.86 159.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 111.016 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.42 145.25 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.09 137.09 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.706 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 147' ' ' VAL . 34.3 m-85 -113.56 175.67 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.66 -70.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.83 157.97 15.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HA ' ' ND2' ' A' ' 121' ' ' ASN . 2.0 tptm -58.14 -29.16 65.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.54 -34.95 76.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.9 -38.48 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.5 ttp -70.79 -62.23 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 173' ' ' ARG . 92.5 m -53.38 -36.81 61.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 28.4 t80 -63.79 -46.54 84.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -54.9 -46.14 74.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 192' ' ' VAL . 15.9 m -68.91 -23.03 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.549 ' HD2' HG22 ' A' ' 169' ' ' THR . 10.2 mtp180 -87.01 -67.2 0.83 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.975 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 1.5 mptp? -76.81 -48.38 18.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.736 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 52.3 mt -84.49 58.48 4.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -117.84 129.84 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.739 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.16 39.44 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.708 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.2 p -81.37 177.61 8.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.94 99.25 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.0 t80 -88.72 152.67 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.89 140.05 40.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.21 155.05 22.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.637 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -53.03 -22.83 6.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -75.73 -21.07 57.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 20.84 8.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.771 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 116.19 32.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.733 0.301 . . . . 0.0 110.715 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 156.94 18.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -165.1 166.04 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.25 119.58 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.9 pt -108.32 141.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.98 0.419 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -106.38 128.63 54.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 172' ' ' VAL . 3.9 t -111.76 142.89 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.084 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.96 140.84 8.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.3 110.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.4 p30 . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.61 0.243 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 119.96 25.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.6 p -102.62 160.12 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 193' ' ' LYS . 11.6 p -120.46 143.71 31.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -129.99 158.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 125' ' ' VAL . 21.4 p -146.75 146.42 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 95.29 46.14 2.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.559 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.61 145.48 37.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.639 0.257 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.92 170.67 19.15 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.381 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.71 -27.47 52.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 31.08 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.72 118.76 5.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.03 168.91 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 58.6 p-90 -62.59 -41.75 99.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -61.58 -33.73 74.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.03 -38.39 52.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.202 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.84 -44.3 32.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.273 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.791 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.1 ttmm -53.19 -39.71 63.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -71.63 -26.7 62.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.621 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -26.01 20.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.422 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.694 ' CE ' HG11 ' A' ' 160' ' ' VAL . 3.3 ppp? -97.01 -10.25 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -18.78 30.89 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.516 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.93 -25.79 3.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -69.57 -27.42 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.745 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.54 -125.87 1.79 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.457 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.459 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.791 HG11 ' HG3' ' A' ' 138' ' ' LYS . 84.0 t -79.94 130.94 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.047 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 -29.44 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -163.28 146.95 10.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.97 136.64 19.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -152.07 125.11 8.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 158' ' ' GLY . 31.3 m -127.88 131.49 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -98.24 155.01 17.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -10.18 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.411 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -29.0 70.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 157' ' ' THR . . . 123.45 36.46 0.64 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.592 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' GLY . 16.7 p -160.3 160.77 32.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.849 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 152' ' ' VAL . . . -149.97 176.78 28.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.576 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.3 m -147.69 146.87 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.324 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.694 HG11 ' CE ' ' A' ' 141' ' ' MET . 3.5 t -141.66 147.78 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.08 126.14 33.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 1.0 OUTLIER -104.98 166.9 10.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.59 -72.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 151.05 24.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.99 -27.53 5.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.246 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -53.98 -44.16 70.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -30.07 64.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.439 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.1 ttp -65.03 -63.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.1 m -57.69 -34.04 69.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.51 80.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.616 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 192' ' ' VAL . 4.5 m -65.22 -24.81 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.446 ' HD2' HG23 ' A' ' 172' ' ' VAL . 0.0 OUTLIER -76.74 -73.05 0.31 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.233 0.539 . . . . 0.0 110.296 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -58.26 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.7 mt -77.27 81.52 3.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.45 138.57 19.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.49 46.64 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -109.83 173.25 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.445 ' HD3' ' CD1' ' A' ' 189' ' ' TYR . 0.3 OUTLIER -105.32 103.37 12.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.93 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -68.89 120.17 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.54 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.24 100.8 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.532 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.05 136.87 56.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -59.37 -19.83 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.187 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -68.77 -17.48 64.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.258 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.99 31.04 3.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.56 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -131.74 138.5 48.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.06 156.8 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 138.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.445 ' CD1' ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -79.21 128.77 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 127' ' ' GLY . 5.4 pt -125.14 140.77 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.371 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -112.7 134.94 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 172' ' ' VAL . 12.2 t -109.62 141.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.362 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 124' ' ' VAL . 39.8 mttp -153.34 137.87 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 194' ' ' VAL . 11.1 p -67.06 115.38 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.175 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.803 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.901 0.382 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -123.42 121.95 37.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.849 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 194' ' ' VAL . 26.1 m -106.97 161.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 158' ' ' GLY . 24.4 t -113.38 140.7 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -120.1 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.0 p -111.71 132.99 54.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.58 35.85 0.96 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 137' ' ' LEU . 4.0 mm? -87.88 153.52 52.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 161.74 44.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.477 2.118 . . . . 0.0 112.301 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 -31.43 20.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 90.57 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.63 -163.34 11.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.59 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 170.72 20.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -60.29 -44.25 95.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.797 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -60.47 -31.64 70.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -53.22 60.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.606 HD13 HD11 ' A' ' 128' ' ' LEU . 63.2 tp -60.0 -40.16 88.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.68 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -60.75 -39.66 89.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.908 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.98 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -87.99 -35.11 17.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.503 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -71.31 -25.21 62.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.4 mtt-85 -46.77 -30.2 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -30.36 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.51 -27.42 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 151.15 -100.43 0.2 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -131.1 111.05 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.961 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 138' ' ' LYS . 95.1 t -78.17 151.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 40.7 t -112.7 -31.82 6.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -165.59 150.41 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.95 173.37 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -176.9 135.01 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.429 HG12 ' HG ' ' A' ' 128' ' ' LEU . 4.2 m -125.56 101.19 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 19.2 p90 -124.12 155.84 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 0.2 OUTLIER 89.38 -4.98 0.4 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.355 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 63.14 31.53 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.94 -45.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.3 p -104.84 160.1 15.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.375 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -159.06 -179.32 33.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.265 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.6 p -146.07 159.52 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.222 0.534 . . . . 0.0 111.208 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 46.0 t -154.74 141.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.2 125.47 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.37 177.13 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.86 -69.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -88.36 149.84 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -61.33 -34.19 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.58 -33.44 72.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.73 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.446 ' OD1' ' HB1' ' A' ' 144' ' ' ALA . 36.9 t0 -72.18 -37.93 69.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.526 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.47 -63.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.428 ' HA ' HG22 ' A' ' 172' ' ' VAL . 53.9 m -53.73 -31.46 48.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 4.3 t80 -60.43 -50.51 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.244 0.545 . . . . 0.0 110.12 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 175' ' ' LEU . . . -57.55 -53.87 53.27 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 169' ' ' THR . 13.9 m -54.82 -22.71 10.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.351 . . . . 0.0 111.752 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -71.75 0.69 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.042 0.449 . . . . 0.0 112.111 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -67.74 -45.55 74.65 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -123.31 84.16 2.23 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.826 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 2.4 p-10 -129.51 -102.03 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.321 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 190' ' ' ILE . 10.3 t-20 -67.62 56.28 0.06 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.467 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -109.39 -167.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -91.36 140.98 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -118.67 133.3 55.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -123.27 119.12 29.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.9 t -79.11 149.83 31.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -55.39 -23.46 24.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.22 -23.0 63.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.13 28.83 4.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.0 136.77 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.69 156.22 18.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.52 168.31 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.43 109.98 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 21.6 pt -102.1 158.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 177' ' ' ASN . 1.2 tmm_? -139.08 117.36 11.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.6 151.45 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.9 144.03 6.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.5 t -61.31 119.71 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 14.6 t0 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.926 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.765 0.317 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -79.92 158.07 26.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.7 p -144.18 160.01 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.496 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.7 p -123.2 141.07 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.09 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -118.82 155.61 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 125' ' ' VAL . 11.0 t -145.46 138.46 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 100.89 37.0 3.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.33 152.98 92.25 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.76 171.84 10.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.313 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.99 -28.49 80.7 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.638 2.225 . . . . 0.0 112.249 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m -122.24 -80.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.38 -168.67 0.31 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.806 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 m -164.5 156.23 15.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 44.8 p-90 -59.26 -44.6 92.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -67.5 -32.89 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.603 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.19 -45.32 77.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.427 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 59.7 tp -59.67 -43.84 93.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.88 -37.93 64.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.956 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -64.42 -26.72 68.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.215 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -84.75 -37.51 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.529 ' HA ' HD21 ' A' ' 175' ' ' LEU . 32.4 mmm -75.85 -20.34 58.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.661 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -43.3 -31.83 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.354 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -50.62 -34.33 25.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.87 -29.68 66.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.8 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.22 -129.04 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.383 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.29 136.93 37.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.532 HG22 ' CE1' ' A' ' 162' ' ' PHE . 92.4 t -115.54 121.37 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.957 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.02 -42.53 16.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.058 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 52.3 t80 -142.98 158.45 43.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -162.99 139.94 7.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.49 161.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.57 133.08 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.85 155.64 37.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.704 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -33.13 -42.78 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.935 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 174.01 65.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.886 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.73 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.814 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 126' ' ' SER . 13.9 p -141.3 -177.13 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.141 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.67 176.71 33.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.463 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 126.93 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 123' ' ' VAL . 16.9 t -119.66 144.32 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.03 106.92 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.82 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.532 ' CE1' HG22 ' A' ' 147' ' ' VAL . 80.4 m-85 -87.53 141.6 28.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.33 -28.62 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -120.0 147.94 44.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -72.1 -32.85 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -60.48 -31.78 70.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.416 ' O ' ' HB1' ' A' ' 144' ' ' ALA . 62.0 m-20 -71.66 -35.89 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.484 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.2 ttp -67.97 -62.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.3 m -53.4 -32.24 48.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 3.1 t80 -61.35 -50.43 72.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.223 0.535 . . . . 0.0 110.076 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 175' ' ' LEU . . . -55.02 -54.1 47.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 194' ' ' VAL . 15.3 m -55.87 -22.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.36 -72.47 0.62 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.322 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -35.77 25.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -110.51 75.45 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.83 162.04 36.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.771 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 p30 42.92 58.8 3.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.445 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.5 p -123.63 170.47 10.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -85.57 134.85 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 187' ' ' THR . 24.7 t80 -91.73 146.81 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -119.64 112.8 19.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.1 t -93.95 144.65 25.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -57.72 -25.64 60.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.01 -23.13 64.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.85 18.02 12.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.66 129.28 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.684 0.278 . . . . 0.0 110.712 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 180' ' ' PHE . 0.2 OUTLIER -101.52 159.61 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.008 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.03 133.62 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.239 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.37 122.69 23.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 127' ' ' GLY . 7.4 pt -117.63 155.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -119.81 139.53 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.52 135.93 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 124' ' ' VAL . 29.2 mmmt -152.69 140.49 20.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.533 HG23 HG11 ' A' ' 172' ' ' VAL . 21.6 t -63.52 111.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.649 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.893 0.378 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -102.51 154.07 19.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.62 152.57 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.58 139.54 51.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.15 146.28 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.3 m -142.45 148.71 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.75 49.97 33.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.555 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.769 ' CB ' HG22 ' A' ' 190' ' ' ILE . 0.3 OUTLIER -130.43 160.21 67.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.621 0.248 . . . . 0.0 111.0 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 57.1 Cg_endo -71.1 137.25 31.21 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.371 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.01 -20.08 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.438 2.092 . . . . 0.0 112.544 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -54.58 -60.96 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.204 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.16 116.74 9.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.633 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -168.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.771 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 38.8 p-90 -64.61 -33.89 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 35.7 mt-30 -65.29 -40.37 93.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -71.84 -38.52 70.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.496 HD22 HG12 ' A' ' 152' ' ' VAL . 46.1 tp -70.45 -46.11 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.4 tttt -57.78 -49.17 77.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.69 -26.62 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.37 17.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 142' ' ' ARG . 10.8 mtp-105 -45.55 -32.04 2.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -32.72 65.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.801 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -76.46 -29.42 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.32 -160.99 31.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.388 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.69 122.02 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.418 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 138' ' ' LYS . 93.8 t -89.23 130.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.006 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.6 t -98.68 -30.54 12.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.406 ' O ' HG13 ' A' ' 160' ' ' VAL . 22.0 t80 -153.07 145.13 23.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.024 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -150.12 133.93 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 159' ' ' VAL . 36.8 t0 -153.73 111.26 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 137' ' ' LEU . 27.5 m -92.9 134.21 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -79.94 152.63 29.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -71.84 -22.28 61.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -42.15 75.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.348 . . . . 0.0 111.116 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 153.53 -27.19 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.543 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -82.56 173.85 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.319 . . . . 0.0 110.719 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.25 177.49 31.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 151' ' ' ASP . 29.6 m -149.09 144.32 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 149' ' ' TYR . 3.7 t -148.06 137.2 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -117.51 127.53 54.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.54 177.13 5.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -70.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.332 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 163.29 14.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.11 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -71.99 -31.33 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -31.94 67.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -72.36 -36.05 68.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.672 ' SD ' HG13 ' A' ' 194' ' ' VAL . 7.7 ttp -65.25 -62.18 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.606 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.3 m -54.68 -32.96 60.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.422 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 44.4 t80 -63.56 -45.65 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.26 -31.43 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.802 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.468 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 0.7 OUTLIER -84.62 -29.37 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.326 . . . . 0.0 110.888 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.468 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 0.7 OUTLIER -105.74 -65.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.863 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 144' ' ' ALA . 70.2 mt -76.84 66.36 2.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -120.93 121.01 37.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.53 12.89 8.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -176.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.999 0.428 . . . . 0.0 111.008 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -101.68 144.25 30.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.996 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -124.8 122.81 38.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.293 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HG3' HG23 ' A' ' 187' ' ' THR . 6.1 ttt-85 -119.62 119.32 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.7 m -87.81 159.39 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -59.95 -17.03 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -92.48 18.59 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.34 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.32 31.09 76.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.544 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 93.3 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 110.8 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -92.2 144.51 25.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -170.06 172.02 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.238 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -106.17 123.51 48.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.769 HG22 ' CB ' ' A' ' 128' ' ' LEU . 13.7 pt -107.62 152.43 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.706 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -112.63 117.6 32.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.11 133.63 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -153.87 150.46 28.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.672 HG13 ' SD ' ' A' ' 168' ' ' MET . 21.8 t -62.49 109.39 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.818 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE ' ' A' ' 165' ' ' LYS . 12.2 m-80 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.845 0.355 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -121.76 169.61 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 160' ' ' VAL . 1.6 p -117.46 159.62 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.963 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 195' ' ' ASP . 9.7 t -114.37 156.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.43 ' N ' HG12 ' A' ' 124' ' ' VAL . 19.3 t -144.35 143.69 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.82 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.448 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -137.26 159.42 41.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.74 45.18 8.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.1 mm? -83.83 142.94 42.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.97 170.44 20.09 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.29 -20.71 66.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.572 2.181 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.7 m -108.88 -157.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.47 -177.94 48.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -176.8 -175.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 110.747 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 56.3 p-90 -59.27 -43.06 92.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 7.2 tp60 -63.01 -38.72 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -35.48 57.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.802 HD22 HG22 ' A' ' 152' ' ' VAL . 30.6 tp -62.29 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.637 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -57.6 -42.48 83.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.5 -26.77 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -89.59 -29.86 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.736 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.525 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -85.44 -19.97 30.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.07 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -46.43 -30.0 1.97 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.32 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.98 -32.43 53.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.88 -28.17 60.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.43 -139.6 6.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.4 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -99.7 101.33 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 162' ' ' PHE . 92.0 t -75.64 120.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.27 -29.07 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 20.4 t80 -146.67 151.59 37.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -159.8 140.92 12.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 159' ' ' VAL . 6.1 t70 -135.4 148.92 49.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.802 HG22 HD22 ' A' ' 137' ' ' LEU . 1.8 t -146.16 106.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.17 151.41 31.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -17.7 61.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.207 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.84 -24.41 67.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.72 25.74 2.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.677 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 126' ' ' SER . 31.8 p -151.42 163.35 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.781 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.62 -166.14 18.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.795 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 151' ' ' ASP . 34.1 m -147.51 172.68 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.509 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.892 HG23 HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -155.0 130.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.402 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.48 120.69 39.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.858 ' CE2' HG22 ' A' ' 147' ' ' VAL . 85.2 m-85 -104.01 139.71 38.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.61 -30.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.781 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.19 125.91 49.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CE ' ' HA ' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -53.62 -24.15 13.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -39.23 89.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.49 -31.94 71.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.583 ' HE3' ' H ' ' A' ' 169' ' ' THR . 9.3 tmm? -61.32 -75.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.798 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.585 HG23 ' NH1' ' A' ' 173' ' ' ARG . 5.0 m -45.64 -45.04 13.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.751 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.8 -40.21 75.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.954 0.407 . . . . 0.0 110.683 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.563 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 192' ' ' VAL . 15.4 m -78.85 -27.65 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.116 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.585 ' NH1' HG23 ' A' ' 169' ' ' THR . 4.5 mmt85 -80.75 -40.12 25.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -103.43 -58.24 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.478 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 96.6 mt -77.53 64.86 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.947 0.403 . . . . 0.0 111.022 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -128.24 138.53 52.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.02 30.2 19.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.7 p -98.41 155.5 17.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -81.24 134.37 35.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -96.04 158.11 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.558 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.683 ' HG2' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -133.14 125.77 30.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.969 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -93.91 149.88 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.831 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -56.16 -23.12 32.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.66 -23.11 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.054 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.19 26.23 6.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.677 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -115.12 136.2 53.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -110.68 161.1 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -168.98 170.91 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.006 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.16 126.15 43.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -117.5 137.68 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.335 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -106.15 122.63 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.677 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 172' ' ' VAL . 3.0 t -104.62 153.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.468 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -164.35 140.63 6.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.675 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.481 HG23 ' SD ' ' A' ' 168' ' ' MET . 11.7 p -66.63 119.59 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.48 . . . . 0.0 111.289 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 124' ' ' VAL . 9.4 t0 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -116.06 170.03 8.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 168' ' ' MET . 2.0 t -123.95 165.34 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.202 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 193' ' ' LYS . 7.4 p -122.42 136.35 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.402 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.14 153.99 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 157' ' ' THR . 3.1 t -141.85 133.57 27.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.44 40.26 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.633 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 128' ' ' LEU . 2.4 mm? -89.05 139.06 28.84 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.531 0.205 . . . . 0.0 110.99 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 169.91 21.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.467 2.112 . . . . 0.0 112.284 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.01 -29.79 26.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.455 2.103 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.07 71.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.38 -160.43 8.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.67 174.08 1.89 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.769 0.318 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 52.8 p-90 -72.7 -40.92 65.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 3.6 pt20 -66.85 -34.67 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -29.45 60.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -73.17 -41.34 63.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -64.31 -53.77 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.145 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -56.34 -26.79 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.252 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.495 ' CD2' ' CE1' ' A' ' 180' ' ' PHE . 10.4 m-70 -86.06 -23.09 26.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.388 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.907 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.5 ppp? -106.66 8.47 31.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 111.544 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -56.9 -15.11 4.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.496 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.827 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -49.83 -23.82 2.09 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.506 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . . . -61.48 -28.23 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.118 0.485 . . . . 0.0 110.396 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 140.46 -55.14 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.427 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.69 117.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.469 ' CG1' ' HG3' ' A' ' 138' ' ' LYS . 61.1 t -100.5 132.26 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.842 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.21 -49.48 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.235 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 14.1 t80 -155.83 160.02 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -147.46 168.01 22.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.75 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.4 t70 -163.14 123.79 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.019 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.13 138.96 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.88 155.04 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -70.8 -18.05 62.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.188 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.14 -25.79 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 5.15 8.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.785 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 126' ' ' SER . 8.4 p -131.75 161.14 33.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.2 -169.05 11.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 151' ' ' ASP . 7.0 m -140.94 167.31 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.907 HG11 ' SD ' ' A' ' 141' ' ' MET . 21.9 t -152.72 140.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -131.28 114.3 14.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 144' ' ' ALA . 16.9 m-85 -88.89 176.49 7.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.85 -66.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -96.84 161.11 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.555 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -25.2 62.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.56 -31.26 72.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.06 -31.36 71.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.724 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.1 ttp -59.86 -62.11 2.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.67 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 172' ' ' VAL . 52.1 m -56.81 -32.41 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 170' ' ' TYR . 4.3 t80 -60.54 -50.31 74.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.227 0.537 . . . . 0.0 110.28 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' LEU . . . -57.8 -51.99 67.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.967 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.82 HG11 HG23 ' A' ' 194' ' ' VAL . 15.8 m -57.11 -22.48 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.974 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -106.52 -73.6 0.68 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.147 0.498 . . . . 0.0 112.25 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -35.18 79.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -125.49 85.5 2.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.645 0.736 . . . . 0.0 111.448 -178.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -142.74 152.69 42.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 71.26 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 p -124.98 169.76 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -89.54 136.35 33.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 140' ' ' HIS . 89.9 t80 -113.74 114.98 27.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.694 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -116.19 103.61 10.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.829 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.6 p -58.45 169.84 0.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.072 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -6.94 34.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.13 -22.93 21.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.712 0.291 . . . . 0.0 111.097 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 30.47 4.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.432 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -112.05 108.28 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.7 156.25 20.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.07 169.7 12.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.59 136.51 43.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.95 142.54 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.282 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.89 150.92 37.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 123' ' ' VAL . 4.0 t -114.97 133.58 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.331 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.665 ' O ' HG12 ' A' ' 124' ' ' VAL . 2.6 mtpm? -141.22 140.45 33.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.82 HG23 HG11 ' A' ' 172' ' ' VAL . 37.6 t -68.49 113.94 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.297 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.598 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.64 169.18 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 194' ' ' VAL . 4.3 m -125.48 165.12 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.88 136.7 48.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.6 t -105.35 154.11 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 157' ' ' THR . 28.1 p -154.86 121.27 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.78 26.75 4.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' HG22 ' A' ' 190' ' ' ILE . 2.9 mt -68.18 155.27 92.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 188' ' ' ALA . 42.8 Cg_endo -68.05 160.57 48.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.627 2.218 . . . . 0.0 112.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.43 -28.99 31.92 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m -118.52 72.19 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.79 147.29 16.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.36 175.81 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.672 0.272 . . . . 0.0 111.025 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -73.97 -32.32 63.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.953 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.72 -44.66 90.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.06 -32.08 59.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 55.3 tp -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.15 -45.06 93.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.195 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.45 -26.77 68.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.727 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 181' ' ' ARG . 22.6 m-70 -99.94 -26.43 14.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.824 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -96.9 4.44 51.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -9.9 45.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.82 -26.74 4.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.804 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.37 -28.75 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.92 -164.91 28.16 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.6 m-20 -60.29 106.38 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.117 0.484 . . . . 0.0 110.781 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.1 t -73.85 153.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.0 t -107.64 -59.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.177 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.52 130.94 5.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.817 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.52 140.34 53.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.13 136.71 33.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.999 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 152' ' ' VAL . 26.7 m -119.4 118.92 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.927 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -93.33 121.22 34.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 63.34 -76.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 1.2 m-20 169.76 -25.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -64.62 -49.93 61.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.633 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 126' ' ' SER . 33.2 p -133.63 -179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.9 -159.05 10.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.468 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 m -156.01 158.85 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.824 HG11 ' SD ' ' A' ' 141' ' ' MET . 16.4 t -152.05 141.93 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.93 135.01 54.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.85 163.23 13.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 146' ' ' ASP . 46.9 t -80.31 -62.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -88.23 152.92 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.58 -30.73 68.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -36.88 85.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.62 -30.62 68.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.763 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.9 ttp -65.14 -64.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -55.04 -32.78 62.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.558 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 64.7 t80 -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . . . -68.02 -39.34 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.634 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 194' ' ' VAL . 11.7 m -79.54 -22.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.818 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.558 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 5.7 ptm180 -91.11 -42.08 10.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HD2' ' HG3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -109.42 -30.45 7.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 144' ' ' ALA . 17.7 mt -94.84 31.51 1.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.61 134.51 45.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 60.71 35.08 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.584 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.36 154.95 17.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.468 ' HD3' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER -81.06 115.63 20.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.1 t80 -92.8 152.98 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.406 ' O ' ' CD2' ' A' ' 140' ' ' HIS . 0.2 OUTLIER -121.09 113.53 20.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.96 158.77 34.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.73 -13.81 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.182 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.7 20.78 7.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.394 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 25.93 73.26 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.573 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 125.21 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.468 HG22 ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -94.09 161.07 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 129' ' ' PRO . . . -165.75 159.41 16.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.43 111.87 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 128' ' ' LEU . 5.6 pt -112.92 148.7 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.527 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.62 154.59 26.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.411 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 172' ' ' VAL . 12.3 t -125.96 144.49 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.148 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 148.01 29.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 123' ' ' VAL . 14.6 t -78.38 141.76 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.304 0.573 . . . . 0.0 110.7 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.661 -179.728 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -144.29 128.54 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.775 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.951 HG12 ' HA ' ' A' ' 194' ' ' VAL . 23.7 m -104.29 165.2 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 195' ' ' ASP . 23.3 t -119.06 154.03 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.093 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.2 143.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 157' ' ' THR . 4.5 t -144.62 134.73 24.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.29 39.16 4.06 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.47 HD21 HD13 ' A' ' 137' ' ' LEU . 15.8 mt -89.02 159.46 45.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.58 160.08 47.77 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.574 2.183 . . . . 0.0 112.304 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.4 -45.41 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.534 2.156 . . . . 0.0 112.279 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.9 p -97.46 61.77 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.14 152.75 23.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.28 4.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.417 ' HB3' HG23 ' A' ' 152' ' ' VAL . 45.1 p-90 -73.98 -32.31 63.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -59.23 -42.21 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -73.66 -30.15 62.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.47 HD13 HD21 ' A' ' 128' ' ' LEU . 67.3 tp -66.81 -43.24 84.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.639 ' HG3' HG11 ' A' ' 147' ' ' VAL . 5.5 ttpt -52.97 -30.11 32.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.69 -26.63 66.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -33.78 16.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.543 ' HB2' HG21 ' A' ' 147' ' ' VAL . 71.7 mmm -72.7 -31.04 64.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.069 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -29.41 23.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.252 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -50.79 -25.62 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.019 0.438 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.861 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -74.53 -27.77 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.53 -69.8 0.28 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -160.48 136.28 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.425 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.4 t -107.59 152.26 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.788 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.4 t -112.07 -33.03 6.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.1 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -162.36 148.95 13.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.72 156.52 45.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.831 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -159.0 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 134' ' ' TRP . 17.6 t -137.05 95.29 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 10.8 p90 -123.14 156.09 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 6.9 ttp180 96.27 -3.06 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.487 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 65.36 37.84 6.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -179.23 -52.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 126' ' ' SER . 3.9 p -97.97 163.71 12.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -143.63 -149.47 5.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.469 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.5 p -169.29 160.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.472 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 21.3 t -152.51 149.56 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -127.96 109.11 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HE2' HG21 ' A' ' 123' ' ' VAL . 95.7 m-85 -85.1 177.14 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.038 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.38 -70.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -95.04 164.13 13.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.145 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -72.25 -31.19 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -59.9 -50.32 74.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.25 -29.07 64.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.699 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.2 ttp -71.11 -64.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.6 m -50.34 -33.92 22.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.15 -45.57 84.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.413 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.45 -47.28 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.446 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 192' ' ' VAL . 16.1 m -66.76 -22.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -86.46 -67.64 0.8 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -52.85 9.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 144' ' ' ALA . 91.2 mt -79.66 60.44 3.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -130.03 141.19 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.65 32.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.265 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.6 p -83.14 -179.15 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 101.95 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.8 t80 -72.94 143.63 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -124.56 107.95 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.007 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 27.5 t -79.54 161.43 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.16 -7.45 51.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -95.41 19.13 11.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.92 28.57 73.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 128.91 55.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 159.73 18.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.02 171.86 6.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.66 119.92 40.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 2.7 pt -107.29 146.53 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -116.34 119.12 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 172' ' ' VAL . 19.4 t -98.23 143.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.41 142.46 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.951 ' HA ' HG12 ' A' ' 123' ' ' VAL . 12.6 p -74.62 118.0 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.474 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.841 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.858 0.361 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 123' ' ' VAL . 25.6 ttm180 -86.61 156.95 19.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.414 ' N ' ' HG2' ' A' ' 122' ' ' ARG . 3.1 m -132.66 165.17 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.91 147.42 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.0 142.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.6 t -140.01 146.61 39.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.83 64.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.289 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 190' ' ' ILE . 0.0 OUTLIER -98.23 148.4 34.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.675 0.274 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 30.9 Cg_endo -63.69 127.53 19.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 111.976 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -22.53 46.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.298 1.998 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.97 43.39 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.42 -166.76 21.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.417 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.54 145.56 51.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.3 p-90 -73.95 -46.36 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -60.8 -32.38 71.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.812 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -35.79 55.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.651 HD22 HG12 ' A' ' 152' ' ' VAL . 51.6 tp -61.38 -37.16 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.482 ' HB3' HG11 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -66.6 -39.06 88.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 110.404 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -66.94 -26.57 66.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.238 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.464 ' HE1' HD11 ' A' ' 190' ' ' ILE . 0.8 OUTLIER -86.62 -22.06 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.834 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.8 ppp? -111.76 -3.38 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -59.02 -20.67 55.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 111.387 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -50.38 -24.95 3.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.176 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 171' ' ' ALA . . . -69.17 -26.38 64.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.726 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.64 -116.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.0 111.71 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 138' ' ' LYS . 89.3 t -82.79 151.28 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 163' ' ' VAL . 1.3 m -119.4 -39.82 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -145.94 148.21 32.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.97 139.53 18.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -142.89 138.32 30.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 137' ' ' LEU . 34.2 m -117.71 118.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -69.15 155.25 40.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.971 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 17.56 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -29.72 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.758 0.314 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 145.95 -16.83 1.76 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.9 p -98.86 -178.48 3.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 111.224 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.7 -176.62 30.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 151' ' ' ASP . 17.2 m -153.5 150.38 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 111.044 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.834 HG11 ' SD ' ' A' ' 141' ' ' MET . 10.5 t -150.65 146.31 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -130.74 131.32 44.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 168' ' ' MET . 3.8 m-85 -104.58 171.1 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.748 HG22 ' SG ' ' A' ' 148' ' ' CYS . 55.5 t -70.03 -70.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -97.35 155.27 16.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -58.29 -28.56 65.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.36 -32.06 73.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.9 -34.95 66.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.43 ' HA ' ' CD1' ' A' ' 162' ' ' PHE . 8.2 ttp -68.58 -62.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.1 m -53.93 -36.32 62.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.01 -44.22 97.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -60.34 -44.64 95.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.471 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.88 -27.09 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.094 0.473 . . . . 0.0 110.725 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -77.99 -53.39 7.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -65.72 0.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.439 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 41.6 mt -63.69 -118.5 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.47 113.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 64.85 72.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 46.3 p -132.0 -176.94 4.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -103.74 139.93 38.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 181' ' ' ARG . 75.5 t80 -126.85 160.78 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.748 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -141.08 149.07 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.027 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.0 p -109.38 157.37 18.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -20.38 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -79.14 -22.93 44.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.99 29.46 5.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.8 121.89 46.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.1 156.58 17.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -167.29 171.65 10.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.29 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -107.51 121.3 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.241 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 128' ' ' LEU . 28.6 pt -101.84 168.45 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 109.47 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.322 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.0 t -86.76 153.53 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.389 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.98 171.29 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 194' ' ' VAL . 12.6 p -87.91 122.36 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.939 0.4 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.223 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.872 0.367 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.478 ' NH2' HG12 ' A' ' 159' ' ' VAL . 2.4 tpt180 -105.33 119.96 40.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 160' ' ' VAL . 7.5 p -108.43 162.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.558 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.3 p -128.23 142.31 44.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.63 149.42 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.1 t -139.51 123.77 18.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 107.53 40.56 1.74 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.599 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -82.13 142.6 47.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.26 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.77 168.6 23.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.486 2.124 . . . . 0.0 112.31 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.53 -43.26 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.605 2.203 . . . . 0.0 112.329 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.87 79.37 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.9 97.07 0.11 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -175.96 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.78 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.448 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 59.1 p-90 -65.43 -40.87 93.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.448 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 2.5 tt0 -59.6 -32.52 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.01 -36.68 56.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.25 -44.99 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -59.51 -50.1 75.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -60.81 -26.6 67.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.543 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -95.11 -24.95 16.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.752 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.433 ' HE3' HD21 ' A' ' 175' ' ' LEU . 0.0 OUTLIER -100.66 6.48 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.597 0.237 . . . . 0.0 111.565 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -77.89 6.0 8.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.661 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -50.65 -26.07 4.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.72 0.295 . . . . 0.0 111.232 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -65.63 -27.58 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.608 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.14 -94.03 0.13 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.2 142.52 49.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.59 128.9 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.849 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.72 -26.32 13.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.485 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 160' ' ' VAL . 41.0 t80 -142.92 153.39 43.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.479 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . . . -163.12 143.13 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.832 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -149.51 146.51 27.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.748 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.54 133.69 59.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.86 147.97 26.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -70.16 -16.85 63.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.99 -31.38 72.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 134.85 -18.11 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.81 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 126' ' ' SER . 17.7 p -108.01 169.85 8.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.6 -167.43 13.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.344 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' NH2' ' A' ' 122' ' ' ARG . 35.5 m -155.14 154.64 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.714 0.293 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -153.16 142.35 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.237 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -121.68 113.29 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.603 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 13.9 m-85 -81.39 155.8 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.073 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.07 -26.63 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.771 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 149.22 46.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -69.18 -36.22 77.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -32.56 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.71 -30.22 64.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.47 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.8 ttp -69.53 -65.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 94.7 m -56.71 -34.34 67.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 0.0 111.073 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 174' ' ' LYS . 9.3 t80 -59.46 -49.63 77.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.249 0.547 . . . . 0.0 110.621 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 175' ' ' LEU . . . -60.55 -50.17 74.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.225 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 192' ' ' VAL . 15.7 m -58.71 -22.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 111.296 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 169' ' ' THR . 9.5 mtp180 -96.41 -37.18 10.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.339 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 170' ' ' TYR . 0.3 OUTLIER -86.59 -69.11 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.817 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -87.2 45.51 1.28 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 15.8 p-10 -83.43 127.1 33.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 47.96 59.98 3.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.24 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -114.85 173.97 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HG3' ' CE1' ' A' ' 189' ' ' TYR . 0.2 OUTLIER -95.16 108.53 20.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.953 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -105.06 157.81 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.367 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HB3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -132.56 138.65 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 p -81.25 171.0 15.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -55.02 -17.86 4.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -82.99 -22.66 33.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.25 -15.07 39.6 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 123.6 19.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -94.41 158.95 15.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.64 155.99 13.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 179' ' ' LYS . 2.0 m-85 -86.37 113.63 22.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 pt -119.88 137.61 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.26 152.9 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 172' ' ' VAL . 13.6 t -127.74 137.61 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.263 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 124' ' ' VAL . 9.8 mtpp -155.55 145.86 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.8 p -68.62 109.29 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -144.02 127.54 16.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.632 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.13 159.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.947 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.46 145.5 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.086 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.21 142.37 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.9 OUTLIER -134.83 -179.55 5.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.49 32.69 75.53 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.606 HD21 HG12 ' A' ' 152' ' ' VAL . 2.3 mp -81.24 146.01 57.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.679 0.276 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.15 169.97 20.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.58 2.187 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.42 -27.27 33.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.508 2.139 . . . . 0.0 112.197 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.36 117.03 22.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.47 175.78 46.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.432 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.577 ' C ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -138.66 179.62 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.891 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.431 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 51.3 p-90 -73.14 -39.1 65.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 46.2 tt0 -63.0 -31.08 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 -44.72 84.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.06 -47.05 54.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.852 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -56.32 -47.18 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.2 -26.73 65.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.518 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 180' ' ' PHE . 45.7 t-80 -87.93 -29.27 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.37 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -97.1 -11.16 24.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.605 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -54.58 -21.64 10.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.801 0.334 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -49.91 -24.42 2.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.211 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.01 -26.7 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.941 0.401 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.43 -110.25 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.51 125.31 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.852 HG11 ' CG ' ' A' ' 138' ' ' LYS . 84.3 t -97.78 146.07 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.39 -67.48 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -127.82 133.18 49.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.036 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 138' ' ' LYS . . . -128.55 135.94 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -139.93 126.08 19.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.606 HG12 HD21 ' A' ' 128' ' ' LEU . 5.6 m -116.29 142.99 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -117.13 153.93 31.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.023 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -73.67 -16.43 61.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.1 -26.08 68.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.56 12.14 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.752 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 126' ' ' SER . 11.5 p -143.97 165.93 26.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 110.661 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.21 -161.51 10.88 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.546 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.3 m -156.38 155.77 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.66 0.267 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.3 t -150.78 142.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -123.35 126.28 46.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.56 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.01 177.06 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.3 t -76.29 -68.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 154.44 22.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -71.96 -34.41 68.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.84 -35.17 66.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -32.05 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.61 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 172' ' ' VAL . 3.0 ttp -58.94 -63.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.815 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 173' ' ' ARG . 95.6 m -56.65 -35.04 67.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 15.7 t80 -61.3 -44.85 96.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -67.14 -45.32 77.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.271 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 168' ' ' MET . 2.1 m -71.97 -21.97 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 111.273 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.534 ' HG3' HG22 ' A' ' 169' ' ' THR . 18.1 mmm180 -90.85 -50.67 5.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.53 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 0.5 OUTLIER -88.62 -52.57 5.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.3 mt -69.33 -4.76 19.5 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 67.6 t0 -53.9 123.83 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.086 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 60.81 76.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.23 161.75 18.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' HG21 ' A' ' 187' ' ' THR . 4.3 tptp -85.65 93.95 8.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.435 ' HA ' ' CE1' ' A' ' 140' ' ' HIS . 40.7 t80 -74.64 154.69 38.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.81 129.21 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.3 p -97.45 162.93 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -6.1 45.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.239 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.7 18.26 9.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.694 0.283 . . . . 0.0 111.334 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.01 73.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.546 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.05 155.52 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.511 HG21 ' NZ ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -120.97 161.05 22.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.96 157.42 11.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.149 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -103.42 114.15 28.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.99 158.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.64 127.67 42.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 172' ' ' VAL . 21.3 t -103.09 145.36 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.863 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.58 150.25 24.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 172' ' ' VAL . 22.0 t -71.11 118.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.326 -179.794 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.095 0.474 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.407 ' NH1' ' CG1' ' A' ' 159' ' ' VAL . 52.7 ttp85 -144.25 147.68 33.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 194' ' ' VAL . 18.6 m -132.77 165.06 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.95 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 158' ' ' GLY . 5.9 t -119.77 150.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.145 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.55 HG22 HG13 ' A' ' 192' ' ' VAL . 6.6 t -132.89 121.41 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.002 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.638 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.7 t -114.75 158.75 21.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 90.41 46.72 3.98 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.93 167.31 34.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.83 170.11 19.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.717 2.278 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.72 -25.98 45.99 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -134.6 82.68 1.98 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.71 -165.32 10.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -171.82 176.67 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.647 ' HB3' HG23 ' A' ' 152' ' ' VAL . 41.5 p-90 -73.35 -33.94 65.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.735 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.453 ' HG2' ' CH2' ' A' ' 134' ' ' TRP . 19.4 mt-30 -58.78 -43.23 90.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.789 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.06 -32.3 56.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.448 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 37.3 tp -59.89 -38.17 81.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -43.03 63.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.38 -26.8 68.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.393 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -88.28 -39.91 14.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.747 ' CE ' HG11 ' A' ' 160' ' ' VAL . 2.1 ppp? -80.16 -5.71 56.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.392 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -53.1 -22.62 6.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -31.15 11.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.071 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.512 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -68.43 -28.7 67.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.41 -159.1 25.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -58.91 117.17 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.5 126.11 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 9.0 t -66.93 -63.81 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.727 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 161' ' ' GLU . 7.1 p90 -171.61 150.34 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.88 4.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.22 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 159' ' ' VAL . 8.3 t0 -163.38 153.69 15.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 134' ' ' TRP . 45.9 t -130.97 122.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.04 139.64 52.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 76.1 0.62 3.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.726 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.93 11.84 8.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.11 -53.05 0.14 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.56 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 126' ' ' SER . 22.7 p -98.96 159.94 14.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -144.73 179.54 21.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.608 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 151' ' ' ASP . 22.9 m -137.43 154.44 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.991 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' CE ' ' A' ' 141' ' ' MET . 4.7 t -142.6 126.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.179 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 149' ' ' TYR . 2.5 mt-10 -111.99 130.04 55.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.727 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.7 OUTLIER -109.51 137.62 47.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.971 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.62 -28.85 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -129.3 142.39 50.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -59.04 -27.49 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.205 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -54.98 -46.33 75.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.099 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.27 -32.56 68.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.442 ' HE2' ' OG1' ' A' ' 169' ' ' THR . 5.2 ttp -61.49 -66.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.576 HG22 ' HD2' ' A' ' 173' ' ' ARG . 96.4 m -54.84 -35.76 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 15.7 t80 -61.57 -47.93 83.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.06 74.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 176' ' ' ASP . 11.8 m -65.61 -22.84 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -80.5 -72.64 0.4 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.122 0.487 . . . . 0.0 110.453 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -54.67 12.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 144' ' ' ALA . 7.3 mt -79.92 76.64 6.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.802 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 20.6 p-10 -141.38 134.51 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.71 25.84 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.16 -174.33 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 145.19 38.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 29.8 t80 -93.16 158.61 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 1.3 tmt_? -125.85 107.17 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.71 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 p -75.74 151.14 37.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -54.67 -23.06 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.44 -19.5 61.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.12 -6.2 36.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.81 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.95 159.62 23.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.747 0.308 . . . . 0.0 110.838 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.7 161.0 29.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.118 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.09 16.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.03 115.66 15.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.7 pt -114.54 161.7 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.11 113.09 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 125' ' ' VAL . 4.3 t -91.0 159.08 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.415 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.7 OUTLIER -176.03 144.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 111.143 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.4 t -59.85 134.69 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.272 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.901 0.381 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -109.18 168.33 9.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.098 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.22 159.88 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.8 t -106.06 146.33 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 HD21 ' A' ' 128' ' ' LEU . 12.3 p -121.9 150.77 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.1 OUTLIER -137.15 170.91 15.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.918 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 63.94 44.31 96.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.46 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 HG13 ' A' ' 125' ' ' VAL . 3.5 mm? -83.92 140.48 40.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.647 0.261 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.95 170.46 20.37 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.538 2.159 . . . . 0.0 112.204 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.04 -26.83 65.83 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.17 . . . . 0.0 112.265 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.0 34.84 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.49 111.6 3.88 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.469 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.57 179.61 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.802 0.334 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.447 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 47.5 p-90 -68.63 -41.72 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.447 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.5 OUTLIER -70.55 -36.06 73.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.78 -57.96 10.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.71 -47.02 88.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.04 -43.76 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.186 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.56 -26.33 65.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.604 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -88.16 -21.14 24.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.695 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.79 ' SD ' HG21 ' A' ' 160' ' ' VAL . 11.0 ptm -112.38 1.62 16.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.84 -17.59 56.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.89 -21.89 4.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.85 68.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.162 0.506 . . . . 0.0 110.481 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.3 -104.47 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.73 107.34 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 110.771 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.704 HG22 ' CD2' ' A' ' 162' ' ' PHE . 96.4 t -79.25 125.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.27 -52.4 6.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 151' ' ' ASP . 80.3 t80 -140.57 160.01 40.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -159.4 134.98 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' A' ' 149' ' ' TYR . 35.0 t0 -146.52 114.4 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.17 112.11 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.227 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -69.22 155.23 40.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -92.68 37.53 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -114.96 -28.85 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 147.87 -21.49 1.45 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 126' ' ' SER . 12.0 p -129.09 167.01 18.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.584 0.23 . . . . 0.0 111.059 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.475 ' CA ' HG12 ' A' ' 125' ' ' VAL . . . -142.02 -161.43 8.75 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.242 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 158' ' ' GLY . 22.3 m -158.02 144.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.79 HG21 ' SD ' ' A' ' 141' ' ' MET . 59.3 t -141.06 149.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.925 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.41 134.57 48.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.306 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.704 ' CD2' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -121.39 132.71 54.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.157 179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 163' ' ' VAL . 5.2 p -70.08 65.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 111.183 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 7.3 ttm-85 172.82 127.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.144 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.18 -40.4 96.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -58.93 -37.27 76.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.56 -34.77 72.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.8 ttp -60.83 -63.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.523 HG23 ' CZ ' ' A' ' 173' ' ' ARG . 70.5 m -61.69 -33.45 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 11.6 t80 -63.55 -48.58 76.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.88 82.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 192' ' ' VAL . 26.6 m -64.04 -22.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.523 ' CZ ' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER -93.34 -75.11 0.51 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 3.9 mmtt -57.17 -49.19 76.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 141' ' ' MET . 29.5 mt -92.64 58.53 3.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.602 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 6.0 t0 -122.86 135.61 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 44.1 t30 54.02 29.76 10.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.87 177.38 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 103.56 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -68.93 117.47 10.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.79 105.28 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 144.09 29.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -21.65 64.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.623 0.249 . . . . 0.0 111.073 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 31.0 3.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.725 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.36 134.66 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 156.57 22.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.9 143.85 2.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -83.62 120.25 25.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 127' ' ' GLY . 40.0 pt -112.67 155.6 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.21 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 172' ' ' VAL . 7.7 t -103.04 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -147.16 145.31 29.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 194' ' ' VAL . 13.6 p -73.07 124.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.073 0.463 . . . . 0.0 110.724 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.3 t0 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.722 -179.551 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.815 0.341 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 161.79 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' A' ' 162' ' ' PHE . 2.9 t -123.86 149.35 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.027 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 195' ' ' ASP . 23.2 t -117.24 144.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.03 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.83 146.44 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -149.22 117.14 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.11 39.67 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.493 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.635 ' HG ' HG22 ' A' ' 190' ' ' ILE . 1.5 mp -99.22 155.12 36.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 60.3 Cg_endo -72.5 166.52 29.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.543 2.162 . . . . 0.0 112.397 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.17 -27.53 35.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.3 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.94 36.59 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.805 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 152' ' ' VAL . . . -93.02 123.37 7.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 p -94.3 150.99 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 0.0 110.798 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.44 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 30.7 p-90 -74.02 -40.02 63.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -55.55 -40.58 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.27 -32.55 55.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 68.7 tp -61.63 -42.24 98.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -67.89 -47.45 68.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.97 -26.74 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.032 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 181' ' ' ARG . 39.5 t-80 -86.1 -31.48 21.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.474 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -93.18 3.61 55.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.451 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -55.56 -20.87 14.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.462 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -49.69 -32.56 13.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 111.003 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -70.9 -29.42 65.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.756 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.75 -172.79 26.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.414 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.22 106.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.435 HG11 ' CG ' ' A' ' 138' ' ' LYS . 86.1 t -74.07 125.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.043 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -56.17 4.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -154.03 148.34 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -143.6 141.23 30.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.181 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -143.41 141.67 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 132' ' ' GLY . 22.5 m -128.29 115.95 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.249 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.85 155.36 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 35.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.294 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -114.76 -22.62 9.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.196 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 157' ' ' THR . . . 122.06 31.36 1.1 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.608 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 156' ' ' GLY . 9.7 p -161.26 169.97 21.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.84 175.38 32.16 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.632 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -142.83 142.05 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.312 . . . . 0.0 111.061 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 141' ' ' MET . 11.4 t -134.55 157.91 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.206 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.423 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -131.68 128.31 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 68.3 m-85 -108.53 154.52 21.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -71.04 -68.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.22 162.26 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -50.08 30.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.015 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -32.4 46.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -35.88 72.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.418 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 5.2 ttp -67.62 -59.76 3.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.321 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.8 m -50.58 -35.06 28.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.855 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 49.6 t80 -64.23 -46.95 81.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.733 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -56.44 -43.05 79.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 192' ' ' VAL . 13.0 m -79.92 -34.69 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 11.9 ptt85 -79.68 -30.33 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.715 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 170' ' ' TYR . 0.1 OUTLIER -106.98 -57.3 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.207 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.4 mt -81.24 66.75 6.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -116.89 131.23 57.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.2 m120 57.63 30.37 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.1 p -73.33 -177.67 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.979 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 95.09 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.026 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 5.9 t80 -68.95 135.35 50.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.612 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 140' ' ' HIS . 4.0 ttm-85 -116.52 100.91 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.4 t -60.85 161.3 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -9.68 58.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.084 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 21.69 6.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.341 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 27.34 73.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.617 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.57 134.6 54.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.27 156.42 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.96 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -162.31 160.31 26.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -98.27 110.97 23.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.53 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.635 HG22 ' HG ' ' A' ' 128' ' ' LEU . 13.7 pt -107.13 136.26 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.463 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.37 109.83 22.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 172' ' ' VAL . 5.1 t -87.16 142.01 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.246 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -150.37 157.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.78 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 172' ' ' VAL . 25.3 t -78.01 114.85 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.568 ' HA ' HG23 ' A' ' 124' ' ' VAL . 19.0 t0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.28 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.703 0.287 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.61 117.5 52.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.95 -168.27 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.406 2.071 . . . . 0.0 112.415 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -169.83 172.47 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.872 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -131.14 32.57 2.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.341 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.13 99.58 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -172.72 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -156.75 123.28 1.28 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.281 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.21 109.1 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.576 2.184 . . . . 0.0 112.168 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.5 157.51 22.41 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.433 2.088 . . . . 0.0 112.198 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -161.6 39.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.709 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.45 -44.88 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.018 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 77.43 -57.34 0.51 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.129 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 73.16 163.92 0.28 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.938 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -79.45 -12.81 59.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.366 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.41 116.83 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.829 0.347 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.404 ' HB3' ' CG ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -144.06 144.89 31.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.18 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 194' ' ' VAL . 34.0 m -113.33 165.14 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 158' ' ' GLY . 12.3 p -117.04 143.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.75 152.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.5 p -143.07 123.08 13.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 130.51 41.53 0.23 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -86.29 144.17 37.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.89 170.68 19.85 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.555 2.17 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.49 -26.25 70.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.62 2.213 . . . . 0.0 112.191 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -124.49 74.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.77 167.97 24.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.534 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -146.39 167.93 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.427 ' HB3' HG22 ' A' ' 152' ' ' VAL . 61.5 p-90 -65.7 -42.16 91.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 29.7 tp60 -58.77 -36.23 74.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -73.49 -29.7 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.92 -42.45 66.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.748 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.808 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -52.94 -44.8 67.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.978 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.78 -26.85 58.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.233 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.43 -41.16 14.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.861 ' SD ' HG21 ' A' ' 160' ' ' VAL . 0.0 OUTLIER -73.68 -22.87 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -46.12 -29.9 1.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.246 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -30.4 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.733 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.11 -28.85 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.04 -134.41 3.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.405 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -103.97 103.86 13.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.808 HG11 ' CG ' ' A' ' 138' ' ' LYS . 99.5 t -73.85 141.93 15.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.969 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.3 p -112.29 -29.32 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -154.71 147.36 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.35 127.26 6.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.13 153.64 51.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 152' ' ' VAL . 34.4 m -143.1 124.72 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -82.71 154.99 24.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.33 -33.63 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.52 -30.34 2.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.627 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -95.32 160.63 14.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -138.46 -166.26 10.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.576 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -155.6 145.51 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.861 HG21 ' SD ' ' A' ' 141' ' ' MET . 24.5 t -133.9 150.15 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.22 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.2 mt-10 -131.85 136.6 47.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.774 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -116.92 160.3 21.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.08 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.98 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.801 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -25.69 60.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -47.05 58.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -72.28 -28.0 62.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.456 ' O ' HG22 ' A' ' 172' ' ' VAL . 10.9 ttp -67.0 -62.91 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' CG2' ' A' ' 172' ' ' VAL . 67.0 m -58.96 -32.92 70.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.029 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -64.98 -44.64 88.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -65.59 -48.16 73.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.894 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.894 HG23 ' HD3' ' A' ' 173' ' ' ARG . 11.0 m -65.14 -22.12 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.894 ' HD3' HG23 ' A' ' 172' ' ' VAL . 6.1 mpt_? -93.13 -75.45 0.49 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.076 0.465 . . . . 0.0 111.189 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -40.95 95.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.503 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 144' ' ' ALA . 29.0 mt -89.58 23.84 2.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 38.4 t70 -83.65 131.22 34.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.73 61.63 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.6 p -113.27 146.67 38.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.744 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.21 112.12 8.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.006 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -80.85 148.4 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 126.5 46.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.9 p -97.01 146.0 25.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -55.92 -22.94 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -23.12 63.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.96 30.75 4.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -130.19 133.09 46.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.91 161.0 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.23 130.21 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.228 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -70.94 114.38 8.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 127' ' ' GLY . 22.0 pt -116.74 151.24 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -131.36 135.37 47.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.35 148.22 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.237 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -156.05 140.12 16.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.846 ' HA ' HG12 ' A' ' 123' ' ' VAL . 23.8 t -70.25 118.58 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.203 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -49.99 117.24 2.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.156 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.25 -143.59 5.15 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.75 88.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.02 117.47 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.46 91.08 1.9 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.7 -24.71 18.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.575 2.184 . . . . 0.0 112.395 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 p -57.65 -167.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -49.3 156.53 0.57 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -59.05 -79.66 0.1 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.26 120.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 111.03 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.1 t -59.09 99.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -53.83 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.0 t -115.03 44.35 1.81 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 -71.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.0 p 175.67 -51.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.33 10.63 7.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.503 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.2 m 68.07 -65.8 0.24 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.774 0.321 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.99 177.41 0.23 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.14 32.98 12.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -149.86 36.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.5 t -117.6 166.23 12.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 53.88 1.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 0.0 111.03 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.72 -81.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.838 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 18.8 ttp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.8 0.333 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.2 134.01 35.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.03 -73.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.465 2.11 . . . . 0.0 112.328 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -143.48 31.23 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.22 66.59 0.45 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -176.23 114.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -75.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.98 67.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.628 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.19 176.45 4.66 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.0 112.13 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.12 -67.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.453 2.102 . . . . 0.0 112.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.6 t 169.38 72.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 -153.66 89.37 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -176.99 -42.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.72 64.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.82 30.58 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -112.03 131.6 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -131.38 133.45 45.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 160' ' ' VAL . 3.5 m -103.8 165.16 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.085 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.27 146.27 23.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.37 144.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -137.97 125.5 22.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.43 40.28 2.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.27 153.58 92.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.27 169.51 20.56 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -27.28 24.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.577 2.185 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -143.03 127.06 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.4 162.72 24.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.81 153.42 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.432 ' CZ2' ' HG3' ' A' ' 135' ' ' GLN . 42.8 p-90 -74.0 -30.07 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CZ2' ' A' ' 134' ' ' TRP . 50.8 mt-30 -58.99 -42.99 91.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -77.15 -21.39 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.926 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 152' ' ' VAL . 29.9 tp -70.17 -47.11 63.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.936 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -40.7 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 142' ' ' ARG . 4.5 m-20 -65.96 -26.65 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.81 -31.9 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -93.16 -2.82 54.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.435 ' HG2' HG23 ' A' ' 147' ' ' VAL . 4.0 mmm-85 -62.67 -15.87 54.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.476 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.74 -31.59 11.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.824 0.345 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 1.113 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.38 -31.41 70.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.513 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.94 -98.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.94 156.39 46.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 142' ' ' ARG . 75.0 t -126.82 149.4 31.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.5 t -117.33 -52.3 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -128.78 149.62 50.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.71 134.57 11.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.026 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 159' ' ' VAL . 4.3 m-20 -149.15 134.66 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 137' ' ' LEU . 29.6 m -128.33 118.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -103.46 131.66 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.0 mtm105 -62.34 96.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -171.45 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 157' ' ' THR . . . 137.53 37.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.74 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 156' ' ' GLY . 1.8 p -166.05 172.36 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.46 173.42 36.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 151' ' ' ASP . 5.8 m -141.7 134.26 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 123' ' ' VAL . 12.9 t -140.28 127.2 22.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -98.17 108.37 21.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.51 156.76 32.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.13 -67.33 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 144.97 24.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -62.83 -40.58 97.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.77 -42.62 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.85 -31.83 69.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.5 ttp -67.22 -62.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 98.9 m -53.24 -32.73 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.416 ' CE2' ' HG2' ' A' ' 174' ' ' LYS . 88.5 t80 -62.77 -46.95 85.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.482 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -59.16 -47.55 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.574 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 169' ' ' THR . 16.2 m -63.29 -22.64 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.026 0.441 . . . . 0.0 110.793 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -85.59 -71.93 0.51 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.268 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -78.68 -36.76 43.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.035 -178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 1.113 HD12 ' HB2' ' A' ' 144' ' ' ALA . 76.1 mt -90.51 47.69 1.46 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -108.88 127.33 53.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.831 0.348 . . . . 0.0 110.679 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.9 31.55 18.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -171.92 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -111.15 118.13 35.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 10.8 t80 -97.41 135.06 39.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.636 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -122.17 117.36 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.7 p -80.13 149.61 30.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -54.74 -23.72 19.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -73.72 -23.07 59.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.984 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.17 5.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -112.86 110.34 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.83 154.41 20.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.001 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.89 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.55 129.74 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.62 143.27 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.291 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -109.95 122.25 47.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.06 151.03 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -156.63 169.22 25.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.759 HG12 ' HD2' ' A' ' 197' ' ' PRO . 17.5 t -91.44 118.97 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.39 121.1 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 115.33 -67.38 0.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.759 ' HD2' HG12 ' A' ' 194' ' ' VAL . 20.3 Cg_exo -65.65 -11.23 29.65 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.819 2.346 . . . . 0.0 112.561 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 38.35 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.52 80.75 0.15 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.84 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.45 -156.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.632 2.221 . . . . 0.0 112.192 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.8 t 72.32 -66.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -109.08 163.73 13.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.76 -134.74 3.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.547 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.61 52.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.945 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 p -101.33 31.91 3.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -119.35 119.07 32.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.2 -78.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.833 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.9 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 54.7 p -124.88 173.73 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 -79.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.95 56.32 4.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.908 0.385 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.98 151.02 26.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.6 p -173.81 -170.44 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.82 -50.14 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.953 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.651 ' C ' HD13 ' A' ' 216' ' ' LEU . 1.4 m -144.55 164.51 30.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.35 -179.74 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.956 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.29 -47.25 51.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.485 ' C ' HD23 ' A' ' 216' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.014 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.5 55.79 0.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.55 -45.31 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.535 2.157 . . . . 0.0 112.371 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.73 126.3 47.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.66 145.9 4.7 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.501 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -154.47 168.05 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 0.0 110.862 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -134.99 -60.18 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.2 98.64 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.86 156.8 64.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.456 2.104 . . . . 0.0 112.301 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.31 173.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.9 t -78.68 129.49 34.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -148.39 175.4 11.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.638 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.66 160.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.859 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.45 19.21 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 54.03 34.31 19.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.991 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 61.3 74.82 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.041 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -131.58 142.31 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.658 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 160' ' ' VAL . 28.2 m -106.96 165.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.63 140.1 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.545 ' CG2' HG23 ' A' ' 160' ' ' VAL . 15.3 t -106.38 140.23 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.56 120.27 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.62 1.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.414 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -75.51 150.05 84.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 171.02 16.45 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.257 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.0 -32.59 21.41 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.589 2.193 . . . . 0.0 112.276 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 t -123.89 115.51 21.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.54 177.05 48.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.22 -175.53 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 32.0 p-90 -67.59 -42.2 82.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.856 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.3 OUTLIER -59.74 -50.57 73.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.723 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.29 -37.39 85.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.652 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.28 -45.57 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.45 -28.33 68.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.107 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -26.94 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.392 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.21 12.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.64 ' HG3' HG21 ' A' ' 160' ' ' VAL . 30.4 mmm -76.87 -25.57 53.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.216 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -51.54 -25.27 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.321 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -23.73 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.312 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.15 -26.45 66.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.658 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.79 -65.61 0.34 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.39 125.62 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.074 0.464 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 142' ' ' ARG . 89.7 t -101.02 146.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.23 -29.66 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.211 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 56.5 t80 -154.76 160.05 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 111.211 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -157.04 177.33 11.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.886 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.85 156.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.97 147.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -123.98 109.23 13.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.0 mtt85 55.55 -87.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -176.24 36.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 110.93 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 157' ' ' THR . . . -118.6 -44.59 0.5 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.439 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.422 ' CA ' HD23 ' A' ' 128' ' ' LEU . 10.4 p -156.67 161.09 39.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.71 -157.48 7.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.573 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.508 HG21 ' NH2' ' A' ' 122' ' ' ARG . 30.5 m -156.09 142.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 141' ' ' MET . 21.9 t -134.22 119.88 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -104.35 123.25 47.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 23.0 m-85 -99.41 167.57 10.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.27 -69.68 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.86 163.92 13.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -26.1 62.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -57.16 -41.49 79.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -30.06 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.417 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 4.6 ttp -61.01 -63.72 1.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 172' ' ' VAL . 97.9 m -57.52 -35.53 70.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.071 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 21.0 t80 -62.56 -47.3 84.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.45 . . . . 0.0 110.653 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.86 84.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.809 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 192' ' ' VAL . 25.6 m -61.64 -22.75 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.546 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -76.49 0.55 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 8.6 mmtt -58.08 -42.6 85.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.623 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.63 36.16 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.207 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 11.9 t0 -94.51 120.07 34.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.642 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 61.81 66.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.6 p -115.75 170.02 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 131.67 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -109.67 145.27 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.89 116.36 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.99 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -88.7 155.7 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -54.54 -22.69 13.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -19.25 61.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.04 40.29 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.732 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.9 150.28 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.21 154.98 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.999 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 172.07 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.262 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -106.45 120.12 41.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.59 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 9.6 pt -106.31 145.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -118.99 124.42 46.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 172' ' ' VAL . 15.0 t -95.6 141.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.264 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 147.82 26.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -71.44 116.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -76.3 -21.4 56.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.12 85.87 0.4 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.549 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.22 -26.74 35.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.265 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -109.77 135.56 50.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.436 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 17.4 m -141.88 64.47 17.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 199' ' ' SER . 3.6 Cg_exo -76.45 168.16 24.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.885 2.39 . . . . 0.0 112.218 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.16 -168.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.32 -168.99 2.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.764 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -96.56 84.49 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.607 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 -168.29 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 111.018 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.5 m -137.78 103.62 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.05 123.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.88 72.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.93 131.93 3.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.2 p -118.58 -7.54 10.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 63.69 -166.81 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.883 0.373 . . . . 0.0 110.518 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.1 p -103.27 117.23 34.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 59.04 165.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 78.3 p -177.54 83.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.991 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -138.0 -81.0 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.552 ' O ' HD22 ' A' ' 216' ' ' LEU . 10.0 t 178.76 -78.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.907 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 215' ' ' SER . 0.1 OUTLIER -163.98 31.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.976 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.831 0.348 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 108' ' ' PRO . . . 59.49 53.13 4.08 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 107' ' ' ALA . 60.9 Cg_endo -73.25 -45.55 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.407 2.071 . . . . 0.0 112.388 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.53 177.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.35 70.69 2.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.575 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -89.45 -166.09 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -71.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.037 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . 142.95 -61.97 0.52 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.816 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 113' ' ' GLY . 11.1 Cg_endo -54.69 148.22 46.03 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.646 2.231 . . . . 0.0 112.319 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 34.0 Cg_exo -57.8 -159.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.617 2.211 . . . . 0.0 112.279 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.96 79.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.36 107.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -171.99 178.13 3.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.65 -86.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 48.64 27.17 1.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.272 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 m120 52.97 92.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 170.01 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.152 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.5 p -130.49 160.72 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.504 ' N ' HG22 ' A' ' 123' ' ' VAL . 14.3 p -122.26 143.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 126' ' ' SER . 21.5 t -125.03 159.12 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.485 ' N ' HG12 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -141.26 170.91 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 65.45 44.37 93.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 157' ' ' THR . 3.9 mm? -78.48 155.23 78.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.735 0.302 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.61 171.71 11.55 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 112.405 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.12 -26.62 73.03 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.613 2.209 . . . . 0.0 112.346 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -135.9 122.14 20.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.63 -172.72 33.37 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.2 p -172.62 -177.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 44.7 p-90 -59.94 -37.47 79.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 21.6 tt0 -70.38 -32.05 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -68.93 -50.32 50.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.79 HD22 ' CG1' ' A' ' 152' ' ' VAL . 11.3 tp -67.6 -44.85 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.89 -40.38 63.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -61.14 -26.73 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.236 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -86.72 -43.6 12.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.705 ' HG3' HG21 ' A' ' 160' ' ' VAL . 77.6 mmm -69.51 -26.32 64.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -45.31 -33.14 2.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.268 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.36 -33.82 63.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.03 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.818 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.99 -140.22 6.87 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.511 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 128.99 39.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.735 HG22 ' HD2' ' A' ' 162' ' ' PHE . 89.5 t -102.72 127.07 56.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.95 -26.23 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 35.4 t80 -151.73 153.87 35.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.399 . . . . 0.0 111.311 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.429 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -163.07 149.04 11.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.915 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.51 124.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.79 ' CG1' HD22 ' A' ' 137' ' ' LEU . 30.6 m -122.01 142.51 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.035 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.96 155.12 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -72.5 -10.95 60.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.397 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.59 -23.18 66.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.25 24.43 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.616 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.478 ' HA ' HD23 ' A' ' 128' ' ' LEU . 33.4 p -155.54 160.26 40.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.26 -175.79 25.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 141' ' ' MET . 12.5 t -127.61 133.44 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.3 118.59 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.735 ' HD2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -114.62 139.32 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.627 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 163' ' ' VAL . 6.4 p -71.18 65.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.926 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER 178.81 125.51 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.561 179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -72.11 -44.84 62.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.546 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.42 -27.79 68.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.668 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.15 -40.59 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.548 ' SD ' HG13 ' A' ' 194' ' ' VAL . 2.0 ttp -59.65 -59.22 5.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.9 m -58.35 -36.44 73.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.357 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -62.89 -45.14 93.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -63.64 -44.9 92.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.683 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 192' ' ' VAL . 24.0 m -71.87 -22.38 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.707 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.405 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 17.8 ptt180 -96.31 -26.53 15.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.602 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 73.9 mmtt -110.71 -60.81 1.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.959 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.4 mt -63.08 -15.82 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 178' ' ' THR . 16.6 p-10 -64.1 159.26 20.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 0.0 111.277 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 50.18 58.6 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.196 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 176' ' ' ASP . 76.1 p -140.51 164.01 31.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.978 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -87.96 123.59 32.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -99.25 149.78 22.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 142.46 50.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.5 p -95.56 151.51 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -52.98 -23.97 8.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.79 -22.3 53.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.08 26.68 5.65 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.549 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -107.88 115.62 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.04 152.16 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.11 135.25 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.98 135.62 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 127' ' ' GLY . 37.0 pt -131.25 161.43 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.374 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -127.7 128.42 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.637 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 172' ' ' VAL . 4.3 t -111.48 142.95 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.318 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -165.17 141.04 5.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 172' ' ' VAL . 23.2 t -59.05 113.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.51 27.36 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 194' ' ' VAL . . . -143.65 -112.64 0.86 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.403 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.51 123.53 13.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.414 2.076 . . . . 0.0 112.206 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -122.28 28.5 7.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.149 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 17.7 p -85.25 160.23 54.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 201' ' ' SER . 39.1 Cg_exo -59.38 -70.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.411 2.074 . . . . 0.0 112.079 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 200' ' ' PRO . 2.1 p 161.81 -82.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.879 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.93 76.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.762 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -137.21 9.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.575 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -74.25 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.811 0.339 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.2 m 62.93 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -165.71 160.04 16.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.852 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -23.88 67.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.073 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 61.57 156.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.941 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.8 m -135.74 -158.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt-85 68.69 97.01 0.06 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.9 p -177.37 71.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.11 -80.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 49.4 -170.05 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -136.37 137.66 40.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.1 m 179.91 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 216' ' ' LEU . 2.6 pp -46.67 107.23 0.1 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.988 0.423 . . . . 0.0 111.345 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -177.69 -72.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.992 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 36.7 mtp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.93 141.21 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.01 -168.69 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.154 . . . . 0.0 112.383 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -151.33 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.74 150.53 15.97 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.414 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 33.25 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.29 34.11 2.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.698 ' N ' ' CD ' ' A' ' 114' ' ' PRO . . . -110.23 4.55 30.0 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.603 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 113' ' ' GLY . 90.6 Cg_endo -79.39 164.86 23.72 Favored 'Trans proline' 0 C--N 1.353 0.811 0 CA-C-N 120.137 1.968 . . . . 0.0 112.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.96 124.65 16.42 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.5 2.134 . . . . 0.0 112.111 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.14 -175.84 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 53.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.037 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 117.07 6.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.1 m -150.92 102.41 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -114.36 31.04 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 3.2 m120 61.59 152.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.583 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 2.1 tmm_? -143.59 142.63 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.044 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.4 p -104.25 159.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 193' ' ' LYS . 8.6 p -118.98 152.66 21.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.25 148.67 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.573 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -141.2 127.98 20.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.798 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.514 ' C ' HG22 ' A' ' 190' ' ' ILE . . . 127.55 -0.65 6.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.924 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.806 HD12 HG21 ' A' ' 190' ' ' ILE . 1.6 mp -56.78 151.44 32.03 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.817 0.341 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.57 171.86 10.11 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.158 . . . . 0.0 112.161 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.02 -25.63 51.5 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.424 2.083 . . . . 0.0 112.4 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 125.52 15.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -170.37 -179.63 41.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.4 m -130.8 149.48 52.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.737 0.303 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -63.59 -33.38 75.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.26 -31.69 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.0 -50.3 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 23.1 tp -60.23 -45.81 91.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' HG22 ' A' ' 147' ' ' VAL . 9.6 tttm -57.43 -39.95 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.97 -26.96 61.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.489 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -91.19 -22.74 20.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.466 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 4.0 ppp? -99.58 -12.77 19.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.574 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -52.72 -24.92 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.748 0.308 . . . . 0.0 111.446 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -24.4 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.853 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -66.89 -28.18 68.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.562 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.74 -129.9 2.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.363 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -103.19 108.59 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.067 0.46 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' HE2' ' A' ' 138' ' ' LYS . 12.0 p -106.12 139.92 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.24 -40.42 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.405 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 161' ' ' GLU . 7.8 t80 -117.83 145.17 44.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 160' ' ' VAL . . . -162.97 133.18 4.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.63 141.48 48.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.965 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.603 HG12 HD21 ' A' ' 128' ' ' LEU . 28.6 m -128.96 114.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.024 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -85.57 143.78 28.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -73.84 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.42 -49.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.65 -26.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 126' ' ' SER . 30.3 p -106.77 164.26 12.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.68 -175.91 20.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.53 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.583 HG11 ' CZ ' ' A' ' 122' ' ' ARG . 26.6 m -143.42 154.48 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 123' ' ' VAL . 2.0 t -149.32 150.28 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 149' ' ' TYR . 0.9 OUTLIER -132.18 116.22 16.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.788 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 141' ' ' MET . 5.3 m-85 -92.68 173.78 7.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.59 -70.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 157.92 16.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -56.16 -32.08 63.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -55.34 -39.99 70.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.12 -30.65 66.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.433 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 7.0 ttp -70.49 -63.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.4 m -53.14 -34.07 55.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.021 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.78 -48.31 79.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.515 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -55.79 -50.66 69.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.245 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 192' ' ' VAL . 16.0 m -62.64 -25.95 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -72.23 0.42 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -56.1 6.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.118 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.853 HD12 ' HB2' ' A' ' 144' ' ' ALA . 46.8 mt -77.19 72.74 3.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.846 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -133.46 120.94 21.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.9 t30 62.04 39.51 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.713 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -92.31 179.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.937 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.472 ' N ' ' OG1' ' A' ' 178' ' ' THR . 6.6 tttp -98.94 125.99 44.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.9 t80 -103.63 143.41 32.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.726 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.39 116.91 26.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.82 152.87 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -68.52 -14.22 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.253 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.83 -23.1 64.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.284 . . . . 0.0 111.112 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.82 31.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.513 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -139.3 144.11 38.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.358 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 154.65 26.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.9 147.61 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.202 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.05 146.05 28.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.806 HG21 HD12 ' A' ' 128' ' ' LEU . 29.8 pt -136.4 145.69 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 127.99 54.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 172' ' ' VAL . 8.9 t -103.7 143.47 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 124' ' ' VAL . 12.8 mttt -161.31 144.49 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.9 p -64.32 113.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -87.15 54.94 3.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.98 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.473 ' N ' ' HD3' ' A' ' 197' ' ' PRO . . . -161.59 61.1 0.29 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 196' ' ' GLY . 5.2 Cg_exo -79.28 178.05 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.996 2.464 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 63.21 -119.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.425 ' H ' ' HD2' ' A' ' 200' ' ' PRO . 0.2 OUTLIER -178.68 -52.73 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.412 0.148 . . . . 0.0 111.24 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 199' ' ' SER . 75.3 Cg_exo -42.34 166.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.665 2.243 . . . . 0.0 112.798 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.3 t -42.05 155.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.001 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -117.55 -175.88 2.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.726 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.03 -96.25 2.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.419 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -108.51 -88.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.494 0.188 . . . . 0.0 110.67 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.1 m 43.59 -162.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.62 68.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.412 . . . . 0.0 110.437 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 22.0 p -85.62 -165.91 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.293 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -111.93 -165.09 0.96 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.957 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 210' ' ' ARG . 1.4 m 72.15 -165.12 0.13 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.993 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER 55.85 27.62 11.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.231 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.7 t -120.42 -43.16 2.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.989 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -157.4 148.42 21.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.4 t -160.24 -83.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 48.31 80.16 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.897 0.38 . . . . 0.0 111.198 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.1 p -57.72 -27.01 62.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.55 101.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.14 -73.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.853 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 61.5 mmm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.66 54.38 1.67 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.01 61.45 3.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.547 2.165 . . . . 0.0 112.332 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.04 59.61 0.6 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.79 41.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 60.25 62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -113.12 -26.45 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -55.47 148.06 26.77 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.66 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 74.4 Cg_endo -75.22 159.42 40.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.613 2.209 . . . . 0.0 112.402 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 14.4 Cg_exo -68.36 -69.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.638 2.225 . . . . 0.0 112.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.11 -173.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.1 mmt-85 79.07 107.42 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.132 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' CB ' ' A' ' 119' ' ' SER . 6.6 ttt85 -112.54 -80.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.571 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 1.4 p 159.77 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.54 0.21 . . . . 0.0 110.85 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 119' ' ' SER . 2.0 mm-40 91.53 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 111.412 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 165' ' ' LYS . 25.0 t-20 53.66 24.8 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 111.057 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -117.72 150.27 39.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.5 p -133.95 159.98 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.492 ' N ' HG22 ' A' ' 123' ' ' VAL . 9.8 p -124.04 147.83 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 126' ' ' SER . 26.7 t -118.13 157.8 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 125' ' ' VAL . 35.8 t -161.18 123.36 3.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.09 39.48 0.64 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.95 154.84 45.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.672 0.272 . . . . 0.0 110.758 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 12.6 Cg_endo -55.98 166.24 3.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 0.0 112.21 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.74 -27.55 20.34 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.678 2.252 . . . . 0.0 112.484 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 129.46 15.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.09 -163.68 13.99 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 t -153.01 162.55 41.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HB3' HG22 ' A' ' 152' ' ' VAL . 60.4 p-90 -74.12 -39.18 63.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -36.91 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -36.0 66.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 22.8 tp -63.17 -45.14 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.792 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -28.12 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.186 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -67.07 -26.7 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.29 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 180' ' ' PHE . 6.6 m80 -96.26 -27.95 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.304 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 147' ' ' VAL . 38.6 mmm -83.58 -26.28 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.248 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.519 ' HA ' HG23 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -51.5 -27.57 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.426 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -53.69 -22.52 9.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.51 66.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.089 0.471 . . . . 0.0 110.64 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.5 -59.58 0.36 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.369 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -174.38 107.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 141' ' ' MET . 84.7 t -88.67 132.05 34.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.5 m -110.52 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.082 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -133.35 145.26 50.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.75 133.94 6.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -138.12 152.21 48.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 134' ' ' TRP . 2.9 m -144.39 107.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.68 100.69 6.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 64.15 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -179.13 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.04 10.86 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.062 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.436 HG22 ' CB ' ' A' ' 126' ' ' SER . 54.5 p -157.63 174.54 15.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.878 0.37 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -160.86 -166.22 19.18 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.414 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 151' ' ' ASP . 24.7 m -149.86 159.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 111.016 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.42 145.25 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.09 137.09 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.706 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 147' ' ' VAL . 34.3 m-85 -113.56 175.67 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.66 -70.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.83 157.97 15.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HA ' ' ND2' ' A' ' 121' ' ' ASN . 2.0 tptm -58.14 -29.16 65.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.54 -34.95 76.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.9 -38.48 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.5 ttp -70.79 -62.23 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 173' ' ' ARG . 92.5 m -53.38 -36.81 61.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 28.4 t80 -63.79 -46.54 84.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -54.9 -46.14 74.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 192' ' ' VAL . 15.9 m -68.91 -23.03 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.549 ' HD2' HG22 ' A' ' 169' ' ' THR . 10.2 mtp180 -87.01 -67.2 0.83 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.975 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 1.5 mptp? -76.81 -48.38 18.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.736 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 52.3 mt -84.49 58.48 4.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -117.84 129.84 55.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.739 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.16 39.44 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.708 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.2 p -81.37 177.61 8.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.94 99.25 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.0 t80 -88.72 152.67 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.89 140.05 40.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.21 155.05 22.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.637 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -53.03 -22.83 6.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -75.73 -21.07 57.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 20.84 8.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.771 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 116.19 32.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.733 0.301 . . . . 0.0 110.715 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 156.94 18.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -165.1 166.04 19.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.25 119.58 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 4.9 pt -108.32 141.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.98 0.419 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -106.38 128.63 54.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.643 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 172' ' ' VAL . 3.9 t -111.76 142.89 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.084 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.96 140.84 8.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.3 110.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -75.42 -170.67 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -177.05 91.75 0.08 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.542 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.41 -162.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.657 2.238 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.55 165.84 12.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.5 76.69 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.512 2.141 . . . . 0.0 112.187 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.72 132.76 42.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -95.77 -176.43 3.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -55.45 -28.46 50.92 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.575 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -89.37 53.35 2.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.6 p 52.4 -89.91 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 48.12 94.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.739 0.304 . . . . 0.0 111.293 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.0 t 62.69 38.11 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.83 118.37 18.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 p -130.94 132.32 45.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.26 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.759 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.1 t -158.09 140.97 14.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -146.18 171.23 15.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.63 34.95 20.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -176.14 123.94 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 13.3 t -106.37 167.68 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.8 mt -119.24 -74.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -133.68 66.54 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.815 0.34 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.38 146.56 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.977 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.95 -94.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.335 2.024 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 46.87 -171.42 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.838 0.351 . . . . 0.0 111.357 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 111' ' ' ARG . . . 86.49 71.27 1.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.856 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 58.27 157.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.61 -54.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -150.59 106.28 0.31 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.55 108.02 1.14 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.487 2.125 . . . . 0.0 112.284 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.56 138.01 37.44 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.702 2.268 . . . . 0.0 112.259 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.3 m -179.72 48.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.959 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -115.06 -20.92 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.236 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.57 18.35 2.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.751 0.31 . . . . 0.0 111.327 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.59 92.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.49 16.74 11.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.342 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -111.8 -0.15 16.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 119.96 25.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 124' ' ' VAL . 2.6 p -102.62 160.12 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 193' ' ' LYS . 11.6 p -120.46 143.71 31.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -129.99 158.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 125' ' ' VAL . 21.4 p -146.75 146.42 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 95.29 46.14 2.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.559 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.61 145.48 37.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.639 0.257 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.92 170.67 19.15 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.381 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.71 -27.47 52.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 31.08 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.72 118.76 5.55 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.03 168.91 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 58.6 p-90 -62.59 -41.75 99.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.2 OUTLIER -61.58 -33.73 74.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.03 -38.39 52.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.202 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.84 -44.3 32.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.273 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.791 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.1 ttmm -53.19 -39.71 63.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -71.63 -26.7 62.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.621 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -26.01 20.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.422 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.694 ' CE ' HG11 ' A' ' 160' ' ' VAL . 3.3 ppp? -97.01 -10.25 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.385 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -18.78 30.89 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.516 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.93 -25.79 3.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -69.57 -27.42 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.745 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.54 -125.87 1.79 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.457 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.459 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.791 HG11 ' HG3' ' A' ' 138' ' ' LYS . 84.0 t -79.94 130.94 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.047 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 -29.44 14.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -163.28 146.95 10.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.97 136.64 19.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -152.07 125.11 8.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 158' ' ' GLY . 31.3 m -127.88 131.49 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -98.24 155.01 17.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -10.18 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.411 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.71 -29.0 70.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 157' ' ' THR . . . 123.45 36.46 0.64 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.592 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 156' ' ' GLY . 16.7 p -160.3 160.77 32.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.849 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 152' ' ' VAL . . . -149.97 176.78 28.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.576 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.3 m -147.69 146.87 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.324 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.694 HG11 ' CE ' ' A' ' 141' ' ' MET . 3.5 t -141.66 147.78 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.182 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.08 126.14 33.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 1.0 OUTLIER -104.98 166.9 10.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.59 -72.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 151.05 24.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.99 -27.53 5.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.246 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -53.98 -44.16 70.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -30.07 64.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.439 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.1 ttp -65.03 -63.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 77.1 m -57.69 -34.04 69.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.51 80.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.616 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 192' ' ' VAL . 4.5 m -65.22 -24.81 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.446 ' HD2' HG23 ' A' ' 172' ' ' VAL . 0.0 OUTLIER -76.74 -73.05 0.31 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.233 0.539 . . . . 0.0 110.296 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -58.26 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.7 mt -77.27 81.52 3.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.45 138.57 19.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.49 46.64 14.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -109.83 173.25 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.445 ' HD3' ' CD1' ' A' ' 189' ' ' TYR . 0.3 OUTLIER -105.32 103.37 12.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.93 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -68.89 120.17 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.54 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.24 100.8 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.532 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.05 136.87 56.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -59.37 -19.83 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.187 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -68.77 -17.48 64.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.258 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.99 31.04 3.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.56 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -131.74 138.5 48.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.06 156.8 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.06 138.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.445 ' CD1' ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -79.21 128.77 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 127' ' ' GLY . 5.4 pt -125.14 140.77 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.371 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -112.7 134.94 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 172' ' ' VAL . 12.2 t -109.62 141.81 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.362 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 124' ' ' VAL . 39.8 mttp -153.34 137.87 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 194' ' ' VAL . 11.1 p -67.06 115.38 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.175 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -97.58 91.33 5.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.803 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -168.74 160.07 33.41 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.782 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.24 -148.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.897 2.398 . . . . 0.0 112.308 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -45.25 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.95 0.405 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.632 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 12.6 p -82.61 -32.4 0.57 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.221 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 199' ' ' SER . 55.2 Cg_exo -52.88 -161.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.319 2.013 . . . . 0.0 112.865 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 200' ' ' PRO . 2.3 m 91.16 -35.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.04 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 120.25 2.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.748 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.46 127.44 4.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.325 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? 62.29 36.05 14.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 110.683 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 -70.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -144.66 123.66 12.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.988 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.5 p -162.99 29.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.78 29.74 4.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.9 p -75.5 169.86 17.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 61.64 43.04 10.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.68 -61.53 1.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -57.64 148.72 23.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.082 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -150.21 176.35 10.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -71.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.8 p -177.92 -114.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.592 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.53 135.54 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.959 0.409 . . . . 0.0 111.015 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -177.13 169.89 2.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.944 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.9 mmm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.709 0.29 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.82 56.49 2.93 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.006 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.53 -40.14 6.06 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.647 2.231 . . . . 0.0 112.357 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 59.76 37.38 22.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.67 -50.98 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.287 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' TYR . 3.5 ptp180 -100.37 -29.87 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 0.0 110.802 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 112' ' ' TYR . 24.9 p90 43.99 84.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . -55.98 -62.77 5.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.808 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 113' ' ' GLY . 12.4 Cg_endo -56.34 108.28 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.706 2.271 . . . . 0.0 112.269 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.47 135.7 47.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.434 2.089 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.7 p -151.9 48.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.7 mmt-85 -100.03 75.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -166.22 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.8 m 57.99 106.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -55.89 5.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.631 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 41.93 60.93 2.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.428 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -123.42 121.95 37.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.849 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 194' ' ' VAL . 26.1 m -106.97 161.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 158' ' ' GLY . 24.4 t -113.38 140.7 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -120.1 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.0 p -111.71 132.99 54.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.58 35.85 0.96 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 137' ' ' LEU . 4.0 mm? -87.88 153.52 52.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 161.74 44.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.477 2.118 . . . . 0.0 112.301 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 -31.43 20.39 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 90.57 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.63 -163.34 11.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.59 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 170.72 20.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -60.29 -44.25 95.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.797 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -60.47 -31.64 70.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -53.22 60.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.606 HD13 HD11 ' A' ' 128' ' ' LEU . 63.2 tp -60.0 -40.16 88.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.68 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -60.75 -39.66 89.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.908 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.98 -26.8 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -87.99 -35.11 17.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.503 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -71.31 -25.21 62.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 37.4 mtt-85 -46.77 -30.2 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -30.36 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.51 -27.42 65.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 151.15 -100.43 0.2 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.539 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -131.1 111.05 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.098 0.475 . . . . 0.0 110.961 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 138' ' ' LYS . 95.1 t -78.17 151.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 40.7 t -112.7 -31.82 6.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -165.59 150.41 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.95 173.37 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -176.9 135.01 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.429 HG12 ' HG ' ' A' ' 128' ' ' LEU . 4.2 m -125.56 101.19 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 19.2 p90 -124.12 155.84 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 0.2 OUTLIER 89.38 -4.98 0.4 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.355 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 63.14 31.53 15.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.94 -45.89 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.3 p -104.84 160.1 15.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.375 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -159.06 -179.32 33.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.265 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.6 p -146.07 159.52 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.222 0.534 . . . . 0.0 111.208 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 46.0 t -154.74 141.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.2 125.47 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.37 177.13 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.86 -69.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -88.36 149.84 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -61.33 -34.19 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.58 -33.44 72.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.73 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' OD1' ' HB1' ' A' ' 144' ' ' ALA . 36.9 t0 -72.18 -37.93 69.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.526 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.47 -63.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.655 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.428 ' HA ' HG22 ' A' ' 172' ' ' VAL . 53.9 m -53.73 -31.46 48.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 4.3 t80 -60.43 -50.51 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.244 0.545 . . . . 0.0 110.12 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 175' ' ' LEU . . . -57.55 -53.87 53.27 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 169' ' ' THR . 13.9 m -54.82 -22.71 10.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.351 . . . . 0.0 111.752 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -71.75 0.69 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.042 0.449 . . . . 0.0 112.111 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -67.74 -45.55 74.65 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -123.31 84.16 2.23 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.826 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 2.4 p-10 -129.51 -102.03 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.321 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 190' ' ' ILE . 10.3 t-20 -67.62 56.28 0.06 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.467 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -109.39 -167.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -91.36 140.98 29.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -118.67 133.3 55.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -123.27 119.12 29.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.9 t -79.11 149.83 31.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -55.39 -23.46 24.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.22 -23.0 63.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.13 28.83 4.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.0 136.77 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.69 156.22 18.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.52 168.31 18.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.43 109.98 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 21.6 pt -102.1 158.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 177' ' ' ASN . 1.2 tmm_? -139.08 117.36 11.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.6 151.45 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.9 144.03 6.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.762 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.5 t -61.31 119.71 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 14.6 t0 -85.36 56.29 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 197' ' ' PRO . . . -154.9 128.51 2.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.55 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 196' ' ' GLY . 31.6 Cg_exo -58.93 -150.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.526 2.15 . . . . 0.0 112.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.66 24.86 1.62 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.947 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.419 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 18.4 p -179.97 63.5 0.13 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 199' ' ' SER . 31.4 Cg_exo -58.94 -64.03 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.716 2.277 . . . . 0.0 112.386 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 m 62.65 -164.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -55.01 91.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.989 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -85.67 -177.2 50.34 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.58 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -177.73 -38.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.298 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.0 m -54.24 -78.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.115 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -65.89 83.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -141.18 -75.79 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 57.97 26.32 13.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.008 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 27.8 p 55.66 102.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -74.02 -168.79 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.747 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.2 t -105.73 -102.75 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.873 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 60.91 138.78 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 38.5 p 50.51 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -173.62 1.43 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.9 p -97.31 -73.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.658 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.72 67.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.14 90.88 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 45.7 t60 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.834 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.82 0.343 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 64.35 89.39 0.1 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.123 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.41 105.12 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.528 2.152 . . . . 0.0 112.189 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -125.64 163.67 22.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.58 27.41 15.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.507 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -33.2 59.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -100.43 29.32 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.07 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -60.15 120.4 22.63 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.27 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.43 107.18 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.501 2.134 . . . . 0.0 112.3 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.11 -158.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.732 2.288 . . . . 0.0 112.21 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 p -67.24 -164.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.85 60.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -170.43 126.46 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.78 158.65 32.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -169.91 56.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.25 -20.37 13.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.097 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -79.92 158.07 26.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.883 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 160' ' ' VAL . 2.7 p -144.18 160.01 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.044 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.496 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.7 p -123.2 141.07 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.09 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 126' ' ' SER . 21.2 t -118.82 155.61 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 125' ' ' VAL . 11.0 t -145.46 138.46 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 100.89 37.0 3.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.33 152.98 92.25 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.76 171.84 10.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.313 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.99 -28.49 80.7 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.638 2.225 . . . . 0.0 112.249 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m -122.24 -80.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.784 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.38 -168.67 0.31 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.806 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 m -164.5 156.23 15.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 44.8 p-90 -59.26 -44.6 92.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -67.5 -32.89 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.603 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.19 -45.32 77.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.427 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 59.7 tp -59.67 -43.84 93.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.88 -37.93 64.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.956 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -64.42 -26.72 68.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.215 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -84.75 -37.51 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.529 ' HA ' HD21 ' A' ' 175' ' ' LEU . 32.4 mmm -75.85 -20.34 58.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.661 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -43.3 -31.83 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.354 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -50.62 -34.33 25.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 170' ' ' TYR . . . -69.87 -29.68 66.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.8 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.22 -129.04 2.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.383 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.29 136.93 37.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.532 HG22 ' CE1' ' A' ' 162' ' ' PHE . 92.4 t -115.54 121.37 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.957 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.02 -42.53 16.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.058 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 52.3 t80 -142.98 158.45 43.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -162.99 139.94 7.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.49 161.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.57 133.08 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.85 155.64 37.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.704 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -33.13 -42.78 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.935 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 174.01 65.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.886 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.73 -58.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.814 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 126' ' ' SER . 13.9 p -141.3 -177.13 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.941 0.4 . . . . 0.0 111.141 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.67 176.71 33.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.463 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 126.93 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 123' ' ' VAL . 16.9 t -119.66 144.32 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.03 106.92 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.82 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.532 ' CE1' HG22 ' A' ' 147' ' ' VAL . 80.4 m-85 -87.53 141.6 28.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.33 -28.62 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -120.0 147.94 44.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -72.1 -32.85 67.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -60.48 -31.78 70.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.416 ' O ' ' HB1' ' A' ' 144' ' ' ALA . 62.0 m-20 -71.66 -35.89 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.484 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.2 ttp -67.97 -62.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.3 m -53.4 -32.24 48.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 144' ' ' ALA . 3.1 t80 -61.35 -50.43 72.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.223 0.535 . . . . 0.0 110.076 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 175' ' ' LEU . . . -55.02 -54.1 47.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 194' ' ' VAL . 15.3 m -55.87 -22.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.36 -72.47 0.62 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.322 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -35.77 25.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -110.51 75.45 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.83 162.04 36.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.771 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 p30 42.92 58.8 3.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.445 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.5 p -123.63 170.47 10.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -85.57 134.85 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 187' ' ' THR . 24.7 t80 -91.73 146.81 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.673 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -119.64 112.8 19.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.955 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.1 t -93.95 144.65 25.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -57.72 -25.64 60.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -69.01 -23.13 64.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.85 18.02 12.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.66 129.28 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.684 0.278 . . . . 0.0 110.712 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 180' ' ' PHE . 0.2 OUTLIER -101.52 159.61 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.008 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.03 133.62 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.239 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -74.37 122.69 23.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 127' ' ' GLY . 7.4 pt -117.63 155.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -119.81 139.53 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.52 135.93 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 124' ' ' VAL . 29.2 mmmt -152.69 140.49 20.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.824 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.533 HG23 HG11 ' A' ' 172' ' ' VAL . 21.6 t -63.52 111.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.3 116.65 4.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.649 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -104.22 99.17 1.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.928 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.63 -177.61 3.71 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.6 2.2 . . . . 0.0 112.177 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -97.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.953 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 164.26 18.9 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.08 116.42 2.79 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.574 2.183 . . . . 0.0 112.29 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.44 -174.2 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.55 173.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 204' ' ' ARG . . . -125.01 158.73 19.57 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.389 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 34.25 77.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.623 0.369 . . . . 0.0 111.776 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.54 158.52 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -112.33 114.91 27.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.4 m -136.63 -81.68 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.92 -169.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.359 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 t -93.35 -138.28 0.2 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.574 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 74.02 47.63 0.15 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.924 0.393 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.05 145.01 32.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.42 161.44 5.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -63.08 -166.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -169.81 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 74.4 m 64.35 -78.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 217' ' ' GLU . 6.5 mp -126.37 -79.64 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 216' ' ' LEU . 0.1 OUTLIER 53.94 173.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.253 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.929 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 29.9 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.791 0.329 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.14 151.7 40.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.64 -70.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.7 2.267 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.89 -48.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 67.78 -154.65 53.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 173.34 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 62.28 -168.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -58.3 140.93 46.3 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.31 112.09 3.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.605 2.203 . . . . 0.0 112.38 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.79 118.97 5.51 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.4 2.067 . . . . 0.0 112.291 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.5 t -167.01 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.08 28.79 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -176.24 138.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.0 p -170.96 176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 58.19 27.83 15.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.15 28.44 7.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.983 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -102.51 154.07 19.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.62 152.57 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.58 139.54 51.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.007 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.15 146.28 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.3 m -142.45 148.71 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.198 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.75 49.97 33.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.555 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.769 ' CB ' HG22 ' A' ' 190' ' ' ILE . 0.3 OUTLIER -130.43 160.21 67.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.621 0.248 . . . . 0.0 111.0 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 57.1 Cg_endo -71.1 137.25 31.21 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.371 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.01 -20.08 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.438 2.092 . . . . 0.0 112.544 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -54.58 -60.96 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.204 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.16 116.74 9.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.633 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -168.1 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.771 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 38.8 p-90 -64.61 -33.89 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 134' ' ' TRP . 35.7 mt-30 -65.29 -40.37 93.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.807 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -71.84 -38.52 70.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.496 HD22 HG12 ' A' ' 152' ' ' VAL . 46.1 tp -70.45 -46.11 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG3' HG11 ' A' ' 147' ' ' VAL . 1.4 tttt -57.78 -49.17 77.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.69 -26.62 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.37 17.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 142' ' ' ARG . 10.8 mtp-105 -45.55 -32.04 2.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -32.72 65.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.801 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -76.46 -29.42 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.769 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.32 -160.99 31.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.388 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.69 122.02 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.418 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 138' ' ' LYS . 93.8 t -89.23 130.73 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.006 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.6 t -98.68 -30.54 12.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.406 ' O ' HG13 ' A' ' 160' ' ' VAL . 22.0 t80 -153.07 145.13 23.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.024 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -150.12 133.93 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 159' ' ' VAL . 36.8 t0 -153.73 111.26 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 137' ' ' LEU . 27.5 m -92.9 134.21 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -79.94 152.63 29.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -71.84 -22.28 61.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -42.15 75.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.348 . . . . 0.0 111.116 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 153.53 -27.19 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.543 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -82.56 173.85 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.319 . . . . 0.0 110.719 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.25 177.49 31.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 151' ' ' ASP . 29.6 m -149.09 144.32 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 149' ' ' TYR . 3.7 t -148.06 137.2 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -117.51 127.53 54.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.54 177.13 5.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -70.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.332 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 163.29 14.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.11 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -71.99 -31.33 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -31.94 67.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.838 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -72.36 -36.05 68.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.672 ' SD ' HG13 ' A' ' 194' ' ' VAL . 7.7 ttp -65.25 -62.18 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.606 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.3 m -54.68 -32.96 60.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.422 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 44.4 t80 -63.56 -45.65 89.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.26 -31.43 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.802 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.468 ' HG2' ' HG2' ' A' ' 174' ' ' LYS . 0.7 OUTLIER -84.62 -29.37 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.326 . . . . 0.0 110.888 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.468 ' HG2' ' HG2' ' A' ' 173' ' ' ARG . 0.7 OUTLIER -105.74 -65.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.863 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 144' ' ' ALA . 70.2 mt -76.84 66.36 2.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -120.93 121.01 37.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.53 12.89 8.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -176.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.999 0.428 . . . . 0.0 111.008 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -101.68 144.25 30.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.996 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -124.8 122.81 38.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.293 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HG3' HG23 ' A' ' 187' ' ' THR . 6.1 ttt-85 -119.62 119.32 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.7 m -87.81 159.39 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -59.95 -17.03 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -92.48 18.59 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.34 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.32 31.09 76.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.544 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 93.3 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 110.8 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -92.2 144.51 25.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -170.06 172.02 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.238 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -106.17 123.51 48.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.404 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.769 HG22 ' CB ' ' A' ' 128' ' ' LEU . 13.7 pt -107.62 152.43 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.706 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -112.63 117.6 32.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.519 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.11 133.63 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -153.87 150.46 28.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.672 HG13 ' SD ' ' A' ' 168' ' ' MET . 21.8 t -62.49 109.39 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -68.14 -79.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.89 140.84 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.26 89.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.28 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -104.9 49.95 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.798 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 47.2 p -142.87 50.09 1.38 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 199' ' ' SER . 84.3 Cg_endo -80.09 96.95 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.548 2.165 . . . . 0.0 112.475 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 30.9 t -63.27 82.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.863 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -77.25 80.44 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.996 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -92.03 13.08 67.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.771 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 55.48 74.2 0.38 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.903 0.382 . . . . 0.0 111.037 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 p -172.14 136.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.14 -33.21 8.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.21 87.85 2.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.71 30.49 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.29 30.98 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.881 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.53 104.36 7.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 78.0 p -174.73 -171.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 4.6 ptt85 -58.8 88.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.53 166.52 24.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.104 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -83.81 98.57 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -76.16 63.38 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 216' ' ' LEU . 23.4 mt -155.68 179.74 8.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.39 142.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 28.3 mtm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.771 0.319 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.18 82.47 0.22 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.79 -68.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.565 2.177 . . . . 0.0 112.317 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 126.46 53.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.899 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.52 -157.76 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 67.08 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.4 t80 59.93 81.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.7 146.28 43.3 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.8 150.09 38.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.617 2.211 . . . . 0.0 112.352 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.56 73.92 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.552 2.168 . . . . 0.0 112.257 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.79 118.8 35.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -162.75 30.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -71.41 -15.17 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.1 p -53.7 92.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.77 36.32 3.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE ' ' A' ' 165' ' ' LYS . 12.2 m-80 -78.29 76.34 4.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -121.76 169.61 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 160' ' ' VAL . 1.6 p -117.46 159.62 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.963 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 199' ' ' SER . 9.7 t -114.37 156.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 111.646 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' N ' HG12 ' A' ' 124' ' ' VAL . 19.3 t -144.35 143.69 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.82 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.448 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -137.26 159.42 41.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.74 45.18 8.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.1 mm? -83.83 142.94 42.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.97 170.44 20.09 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.29 -20.71 66.98 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.572 2.181 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.7 m -108.88 -157.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.47 -177.94 48.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -176.8 -175.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 110.747 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.405 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 56.3 p-90 -59.27 -43.06 92.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 7.2 tp60 -63.01 -38.72 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -35.48 57.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.802 HD22 HG22 ' A' ' 152' ' ' VAL . 30.6 tp -62.29 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.637 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -57.6 -42.48 83.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.5 -26.77 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -89.59 -29.86 18.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.736 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.525 ' HB2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -85.44 -19.97 30.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.07 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -46.43 -30.0 1.97 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.32 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.98 -32.43 53.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.88 -28.17 60.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.43 -139.6 6.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.4 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -99.7 101.33 12.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 162' ' ' PHE . 92.0 t -75.64 120.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.036 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.27 -29.07 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 20.4 t80 -146.67 151.59 37.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -159.8 140.92 12.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.683 ' HB3' HG22 ' A' ' 159' ' ' VAL . 6.1 t70 -135.4 148.92 49.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.802 HG22 HD22 ' A' ' 137' ' ' LEU . 1.8 t -146.16 106.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.17 151.41 31.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -17.7 61.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.207 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.84 -24.41 67.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.72 25.74 2.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.677 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 126' ' ' SER . 31.8 p -151.42 163.35 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.781 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.62 -166.14 18.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.795 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 151' ' ' ASP . 34.1 m -147.51 172.68 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 110.509 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.892 HG23 HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -155.0 130.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.402 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.48 120.69 39.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.858 ' CE2' HG22 ' A' ' 147' ' ' VAL . 85.2 m-85 -104.01 139.71 38.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.61 -30.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.781 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.19 125.91 49.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CE ' ' HA ' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -53.62 -24.15 13.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -39.23 89.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.49 -31.94 71.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.99 0.424 . . . . 0.0 110.575 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.583 ' HE3' ' H ' ' A' ' 169' ' ' THR . 9.3 tmm? -61.32 -75.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.798 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.585 HG23 ' NH1' ' A' ' 173' ' ' ARG . 5.0 m -45.64 -45.04 13.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.751 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.8 -40.21 75.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.954 0.407 . . . . 0.0 110.683 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.563 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 192' ' ' VAL . 15.4 m -78.85 -27.65 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.116 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.585 ' NH1' HG23 ' A' ' 169' ' ' THR . 4.5 mmt85 -80.75 -40.12 25.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -103.43 -58.24 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.478 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 96.6 mt -77.53 64.86 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.947 0.403 . . . . 0.0 111.022 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -128.24 138.53 52.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 60.02 30.2 19.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.7 p -98.41 155.5 17.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -81.24 134.37 35.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -96.04 158.11 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.558 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.683 ' HG2' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -133.14 125.77 30.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.969 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -93.91 149.88 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.831 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -56.16 -23.12 32.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.66 -23.11 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.054 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.19 26.23 6.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.677 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -115.12 136.2 53.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -110.68 161.1 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -168.98 170.91 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.006 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.16 126.15 43.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 5.4 pt -117.5 137.68 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.335 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -106.15 122.63 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.677 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 172' ' ' VAL . 3.0 t -104.62 153.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.468 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -164.35 140.63 6.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.675 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.481 HG23 ' SD ' ' A' ' 168' ' ' MET . 11.7 p -66.63 119.59 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.48 . . . . 0.0 111.289 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 124' ' ' VAL . 9.4 t0 -80.96 136.58 36.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -160.94 -98.58 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.87 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.34 -67.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.483 2.122 . . . . 0.0 112.688 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -138.46 7.65 2.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.768 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.662 ' HB2' HG21 ' A' ' 124' ' ' VAL . 53.3 p 49.4 57.29 18.2 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-O 120.725 0.297 . . . . 0.0 111.318 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.22 124.27 4.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.667 2.244 . . . . 0.0 112.356 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -60.18 -47.17 87.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 68.43 -69.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.91 174.84 30.88 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -125.29 -70.91 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.3 t -172.5 -76.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 27.6 mtm105 -157.32 42.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -120.48 -48.89 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 -148.09 106.47 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.8 p -159.92 39.53 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -76.2 -30.13 57.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m 62.2 116.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.05 75.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.73 -170.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.73 90.84 3.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 81.8 p -133.67 83.5 2.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 218' ' ' HIS . 0.6 OUTLIER -71.96 157.63 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.18 42.11 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.843 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.472 ' N ' HD12 ' A' ' 216' ' ' LEU . 5.2 m-70 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.797 0.332 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.65 92.92 7.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.43 125.49 13.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.524 2.149 . . . . 0.0 112.275 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.69 -67.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.52 -48.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.603 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -174.65 65.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.926 0.393 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.06 -26.8 6.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.458 ' C ' ' HD2' ' A' ' 115' ' ' PRO . . . -56.53 161.61 7.14 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.934 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' N ' ' CD ' ' A' ' 115' ' ' PRO . 7.5 Cg_endo -54.84 -33.55 81.94 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.844 2.363 . . . . 0.0 113.844 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 48.9 Cg_exo -57.23 -153.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.021 1.814 . . . . 0.0 112.686 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.9 m -40.79 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.66 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HB3' ' NH1' ' A' ' 117' ' ' ARG . 5.5 ttm105 -136.94 -37.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.07 172.68 8.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.989 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.2 p -132.98 11.02 4.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 61.29 17.45 8.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.457 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.2 m120 55.58 105.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -116.06 170.03 8.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 168' ' ' MET . 2.0 t -123.95 165.34 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.202 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 193' ' ' LYS . 7.4 p -122.42 136.35 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.402 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.14 153.99 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 157' ' ' THR . 3.1 t -141.85 133.57 27.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.44 40.26 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.633 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 128' ' ' LEU . 2.4 mm? -89.05 139.06 28.84 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.531 0.205 . . . . 0.0 110.99 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 169.91 21.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.467 2.112 . . . . 0.0 112.284 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.01 -29.79 26.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.455 2.103 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.07 71.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.38 -160.43 8.31 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.67 174.08 1.89 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.769 0.318 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 52.8 p-90 -72.7 -40.92 65.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 3.6 pt20 -66.85 -34.67 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -29.45 60.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -73.17 -41.34 63.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -64.31 -53.77 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.145 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -56.34 -26.79 53.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.252 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.495 ' CD2' ' CE1' ' A' ' 180' ' ' PHE . 10.4 m-70 -86.06 -23.09 26.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.388 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.907 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.5 ppp? -106.66 8.47 31.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 111.544 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -56.9 -15.11 4.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.496 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.827 ' HB3' HD22 ' A' ' 175' ' ' LEU . 0.1 OUTLIER -49.83 -23.82 2.09 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.506 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . . . -61.48 -28.23 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.118 0.485 . . . . 0.0 110.396 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 140.46 -55.14 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.427 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.69 117.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.469 ' CG1' ' HG3' ' A' ' 138' ' ' LYS . 61.1 t -100.5 132.26 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.842 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.21 -49.48 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.235 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 150' ' ' ALA . 14.1 t80 -155.83 160.02 39.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 149' ' ' TYR . . . -147.46 168.01 22.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.75 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.4 t70 -163.14 123.79 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.019 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.13 138.96 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.88 155.04 18.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.016 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -70.8 -18.05 62.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.188 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.14 -25.79 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 5.15 8.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.785 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 126' ' ' SER . 8.4 p -131.75 161.14 33.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.2 -169.05 11.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 151' ' ' ASP . 7.0 m -140.94 167.31 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.907 HG11 ' SD ' ' A' ' 141' ' ' MET . 21.9 t -152.72 140.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.059 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -131.28 114.3 14.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 144' ' ' ALA . 16.9 m-85 -88.89 176.49 7.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.85 -66.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.703 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.7 mmt-85 -96.84 161.11 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.555 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -25.2 62.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.56 -31.26 72.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.06 -31.36 71.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.724 ' SD ' HG13 ' A' ' 194' ' ' VAL . 4.1 ttp -59.86 -62.11 2.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.67 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 172' ' ' VAL . 52.1 m -56.81 -32.41 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.732 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 170' ' ' TYR . 4.3 t80 -60.54 -50.31 74.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.227 0.537 . . . . 0.0 110.28 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' LEU . . . -57.8 -51.99 67.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.967 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.82 HG11 HG23 ' A' ' 194' ' ' VAL . 15.8 m -57.11 -22.48 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.974 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -106.52 -73.6 0.68 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.147 0.498 . . . . 0.0 112.25 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -35.18 79.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -125.49 85.5 2.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.645 0.736 . . . . 0.0 111.448 -178.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -142.74 152.69 42.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 71.26 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 p -124.98 169.76 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -89.54 136.35 33.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 140' ' ' HIS . 89.9 t80 -113.74 114.98 27.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.694 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -116.19 103.61 10.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.829 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.6 p -58.45 169.84 0.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.072 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -6.94 34.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.03 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -90.13 -22.93 21.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.712 0.291 . . . . 0.0 111.097 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.04 30.47 4.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.432 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -112.05 108.28 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.7 156.25 20.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.131 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -167.07 169.7 12.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.126 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.59 136.51 43.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.95 142.54 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.282 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.89 150.92 37.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 123' ' ' VAL . 4.0 t -114.97 133.58 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.331 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.665 ' O ' HG12 ' A' ' 124' ' ' VAL . 2.6 mtpm? -141.22 140.45 33.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.745 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.82 HG23 HG11 ' A' ' 172' ' ' VAL . 37.6 t -68.49 113.94 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.297 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 124' ' ' VAL . 0.4 OUTLIER -96.1 124.72 40.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.598 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -108.69 -68.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.705 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.5 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.651 2.234 . . . . 0.0 112.626 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 152.28 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.401 ' CB ' ' CD ' ' A' ' 200' ' ' PRO . 4.2 p -119.84 175.83 2.07 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.065 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 199' ' ' SER . 31.6 Cg_exo -59.19 -145.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.827 2.352 . . . . 0.0 112.19 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 202' ' ' TYR . 1.5 m -73.78 1.05 11.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 201' ' ' SER . 19.6 m-85 67.26 -69.96 0.12 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.809 0.338 . . . . 0.0 111.072 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.92 174.05 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.218 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.91 -163.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.671 0.272 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 t 69.9 -137.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.709 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -46.8 108.92 0.16 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.856 0.36 . . . . 0.0 111.26 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 m -133.42 91.06 2.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.801 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -59.13 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.4 p -117.11 -169.27 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.82 28.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.46 -47.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -98.57 31.87 2.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.5 100.47 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 120.78 24.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.535 ' C ' HD22 ' A' ' 216' ' ' LEU . 1.2 m -129.9 78.25 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 215' ' ' SER . 4.0 mm? -128.0 122.53 32.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.78 -77.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.15 90.28 3.65 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.27 152.39 75.86 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.517 2.144 . . . . 0.0 112.25 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.74 -30.5 67.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.08 116.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.454 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 101.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -173.43 4.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.96 57.49 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.768 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.452 ' HG2' ' HD3' ' A' ' 115' ' ' PRO . 4.1 Cg_exo -40.63 -51.45 3.53 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.087 2.525 . . . . 0.0 112.897 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' HD3' ' HG2' ' A' ' 114' ' ' PRO . 78.6 Cg_exo -47.08 173.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.543 2.162 . . . . 0.0 112.61 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -136.49 44.47 2.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.752 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 71.77 -63.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.92 152.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.46 -32.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 74.38 51.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.823 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 63.33 88.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.02 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.64 169.18 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 194' ' ' VAL . 4.3 m -125.48 165.12 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.88 136.7 48.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.6 t -105.35 154.11 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 157' ' ' THR . 28.1 p -154.86 121.27 5.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.78 26.75 4.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' HG22 ' A' ' 190' ' ' ILE . 2.9 mt -68.18 155.27 92.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 188' ' ' ALA . 42.8 Cg_endo -68.05 160.57 48.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.627 2.218 . . . . 0.0 112.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.43 -28.99 31.92 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m -118.52 72.19 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.79 147.29 16.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.36 175.81 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.672 0.272 . . . . 0.0 111.025 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -73.97 -32.32 63.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.953 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.72 -44.66 90.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.06 -32.08 59.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 55.3 tp -61.57 -47.29 86.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.15 -45.06 93.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.195 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.45 -26.77 68.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.727 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 181' ' ' ARG . 22.6 m-70 -99.94 -26.43 14.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.824 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -96.9 4.44 51.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -9.9 45.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.82 -26.74 4.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.804 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -68.37 -28.75 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.92 -164.91 28.16 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.6 m-20 -60.29 106.38 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.117 0.484 . . . . 0.0 110.781 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.1 t -73.85 153.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.0 t -107.64 -59.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.177 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.52 130.94 5.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.817 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.52 140.34 53.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.13 136.71 33.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.999 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 152' ' ' VAL . 26.7 m -119.4 118.92 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.927 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -93.33 121.22 34.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 63.34 -76.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 1.2 m-20 169.76 -25.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -64.62 -49.93 61.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.633 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 126' ' ' SER . 33.2 p -133.63 -179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.9 -159.05 10.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.468 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.3 m -156.01 158.85 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.824 HG11 ' SD ' ' A' ' 141' ' ' MET . 16.4 t -152.05 141.93 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.93 135.01 54.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.85 163.23 13.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 146' ' ' ASP . 46.9 t -80.31 -62.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -88.23 152.92 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.58 -30.73 68.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -36.88 85.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.62 -30.62 68.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.763 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.9 ttp -65.14 -64.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 99.5 m -55.04 -32.78 62.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.558 ' HA ' ' CD ' ' A' ' 173' ' ' ARG . 64.7 t80 -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . . . -68.02 -39.34 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.634 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 194' ' ' VAL . 11.7 m -79.54 -22.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.818 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.558 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 5.7 ptm180 -91.11 -42.08 10.68 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HD2' ' HG3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -109.42 -30.45 7.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.804 HD12 ' HB2' ' A' ' 144' ' ' ALA . 17.7 mt -94.84 31.51 1.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.61 134.51 45.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 60.71 35.08 19.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.584 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.36 154.95 17.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.468 ' HD3' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER -81.06 115.63 20.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 18.1 t80 -92.8 152.98 19.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.406 ' O ' ' CD2' ' A' ' 140' ' ' HIS . 0.2 OUTLIER -121.09 113.53 20.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.96 158.77 34.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.73 -13.81 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.182 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.7 20.78 7.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.394 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 25.93 73.26 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.573 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 125.21 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.88 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.468 HG22 ' HD3' ' A' ' 179' ' ' LYS . 0.3 OUTLIER -94.09 161.07 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 129' ' ' PRO . . . -165.75 159.41 16.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.43 111.87 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 128' ' ' LEU . 5.6 pt -112.92 148.7 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.527 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.62 154.59 26.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.411 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 172' ' ' VAL . 12.3 t -125.96 144.49 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 111.148 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 148.01 29.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 123' ' ' VAL . 14.6 t -78.38 141.76 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.304 0.573 . . . . 0.0 110.7 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -83.0 11.64 5.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.661 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.538 ' H ' HG12 ' A' ' 194' ' ' VAL . . . -111.96 90.69 0.57 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.348 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.47 113.11 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.727 2.285 . . . . 0.0 112.443 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.09 -170.1 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 21.3 t -156.35 102.63 2.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -51.27 90.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.426 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' GLY . 0.1 OUTLIER -126.61 -84.06 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 57.68 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' SER . . . -132.77 -102.02 0.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.446 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -174.3 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.34 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 t -96.34 119.93 35.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.28 164.27 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.3 t -109.48 146.13 35.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.64 70.34 10.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.68 62.84 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.756 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.98 50.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.852 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p 50.52 -177.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.37 35.66 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 30.75 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -19.28 65.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.86 68.67 0.51 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.843 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.5 -29.64 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -179.34 3.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.932 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.854 0.359 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -108.65 141.34 23.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 -43.66 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.476 2.117 . . . . 0.0 112.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 178.92 4.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.11 -30.67 9.01 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.436 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.73 -174.22 4.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.734 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 112' ' ' TYR . 39.5 p90 -101.55 112.5 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -131.41 107.21 0.72 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.583 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.68 111.79 2.69 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.496 2.13 . . . . 0.0 112.232 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.65 145.3 39.15 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.384 2.056 . . . . 0.0 112.419 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.23 -174.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.33 94.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -70.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.136 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER 178.81 -162.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 119' ' ' SER . 0.9 OUTLIER 82.0 -8.57 1.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.675 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.98 160.59 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.936 0.398 . . . . 0.0 111.128 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -144.29 128.54 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.775 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.951 HG12 ' HA ' ' A' ' 194' ' ' VAL . 23.7 m -104.29 165.2 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 195' ' ' ASP . 23.3 t -119.06 154.03 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.093 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.2 143.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 157' ' ' THR . 4.5 t -144.62 134.73 24.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.29 39.16 4.06 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.47 HD21 HD13 ' A' ' 137' ' ' LEU . 15.8 mt -89.02 159.46 45.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.58 160.08 47.77 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.574 2.183 . . . . 0.0 112.304 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.4 -45.41 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.534 2.156 . . . . 0.0 112.279 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.9 p -97.46 61.77 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.14 152.75 23.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.28 4.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.417 ' HB3' HG23 ' A' ' 152' ' ' VAL . 45.1 p-90 -73.98 -32.31 63.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.941 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -59.23 -42.21 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -73.66 -30.15 62.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.47 HD13 HD21 ' A' ' 128' ' ' LEU . 67.3 tp -66.81 -43.24 84.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.639 ' HG3' HG11 ' A' ' 147' ' ' VAL . 5.5 ttpt -52.97 -30.11 32.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.174 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.69 -26.63 66.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -33.78 16.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.543 ' HB2' HG21 ' A' ' 147' ' ' VAL . 71.7 mmm -72.7 -31.04 64.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.069 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -29.41 23.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.252 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -50.79 -25.62 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.019 0.438 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.861 ' HB2' HD12 ' A' ' 175' ' ' LEU . . . -74.53 -27.77 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.53 -69.8 0.28 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -160.48 136.28 8.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.425 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 138' ' ' LYS . 87.4 t -107.59 152.26 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.788 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.4 t -112.07 -33.03 6.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.1 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -162.36 148.95 13.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.72 156.52 45.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.831 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -159.0 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 134' ' ' TRP . 17.6 t -137.05 95.29 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ARG . 10.8 p90 -123.14 156.09 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' TYR . 6.9 ttp180 96.27 -3.06 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.487 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 65.36 37.84 6.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -179.23 -52.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 126' ' ' SER . 3.9 p -97.97 163.71 12.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -143.63 -149.47 5.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.469 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 1.5 p -169.29 160.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.071 0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 21.3 t -152.51 149.56 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -127.96 109.11 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HE2' HG21 ' A' ' 123' ' ' VAL . 95.7 m-85 -85.1 177.14 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.038 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.0 t -90.38 -70.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -95.04 164.13 13.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.145 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -72.25 -31.19 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -59.9 -50.32 74.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.25 -29.07 64.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.699 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.2 ttp -71.11 -64.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 62.6 m -50.34 -33.92 22.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.15 -45.57 84.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.413 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -55.45 -47.28 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.446 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 192' ' ' VAL . 16.1 m -66.76 -22.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -86.46 -67.64 0.8 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -52.85 9.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 144' ' ' ALA . 91.2 mt -79.66 60.44 3.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -130.03 141.19 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.65 32.39 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.265 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.6 p -83.14 -179.15 7.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 101.95 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 59.8 t80 -72.94 143.63 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -124.56 107.95 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.007 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 27.5 t -79.54 161.43 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.16 -7.45 51.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -95.41 19.13 11.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.92 28.57 73.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 128.91 55.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 159.73 18.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -170.02 171.86 6.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.66 119.92 40.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 2.7 pt -107.29 146.53 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -116.34 119.12 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 172' ' ' VAL . 19.4 t -98.23 143.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.41 142.46 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.951 ' HA ' HG12 ' A' ' 123' ' ' VAL . 12.6 p -74.62 118.0 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.474 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -116.8 77.45 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.841 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -126.59 97.89 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.571 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.57 -24.13 21.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.558 2.172 . . . . 0.0 112.338 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.05 -174.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 200' ' ' PRO . 1.9 t 59.41 64.54 2.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 199' ' ' SER . 6.1 Cg_exo -78.22 57.73 6.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.971 2.447 . . . . 0.0 112.31 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 m -178.46 136.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.256 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 202' ' ' TYR . 0.6 OUTLIER -147.35 -63.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.624 179.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 39.8 -96.53 0.01 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.296 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.19 13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 0.0 111.433 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 -171.31 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.9 0.381 . . . . 0.0 111.444 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -60.3 91.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.85 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.66 -54.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.708 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 210' ' ' ARG . 0.7 OUTLIER 63.47 13.74 7.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.81 -89.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.558 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -154.12 161.41 41.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.695 0.283 . . . . 0.0 110.871 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.1 m -125.34 159.6 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -68.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.96 -165.06 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.805 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 66.82 46.78 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 110.972 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.39 108.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.806 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 216' ' ' LEU . 1.9 pp -154.51 51.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.47 91.74 3.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 8.0 t60 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.9 179.907 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 ptp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.819 0.342 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.96 20.81 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.26 98.22 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.501 2.134 . . . . 0.0 112.22 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.05 96.44 6.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.12 12.49 3.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.803 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.41 23.18 5.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 58.73 161.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.048 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.08 -167.57 2.47 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.605 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.09 110.26 2.9 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.609 2.206 . . . . 0.0 112.15 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 116' ' ' SER . 9.7 Cg_exo -70.67 -72.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.573 2.182 . . . . 0.0 112.207 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.6 p 165.57 152.43 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.58 134.82 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.31 122.93 0.93 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m -163.81 -148.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.769 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 76.76 57.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.001 0.429 . . . . 0.0 110.804 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.68 41.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.714 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 123' ' ' VAL . 25.6 ttm180 -86.61 156.95 19.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.414 ' N ' ' HG2' ' A' ' 122' ' ' ARG . 3.1 m -132.66 165.17 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.91 147.42 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.24 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.0 142.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.6 t -140.01 146.61 39.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.83 64.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.289 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 190' ' ' ILE . 0.0 OUTLIER -98.23 148.4 34.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.675 0.274 . . . . 0.0 110.701 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 30.9 Cg_endo -63.69 127.53 19.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.574 2.182 . . . . 0.0 111.976 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -22.53 46.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.298 1.998 . . . . 0.0 112.348 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.97 43.39 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.42 -166.76 21.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.417 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.54 145.56 51.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 61.3 p-90 -73.95 -46.36 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -60.8 -32.38 71.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.812 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.25 -35.79 55.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.651 HD22 HG12 ' A' ' 152' ' ' VAL . 51.6 tp -61.38 -37.16 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.482 ' HB3' HG11 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -66.6 -39.06 88.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 110.404 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -66.94 -26.57 66.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.238 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.464 ' HE1' HD11 ' A' ' 190' ' ' ILE . 0.8 OUTLIER -86.62 -22.06 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.834 ' SD ' HG11 ' A' ' 160' ' ' VAL . 1.8 ppp? -111.76 -3.38 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -59.02 -20.67 55.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 111.387 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -50.38 -24.95 3.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.176 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 171' ' ' ALA . . . -69.17 -26.38 64.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.726 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.64 -116.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.0 111.71 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 138' ' ' LYS . 89.3 t -82.79 151.28 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 163' ' ' VAL . 1.3 m -119.4 -39.82 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -145.94 148.21 32.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.97 139.53 18.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -142.89 138.32 30.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 137' ' ' LEU . 34.2 m -117.71 118.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -69.15 155.25 40.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.971 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 17.56 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -29.72 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.758 0.314 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 145.95 -16.83 1.76 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.9 p -98.86 -178.48 3.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 111.224 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.7 -176.62 30.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.245 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 151' ' ' ASP . 17.2 m -153.5 150.38 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 111.044 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.834 HG11 ' SD ' ' A' ' 141' ' ' MET . 10.5 t -150.65 146.31 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -130.74 131.32 44.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 168' ' ' MET . 3.8 m-85 -104.58 171.1 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.748 HG22 ' SG ' ' A' ' 148' ' ' CYS . 55.5 t -70.03 -70.15 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -97.35 155.27 16.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -58.29 -28.56 65.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.36 -32.06 73.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -72.9 -34.95 66.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.43 ' HA ' ' CD1' ' A' ' 162' ' ' PHE . 8.2 ttp -68.58 -62.94 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 96.1 m -53.93 -36.32 62.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.01 -44.22 97.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.831 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -60.34 -44.64 95.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.471 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 m -70.88 -27.09 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.094 0.473 . . . . 0.0 110.725 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -77.99 -53.39 7.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.828 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -65.72 0.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.439 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 41.6 mt -63.69 -118.5 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.47 113.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 64.85 72.72 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 46.3 p -132.0 -176.94 4.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -103.74 139.93 38.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 181' ' ' ARG . 75.5 t80 -126.85 160.78 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.748 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -141.08 149.07 41.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.027 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.0 p -109.38 157.37 18.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -20.38 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.967 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -79.14 -22.93 44.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.99 29.46 5.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.8 121.89 46.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.78 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.1 156.58 17.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -167.29 171.65 10.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.29 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -107.51 121.3 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.241 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 128' ' ' LEU . 28.6 pt -101.84 168.45 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.066 0.46 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 109.47 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.322 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.0 t -86.76 153.53 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.389 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.98 171.29 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.667 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 196' ' ' GLY . 12.6 p -87.91 122.36 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.939 0.4 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -48.86 -34.92 13.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.508 ' H ' HG22 ' A' ' 194' ' ' VAL . . . -114.28 80.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.627 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.3 -53.22 7.49 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.525 2.15 . . . . 0.0 112.23 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 30.0 ttp85 -92.36 105.89 18.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.721 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER -177.77 -56.7 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 71.2 Cg_exo -50.32 152.15 8.76 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.313 2.009 . . . . 0.0 112.312 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 -63.58 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -54.13 179.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.093 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.65 -72.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.597 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -176.47 -40.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.1 m -147.31 100.66 3.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -118.91 30.76 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.69 88.06 3.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 100.36 11.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.984 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m 64.52 -75.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -52.09 -80.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.033 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 34.2 t 63.53 -78.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -173.72 146.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.9 t -50.95 98.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.65 ' HD2' HD21 ' A' ' 216' ' ' LEU . 11.7 ptt-85 -54.72 141.34 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.6 t -89.96 107.98 19.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.65 HD21 ' HD2' ' A' ' 214' ' ' ARG . 2.0 mm? -116.0 -173.2 2.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.817 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.94 46.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.024 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.8 p80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.881 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.826 0.346 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.677 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -178.06 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 41.1 Cg_endo -67.3 -29.81 38.06 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.492 2.128 . . . . 0.0 112.345 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -98.26 162.68 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.64 -24.73 13.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.652 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 61.27 90.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -179.86 -74.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.7 -77.83 0.39 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.549 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.436 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 6.2 Cg_exo -37.82 -49.32 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.41 2.74 . . . . 0.0 113.009 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 52.2 Cg_exo -55.1 88.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.308 2.005 . . . . 0.0 112.268 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 p -128.13 110.62 12.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -143.99 29.09 1.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.09 162.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.24 100.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.4 -41.65 76.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.011 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -175.2 94.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.478 ' NH2' HG12 ' A' ' 159' ' ' VAL . 2.4 tpt180 -105.33 119.96 40.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 160' ' ' VAL . 7.5 p -108.43 162.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.558 ' N ' HG22 ' A' ' 123' ' ' VAL . 10.3 p -128.23 142.31 44.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.63 149.42 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.93 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.1 t -139.51 123.77 18.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 107.53 40.56 1.74 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.599 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -82.13 142.6 47.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.26 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.77 168.6 23.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.486 2.124 . . . . 0.0 112.31 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.53 -43.26 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.605 2.203 . . . . 0.0 112.329 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.87 79.37 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.861 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 177.9 97.07 0.11 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.469 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -175.96 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.78 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.448 ' CE3' ' N ' ' A' ' 135' ' ' GLN . 59.1 p-90 -65.43 -40.87 93.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.448 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 2.5 tt0 -59.6 -32.52 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.943 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.01 -36.68 56.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.25 -44.99 58.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -59.51 -50.1 75.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -60.81 -26.6 67.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.543 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -95.11 -24.95 16.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.752 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.433 ' HE3' HD21 ' A' ' 175' ' ' LEU . 0.0 OUTLIER -100.66 6.48 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.597 0.237 . . . . 0.0 111.565 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -77.89 6.0 8.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.661 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -50.65 -26.07 4.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.72 0.295 . . . . 0.0 111.232 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -65.63 -27.58 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.608 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.14 -94.03 0.13 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.416 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.2 142.52 49.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.944 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.59 128.9 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.849 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.72 -26.32 13.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.485 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 160' ' ' VAL . 41.0 t80 -142.92 153.39 43.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.479 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . . . -163.12 143.13 9.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.832 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -149.51 146.51 27.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.748 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.54 133.69 59.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.86 147.97 26.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -70.16 -16.85 63.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.99 -31.38 72.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 134.85 -18.11 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.81 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 126' ' ' SER . 17.7 p -108.01 169.85 8.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.6 -167.43 13.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.344 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' NH2' ' A' ' 122' ' ' ARG . 35.5 m -155.14 154.64 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.714 0.293 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.9 t -153.16 142.35 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.237 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -121.68 113.29 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.603 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 168' ' ' MET . 13.9 m-85 -81.39 155.8 25.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.073 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.07 -26.63 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.771 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 149.22 46.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -69.18 -36.22 77.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -32.56 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.71 -30.22 64.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.47 ' HA ' ' CE1' ' A' ' 162' ' ' PHE . 5.8 ttp -69.53 -65.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 94.7 m -56.71 -34.34 67.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 0.0 111.073 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 174' ' ' LYS . 9.3 t80 -59.46 -49.63 77.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.249 0.547 . . . . 0.0 110.621 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 175' ' ' LEU . . . -60.55 -50.17 74.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.225 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 192' ' ' VAL . 15.7 m -58.71 -22.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 111.296 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 169' ' ' THR . 9.5 mtp180 -96.41 -37.18 10.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.339 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 170' ' ' TYR . 0.3 OUTLIER -86.59 -69.11 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.817 -178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -87.2 45.51 1.28 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 15.8 p-10 -83.43 127.1 33.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 47.96 59.98 3.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.24 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -114.85 173.97 6.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.446 ' HG3' ' CE1' ' A' ' 189' ' ' TYR . 0.2 OUTLIER -95.16 108.53 20.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.953 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -105.06 157.81 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.367 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HB3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -132.56 138.65 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 p -81.25 171.0 15.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -55.02 -17.86 4.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -82.99 -22.66 33.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.25 -15.07 39.6 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 123.6 19.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.779 0.323 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -94.41 158.95 15.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.64 155.99 13.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 179' ' ' LYS . 2.0 m-85 -86.37 113.63 22.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 pt -119.88 137.61 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.26 152.9 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 172' ' ' VAL . 13.6 t -127.74 137.61 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.263 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 124' ' ' VAL . 9.8 mtpp -155.55 145.86 21.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 194' ' ' VAL . 10.8 p -68.62 109.29 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.66 93.24 9.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.761 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -55.97 158.27 8.62 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.666 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.41 -167.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.649 2.232 . . . . 0.0 112.287 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 131.86 52.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 0.6 OUTLIER -59.44 -50.89 84.95 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.1 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 199' ' ' SER . 83.8 Cg_exo -47.62 119.26 3.56 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.619 2.213 . . . . 0.0 112.441 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.5 m -65.78 -68.35 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.979 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 202' ' ' TYR . 0.0 OUTLIER -140.06 -76.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 119.19 119.1 2.8 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.486 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -65.68 -175.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 t 61.01 99.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 53.0 mmm-85 -70.4 93.04 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -80.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.963 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 177.22 -178.45 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.8 t -129.39 107.66 9.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -97.39 -53.2 3.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.973 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.59 168.29 13.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 59.97 31.46 20.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.2 m -114.18 94.45 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 62.77 146.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 69.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.63 31.71 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 63.14 -79.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 5.3 m170 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.93 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.761 0.315 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -178.47 -61.64 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 69.5 Cg_endo -74.56 61.84 5.35 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.502 2.135 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.0 ttm-85 51.36 39.72 24.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.037 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.11 -75.47 1.13 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.455 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.0 88.73 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -93.59 -31.21 14.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.84 -165.51 33.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 55.3 Cg_endo -69.83 157.84 58.9 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.529 2.153 . . . . 0.0 112.227 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 34.4 Cg_exo -60.4 -68.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.441 2.094 . . . . 0.0 112.065 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 m 43.95 57.69 4.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.335 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -126.68 -38.89 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -135.73 144.37 45.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.8 m -160.47 56.43 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.021 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.43 30.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.741 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 60.32 105.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.49 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -144.02 127.54 16.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.632 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.13 159.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.947 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.46 145.5 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.086 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.21 142.37 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.9 OUTLIER -134.83 -179.55 5.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.49 32.69 75.53 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.552 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.606 HD21 HG12 ' A' ' 152' ' ' VAL . 2.3 mp -81.24 146.01 57.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.679 0.276 . . . . 0.0 110.85 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.15 169.97 20.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.58 2.187 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.42 -27.27 33.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.508 2.139 . . . . 0.0 112.197 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.36 117.03 22.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.47 175.78 46.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.432 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.577 ' C ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -138.66 179.62 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.891 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.431 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 51.3 p-90 -73.14 -39.1 65.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 46.2 tt0 -63.0 -31.08 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 -44.72 84.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.06 -47.05 54.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.852 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -56.32 -47.18 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.2 -26.73 65.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.518 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 180' ' ' PHE . 45.7 t-80 -87.93 -29.27 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.37 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.64 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -97.1 -11.16 24.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.605 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -54.58 -21.64 10.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.801 0.334 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -49.91 -24.42 2.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.211 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.01 -26.7 66.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.941 0.401 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 150.43 -110.25 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.51 125.31 52.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.852 HG11 ' CG ' ' A' ' 138' ' ' LYS . 84.3 t -97.78 146.07 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.021 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.39 -67.48 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -127.82 133.18 49.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.036 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 138' ' ' LYS . . . -128.55 135.94 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -139.93 126.08 19.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.606 HG12 HD21 ' A' ' 128' ' ' LEU . 5.6 m -116.29 142.99 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -117.13 153.93 31.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.023 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -73.67 -16.43 61.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.211 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.1 -26.08 68.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.56 12.14 7.51 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.752 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 126' ' ' SER . 11.5 p -143.97 165.93 26.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 110.661 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.21 -161.51 10.88 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.546 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.3 m -156.38 155.77 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.66 0.267 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.3 t -150.78 142.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -123.35 126.28 46.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.56 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -97.01 177.06 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.3 t -76.29 -68.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 154.44 22.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -71.96 -34.41 68.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.84 -35.17 66.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -32.05 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.61 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 172' ' ' VAL . 3.0 ttp -58.94 -63.29 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.815 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 173' ' ' ARG . 95.6 m -56.65 -35.04 67.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.425 ' CE2' ' HE3' ' A' ' 174' ' ' LYS . 15.7 t80 -61.3 -44.85 96.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 175' ' ' LEU . . . -67.14 -45.32 77.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.271 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 168' ' ' MET . 2.1 m -71.97 -21.97 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 111.273 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.534 ' HG3' HG22 ' A' ' 169' ' ' THR . 18.1 mmm180 -90.85 -50.67 5.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.53 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' HE3' ' CE2' ' A' ' 170' ' ' TYR . 0.5 OUTLIER -88.62 -52.57 5.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 171' ' ' ALA . 22.3 mt -69.33 -4.76 19.5 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 67.6 t0 -53.9 123.83 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.086 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 60.81 76.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.23 161.75 18.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' HG21 ' A' ' 187' ' ' THR . 4.3 tptp -85.65 93.95 8.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.851 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.435 ' HA ' ' CE1' ' A' ' 140' ' ' HIS . 40.7 t80 -74.64 154.69 38.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.81 129.21 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.3 p -97.45 162.93 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -6.1 45.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.239 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.7 18.26 9.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.694 0.283 . . . . 0.0 111.334 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.01 73.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.546 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.05 155.52 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.511 HG21 ' NZ ' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -120.97 161.05 22.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.96 157.42 11.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.149 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -103.42 114.15 28.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.99 158.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.64 127.67 42.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 172' ' ' VAL . 21.3 t -103.09 145.36 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.863 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.58 150.25 24.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 172' ' ' VAL . 22.0 t -71.11 118.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.911 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -55.1 92.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.326 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 57.56 83.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.679 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.0 -157.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.506 2.137 . . . . 0.0 111.997 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -78.4 113.64 16.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.725 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.411 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 1.4 t -62.13 -52.1 69.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 199' ' ' SER . 79.8 Cg_exo -44.63 -29.01 3.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.633 2.222 . . . . 0.0 112.658 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.5 m -100.34 115.31 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.17 168.24 2.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.28 102.29 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.566 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 31.44 3.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 110.815 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -161.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.806 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 72.35 74.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.8 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.3 40.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -98.19 149.5 22.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 79.8 p -177.65 38.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -159.86 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.687 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 m 76.97 149.26 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.849 0.357 . . . . 0.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -110.65 114.92 28.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.12 112.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -169.23 150.72 4.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.805 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 21.1 t 60.72 31.59 20.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tp -102.09 -161.12 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.826 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 74.64 -67.88 0.24 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.0 m80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.919 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.57 142.58 94.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.654 0.264 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.1 -168.31 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.561 2.174 . . . . 0.0 112.474 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -98.95 136.23 39.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.804 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.41 -141.57 12.95 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.57 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 29.85 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.985 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -85.8 79.06 9.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.71 -178.67 33.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.73 174.94 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.587 2.191 . . . . 0.0 112.303 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.44 148.74 10.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.678 2.252 . . . . 0.0 112.374 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.9 p -70.53 -169.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -141.89 -44.05 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.983 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 70.55 -64.51 0.37 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER 65.83 -167.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' SER . 2.9 mt-10 72.95 -1.97 2.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.966 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.86 146.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.095 0.474 . . . . 0.0 111.27 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.407 ' NH1' ' CG1' ' A' ' 159' ' ' VAL . 52.7 ttp85 -144.25 147.68 33.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 194' ' ' VAL . 18.6 m -132.77 165.06 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.95 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 158' ' ' GLY . 5.9 t -119.77 150.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.145 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.55 HG22 HG13 ' A' ' 192' ' ' VAL . 6.6 t -132.89 121.41 44.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.002 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.638 ' HB2' HG22 ' A' ' 157' ' ' THR . 10.7 t -114.75 158.75 21.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 90.41 46.72 3.98 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.93 167.31 34.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.83 170.11 19.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.717 2.278 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.72 -25.98 45.99 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -134.6 82.68 1.98 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.71 -165.32 10.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.485 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.6 t -171.82 176.67 3.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.647 ' HB3' HG23 ' A' ' 152' ' ' VAL . 41.5 p-90 -73.35 -33.94 65.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.735 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.453 ' HG2' ' CH2' ' A' ' 134' ' ' TRP . 19.4 mt-30 -58.78 -43.23 90.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.789 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.06 -32.3 56.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.448 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 37.3 tp -59.89 -38.17 81.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -43.03 63.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.38 -26.8 68.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.393 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -88.28 -39.91 14.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.747 ' CE ' HG11 ' A' ' 160' ' ' VAL . 2.1 ppp? -80.16 -5.71 56.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.392 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -53.1 -22.62 6.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -31.15 11.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.071 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.512 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -68.43 -28.7 67.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.41 -159.1 25.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -58.91 117.17 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.5 126.11 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 9.0 t -66.93 -63.81 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.727 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 161' ' ' GLU . 7.1 p90 -171.61 150.34 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.01 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.88 4.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.22 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 159' ' ' VAL . 8.3 t0 -163.38 153.69 15.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 134' ' ' TRP . 45.9 t -130.97 122.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.012 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -120.04 139.64 52.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 76.1 0.62 3.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.726 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.93 11.84 8.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.11 -53.05 0.14 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.56 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 126' ' ' SER . 22.7 p -98.96 159.94 14.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -144.73 179.54 21.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.608 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 151' ' ' ASP . 22.9 m -137.43 154.44 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.736 0.303 . . . . 0.0 110.991 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' CE ' ' A' ' 141' ' ' MET . 4.7 t -142.6 126.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.179 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 149' ' ' TYR . 2.5 mt-10 -111.99 130.04 55.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.727 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 162' ' ' PHE . 0.7 OUTLIER -109.51 137.62 47.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.971 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.62 -28.85 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -129.3 142.39 50.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -59.04 -27.49 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.205 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -54.98 -46.33 75.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.099 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -71.27 -32.56 68.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.442 ' HE2' ' OG1' ' A' ' 169' ' ' THR . 5.2 ttp -61.49 -66.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.576 HG22 ' HD2' ' A' ' 173' ' ' ARG . 96.4 m -54.84 -35.76 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 15.7 t80 -61.57 -47.93 83.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.06 74.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 176' ' ' ASP . 11.8 m -65.61 -22.84 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -80.5 -72.64 0.4 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.122 0.487 . . . . 0.0 110.453 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -54.67 12.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.962 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 144' ' ' ALA . 7.3 mt -79.92 76.64 6.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.802 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 172' ' ' VAL . 20.6 p-10 -141.38 134.51 29.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.71 25.84 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.16 -174.33 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 145.19 38.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 29.8 t80 -93.16 158.61 15.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 180' ' ' PHE . 1.3 tmt_? -125.85 107.17 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.71 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 p -75.74 151.14 37.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -54.67 -23.06 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.44 -19.5 61.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.174 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.12 -6.2 36.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.81 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -81.95 159.62 23.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.747 0.308 . . . . 0.0 110.838 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.7 161.0 29.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.118 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.09 16.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.03 115.66 15.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.7 pt -114.54 161.7 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.184 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.11 113.09 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 125' ' ' VAL . 4.3 t -91.0 159.08 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.415 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.7 OUTLIER -176.03 144.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 111.143 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.828 ' HA ' HG12 ' A' ' 123' ' ' VAL . 21.4 t -59.85 134.69 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -46.77 159.57 0.1 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.272 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.67 -102.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.91 169.69 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.544 2.163 . . . . 0.0 112.469 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 171.59 7.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.414 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER -92.44 -53.0 0.27 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 199' ' ' SER . 30.2 Cg_exo -61.68 92.95 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.443 2.095 . . . . 0.0 112.024 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -116.41 166.54 11.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.5 -65.6 0.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.201 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.81 -92.64 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.814 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 117.5 29.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.39 -78.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -176.06 -42.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -115.05 -169.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 -47.0 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.9 p -151.3 174.9 12.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.51 -2.5 58.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.368 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.3 p 59.59 109.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 42.9 mmm-85 -79.76 76.46 6.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -170.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -103.17 122.43 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.3 m 60.45 173.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.1 tp -111.99 54.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 218' ' ' HIS . 15.6 mt-10 -85.94 111.6 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' A' ' 217' ' ' GLU . 27.9 p-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.421 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.4 mtm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.899 0.38 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 108' ' ' PRO . . . -131.63 52.57 9.51 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 107' ' ' ALA . 72.6 Cg_endo -76.39 171.95 17.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.558 2.172 . . . . 0.0 112.354 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.94 155.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.74 69.79 1.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.549 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.65 173.36 10.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.311 . . . . 0.0 110.838 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.82 172.36 6.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -132.4 149.98 19.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.517 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.09 111.07 3.09 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.06 -173.89 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.493 2.129 . . . . 0.0 112.058 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -167.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.724 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 3.7 ttm-85 -158.89 -38.1 0.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.989 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER 178.07 146.82 0.14 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.045 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 118' ' ' ARG . 62.5 p -106.33 150.64 25.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.542 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -143.59 41.09 1.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.246 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -130.2 44.79 2.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.901 0.381 . . . . 0.0 110.669 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -109.18 168.33 9.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.098 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.22 159.88 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.846 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.8 t -106.06 146.33 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 HD21 ' A' ' 128' ' ' LEU . 12.3 p -121.9 150.77 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.829 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.1 OUTLIER -137.15 170.91 15.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.918 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 190' ' ' ILE . . . 63.94 44.31 96.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.46 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 HG13 ' A' ' 125' ' ' VAL . 3.5 mm? -83.92 140.48 40.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.647 0.261 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.95 170.46 20.37 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.538 2.159 . . . . 0.0 112.204 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.04 -26.83 65.83 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.17 . . . . 0.0 112.265 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.0 34.84 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.49 111.6 3.88 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.469 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.57 179.61 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.802 0.334 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.447 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 47.5 p-90 -68.63 -41.72 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.447 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.5 OUTLIER -70.55 -36.06 73.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.78 -57.96 10.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.71 -47.02 88.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.04 -43.76 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.186 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.56 -26.33 65.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.604 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -88.16 -21.14 24.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.695 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.79 ' SD ' HG21 ' A' ' 160' ' ' VAL . 11.0 ptm -112.38 1.62 16.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.84 -17.59 56.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.89 -21.89 4.84 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.9 -26.85 68.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.162 0.506 . . . . 0.0 110.481 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 154.3 -104.47 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.73 107.34 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 110.771 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.704 HG22 ' CD2' ' A' ' 162' ' ' PHE . 96.4 t -79.25 125.19 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 52.2 t -83.27 -52.4 6.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 151' ' ' ASP . 80.3 t80 -140.57 160.01 40.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -159.4 134.98 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' A' ' 149' ' ' TYR . 35.0 t0 -146.52 114.4 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.17 112.11 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.227 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -69.22 155.23 40.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -92.68 37.53 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -114.96 -28.85 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 147.87 -21.49 1.45 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 126' ' ' SER . 12.0 p -129.09 167.01 18.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.584 0.23 . . . . 0.0 111.059 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.475 ' CA ' HG12 ' A' ' 125' ' ' VAL . . . -142.02 -161.43 8.75 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.242 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 158' ' ' GLY . 22.3 m -158.02 144.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.79 HG21 ' SD ' ' A' ' 141' ' ' MET . 59.3 t -141.06 149.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.925 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.41 134.57 48.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.306 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.704 ' CD2' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -121.39 132.71 54.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.157 179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 163' ' ' VAL . 5.2 p -70.08 65.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 111.183 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 7.3 ttm-85 172.82 127.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.144 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.18 -40.4 96.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -58.93 -37.27 76.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.56 -34.77 72.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 7.8 ttp -60.83 -63.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.523 HG23 ' CZ ' ' A' ' 173' ' ' ARG . 70.5 m -61.69 -33.45 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 174' ' ' LYS . 11.6 t80 -63.55 -48.58 76.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.88 82.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 192' ' ' VAL . 26.6 m -64.04 -22.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.27 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.523 ' CZ ' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER -93.34 -75.11 0.51 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.984 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 170' ' ' TYR . 3.9 mmtt -57.17 -49.19 76.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 141' ' ' MET . 29.5 mt -92.64 58.53 3.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.602 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 6.0 t0 -122.86 135.61 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 44.1 t30 54.02 29.76 10.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.87 177.38 8.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 103.56 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -68.93 117.47 10.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.79 105.28 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 144.09 29.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -63.2 -16.28 59.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -21.65 64.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.623 0.249 . . . . 0.0 111.073 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 107.05 31.0 3.99 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.725 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.36 134.66 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 156.57 22.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.9 143.85 2.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -83.62 120.25 25.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 127' ' ' GLY . 40.0 pt -112.67 155.6 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.97 129.21 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.745 HG12 HG12 ' A' ' 172' ' ' VAL . 7.7 t -103.04 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -147.16 145.31 29.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 194' ' ' VAL . 13.6 p -73.07 124.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.073 0.463 . . . . 0.0 110.724 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -42.27 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.722 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 63.77 123.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.289 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.05 -48.27 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.443 2.095 . . . . 0.0 112.534 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 138.28 51.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.968 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.55 146.96 4.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 -175.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.302 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 12.8 p 58.56 -179.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 60.46 80.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 155.14 -77.17 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.59 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.17 148.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 110.953 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.2 p -132.68 -85.56 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 61.74 2.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.875 0.369 . . . . 0.0 111.239 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.6 m -106.54 -168.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.95 159.06 21.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.45 -162.79 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.71 96.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.0 t -171.01 91.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? 60.73 71.71 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 28.0 m -59.63 -58.46 8.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.01 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 69.72 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.969 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.2 p -141.39 110.64 6.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.73 -179.25 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -100.36 -36.65 9.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.895 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.794 0.33 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.87 120.88 45.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.64 -55.04 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.373 2.049 . . . . 0.0 112.331 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.59 170.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.5 -157.18 20.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.589 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.66 -113.36 0.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.01 -0.112 . . . . 0.0 110.755 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 112' ' ' TYR . 11.8 t80 179.86 56.73 0.01 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.846 0.355 . . . . 0.0 111.029 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 114' ' ' PRO . . . -178.1 49.89 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.892 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.442 ' HG2' ' HD3' ' A' ' 115' ' ' PRO . 3.9 Cg_exo -41.0 -51.26 3.85 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.996 2.464 . . . . 0.0 112.728 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HD3' ' HG2' ' A' ' 114' ' ' PRO . 79.8 Cg_exo -47.36 -59.02 1.4 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.462 2.108 . . . . 0.0 112.471 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.69 124.51 17.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -159.98 33.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -128.24 -53.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.02 31.07 19.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.32 30.08 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -152.58 98.62 2.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 161.79 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' A' ' 162' ' ' PHE . 2.9 t -123.86 149.35 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.027 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 195' ' ' ASP . 23.2 t -117.24 144.53 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.03 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.83 146.44 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.077 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -149.22 117.14 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.11 39.67 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.493 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.635 ' HG ' HG22 ' A' ' 190' ' ' ILE . 1.5 mp -99.22 155.12 36.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 188' ' ' ALA . 60.3 Cg_endo -72.5 166.52 29.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.543 2.162 . . . . 0.0 112.397 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.17 -27.53 35.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.3 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.94 36.59 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.805 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 152' ' ' VAL . . . -93.02 123.37 7.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.7 p -94.3 150.99 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 0.0 110.798 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.44 ' CD2' ' N ' ' A' ' 135' ' ' GLN . 30.7 p-90 -74.02 -40.02 63.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 134' ' ' TRP . 0.0 OUTLIER -55.55 -40.58 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.27 -32.55 55.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 68.7 tp -61.63 -42.24 98.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' CG ' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -67.89 -47.45 68.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.97 -26.74 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.032 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 181' ' ' ARG . 39.5 t-80 -86.1 -31.48 21.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.474 ' SD ' HG11 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -93.18 3.61 55.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.451 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -55.56 -20.87 14.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.462 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -49.69 -32.56 13.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 111.003 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 175' ' ' LEU . . . -70.9 -29.42 65.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.756 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 145.75 -172.79 26.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.414 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.22 106.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.02 0.438 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.435 HG11 ' CG ' ' A' ' 138' ' ' LYS . 86.1 t -74.07 125.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.043 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -56.17 4.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -154.03 148.34 25.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -143.6 141.23 30.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.181 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -143.41 141.67 30.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 132' ' ' GLY . 22.5 m -128.29 115.95 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.249 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.85 155.36 21.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 35.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.294 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -114.76 -22.62 9.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.196 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 157' ' ' THR . . . 122.06 31.36 1.1 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.608 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 156' ' ' GLY . 9.7 p -161.26 169.97 21.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.84 175.38 32.16 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.632 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.3 m -142.83 142.05 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.312 . . . . 0.0 111.061 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 141' ' ' MET . 11.4 t -134.55 157.91 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.206 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.423 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -131.68 128.31 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 168' ' ' MET . 68.3 m-85 -108.53 154.52 21.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.856 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -71.04 -68.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.22 162.26 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -50.08 30.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.015 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -32.4 46.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.87 -35.88 72.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.418 ' HA ' ' CD2' ' A' ' 162' ' ' PHE . 5.2 ttp -67.62 -59.76 3.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.321 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 81.8 m -50.58 -35.06 28.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.855 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 49.6 t80 -64.23 -46.95 81.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.733 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . . . -56.44 -43.05 79.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 192' ' ' VAL . 13.0 m -79.92 -34.69 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 170' ' ' TYR . 11.9 ptt85 -79.68 -30.33 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.715 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 170' ' ' TYR . 0.1 OUTLIER -106.98 -57.3 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.207 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 144' ' ' ALA . 9.4 mt -81.24 66.75 6.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -116.89 131.23 57.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.2 m120 57.63 30.37 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.1 p -73.33 -177.67 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.979 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 95.09 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.026 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 137' ' ' LEU . 5.9 t80 -68.95 135.35 50.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.612 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 140' ' ' HIS . 4.0 ttm-85 -116.52 100.91 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.4 t -60.85 161.3 8.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -9.68 58.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.084 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 21.69 6.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.616 0.246 . . . . 0.0 111.341 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 66.98 27.34 73.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.617 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.57 134.6 54.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.27 156.42 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.96 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . . . -162.31 160.31 26.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -98.27 110.97 23.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.53 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.635 HG22 ' HG ' ' A' ' 128' ' ' LEU . 13.7 pt -107.13 136.26 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.463 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.37 109.83 22.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.632 HG12 HG12 ' A' ' 172' ' ' VAL . 5.1 t -87.16 142.01 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.246 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -150.37 157.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.78 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 172' ' ' VAL . 25.3 t -78.01 114.85 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.568 ' HA ' HG23 ' A' ' 124' ' ' VAL . 19.0 t0 -47.68 -65.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.28 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 82.27 -107.32 2.79 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.423 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 198' ' ' ARG . 32.3 Cg_exo -58.42 -151.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.642 2.228 . . . . 0.0 112.057 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 197' ' ' PRO . 15.2 mtp85 81.0 -127.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.4 OUTLIER -33.14 -54.86 0.64 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 202' ' ' TYR . 53.6 Cg_exo -52.14 -58.82 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.365 2.043 . . . . 0.0 112.084 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.5 m 61.77 118.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 200' ' ' PRO . 5.9 m-85 -128.73 27.84 5.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.44 -171.48 18.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.69 -43.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -53.96 52.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -140.11 66.43 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.774 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.4 t -137.55 70.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 43.27 65.49 0.96 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.507 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.74 146.81 35.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -150.37 56.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.5 p 58.28 -169.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 -166.25 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 49.6 m 61.8 -124.25 0.79 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.599 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -154.86 26.36 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.73 0.3 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.73 -173.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -76.17 126.06 30.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.794 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -123.61 -167.38 1.61 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.977 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 217' ' ' GLU . 46.0 p-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.326 -179.953 . . . . . . . . 1 1 . 1 stop_ save_